KNS-42::Doramapimod
P31-FUJ::Doramapimod
KELLY::Doramapimod
MDA-MB-453::Avagacestat
SK-ES-1::I-BRD9
GCT::VX-11e
MKN7::I-BRD9
H-EMC-SS::ZM447439
CHSA0011::I-BRD9
NCI-H146::ZM447439
P30-OHK::Foretinib
VA-ES-BJ::Doramapimod
NCI-H345::Doramapimod
VMRC-LCD::Sepantronium bromide
Calu-6::AGI-6780
NCI-H211::Telomerase Inhibitor IX
CGTH-W-1::ZM447439
CAL-27::MK-8776
TE-15::ZM447439
ST486::Sepantronium bromide
IGR-1::Afatinib
EW-7::Dabrafenib
GA-10::Telomerase Inhibitor IX
G-402::Cediranib
KP-3::Telomerase Inhibitor IX
GB-1::Doramapimod
HCC-15::Alisertib
TOV-112D::Cediranib
MPP-89::VX-11e
CS1::Sepantronium bromide
SK-N-FI::ZM447439
COLO-205::AZD7762
TUR::Cediranib
NCI-H1105::BX795
OVTOKO::Osimertinib
TE-10::Sepantronium bromide
MEL-JUSO::AGI-6780
CHP-126::Doramapimod
RCC-MF::AGI-6780
SW1990::Doramapimod
U-266::Foretinib
D-423MG::Alisertib
H4::I-BRD9
TE-1::Telomerase Inhibitor IX
EMC-BAC-1::BX795
AMO-1::AZD7762
CESS::Dabrafenib
NCI-H2029::MK-8776
AN3-CA::I-BRD9
LU-165::Dabrafenib
NB14::ZM447439
OVCAR-8::AZD7762
ES6::Motesanib
ECC10::ZM447439
LC-1-sq::Cediranib
RCC-MF::Avagacestat
LC-1-sq::AGI-6780
ES4::Sepantronium bromide
RH-1::AGI-6780
EW-7::AZD7762
TK::Dabrafenib
UACC-893::I-BRD9
HH::ZM447439
CAL-72::Doramapimod
MHH-CALL-4::Foretinib
NCI-H23::XAV939
ASH-3::Motesanib
JHH-6::Motesanib
KYSE-50::I-BRD9
SW1710::Afatinib
TGBC24TKB::Dabrafenib
CA46::Sepantronium bromide
NCI-H2444::Alisertib
RXF393::Cediranib
NCI-H1048::Afatinib
RCC-AB::Sepantronium bromide
451Lu::Afatinib
MDA-MB-157::MK-8776
MOLT-4::Foretinib
A4-Fuk::Alisertib
LU-65::I-BRD9
KYSE-410::Alisertib
D-542MG::AGI-6780
CAKI-1::Dabrafenib
CAL-54::Sepantronium bromide
TUR::Doramapimod
OV-17R::BX795
CAL-62::XAV939
ES1::Afatinib
BB65-RCC::Osimertinib
LU-65::Telomerase Inhibitor IX
A101D::ZM447439
Hs-578-T::XAV939
PCI-15A::Telomerase Inhibitor IX
SK-MEL-31::Dabrafenib
EJM::XAV939
8305C::XAV939
TE-4::MK-8776
JHOS-4::AGI-6780
MCF7::Motesanib
NCI-H596::XAV939
GAMG::Alisertib
BICR31::Motesanib
EC-GI-10::AGI-6780
CS1::Telomerase Inhibitor IX
LB831-BLC::Sepantronium bromide
NCI-H1915::XAV939
NCI-H1693::Foretinib
ChaGo-K-1::I-BRD9
RXF393::Doramapimod
BE2-M17::XAV939
DND-41::MK-8776
NCI-H1755::Osimertinib
SK-MEL-1::Osimertinib
FADU::AGI-6780
TE-12::Telomerase Inhibitor IX
TC-71::XAV939
SUP-B8::ZM447439
OCI-M1::Osimertinib
LN-405::Avagacestat
SHP-77::Avagacestat
SF539::ZM447439
SW756::XAV939
LU-99A::Cediranib
MZ2-MEL::Telomerase Inhibitor IX
KNS-62::AZD7762
CPC-N::Avagacestat
BHT-101::Dabrafenib
NCI-H2085::Telomerase Inhibitor IX
PL-21::Avagacestat
NCI-H1694::AGI-6780
SUP-M2::Motesanib
KG-1::AGI-6780
NCI-H716::Sepantronium bromide
SIMA::Foretinib
KYSE-150::AZD7762
SK-LU-1::AGI-6780
A2058::VX-11e
SNU-449::AZD7762
CHP-212::ZM447439
TT2609-C02::VX-11e
RH-41::AZD7762
NCI-H2023::VX-11e
A388::Foretinib
G-402::Foretinib
EBC-1::XAV939
SCH::AGI-6780
COLO-668::I-BRD9
C3A::MK-8776
NCI-H1299::I-BRD9
NCI-H740::Telomerase Inhibitor IX
JHOS-4::MK-8776
MN-60::AZD7762
Hey::Dabrafenib
LOU-NH91::ZM447439
QGP-1::AZD7762
NCI-H647::AGI-6780
HH::Telomerase Inhibitor IX
SK-MM-2::Motesanib
SK-MG-1::VX-11e
JHU-029::XAV939
TE-1::Osimertinib
K-562::Alisertib
D-283MED::AZD7762
SW156::I-BRD9
LN-18::Osimertinib
NCI-H2052::Doramapimod
MDA-MB-436::Dabrafenib
HCT-15::I-BRD9
Hs-578-T::Osimertinib
NCI-H1048::Sepantronium bromide
Daudi::Alisertib
LS-1034::Foretinib
JHH-1::Sepantronium bromide
HT55::Alisertib
EN::XAV939
PANC-02-03::I-BRD9
SNU-423::Telomerase Inhibitor IX
CHP-212::Alisertib
ALL-PO::Motesanib
NB6::XAV939
GOTO::AZD7762
COLO-792::AZD7762
TC-71::VX-11e
Mo-T::Sepantronium bromide
BE-13::Dabrafenib
ECC10::XAV939
EFO-21::ZM447439
JJN-3::Cediranib
SiHa::VX-11e
EW-22::ZM447439
BALL-1::Sepantronium bromide
HSC-3::Alisertib
ATN-1::Afatinib
NCI-H2342::Telomerase Inhibitor IX
CP50-MEL-B::XAV939
NCI-H520::Cediranib
HT-29::Avagacestat
NB13::Dabrafenib
LCLC-97TM1::Alisertib
BFTC-905::Avagacestat
MS-1::ZM447439
IST-SL2::Osimertinib
STS-0421::ZM447439
JVM-2::Motesanib
G-MEL::MK-8776
BEN::Alisertib
RKO::Avagacestat
COLO-320-HSR::Afatinib
HDQ-P1::Cediranib
A204::Osimertinib
TT::VX-11e
MM1S::AZD7762
SW13::Cediranib
NCI-H1781::Doramapimod
MIA-PaCa-2::Avagacestat
NCI-H2023::Alisertib
MEG-01::Motesanib
JJN-3::Motesanib
SU-DHL-5::XAV939
WSU-NHL::VX-11e
NOS-1::ZM447439
LB996-RCC::Afatinib
SK-MEL-24::Sepantronium bromide
ALL-PO::Osimertinib
MV-4-11::Foretinib
UWB1.289::MK-8776
SU-DHL-1::I-BRD9
CTV-1::Cediranib
COLO-684::Afatinib
RCC-JW::Telomerase Inhibitor IX
SK-N-AS::Foretinib
TT2609-C02::Alisertib
SiHa::I-BRD9
HCC1954::Osimertinib
NB17::VX-11e
KYSE-410::Avagacestat
AN3-CA::AGI-6780
RCC10RGB::Doramapimod
VMRC-RCZ::Foretinib
NCI-H1944::XAV939
BT-474::Telomerase Inhibitor IX
NCI-H1703::Doramapimod
KNS-62::VX-11e
NCI-H1573::Motesanib
KURAMOCHI::Motesanib
LU-65::Motesanib
RXF393::I-BRD9
NCI-H2023::Sepantronium bromide
U031::ZM447439
MEL-HO::XAV939
OCUB-M::MK-8776
Caov-4::Sepantronium bromide
JHH-1::VX-11e
CAL-12T::AZD7762
OCI-AML3::VX-11e
OACp4C::Doramapimod
SCC-4::Cediranib
CP50-MEL-B::Motesanib
TGW::Alisertib
EPLC-272H::Telomerase Inhibitor IX
CAL-72::Foretinib
P30-OHK::AZD7762
SW948::MK-8776
JSC-1::Sepantronium bromide
TE-10::AGI-6780
MLMA::Avagacestat
SK-ES-1::Telomerase Inhibitor IX
HEC-1::Motesanib
HPAC::Dabrafenib
HuO9::Motesanib
RO82-W-1::Dabrafenib
JSC-1::Doramapimod
CAL-120::MK-8776
MDA-MB-453::XAV939
NCI-H82::Motesanib
HAL-01::VX-11e
SNG-M::Foretinib
TE-12::AZD7762
OAW-28::Dabrafenib
IMR-5::Osimertinib
KM-H2::VX-11e
BEN::Telomerase Inhibitor IX
UACC-62::Avagacestat
U251::AZD7762
EW-7::Telomerase Inhibitor IX
LCLC-103H::Afatinib
NCI-H838::Motesanib
KMRC-20::MK-8776
HCC1806::Dabrafenib
KATOIII::XAV939
LS-1034::VX-11e
SU-DHL-5::VX-11e
HMV-II::XAV939
BT-474::Alisertib
RPMI-6666::Telomerase Inhibitor IX
OACM5-1::Sepantronium bromide
JHH-7::Motesanib
SNU-387::Alisertib
KP-3::ZM447439
SBC-5::Motesanib
Hs-445::Motesanib
NCI-H526::Dabrafenib
D-502MG::MK-8776
NY::Cediranib
DOV13::Cediranib
SW156::BX795
EMC-BAC-1::Alisertib
G-401::XAV939
NCI-H1573::MK-8776
GI-ME-N::Avagacestat
NCI-H2342::Cediranib
NCI-H1770::Afatinib
A388::Cediranib
ME-180::Motesanib
NCI-H3122::Alisertib
RC-K8::Afatinib
HuP-T4::AGI-6780
MSTO-211H::Alisertib
GOTO::Avagacestat
NB10::VX-11e
JHOS-2::Foretinib
OVK-18::Osimertinib
NOS-1::Doramapimod
NCI-H2291::MK-8776
NCI-H250::BX795
U-698-M::MK-8776
NB13::Cediranib
RCC-FG2::XAV939
IST-MES1::Doramapimod
L-428::VX-11e
P12-ICHIKAWA::AGI-6780
LAMA-84::Doramapimod
SBC-1::MK-8776
NCI-H2347::Avagacestat
MRK-nu-1::VX-11e
NCI-H1581::Avagacestat
CS1::Dabrafenib
ST486::Foretinib
no-11::MK-8776
OCI-LY7::AZD7762
IM-95::Telomerase Inhibitor IX
SAS::Cediranib
CML-T1::MK-8776
HuO9::I-BRD9
SK-HEP-1::Sepantronium bromide
GCT::Motesanib
SK-MM-2::ZM447439
NCI-H69::Telomerase Inhibitor IX
AU565::Dabrafenib
JHH-2::Doramapimod
HCC2218::Dabrafenib
COR-L321::Foretinib
JHU-022::Motesanib
BT-549::VX-11e
SNU-387::ZM447439
L-363::VX-11e
HCC1395::Foretinib
MHH-PREB-1::Dabrafenib
EW-7::Motesanib
23132-87::ZM447439
HSC-4::I-BRD9
NCI-H2135::VX-11e
SK-MEL-1::Cediranib
NCI-H209::Cediranib
LoVo::Doramapimod
647-V::Sepantronium bromide
SISO::Foretinib
GB-1::XAV939
LS-123::Sepantronium bromide
PA-1::Alisertib
YH-13::Doramapimod
K2::MK-8776
NALM-6::AZD7762
MOG-G-UVW::I-BRD9
M059J::Sepantronium bromide
NCI-H1963::Avagacestat
NCC010::I-BRD9
DND-41::Sepantronium bromide
RT4::Avagacestat
HCC1599::Foretinib
NCI-H196::Avagacestat
SW962::Avagacestat
SIG-M5::Sepantronium bromide
MG-63::AZD7762
NCI-H2405::MK-8776
ALL-SIL::VX-11e
NCI-H661::Foretinib
DU-145::Foretinib
HMV-II::I-BRD9
RERF-LC-Sq1::VX-11e
ES1::VX-11e
C-33-A::Dabrafenib
A172::Alisertib
NCI-H2452::Motesanib
NCI-H2227::MK-8776
NCI-H1355::I-BRD9
RCC-JF::Osimertinib
CAMA-1::XAV939
LC-1-sq::XAV939
PANC-03-27::Alisertib
PA-TU-8902::Osimertinib
NCI-H1869::Telomerase Inhibitor IX
DMS-53::VX-11e
H4::VX-11e
KM-H2::AGI-6780
MOG-G-CCM::Telomerase Inhibitor IX
NCI-H2087::Motesanib
ALL-PO::Telomerase Inhibitor IX
NCI-H1781::I-BRD9
CP66-MEL::Dabrafenib
SW1417::Cediranib
MDA-MB-415::ZM447439
A427::AGI-6780
CAL-62::Sepantronium bromide
HuH-7::AGI-6780
FTC-133::Afatinib
LP-1::Dabrafenib
NB69::Cediranib
MEL-HO::Afatinib
FLO-1::Dabrafenib
D-392MG::AGI-6780
EW-24::Osimertinib
GI-1::ZM447439
EBC-1::Foretinib
SAS::Dabrafenib
BICR10::Foretinib
EW-18::Telomerase Inhibitor IX
EJM::Avagacestat
WM278::Telomerase Inhibitor IX
SUP-M2::I-BRD9
CHSA8926::Cediranib
RERF-LC-MS::Avagacestat
NCI-H520::Foretinib
ES8::AGI-6780
HLE::Alisertib
L-540::Avagacestat
OV-7::Telomerase Inhibitor IX
MS751::Avagacestat
SHP-77::XAV939
HSC-2::Doramapimod
NY::Sepantronium bromide
NCI-H1092::Osimertinib
PEO1::Alisertib
SCC90::AZD7762
BB49-HNC::AZD7762
CAL-51::Alisertib
STS-0421::Foretinib
no-11::Dabrafenib
LCLC-103H::Foretinib
COLO-678::Doramapimod
HSC-3::AZD7762
LB1047-RCC::XAV939
KURAMOCHI::Telomerase Inhibitor IX
ST486::Cediranib
HCE-4::Afatinib
697::Alisertib
NCI-H358::Doramapimod
SCC-9::MK-8776
KYSE-140::Cediranib
NCI-H1876::I-BRD9
8305C::Afatinib
CAL-85-1::Sepantronium bromide
TOV-21G::Avagacestat
JM1::AZD7762
PCI-6A::AZD7762
A2780::Cediranib
SCC90::ZM447439
SNG-M::Afatinib
OVCAR-3::Dabrafenib
MOLP-8::ZM447439
RERF-LC-KJ::Dabrafenib
CAS-1::XAV939
D-247MG::Dabrafenib
ACHN::Sepantronium bromide
MDA-MB-453::MK-8776
COR-L105::AZD7762
HCC1937::Cediranib
HuO-3N1::Foretinib
TYK-nu::Sepantronium bromide
NCI-H226::Foretinib
BC-1::I-BRD9
LU-134-A::Dabrafenib
KELLY::Telomerase Inhibitor IX
MHH-PREB-1::Motesanib
LCLC-97TM1::Avagacestat
RMG-I::Telomerase Inhibitor IX
KU-19-19::Motesanib
NCI-H810::ZM447439
RCC-MF::Motesanib
NCI-H1105::Cediranib
NCI-H1666::Motesanib
451Lu::Alisertib
CCRF-CEM::Osimertinib
CAL-29::ZM447439
Ca9-22::AZD7762
HSC-2::MK-8776
TGBC24TKB::Doramapimod
23132-87::Foretinib
MOLT-16::Alisertib
DOHH-2::Cediranib
DBTRG-05MG::Afatinib
LS-513::AGI-6780
HT-3::Dabrafenib
OVCAR-4::Alisertib
CADO-ES1::Alisertib
CHP-212::VX-11e
OV-90::I-BRD9
EB-3::Dabrafenib
RKO::AZD7762
CHL-1::Alisertib
SNU-61::Telomerase Inhibitor IX
HL-60::Doramapimod
SNU-407::Motesanib
NCI-H1623::Avagacestat
LB831-BLC::Afatinib
L-540::XAV939
HCC1428::Avagacestat
NCI-H1623::ZM447439
EFM-192A::Dabrafenib
HCC-827::MK-8776
HCC-44::Telomerase Inhibitor IX
A388::Afatinib
SCC-15::Alisertib
RO82-W-1::ZM447439
NCI-H292::Cediranib
RPMI-7951::MK-8776
EFO-21::VX-11e
KYM-1::I-BRD9
AsPC-1::AZD7762
HCC1419::MK-8776
NB7::VX-11e
COLO-792::VX-11e
HCC-827::Sepantronium bromide
RO82-W-1::Osimertinib
CHP-126::BX795
ME-180::ZM447439
TE-10::BX795
RCC-AB::AGI-6780
UACC-62::Osimertinib
NB5::Sepantronium bromide
NUGC-3::Doramapimod
LN-405::XAV939
BT-474::MK-8776
HPAF-II::XAV939
HEC-1::VX-11e
LOXIMVI::Sepantronium bromide
NY::VX-11e
OVISE::AZD7762
WM35::AGI-6780
HCE-4::I-BRD9
CESS::Afatinib
SW948::Motesanib
SK-LU-1::Cediranib
COR-L303::Cediranib
MM1S::Sepantronium bromide
OVK-18::AZD7762
TE-12::Foretinib
NCI-H196::AZD7762
IST-MES1::Sepantronium bromide
MKN28::Doramapimod
SUP-T1::VX-11e
Caov-4::VX-11e
NCI-H748::Motesanib
NCI-H23::Osimertinib
SK-N-FI::Doramapimod
SK-MEL-3::VX-11e
NCI-H2135::Sepantronium bromide
CML-T1::Alisertib
JHU-022::Dabrafenib
CRO-AP2::BX795
Daoy::VX-11e
MZ1-PC::Telomerase Inhibitor IX
P31-FUJ::Osimertinib
HEC-1::Alisertib
GB-1::Sepantronium bromide
IA-LM::XAV939
NCI-H2196::Telomerase Inhibitor IX
COLO-792::Sepantronium bromide
JHOS-3::AZD7762
BICR22::XAV939
EFM-192A::Telomerase Inhibitor IX
COR-L105::Cediranib
K2::AGI-6780
OAW-28::Alisertib
HA7-RCC::ZM447439
NCI-H2228::MK-8776
NCI-H647::Alisertib
MZ2-MEL::Osimertinib
EW-7::Doramapimod
LoVo::VX-11e
Ca9-22::VX-11e
H4::Cediranib
NCI-H841::Telomerase Inhibitor IX
SNU-449::Telomerase Inhibitor IX
MM1S::ZM447439
CHSA8926::Osimertinib
Daudi::Dabrafenib
MOLT-13::Alisertib
BONNA-12::VX-11e
SW1783::Cediranib
KYSE-220::Motesanib
NOS-1::Avagacestat
NCI-H1915::I-BRD9
Ca-Ski::XAV939
NCI-H446::XAV939
VMRC-RCZ::Afatinib
TE-4::Sepantronium bromide
KARPAS-620::VX-11e
MFE-280::Avagacestat
NH-12::Motesanib
H9::Alisertib
GOTO::I-BRD9
GCIY::Alisertib
SW1116::Afatinib
NCI-H2141::Motesanib
NCI-H1993::AGI-6780
THP-1::Afatinib
647-V::Motesanib
NEC8::I-BRD9
KOSC-2::Alisertib
NCI-H835::Doramapimod
ML-2::AZD7762
HCC2998::Osimertinib
GAMG::Dabrafenib
MEL-HO::Motesanib
SK-MEL-2::AGI-6780
SK-MEL-31::Telomerase Inhibitor IX
Daudi::MK-8776
LU-134-A::Motesanib
TGBC24TKB::Alisertib
NCI-H522::XAV939
RT4::Osimertinib
MSTO-211H::I-BRD9
YH-13::I-BRD9
CGTH-W-1::AZD7762
5637::AZD7762
SNU-283::Motesanib
NCC021::Cediranib
KARPAS-231::AZD7762
OVCAR-3::AGI-6780
NCI-H2228::Alisertib
HC-1::XAV939
GB-1::Alisertib
CAS-1::Cediranib
MS-1::XAV939
ECC12::BX795
A427::Cediranib
OCUM-1::Doramapimod
BT-474::Avagacestat
HT-3::Osimertinib
NCI-H1688::MK-8776
A431::XAV939
SK-MEL-1::Telomerase Inhibitor IX
JHOS-3::AGI-6780
SW684::Telomerase Inhibitor IX
MFE-296::Telomerase Inhibitor IX
NCI-H1435::VX-11e
JVM-2::AGI-6780
DJM-1::Afatinib
KURAMOCHI::MK-8776
LCLC-103H::Doramapimod
D-423MG::Dabrafenib
EBC-1::Motesanib
K5::Telomerase Inhibitor IX
GCIY::VX-11e
RL::MK-8776
BT-549::Foretinib
SK-LU-1::MK-8776
LOXIMVI::Doramapimod
SF295::Dabrafenib
BICR78::Sepantronium bromide
SW1710::AZD7762
THP-1::Avagacestat
Ramos-2G6-4C10::Telomerase Inhibitor IX
LS-1034::Sepantronium bromide
HPAC::Afatinib
H4::XAV939
CCRF-CEM::ZM447439
RCC-MF::ZM447439
LCLC-97TM1::Foretinib
WM35::Doramapimod
QGP-1::Sepantronium bromide
DEL::Motesanib
NCI-H2009::Motesanib
P30-OHK::ZM447439
HCC1569::Motesanib
NCI-H526::I-BRD9
CAL-62::Alisertib
HAL-01::Avagacestat
Daudi::I-BRD9
NALM-6::XAV939
NCI-H520::Doramapimod
LNZTA3WT4::Afatinib
SCC-25::Motesanib
LAMA-84::Alisertib
786-0::MK-8776
AM-38::Motesanib
PC-14::Osimertinib
BHY::I-BRD9
COR-L303::AGI-6780
HuH-7::Sepantronium bromide
DMS-53::AGI-6780
CL-11::XAV939
LC-1-sq::Afatinib
EC-GI-10::Avagacestat
MDA-MB-453::Alisertib
P30-OHK::I-BRD9
SK-ES-1::XAV939
COR-L88::Motesanib
DMS-53::Doramapimod
OVCAR-8::VX-11e
HCC-366::Dabrafenib
IMR-5::Doramapimod
ME-1::AZD7762
LK-2::Alisertib
HCC70::Osimertinib
COR-L23::XAV939
HCC-44::Doramapimod
CHSA0108::MK-8776
647-V::ZM447439
BFTC-905::Alisertib
Hey::Osimertinib
NCI-H250::Sepantronium bromide
SIG-M5::Foretinib
LP-1::Motesanib
SK-MEL-28::BX795
SW1573::Doramapimod
RL95-2::AGI-6780
COR-L88::Avagacestat
HCC-44::I-BRD9
L-428::Doramapimod
SK-MEL-5::ZM447439
HT-115::Dabrafenib
DB::Cediranib
KALS-1::AGI-6780
SN12C::MK-8776
NCI-H209::Afatinib
EW-12::Afatinib
SF295::I-BRD9
KYSE-180::Dabrafenib
RO82-W-1::XAV939
EW-18::Motesanib
EW-18::ZM447439
NCI-H2228::Osimertinib
OE21::Sepantronium bromide
ALL-PO::I-BRD9
MHH-CALL-2::Sepantronium bromide
LC-2-ad::BX795
LN-405::AZD7762
8305C::Telomerase Inhibitor IX
ALL-SIL::Avagacestat
A704::AZD7762
NCI-H1573::Foretinib
KG-1::Telomerase Inhibitor IX
OVCA420::Osimertinib
MS-1::Sepantronium bromide
LC-1-sq::AZD7762
HCC1806::Motesanib
OVCAR-8::Telomerase Inhibitor IX
22RV1::VX-11e
TK10::I-BRD9
OV-56::AGI-6780
KON::Afatinib
BICR22::Doramapimod
HCT-116::I-BRD9
NCI-H1666::Afatinib
SK-GT-4::Doramapimod
KLE::Osimertinib
JVM-3::Alisertib
PCI-30::I-BRD9
Farage::BX795
NCI-H2405::Afatinib
LU-99A::Sepantronium bromide
FU-OV-1::Motesanib
SW156::Sepantronium bromide
NCC021::Telomerase Inhibitor IX
HCC1187::Osimertinib
U-87-MG::MK-8776
SU-DHL-4::AGI-6780
WM-115::Avagacestat
KATOIII::Dabrafenib
KCL-22::Telomerase Inhibitor IX
RPMI-7951::XAV939
JHOS-3::I-BRD9
ECC10::I-BRD9
MDA-MB-453::ZM447439
HTC-C3::Alisertib
CHL-1::AZD7762
NCI-H1703::Avagacestat
MONO-MAC-6::AZD7762
SW48::AGI-6780
HCC2157::ZM447439
A172::Telomerase Inhibitor IX
CAPAN-1::Dabrafenib
Caov-4::I-BRD9
SW620::AZD7762
ASH-3::AGI-6780
SNU-1040::Afatinib
SK-MG-1::Telomerase Inhibitor IX
SNU-283::Avagacestat
MOG-G-UVW::Motesanib
SK-N-AS::XAV939
8-MG-BA::Osimertinib
RERF-GC-1B::VX-11e
KYSE-50::AGI-6780
NCI-H510A::Foretinib
OVCAR-3::Afatinib
ATN-1::Osimertinib
CCK-81::Alisertib
KU812::Foretinib
RCM-1::AGI-6780
ES7::Alisertib
CAL-27::Doramapimod
MDA-MB-231::Afatinib
HuCCT1::Doramapimod
TE-12::Alisertib
Hey::AGI-6780
KARPAS-1106P::Sepantronium bromide
SR::Sepantronium bromide
DK-MG::Alisertib
697::Telomerase Inhibitor IX
COR-L303::Doramapimod
CA46::Doramapimod
ES8::I-BRD9
CHSA0011::Cediranib
ETK-1::MK-8776
CAMA-1::AGI-6780
SK-UT-1::Dabrafenib
WM793B::Foretinib
BB65-RCC::Doramapimod
SK-OV-3::Cediranib
TE-5::Alisertib
WM1552C::Afatinib
HMV-II::AGI-6780
KU-19-19::MK-8776
EW-16::Sepantronium bromide
NCCIT::Osimertinib
NCI-H2196::XAV939
SK-N-FI::Avagacestat
SW1088::Osimertinib
SW13::MK-8776
CESS::Telomerase Inhibitor IX
HT-1376::AZD7762
KYSE-270::Cediranib
C3A::AGI-6780
SF268::AGI-6780
EW-16::Afatinib
EN::ZM447439
NCI-H2029::Foretinib
CAL-27::Dabrafenib
NCI-H2066::VX-11e
OVCA420::Sepantronium bromide
SK-PN-DW::Telomerase Inhibitor IX
TGBC11TKB::MK-8776
HT-1376::Osimertinib
IA-LM::Doramapimod
SJRH30::Cediranib
BICR10::AGI-6780
SK-UT-1::VX-11e
KASUMI-1::Avagacestat
OVISE::Motesanib
OVCAR-3::Avagacestat
RCC-JF::Sepantronium bromide
COLO-679::Sepantronium bromide
OVCAR-5::Motesanib
TE-11::VX-11e
NCI-H2452::Afatinib
KYM-1::ZM447439
HCC-827::VX-11e
SK-MEL-1::Motesanib
EW-3::ZM447439
P12-ICHIKAWA::AZD7762
ES7::AGI-6780
NCI-H1299::Foretinib
ESO51::AGI-6780
MM1S::Osimertinib
SH-4::Dabrafenib
L-428::Motesanib
NB7::AGI-6780
NCI-H660::Osimertinib
NCI-H23::Foretinib
TUR::XAV939
SW1271::Sepantronium bromide
KARPAS-45::Sepantronium bromide
IST-MEL1::Sepantronium bromide
GAK::Afatinib
DOHH-2::Dabrafenib
BHT-101::I-BRD9
IST-MES1::Osimertinib
JHU-011::I-BRD9
TUR::AGI-6780
KYSE-510::Sepantronium bromide
BxPC-3::Osimertinib
MES-SA::Sepantronium bromide
BE2-M17::ZM447439
SNU-1040::XAV939
U031::Alisertib
EFM-19::Dabrafenib
KY821::Dabrafenib
NCI-H647::AZD7762
KASUMI-1::BX795
NCI-H510A::Alisertib
SK-HEP-1::Avagacestat
SNU-449::Foretinib
YAPC::AZD7762
KP-1N::Avagacestat
EW-13::AZD7762
Caov-4::Doramapimod
IGR-37::Cediranib
JAR::Doramapimod
COR-L321::I-BRD9
HuO-3N1::Afatinib
NCI-H1341::Motesanib
YKG-1::VX-11e
ARH-77::AGI-6780
IPC-298::Cediranib
HCC-44::Foretinib
EBC-1::Dabrafenib
SK-LU-1::VX-11e
JURL-MK1::Avagacestat
PFSK-1::I-BRD9
KOPN-8::Alisertib
U-118-MG::Osimertinib
LNCaP-Clone-FGC::Cediranib
COLO-829::Cediranib
MSTO-211H::VX-11e
BL-41::Dabrafenib
LB771-HNC::XAV939
SK-MEL-3::Avagacestat
EFO-27::Afatinib
COR-L321::MK-8776
LCLC-103H::Cediranib
SKN-3::Telomerase Inhibitor IX
COR-L105::Doramapimod
U251::Cediranib
QIMR-WIL::Dabrafenib
MDA-MB-415::Dabrafenib
LC-1-sq::ZM447439
GP5d::Afatinib
MDA-MB-361::AZD7762
RERF-GC-1B::AZD7762
LB373-MEL-D::XAV939
RCM-1::Alisertib
HT-1197::Foretinib
RT-112::Osimertinib
MFH-ino::Afatinib
NALM-6::Telomerase Inhibitor IX
SU-DHL-4::Cediranib
SN12C::Doramapimod
SNU-C2B::Osimertinib
COR-L321::ZM447439
8-MG-BA::AGI-6780
L-428::AGI-6780
HCC-15::AZD7762
451Lu::AZD7762
LU-139::ZM447439
NCI-H211::Alisertib
A172::Foretinib
HL-60::MK-8776
HCC2218::Afatinib
NCI-H446::Doramapimod
WSU-DLCL2::Osimertinib
HSC-39::Doramapimod
SK-MEL-1::MK-8776
OCUM-1::XAV939
HC-1::Cediranib
KYSE-220::AGI-6780
COR-L321::Avagacestat
NCI-H2405::Sepantronium bromide
HT-144::XAV939
ASH-3::XAV939
D-283MED::MK-8776
BT-549::I-BRD9
TE-8::Foretinib
NCI-H727::Afatinib
NCI-H1299::Dabrafenib
NCI-H2030::Motesanib
NCI-H838::Doramapimod
ASH-3::Dabrafenib
JHOS-4::Alisertib
HGC-27::MK-8776
no-10::XAV939
CAL-12T::MK-8776
DSH1::AZD7762
HT-1376::VX-11e
RCC10RGB::ZM447439
MOLP-8::AZD7762
HCT-15::Doramapimod
PA-1::Sepantronium bromide
JHH-4::Telomerase Inhibitor IX
RPMI-8402::Dabrafenib
KARPAS-231::MK-8776
ES6::Osimertinib
RERF-GC-1B::I-BRD9
COLO-205::Afatinib
KCL-22::VX-11e
EW-7::Alisertib
MKN45::AZD7762
COR-L23::Avagacestat
NCI-H2291::BX795
NB69::Alisertib
HCC2998::Dabrafenib
EC-GI-10::AZD7762
SNU-387::Telomerase Inhibitor IX
HCC1569::Sepantronium bromide
NCI-H1963::Motesanib
KS-1::Afatinib
no-11::BX795
Becker::ZM447439
RERF-LC-Sq1::XAV939
IST-SL2::Avagacestat
SBC-5::Avagacestat
EC-GI-10::Doramapimod
CW-2::VX-11e
OVCAR-3::Telomerase Inhibitor IX
TGBC24TKB::MK-8776
FADU::ZM447439
NCI-H322M::ZM447439
NUGC-4::ZM447439
RPMI-8866::Avagacestat
MRK-nu-1::MK-8776
BxPC-3::Afatinib
ChaGo-K-1::Sepantronium bromide
HCC-78::Osimertinib
OVKATE::Doramapimod
VMRC-LCD::Telomerase Inhibitor IX
PA-1::Cediranib
OE19::Doramapimod
CAL-120::AZD7762
NCI-H2087::Telomerase Inhibitor IX
MOLP-8::Avagacestat
MSTO-211H::Doramapimod
COR-L95::Afatinib
KON::Motesanib
A431::Foretinib
CAKI-1::Avagacestat
LB2241-RCC::Motesanib
NCI-H1355::AGI-6780
COR-L279::Dabrafenib
451Lu::Osimertinib
RERF-GC-1B::Osimertinib
OV-17R::Alisertib
WSU-NHL::Afatinib
HCC-15::Sepantronium bromide
CP66-MEL::AZD7762
CTV-1::XAV939
UACC-812::Avagacestat
NCI-H1755::XAV939
SCC-3::Motesanib
JM1::AGI-6780
KNS-42::Motesanib
KYSE-140::Telomerase Inhibitor IX
IMR-5::Alisertib
YH-13::Avagacestat
IGROV-1::Dabrafenib
P31-FUJ::Sepantronium bromide
JHH-1::Foretinib
HSC-2::Foretinib
PWR-1E::AGI-6780
TE-8::Afatinib
HA7-RCC::VX-11e
LNCaP-Clone-FGC::Osimertinib
OVCA420::ZM447439
ASH-3::AZD7762
NCI-H1568::Afatinib
LB831-BLC::VX-11e
CAL-85-1::Avagacestat
HCC-827::Alisertib
PANC-03-27::Cediranib
NCI-H2110::MK-8776
OVCA420::AZD7762
NB6::AZD7762
PANC-02-03::Cediranib
IST-MEL1::VX-11e
PCI-6A::VX-11e
LXF-289::Telomerase Inhibitor IX
TE-9::Cediranib
GAMG::ZM447439
NCI-H1755::AGI-6780
TOV-21G::Sepantronium bromide
SK-LMS-1::Alisertib
KU-19-19::Cediranib
PL-21::VX-11e
SCC-4::Osimertinib
BHT-101::AGI-6780
Detroit562::ZM447439
ETK-1::Osimertinib
ECC12::Sepantronium bromide
OC-314::ZM447439
KP-1N::Dabrafenib
PCI-15A::Foretinib
G-402::Alisertib
FU-OV-1::AZD7762
SNU-C5::Osimertinib
MDA-MB-231::VX-11e
NCI-H28::I-BRD9
NCI-H2085::Foretinib
BT-483::MK-8776
MKN7::Alisertib
HPAC::XAV939
NCI-H748::VX-11e
HuH-7::Motesanib
NCI-H520::MK-8776
WIL2-NS::Osimertinib
KYSE-50::XAV939
CHSA0108::XAV939
NCI-H520::Avagacestat
MFE-319::AZD7762
SK-N-FI::I-BRD9
ALL-SIL::Cediranib
RT-112::Afatinib
KY821::Cediranib
LXF-289::Dabrafenib
BE-13::I-BRD9
GCT::XAV939
CAL-29::MK-8776
DND-41::Afatinib
SNU-81::MK-8776
Detroit562::AZD7762
MZ1-PC::Cediranib
EW-11::VX-11e
LU-165::Foretinib
NCI-H345::AGI-6780
LS-1034::Motesanib
MM1S::AGI-6780
RKN::AZD7762
H3255::Afatinib
MDA-MB-330::Telomerase Inhibitor IX
no-11::Sepantronium bromide
SW1271::ZM447439
MDA-MB-361::VX-11e
SUIT-2::Doramapimod
NCI-H1781::Motesanib
Farage::Osimertinib
NCCIT::Sepantronium bromide
NCI-H2228::AGI-6780
WSU-DLCL2::Telomerase Inhibitor IX
HDQ-P1::I-BRD9
HOS::Osimertinib
CAKI-1::Sepantronium bromide
MZ1-PC::Doramapimod
A431::VX-11e
NOMO-1::ZM447439
A101D::AGI-6780
HA7-RCC::Alisertib
NCI-H522::Foretinib
HCT-116::MK-8776
MHH-NB-11::Dabrafenib
NCI-H209::VX-11e
CL-11::MK-8776
EC-GI-10::Alisertib
451Lu::Avagacestat
M059J::Doramapimod
NCI-H2172::Avagacestat
NCI-H1792::I-BRD9
PF-382::Sepantronium bromide
CAL-12T::Afatinib
MG-63::MK-8776
NCI-H2196::VX-11e
A549::Foretinib
PANC-08-13::Cediranib
CTB-1::VX-11e
KATOIII::Telomerase Inhibitor IX
CHL-1::XAV939
NCI-H358::AZD7762
SJSA-1::Afatinib
LS-411N::Osimertinib
LOU-NH91::Afatinib
SK-ES-1::ZM447439
ONS-76::Avagacestat
HCC70::Foretinib
ES-2::Afatinib
BHT-101::VX-11e
CAL-12T::ZM447439
P31-FUJ::Telomerase Inhibitor IX
SUP-HD1::Dabrafenib
H3255::AZD7762
AsPC-1::Avagacestat
LS-123::Osimertinib
DOK::Avagacestat
OVCAR-3::AZD7762
JHH-6::ZM447439
HCC1599::Osimertinib
SK-GT-4::Motesanib
PC-3::Doramapimod
RERF-LC-KJ::Osimertinib
PCI-30::Osimertinib
SNU-C5::MK-8776
EMC-BAC-2::Motesanib
TK::I-BRD9
HSC-2::ZM447439
TT2609-C02::ZM447439
CW-2::Doramapimod
SUP-B15::I-BRD9
NCI-H358::VX-11e
L-363::Telomerase Inhibitor IX
MOLM-13::Telomerase Inhibitor IX
OVKATE::Avagacestat
IGROV-1::Cediranib
SW1463::Alisertib
NCI-H226::Telomerase Inhibitor IX
SW1573::ZM447439
NCI-H1092::I-BRD9
PL4::AGI-6780
SCC-3::AGI-6780
U031::Sepantronium bromide
MM1S::Foretinib
JEKO-1::Motesanib
COR-L32::Sepantronium bromide
ARH-77::Sepantronium bromide
NCI-H1944::VX-11e
KG-1::Doramapimod
PCI-30::Alisertib
SK-MEL-2::VX-11e
UACC-257::Avagacestat
NCI-H82::Osimertinib
MDA-MB-157::VX-11e
KMS-12-BM::I-BRD9
SNU-C2B::Telomerase Inhibitor IX
HA7-RCC::BX795
RKN::MK-8776
NCI-H2030::VX-11e
EFO-21::Cediranib
OCI-M1::Foretinib
EW-16::ZM447439
MCF7::AZD7762
MKN28::I-BRD9
no-11::AGI-6780
PANC-02-03::Telomerase Inhibitor IX
KMOE-2::AZD7762
WIL2-NS::Afatinib
NCI-H1666::AGI-6780
DMS-53::Sepantronium bromide
SK-MEL-31::Cediranib
IST-MEL1::Alisertib
NCI-H522::Dabrafenib
VAL::I-BRD9
OVCAR-8::Sepantronium bromide
T98G::Doramapimod
KYSE-450::VX-11e
SCC-3::VX-11e
GRANTA-519::AZD7762
PSN1::XAV939
no-11::Foretinib
SJSA-1::VX-11e
KE-37::Motesanib
NCI-H1793::AGI-6780
786-0::Sepantronium bromide
KS-1::Foretinib
ALL-PO::Cediranib
Jurkat::Avagacestat
U-698-M::Foretinib
WM35::Dabrafenib
DG-75::AZD7762
SKN::Avagacestat
RPMI-6666::Sepantronium bromide
SK-PN-DW::Avagacestat
RERF-GC-1B::Doramapimod
RCC-JF::Foretinib
SNU-C2B::Dabrafenib
COLO-783::Alisertib
ES-2::Dabrafenib
NCC021::Avagacestat
MKN45::XAV939
SUP-HD1::Foretinib
COLO-684::AGI-6780
KM12::ZM447439
OV-90::MK-8776
NY::Dabrafenib
C-33-A::Cediranib
KARPAS-45::Dabrafenib
C3A::Cediranib
AGS::Motesanib
RCH-ACV::I-BRD9
CFPAC-1::ZM447439
OVKATE::Motesanib
SK-OV-3::I-BRD9
HOS::XAV939
KASUMI-1::Telomerase Inhibitor IX
EW-13::Sepantronium bromide
LS-411N::Foretinib
HPAF-II::Doramapimod
GA-10::MK-8776
KON::Osimertinib
SW684::AGI-6780
CTB-1::ZM447439
RKN::ZM447439
LCLC-97TM1::Telomerase Inhibitor IX
SK-MM-2::Osimertinib
COLO-800::AGI-6780
NB14::Foretinib
CTV-1::Doramapimod
SK-GT-4::I-BRD9
OSC-20::Dabrafenib
D-263MG::Dabrafenib
LS-411N::VX-11e
HCC1569::Dabrafenib
NCI-H716::ZM447439
PCI-30::Avagacestat
SW48::Afatinib
KMS-12-BM::Osimertinib
CAKI-1::Cediranib
SF268::MK-8776
G-MEL::Afatinib
BFTC-909::Afatinib
RH-41::Avagacestat
JHH-4::Alisertib
NCI-H2196::MK-8776
AMO-1::I-BRD9
IGROV-1::Alisertib
DK-MG::Sepantronium bromide
YH-13::Foretinib
KARPAS-299::Cediranib
SW962::VX-11e
HCC-827::Afatinib
AM-38::Alisertib
RVH-421::I-BRD9
HuO9::Sepantronium bromide
CAL-120::Motesanib
OV-90::ZM447439
REH::Afatinib
TE-4::AGI-6780
CHSA0108::Telomerase Inhibitor IX
A673::Doramapimod
HLE::I-BRD9
SK-LU-1::XAV939
CAL-29::VX-11e
TE-11::Telomerase Inhibitor IX
Mewo::Doramapimod
EKVX::AZD7762
SH-4::Osimertinib
HH::Motesanib
RPMI-8402::Alisertib
P32-ISH::I-BRD9
JAR::Cediranib
EoL-1-cell::ZM447439
GAMG::Motesanib
NUGC-3::Sepantronium bromide
ECC12::Afatinib
CFPAC-1::Osimertinib
NCI-H69::Doramapimod
PF-382::Cediranib
C-33-A::Doramapimod
BE2-M17::Foretinib
CAKI-1::I-BRD9
LOU-NH91::MK-8776
IM-9::I-BRD9
LP-1::Avagacestat
NCI-H1915::VX-11e
VMRC-LCD::XAV939
ES6::AGI-6780
KMS-11::MK-8776
OCI-LY7::ZM447439
T-T::Doramapimod
HCC-78::Doramapimod
NCI-H82::AGI-6780
RL::AZD7762
SK-MEL-5::I-BRD9
HOP-62::AGI-6780
JHOS-3::Telomerase Inhibitor IX
LS-180::Telomerase Inhibitor IX
DOV13::AGI-6780
WM793B::I-BRD9
SK-MEL-1::ZM447439
IST-SL2::Telomerase Inhibitor IX
KP-N-YN::Doramapimod
NCI-H660::Alisertib
NCC021::Foretinib
A101D::Osimertinib
OVTOKO::VX-11e
IPC-298::AZD7762
FU97::Alisertib
TK10::Osimertinib
OV-56::Telomerase Inhibitor IX
NCI-H2405::Cediranib
HCC-15::AGI-6780
AM-38::XAV939
NCI-H2196::I-BRD9
U031::Afatinib
DBTRG-05MG::Avagacestat
PCI-30::AZD7762
ALL-SIL::I-BRD9
Becker::VX-11e
RERF-LC-KJ::MK-8776
DBTRG-05MG::Osimertinib
U-266::ZM447439
AN3-CA::ZM447439
ES8::Doramapimod
OCI-LY-19::Doramapimod
HuP-T4::Telomerase Inhibitor IX
EW-1::I-BRD9
HOP-92::AGI-6780
SHP-77::ZM447439
OC-314::Osimertinib
NCI-H1770::Alisertib
CAKI-1::MK-8776
HCC-44::Osimertinib
NCI-H1693::Osimertinib
BICR10::Dabrafenib
CFPAC-1::XAV939
MDST8::Osimertinib
AGS::AGI-6780
COR-L105::Afatinib
NCI-H1105::Sepantronium bromide
SUIT-2::Avagacestat
MFM-223::I-BRD9
NCI-H661::Dabrafenib
RT-112::Motesanib
ML-2::Osimertinib
ESO26::VX-11e
RPMI-8402::Osimertinib
HSC-4::Dabrafenib
HC-1::MK-8776
LB647-SCLC::Avagacestat
DEL::Osimertinib
RPMI-8226::Alisertib
OV-56::Cediranib
DG-75::Osimertinib
HT-1080::Alisertib
DU-4475::Avagacestat
HT-144::Alisertib
NCI-H1915::Motesanib
SK-MEL-2::Telomerase Inhibitor IX
NCI-H929::ZM447439
NCI-H1944::Doramapimod
Daoy::AZD7762
ATN-1::Foretinib
SU-DHL-16::Foretinib
786-0::Doramapimod
NCI-H1623::AZD7762
ECC12::AZD7762
NCC010::ZM447439
BT-549::Dabrafenib
EFM-19::Foretinib
LB996-RCC::Motesanib
TUR::Avagacestat
NCI-H23::Motesanib
COLO-792::MK-8776
LNZTA3WT4::Avagacestat
OVTOKO::ZM447439
NCI-H747::Osimertinib
SW1783::I-BRD9
NCI-H2228::Dabrafenib
ECC12::MK-8776
REH::VX-11e
JHOS-4::AZD7762
NUGC-3::MK-8776
BALL-1::Osimertinib
NCI-H1573::I-BRD9
JHH-6::Osimertinib
Daoy::ZM447439
MOG-G-CCM::Afatinib
DSH1::Foretinib
MFE-296::Doramapimod
EPLC-272H::MK-8776
TE-12::Afatinib
SK-MES-1::Telomerase Inhibitor IX
NCI-H226::Cediranib
CAL-27::VX-11e
DAN-G::MK-8776
NCCIT::MK-8776
LOXIMVI::Dabrafenib
KYSE-180::ZM447439
IGR-37::Dabrafenib
COLO-792::Doramapimod
NCI-H835::Dabrafenib
HuP-T3::MK-8776
NCI-H2172::Osimertinib
RPMI-8226::Sepantronium bromide
A172::MK-8776
MHH-CALL-4::MK-8776
TE-11::Alisertib
KNS-62::Alisertib
SK-PN-DW::ZM447439
LB996-RCC::Avagacestat
BT-483::Dabrafenib
NCI-H1650::Cediranib
SU-DHL-16::Avagacestat
PANC-08-13::AGI-6780
SW837::I-BRD9
HT-1080::I-BRD9
LOU-NH91::Sepantronium bromide
CTB-1::Avagacestat
BPH-1::MK-8776
SNU-81::VX-11e
WM1552C::VX-11e
Farage::Avagacestat
UWB1.289::AZD7762
SK-MEL-5::Cediranib
HLE::AZD7762
VAL::Foretinib
LP-1::Osimertinib
KU-19-19::Sepantronium bromide
ARH-77::VX-11e
KURAMOCHI::ZM447439
C2BBe1::Doramapimod
NOMO-1::Dabrafenib
NB1::Sepantronium bromide
G-402::VX-11e
A498::Afatinib
SiHa::Afatinib
EW-22::AZD7762
T47D::Dabrafenib
NOMO-1::Avagacestat
A253::Afatinib
MG-63::Motesanib
KM-H2::Motesanib
K5::I-BRD9
HSC-4::Foretinib
LK-2::Sepantronium bromide
NCI-N87::AGI-6780
A431::Cediranib
NCI-H660::XAV939
NCI-H69::Cediranib
MDA-MB-436::XAV939
5637::MK-8776
Hey::Afatinib
CML-T1::Dabrafenib
NCI-H1105::MK-8776
HuO9::AGI-6780
REH::Alisertib
HCC-78::MK-8776
OVCAR-4::Telomerase Inhibitor IX
AM-38::Foretinib
DMS-273::Sepantronium bromide
NCI-H2087::Afatinib
KYSE-450::Foretinib
NCI-H847::VX-11e
HPAF-II::MK-8776
NCI-H2347::Doramapimod
IA-LM::Telomerase Inhibitor IX
AM-38::Dabrafenib
NCI-H250::Afatinib
HEL::AGI-6780
MDA-MB-231::Dabrafenib
NCI-H2009::Alisertib
NCI-H1944::Alisertib
SAT::Osimertinib
SJSA-1::Osimertinib
U031::Motesanib
SK-N-DZ::Motesanib
NB14::Dabrafenib
LNCaP-Clone-FGC::Alisertib
OVK-18::BX795
786-0::ZM447439
RL::AGI-6780
HAL-01::Osimertinib
K-562::XAV939
NCI-H441::Motesanib
NCI-H226::Afatinib
OVCAR-8::Alisertib
EW-24::Dabrafenib
MDA-MB-361::Avagacestat
RERF-LC-KJ::Afatinib
SKN-3::Cediranib
IMR-5::Dabrafenib
G-402::Sepantronium bromide
HCC1599::Cediranib
NCI-H2405::Telomerase Inhibitor IX
SK-OV-3::Sepantronium bromide
EMC-BAC-2::Dabrafenib
ABC-1::ZM447439
BxPC-3::MK-8776
HDLM-2::Osimertinib
G-361::Avagacestat
P32-ISH::Avagacestat
SNU-175::AGI-6780
NCI-H1355::ZM447439
NMC-G1::Alisertib
CAMA-1::Alisertib
CCK-81::Osimertinib
NCI-H1838::Doramapimod
G-402::Motesanib
HCC1187::Cediranib
NB10::Dabrafenib
HCC38::MK-8776
SK-N-DZ::Dabrafenib
NCI-H446::ZM447439
RXF393::Alisertib
HuCCT1::AGI-6780
QIMR-WIL::AZD7762
NCI-N87::Dabrafenib
LB1047-RCC::AGI-6780
NCI-H720::Dabrafenib
HCC-15::Osimertinib
RCC-JF::Doramapimod
DG-75::ZM447439
A375::Telomerase Inhibitor IX
SUP-M2::MK-8776
MKN7::Cediranib
UACC-893::Motesanib
ROS-50::Afatinib
CAL-39::VX-11e
NCI-H2170::Doramapimod
MZ7-mel::Doramapimod
SCC-3::Doramapimod
CCK-81::AZD7762
LB831-BLC::Motesanib
LU-65::Dabrafenib
JIMT-1::I-BRD9
COLO-829::VX-11e
RT-112::Telomerase Inhibitor IX
PCI-15A::BX795
SUP-B8::AGI-6780
NCI-H1573::ZM447439
NY::MK-8776
D-566MG::Afatinib
KMS-11::I-BRD9
HLE::Avagacestat
BICR31::Doramapimod
LU-99A::I-BRD9
KYSE-140::Osimertinib
OVCAR-8::Motesanib
PCI-4B::ZM447439
BICR78::AZD7762
PFSK-1::Afatinib
WM793B::Sepantronium bromide
SF126::Cediranib
UWB1.289::Avagacestat
ALL-PO::Afatinib
GCIY::AZD7762
COR-L311::Foretinib
NCI-H1436::ZM447439
RCC-FG2::ZM447439
CA46::XAV939
NCI-H1770::BX795
PCI-4B::Afatinib
MDA-MB-231::Doramapimod
GCT::I-BRD9
SIMA::Telomerase Inhibitor IX
FADU::Avagacestat
QGP-1::Cediranib
NCI-H1734::Telomerase Inhibitor IX
MOLT-16::Motesanib
A427::VX-11e
ES-2::XAV939
HCT-15::Afatinib
NCI-H2444::XAV939
L-363::Cediranib
IGROV-1::AGI-6780
EVSA-T::Avagacestat
HCE-4::AGI-6780
P30-OHK::Sepantronium bromide
JVM-2::ZM447439
SK-N-AS::ZM447439
22RV1::Osimertinib
TK10::Foretinib
MEL-HO::Sepantronium bromide
SW620::Alisertib
PANC-04-03::Alisertib
LC-2-ad::XAV939
ML-1::Osimertinib
NCI-H1963::ZM447439
8-MG-BA::I-BRD9
IM-95::Motesanib
Raji::Alisertib
SNU-283::Telomerase Inhibitor IX
SK-MEL-1::Sepantronium bromide
MLMA::Doramapimod
NCI-H1944::ZM447439
H-EMC-SS::Telomerase Inhibitor IX
NCI-H1770::XAV939
MOLT-13::Dabrafenib
OS-RC-2::Cediranib
SK-MES-1::Afatinib
RERF-LC-Sq1::Telomerase Inhibitor IX
TE-10::AZD7762
C-4-I::Alisertib
EMC-BAC-1::AGI-6780
L-540::Sepantronium bromide
HeLa::Alisertib
JHOS-2::Telomerase Inhibitor IX
SW962::Alisertib
CRO-AP2::Telomerase Inhibitor IX
EFM-19::Cediranib
G-402::Osimertinib
NCI-H524::Sepantronium bromide
NCI-H146::MK-8776
KYM-1::Alisertib
SNU-C5::Cediranib
M14::I-BRD9
WM278::Avagacestat
SNU-283::Osimertinib
COLO-205::ZM447439
EKVX::Foretinib
COR-L88::Alisertib
EW-12::XAV939
ES1::Dabrafenib
NCI-H740::Afatinib
LoVo::Alisertib
MOG-G-CCM::I-BRD9
NCI-H1581::Foretinib
TGBC24TKB::Afatinib
PA-TU-8988T::I-BRD9
OE21::XAV939
COLO-679::Motesanib
SW1116::Dabrafenib
NCI-H522::MK-8776
MDA-MB-436::Avagacestat
CML-T1::Doramapimod
VMRC-RCZ::Doramapimod
EB-3::XAV939
HeLa::Afatinib
HCC1428::Afatinib
ECC10::AZD7762
EB-3::Osimertinib
JHOS-2::MK-8776
NCI-H2170::I-BRD9
NCI-H1568::Doramapimod
NCI-H748::Avagacestat
SBC-3::MK-8776
PCI-6A::XAV939
HOP-92::Foretinib
RCH-ACV::Cediranib
U-87-MG::AZD7762
RCC10RGB::AZD7762
SW13::Doramapimod
HeLa::I-BRD9
DB::ZM447439
CESS::Osimertinib
CHSA0011::BX795
NCI-H2141::Doramapimod
KON::VX-11e
OVTOKO::XAV939
TGBC11TKB::Afatinib
SK-LMS-1::Avagacestat
GAMG::MK-8776
SR::Motesanib
NCI-H2444::Afatinib
BPH-1::Sepantronium bromide
MDA-MB-157::Motesanib
Calu-3::Dabrafenib
TGBC11TKB::AZD7762
LAN-6::Sepantronium bromide
CAL-27::AZD7762
SU-DHL-5::Dabrafenib
Daudi::Afatinib
SU-DHL-1::Sepantronium bromide
TK::Avagacestat
NCI-H1755::Doramapimod
SW1710::Sepantronium bromide
CHL-1::Dabrafenib
HMV-II::Doramapimod
D-502MG::Doramapimod
PCI-15A::VX-11e
DMS-53::Osimertinib
NCI-H841::XAV939
647-V::Cediranib
JHOS-4::Foretinib
SNU-175::ZM447439
Hey::Avagacestat
LB2518-MEL::MK-8776
JHOS-4::Telomerase Inhibitor IX
NCI-H520::I-BRD9
SW1116::XAV939
CAL-120::Afatinib
23132-87::I-BRD9
NCI-H1944::Dabrafenib
TE-8::Avagacestat
ME-1::Doramapimod
HSC-4::Sepantronium bromide
SN12C::Motesanib
LU-65::MK-8776
NCI-H2228::Telomerase Inhibitor IX
M14::Osimertinib
CHSA8926::Afatinib
SW872::Telomerase Inhibitor IX
SU-DHL-8::I-BRD9
HOP-92::Motesanib
OVTOKO::Telomerase Inhibitor IX
SBC-3::Doramapimod
NCI-H2085::Cediranib
KMOE-2::Afatinib
SUP-M2::Foretinib
RMG-I::AZD7762
OCI-AML2::Telomerase Inhibitor IX
Ramos-2G6-4C10::XAV939
NCI-H524::Afatinib
NCI-H1792::ZM447439
ES4::AGI-6780
NCI-H292::Sepantronium bromide
JVM-3::Avagacestat
OACM5-1::VX-11e
BB65-RCC::AZD7762
JHOS-2::Avagacestat
A549::MK-8776
Calu-3::ZM447439
MFE-280::XAV939
HH::AGI-6780
Ramos-2G6-4C10::Dabrafenib
BONNA-12::AZD7762
OVTOKO::MK-8776
HAL-01::Telomerase Inhibitor IX
U-118-MG::AGI-6780
LU-99A::AGI-6780
TT::ZM447439
PFSK-1::VX-11e
NCI-H2141::AGI-6780
COLO-678::ZM447439
NCI-H1581::ZM447439
SF268::Alisertib
SK-GT-4::Telomerase Inhibitor IX
RCM-1::Cediranib
SW756::Telomerase Inhibitor IX
RD::Osimertinib
BONNA-12::MK-8776
PCI-15A::Sepantronium bromide
MHH-CALL-2::Cediranib
NCI-H2170::Motesanib
NCI-H1975::VX-11e
NCI-H209::Avagacestat
KYM-1::Osimertinib
COR-L105::ZM447439
DMS-114::Afatinib
NAMALWA::Motesanib
KP-N-YN::Alisertib
PANC-02-03::Osimertinib
Farage::Motesanib
T84::Foretinib
Jurkat::MK-8776
HT55::MK-8776
EMC-BAC-2::ZM447439
ES1::MK-8776
LN-229::Cediranib
JHH-1::XAV939
DND-41::VX-11e
IST-SL1::MK-8776
HuH-7::Osimertinib
LU-165::Motesanib
TE-441-T::ZM447439
MHH-CALL-2::VX-11e
CAMA-1::AZD7762
CADO-ES1::Foretinib
SF295::Foretinib
NCI-H1105::ZM447439
SK-HEP-1::MK-8776
JHH-7::XAV939
RD::Motesanib
OVCAR-4::ZM447439
TK::Telomerase Inhibitor IX
U-266::Doramapimod
NCI-H1770::Motesanib
J82::Avagacestat
CFPAC-1::Cediranib
NMC-G1::Doramapimod
NB17::AZD7762
VCaP::I-BRD9
COLO-678::Osimertinib
ES8::Afatinib
RPMI-8402::MK-8776
KYSE-150::Alisertib
TE-1::Cediranib
ALL-PO::VX-11e
BICR31::XAV939
NOS-1::Cediranib
GP5d::Alisertib
BHY::Sepantronium bromide
SK-GT-2::Motesanib
NCI-H1573::Cediranib
COLO-684::Cediranib
EW-22::VX-11e
SKN::Doramapimod
TT2609-C02::Foretinib
ECC10::Telomerase Inhibitor IX
ChaGo-K-1::AZD7762
BONNA-12::Osimertinib
OSC-19::Alisertib
LAMA-84::AGI-6780
COLO-800::I-BRD9
EW-13::Motesanib
NB(TU)1-10::MK-8776
TGBC24TKB::Telomerase Inhibitor IX
MEG-01::Osimertinib
SBC-1::Avagacestat
42-MG-BA::MK-8776
ST486::Avagacestat
EFM-19::Afatinib
SNU-81::Osimertinib
NCI-H510A::Dabrafenib
CHP-212::Sepantronium bromide
SF295::BX795
G-401::Afatinib
DMS-53::Foretinib
OSC-19::AGI-6780
NCI-H146::VX-11e
NCI-H2110::ZM447439
SK-MEL-2::Alisertib
K2::Dabrafenib
K-562::Osimertinib
FTC-133::Dabrafenib
NCI-H1693::Telomerase Inhibitor IX
OPM-2::Osimertinib
TE-6::AGI-6780
KOPN-8::Motesanib
SNU-449::XAV939
SF539::AZD7762
SU-DHL-10::Foretinib
EW-12::Dabrafenib
BICR31::AZD7762
NCI-H1838::ZM447439
CAL-39::AZD7762
KASUMI-1::Dabrafenib
LC4-1::Avagacestat
ES7::MK-8776
ChaGo-K-1::Dabrafenib
A673::Alisertib
NB(TU)1-10::Sepantronium bromide
JAR::Avagacestat
RERF-LC-KJ::VX-11e
LP-1::Foretinib
NCI-H1694::Avagacestat
FLO-1::MK-8776
MC116::Afatinib
OVCA420::Doramapimod
NCI-H211::Osimertinib
NCI-H226::Dabrafenib
OACM5-1::Dabrafenib
OACM5-1::Cediranib
COLO-679::Afatinib
LB2518-MEL::I-BRD9
NCI-H2141::AZD7762
U-118-MG::ZM447439
MDA-MB-415::Cediranib
NCI-H292::AGI-6780
SCC-9::XAV939
HDLM-2::MK-8776
PCI-15A::Avagacestat
MES-SA::Afatinib
SNU-C5::Avagacestat
SK-N-AS::Motesanib
TYK-nu::Alisertib
U-266::I-BRD9
SU-DHL-16::AGI-6780
NCI-H1568::Sepantronium bromide
HOS::ZM447439
CAL-54::Alisertib
JVM-3::Cediranib
KYSE-510::Dabrafenib
TE-8::XAV939
RERF-LC-MS::Osimertinib
CAPAN-1::Afatinib
BPH-1::I-BRD9
COLO-678::Avagacestat
LOXIMVI::XAV939
HEL::Dabrafenib
KMRC-20::ZM447439
EW-18::I-BRD9
YKG-1::Afatinib
ACHN::AZD7762
SJRH30::Doramapimod
P12-ICHIKAWA::Dabrafenib
Becker::Avagacestat
ME-1::Telomerase Inhibitor IX
Hey::Motesanib
KARPAS-45::Avagacestat
COR-L88::Sepantronium bromide
NCI-H2291::Foretinib
PA-TU-8988T::Cediranib
SK-LMS-1::MK-8776
NCI-H2172::Doramapimod
HT-29::XAV939
A172::Motesanib
SN12C::Alisertib
NCI-H727::Alisertib
QGP-1::Foretinib
IGR-37::Alisertib
KYSE-180::AGI-6780
EoL-1-cell::Telomerase Inhibitor IX
SLVL::AGI-6780
LU-99A::Afatinib
TC-71::Osimertinib
FU-OV-1::Telomerase Inhibitor IX
ATN-1::XAV939
ChaGo-K-1::Cediranib
D-247MG::VX-11e
ZR-75-30::VX-11e
HCC1428::Cediranib
TGBC24TKB::Foretinib
RXF393::AGI-6780
CRO-AP2::XAV939
RCC-ER::MK-8776
RC-K8::Osimertinib
SW982::Afatinib
CAKI-1::VX-11e
COLO-320-HSR::Motesanib
NB14::XAV939
HTC-C3::I-BRD9
SCC-25::XAV939
NCI-H2291::AZD7762
A253::Osimertinib
BxPC-3::Motesanib
C3A::Foretinib
SLVL::Osimertinib
KU-19-19::Afatinib
PANC-02-03::Avagacestat
no-10::Osimertinib
COLO-792::Foretinib
CAL-85-1::Cediranib
SBC-5::I-BRD9
KM-H2::Cediranib
L-540::AGI-6780
SAS::AZD7762
ES7::Afatinib
SCH::MK-8776
RF-48::XAV939
NCI-H1623::Dabrafenib
H-EMC-SS::Sepantronium bromide
ABC-1::Osimertinib
CAL-120::Sepantronium bromide
NCI-H1648::VX-11e
SK-MG-1::Osimertinib
NCI-H929::AGI-6780
SUP-T1::MK-8776
C32::Alisertib
ES5::XAV939
MOLP-8::Sepantronium bromide
SK-MG-1::Cediranib
EFO-27::MK-8776
HMV-II::Motesanib
MKN1::Foretinib
PCI-6A::Telomerase Inhibitor IX
SK-MEL-28::MK-8776
OVISE::XAV939
WM35::VX-11e
SU-DHL-6::Doramapimod
NCI-H1341::AZD7762
NCI-H1155::AGI-6780
A704::Cediranib
BT-549::AZD7762
CHP-134::Afatinib
CTB-1::Foretinib
OE33::Dabrafenib
FADU::Doramapimod
GDM-1::Alisertib
NCI-H1836::Alisertib
DMS-273::Dabrafenib
A704::XAV939
NCI-H1650::Sepantronium bromide
U-118-MG::Doramapimod
HGC-27::Afatinib
SNU-398::AGI-6780
SK-MEL-24::I-BRD9
CPC-N::Telomerase Inhibitor IX
OCI-LY-19::MK-8776
DU-4475::I-BRD9
SW756::Foretinib
COR-L321::VX-11e
OCI-LY7::Alisertib
OVCAR-3::I-BRD9
MKN7::AZD7762
DBTRG-05MG::Telomerase Inhibitor IX
ECC10::AGI-6780
AM-38::AZD7762
JVM-3::VX-11e
CPC-N::XAV939
LB771-HNC::AGI-6780
KYSE-140::AGI-6780
MIA-PaCa-2::VX-11e
BEN::XAV939
AGS::XAV939
EC-GI-10::ZM447439
EW-22::Foretinib
NCI-H1048::XAV939
C-33-A::Motesanib
MN-60::I-BRD9
NCI-H727::Doramapimod
COR-L279::Cediranib
huH-1::Avagacestat
SW1463::MK-8776
D-542MG::MK-8776
LAMA-84::Cediranib
EJM::Dabrafenib
OS-RC-2::Avagacestat
SF295::Sepantronium bromide
D-336MG::XAV939
Jurkat::Afatinib
KARPAS-299::Afatinib
WM35::Osimertinib
H3255::Doramapimod
SK-MEL-24::VX-11e
Calu-3::AGI-6780
SNU-61::Sepantronium bromide
DSH1::MK-8776
NCI-H1975::Alisertib
IGR-37::Osimertinib
PWR-1E::Alisertib
LU-65::AZD7762
A101D::Sepantronium bromide
HCC38::Dabrafenib
TE-441-T::Telomerase Inhibitor IX
L-1236::Foretinib
RCH-ACV::BX795
NCI-H716::XAV939
Daoy::XAV939
SK-LMS-1::AZD7762
KARPAS-422::I-BRD9
WIL2-NS::AZD7762
DSH1::XAV939
SiHa::Dabrafenib
SKN::Motesanib
NCI-H747::AGI-6780
CHP-212::AZD7762
AGS::Afatinib
MLMA::Sepantronium bromide
NCI-H1836::ZM447439
SUP-M2::Telomerase Inhibitor IX
LCLC-97TM1::Dabrafenib
RT-112::Avagacestat
OPM-2::Foretinib
OVCAR-3::Alisertib
BV-173::Afatinib
ChaGo-K-1::Afatinib
SW1271::XAV939
OVCA420::Cediranib
STS-0421::Motesanib
KYSE-220::Avagacestat
MDA-MB-361::ZM447439
SW982::Motesanib
JVM-3::MK-8776
RCC-AB::Foretinib
K-562::Cediranib
C-33-A::I-BRD9
NCI-H196::XAV939
BICR10::VX-11e
HCC1500::Afatinib
EFM-192A::Avagacestat
MKN7::Sepantronium bromide
T47D::AZD7762
SK-N-FI::Foretinib
A253::Motesanib
RH-41::MK-8776
MOLT-13::VX-11e
BT-549::Telomerase Inhibitor IX
IM-95::Dabrafenib
U-2-OS::BX795
HL-60::AZD7762
NCI-H929::VX-11e
MOLP-8::XAV939
SAS::Telomerase Inhibitor IX
MG-63::Doramapimod
A498::Foretinib
SW1463::Avagacestat
UACC-62::VX-11e
EFO-21::Avagacestat
COR-L23::Motesanib
GR-ST::Afatinib
HCC1569::Afatinib
PL4::ZM447439
NCI-H2029::Afatinib
MEL-JUSO::ZM447439
SW982::AZD7762
KURAMOCHI::Afatinib
P31-FUJ::ZM447439
P12-ICHIKAWA::Foretinib
COLO-783::ZM447439
ROS-50::AGI-6780
DOV13::VX-11e
MEL-HO::Cediranib
TGBC1TKB::Osimertinib
SK-GT-4::AZD7762
OCI-LY-19::Alisertib
EFM-192A::Alisertib
WSU-NHL::Foretinib
OCI-LY7::Cediranib
KYSE-220::Doramapimod
HCC1500::Doramapimod
HH::Sepantronium bromide
CAPAN-1::VX-11e
NB7::Cediranib
HO-1-N-1::Doramapimod
PC-14::Afatinib
CHP-126::Avagacestat
SNU-81::I-BRD9
OSC-19::Motesanib
SK-MEL-30::Alisertib
TE-8::MK-8776
GCT::Avagacestat
SNU-C5::ZM447439
EB-3::Afatinib
COR-L303::Sepantronium bromide
NCI-H838::VX-11e
L-363::AZD7762
OVTOKO::I-BRD9
CTV-1::I-BRD9
SCH::Afatinib
OCUB-M::XAV939
LOXIMVI::Avagacestat
HT55::ZM447439
MEL-JUSO::Telomerase Inhibitor IX
SUIT-2::Afatinib
SUP-T1::I-BRD9
OSC-19::XAV939
BE-13::AZD7762
OVCAR-8::ZM447439
NB12::Afatinib
COR-L303::VX-11e
SW954::I-BRD9
TCCSUP::XAV939
DOHH-2::BX795
RXF393::XAV939
SF126::MK-8776
HPAC::Foretinib
RCC-ER::BX795
SJSA-1::Alisertib
EoL-1-cell::XAV939
OSC-20::VX-11e
CTV-1::Dabrafenib
KYSE-520::ZM447439
U031::Telomerase Inhibitor IX
MV-4-11::Alisertib
23132-87::MK-8776
SBC-3::AGI-6780
NB12::Avagacestat
M059J::I-BRD9
A388::MK-8776
PCI-30::Foretinib
SW1271::Avagacestat
NCI-H524::Foretinib
MZ1-PC::I-BRD9
COLO-679::XAV939
EB-3::VX-11e
NCI-H747::Motesanib
KARPAS-299::Foretinib
U-87-MG::Foretinib
NCI-H596::AGI-6780
MDA-MB-330::MK-8776
SISO::Motesanib
ETK-1::Foretinib
SU-DHL-10::Alisertib
SK-CO-1::MK-8776
MHH-CALL-4::Dabrafenib
PEO1::Motesanib
OSC-19::Doramapimod
CL-11::Sepantronium bromide
HCC-366::Osimertinib
KY821::Osimertinib
VMRC-RCZ::AGI-6780
MEL-HO::VX-11e
SCC90::Doramapimod
BHY::Foretinib
G-361::ZM447439
HT55::I-BRD9
SU-DHL-6::Avagacestat
HCC1937::XAV939
NCI-H2170::ZM447439
22RV1::Alisertib
LB2241-RCC::AZD7762
UM-UC-3::Osimertinib
KNS-42::Osimertinib
ETK-1::Doramapimod
NCI-H596::Telomerase Inhibitor IX
TK10::Avagacestat
C32::Dabrafenib
NCI-H2135::Cediranib
LU-165::VX-11e
SK-MEL-24::ZM447439
IST-SL1::VX-11e
SU-DHL-8::Osimertinib
KARPAS-1106P::Dabrafenib
BICR22::Dabrafenib
SW1088::ZM447439
YH-13::AZD7762
EW-22::Osimertinib
5637::Avagacestat
8305C::AZD7762
NB(TU)1-10::Dabrafenib
Jurkat::VX-11e
D-263MG::I-BRD9
DJM-1::VX-11e
SW756::Cediranib
HuP-T3::Osimertinib
NCI-H1155::Cediranib
MOLT-13::Osimertinib
SK-MEL-2::Motesanib
NCI-H596::Foretinib
RC-K8::AGI-6780
MEG-01::Alisertib
JHH-1::Avagacestat
CAL-78::AZD7762
SN12C::Osimertinib
SLVL::Sepantronium bromide
Hey::XAV939
THP-1::Sepantronium bromide
BHY::Doramapimod
VCaP::Dabrafenib
DG-75::AGI-6780
ME-1::VX-11e
NCI-H1651::VX-11e
KOPN-8::Doramapimod
MOLT-4::VX-11e
OCI-AML2::AGI-6780
EW-1::Motesanib
QGP-1::AGI-6780
SK-MEL-2::Sepantronium bromide
KMRC-20::AGI-6780
SK-UT-1::MK-8776
BL-41::AGI-6780
KMOE-2::Foretinib
ALL-PO::AGI-6780
MDA-MB-231::Foretinib
ALL-SIL::ZM447439
RCC-MF::Foretinib
MKN1::Sepantronium bromide
EMC-BAC-2::I-BRD9
MEL-JUSO::Doramapimod
SK-MEL-5::Alisertib
D-502MG::XAV939
NCI-H2141::Alisertib
GP5d::Dabrafenib
NCI-H2029::AZD7762
NCI-H292::BX795
HPAC::ZM447439
ESS-1::Motesanib
PANC-10-05::VX-11e
DU-145::Afatinib
SU-DHL-10::Doramapimod
SNG-M::AGI-6780
CTV-1::Afatinib
OACM5-1::MK-8776
ZR-75-30::Afatinib
BB49-HNC::I-BRD9
P12-ICHIKAWA::VX-11e
NCI-H2085::Sepantronium bromide
22RV1::ZM447439
NCI-H1755::Motesanib
HuCCT1::ZM447439
LB1047-RCC::ZM447439
CAL-29::Dabrafenib
AN3-CA::Cediranib
HT-144::AZD7762
BALL-1::Dabrafenib
SKN-3::Foretinib
BFTC-905::VX-11e
SNU-387::Avagacestat
CAL-62::ZM447439
OAW-42::VX-11e
JHOS-4::Afatinib
KY821::Foretinib
IMR-5::VX-11e
IST-SL1::ZM447439
KM12::Avagacestat
KMRC-20::AZD7762
DAN-G::Osimertinib
SU-DHL-4::BX795
COLO-824::MK-8776
OE33::XAV939
Ca9-22::AGI-6780
SW684::Doramapimod
SW756::Doramapimod
SK-OV-3::Telomerase Inhibitor IX
SUP-B15::Doramapimod
ACHN::Cediranib
HOP-62::I-BRD9
KP-4::Alisertib
SU-DHL-4::ZM447439
FLO-1::ZM447439
MFE-280::ZM447439
ESO26::Motesanib
YKG-1::Cediranib
KMS-11::AGI-6780
LU-165::Afatinib
COR-L279::MK-8776
HC-1::VX-11e
BB30-HNC::Osimertinib
JHH-1::I-BRD9
A253::Telomerase Inhibitor IX
22RV1::Dabrafenib
NCI-H2444::Dabrafenib
K5::Doramapimod
TE-6::Foretinib
DU-4475::Osimertinib
MES-SA::Alisertib
SAS::Osimertinib
NB5::XAV939
MCF7::VX-11e
SW982::Sepantronium bromide
NOMO-1::XAV939
UWB1.289::Motesanib
T47D::Sepantronium bromide
SW1088::Doramapimod
DOHH-2::Motesanib
MFE-296::I-BRD9
SK-MEL-3::Sepantronium bromide
ATN-1::I-BRD9
NCI-H1693::Cediranib
NCI-H1836::VX-11e
DOHH-2::Telomerase Inhibitor IX
COLO-668::Cediranib
WSU-NHL::I-BRD9
BICR78::VX-11e
NCI-H2110::Avagacestat
CP66-MEL::ZM447439
KCL-22::AZD7762
NB6::Sepantronium bromide
ATN-1::ZM447439
CAL-85-1::AGI-6780
JiyoyeP-2003::Alisertib
VMRC-RCZ::ZM447439
CHP-126::Cediranib
KMRC-1::AZD7762
NCI-H841::Doramapimod
PWR-1E::Cediranib
HT-3::Doramapimod
TE-6::I-BRD9
EFO-21::Dabrafenib
HC-1::Telomerase Inhibitor IX
GI-ME-N::I-BRD9
CHSA8926::Dabrafenib
WSU-NHL::Alisertib
JiyoyeP-2003::VX-11e
GCIY::Avagacestat
JHOS-2::Doramapimod
EVSA-T::XAV939
MKN1::Telomerase Inhibitor IX
COLO-824::AZD7762
CHP-134::Foretinib
TE-15::AGI-6780
EW-11::MK-8776
SNU-423::AGI-6780
CHSA0011::VX-11e
COLO-829::Sepantronium bromide
BICR31::Telomerase Inhibitor IX
697::XAV939
NCI-H838::MK-8776
OE21::AZD7762
NCI-H1793::Foretinib
LB647-SCLC::Motesanib
P31-FUJ::VX-11e
MKN28::Alisertib
NCI-H146::Alisertib
U-87-MG::Osimertinib
NCI-H2227::Cediranib
UACC-812::Motesanib
HCE-4::Dabrafenib
NCI-H1688::Motesanib
NH-12::Avagacestat
OE21::I-BRD9
JHH-4::Avagacestat
JVM-3::Foretinib
OSC-19::I-BRD9
no-10::AZD7762
COR-L23::Alisertib
DBTRG-05MG::Alisertib
SF295::Telomerase Inhibitor IX
MFH-ino::Telomerase Inhibitor IX
YT::VX-11e
JHOS-3::Osimertinib
42-MG-BA::I-BRD9
NMC-G1::Motesanib
ML-1::Avagacestat
MC116::Cediranib
NCI-H1703::Dabrafenib
RO82-W-1::Afatinib
OS-RC-2::XAV939
786-0::Cediranib
DBTRG-05MG::Foretinib
OVTOKO::Motesanib
NEC8::Doramapimod
COR-L88::AZD7762
42-MG-BA::Sepantronium bromide
SW962::BX795
NCI-H1435::ZM447439
MKN28::Sepantronium bromide
VMRC-LCD::Osimertinib
SNB75::Doramapimod
U-698-M::Afatinib
HARA::I-BRD9
SK-MEL-1::AZD7762
Raji::AGI-6780
OCI-AML2::Doramapimod
COLO-205::Osimertinib
D-542MG::ZM447439
ALL-SIL::XAV939
OVCAR-4::Sepantronium bromide
HCC1806::ZM447439
D-263MG::AZD7762
CAL-54::Avagacestat
CGTH-W-1::Sepantronium bromide
RS4-11::I-BRD9
KLE::I-BRD9
IMR-5::Cediranib
PANC-03-27::Sepantronium bromide
DEL::ZM447439
OACp4C::AZD7762
SU-DHL-1::ZM447439
NCI-H2227::XAV939
BB30-HNC::Doramapimod
RKN::Sepantronium bromide
HLE::Doramapimod
CGTH-W-1::Doramapimod
NCCIT::Alisertib
GA-10::Motesanib
SU-DHL-10::Afatinib
LB2241-RCC::Cediranib
NCI-H196::MK-8776
NCI-H1792::Sepantronium bromide
ACHN::Telomerase Inhibitor IX
ABC-1::AZD7762
COR-L279::VX-11e
NCI-H522::Motesanib
NCI-H1975::Dabrafenib
SR::Dabrafenib
JHU-011::XAV939
OC-314::Foretinib
HCC1954::VX-11e
KYSE-220::ZM447439
NCI-H146::Foretinib
NCI-H1793::Cediranib
SNG-M::Alisertib
KMOE-2::Cediranib
HCC1937::Dabrafenib
SK-MG-1::AGI-6780
NCI-H1793::MK-8776
NEC8::Alisertib
EW-3::AZD7762
BT-474::Osimertinib
SW1990::MK-8776
SLVL::I-BRD9
RL::Foretinib
NCI-H1688::Sepantronium bromide
MFE-296::Afatinib
UACC-257::Foretinib
NCI-H1770::Doramapimod
U-118-MG::Motesanib
MDA-MB-415::XAV939
OVCAR-4::AGI-6780
ME-1::Foretinib
NCI-H1993::I-BRD9
KYSE-450::ZM447439
SW756::ZM447439
NCI-H1155::Doramapimod
LC-2-ad::Alisertib
SJSA-1::MK-8776
WSU-NHL::Doramapimod
TUR::Motesanib
GOTO::Doramapimod
HARA::Doramapimod
NB17::BX795
HCC1395::Avagacestat
SF295::Osimertinib
CADO-ES1::AZD7762
L-363::ZM447439
JHH-2::Motesanib
IST-MEL1::Doramapimod
IGROV-1::Afatinib
KYSE-520::Afatinib
ESO26::MK-8776
RPMI-8226::Doramapimod
MV-4-11::MK-8776
NY::Motesanib
NCI-H211::Foretinib
NCI-H250::VX-11e
MFH-ino::AZD7762
FADU::Osimertinib
MZ2-MEL::Afatinib
RCC-JF::Avagacestat
SNU-387::AZD7762
ST486::Afatinib
A704::Avagacestat
OCI-AML3::Alisertib
THP-1::Foretinib
RO82-W-1::I-BRD9
CHP-126::Telomerase Inhibitor IX
JSC-1::ZM447439
MDA-MB-361::Cediranib
KARPAS-45::VX-11e
HuH-7::Afatinib
NU-DUL-1::Avagacestat
Raji::Foretinib
KARPAS-45::Motesanib
NCI-H196::Doramapimod
GA-10::Dabrafenib
CAL-29::Osimertinib
COR-L32::BX795
BFTC-905::Motesanib
NB5::Alisertib
NY::Osimertinib
OCI-LY-19::XAV939
NCI-H1993::MK-8776
COR-L95::Doramapimod
M14::Alisertib
ME-1::Osimertinib
KARPAS-299::ZM447439
TK::AGI-6780
LN-405::Osimertinib
SF539::Motesanib
NCI-H2196::Sepantronium bromide
JHU-029::I-BRD9
LS-123::I-BRD9
PC-3::VX-11e
FU97::Telomerase Inhibitor IX
LC4-1::Motesanib
SK-N-DZ::MK-8776
NCI-H2110::Afatinib
CFPAC-1::VX-11e
WM1552C::Foretinib
IST-MEL1::Afatinib
HGC-27::Cediranib
CHP-212::Osimertinib
ROS-50::Avagacestat
ALL-SIL::Dabrafenib
KYSE-220::Telomerase Inhibitor IX
HCT-15::Dabrafenib
HT-1080::AGI-6780
GAMG::Doramapimod
NUGC-3::Motesanib
LU-165::Osimertinib
NCI-H660::BX795
PA-1::I-BRD9
HCC1599::VX-11e
BICR22::Alisertib
RCC-ER::Motesanib
JVM-3::Motesanib
A253::VX-11e
ES5::Motesanib
DEL::VX-11e
HEC-1::AZD7762
KYSE-50::MK-8776
ASH-3::Cediranib
SW954::Telomerase Inhibitor IX
EW-3::I-BRD9
U-2-OS::Foretinib
SK-MEL-5::BX795
EC-GI-10::XAV939
KM12::Doramapimod
JHH-4::Dabrafenib
SNU-C1::Dabrafenib
RL::Alisertib
NCI-H146::AGI-6780
MDA-MB-415::Avagacestat
OCI-AML5::MK-8776
TGW::Motesanib
SK-MG-1::XAV939
IGR-1::Cediranib
J82::Cediranib
HCC2218::Osimertinib
MHH-PREB-1::Avagacestat
SU8686::Sepantronium bromide
NCI-H2170::Sepantronium bromide
LCLC-103H::XAV939
A2780::Sepantronium bromide
KYSE-220::Foretinib
EW-12::Sepantronium bromide
23132-87::Telomerase Inhibitor IX
HDQ-P1::MK-8776
OS-RC-2::AZD7762
D-336MG::I-BRD9
697::AGI-6780
LU-135::Alisertib
SK-MEL-3::Dabrafenib
PL4::AZD7762
BT-483::Osimertinib
FU97::AZD7762
ML-2::Afatinib
SJSA-1::Telomerase Inhibitor IX
MOLT-16::VX-11e
SAS::ZM447439
8505C::Sepantronium bromide
PA-TU-8988T::Dabrafenib
GCIY::XAV939
LOUCY::Telomerase Inhibitor IX
HOS::Foretinib
HCC1806::Avagacestat
RPMI-8866::XAV939
HT-1197::Afatinib
HCC1419::ZM447439
KYSE-220::Cediranib
KP-2::Sepantronium bromide
JVM-2::Doramapimod
SUP-HD1::Doramapimod
SU-DHL-5::Telomerase Inhibitor IX
RCC-AB::VX-11e
HCC1806::VX-11e
SW48::Foretinib
C-33-A::Foretinib
SNU-C1::Afatinib
EFM-19::Alisertib
U251::VX-11e
VA-ES-BJ::Motesanib
EFM-192A::AZD7762
KYSE-510::I-BRD9
TOV-112D::VX-11e
IST-SL2::ZM447439
RL::Doramapimod
SUP-T1::XAV939
GAMG::Avagacestat
TK10::Dabrafenib
NCI-H810::I-BRD9
NCI-H1435::Avagacestat
RCC-JF::Telomerase Inhibitor IX
KARPAS-231::Alisertib
NUGC-4::Telomerase Inhibitor IX
NCI-H1355::Dabrafenib
BB65-RCC::Telomerase Inhibitor IX
KYAE-1::Sepantronium bromide
HCC1806::I-BRD9
LB1047-RCC::Sepantronium bromide
MFM-223::Motesanib
NCI-H3122::Avagacestat
ML-1::ZM447439
A549::Sepantronium bromide
A427::XAV939
MOLM-16::BX795
A431::Alisertib
KCL-22::Sepantronium bromide
SW626::XAV939
LN-229::MK-8776
D-566MG::Osimertinib
G-MEL::Foretinib
RERF-LC-KJ::I-BRD9
T84::Avagacestat
M059J::AZD7762
NCI-H2227::Telomerase Inhibitor IX
RO82-W-1::VX-11e
BT-20::Afatinib
KYAE-1::Dabrafenib
COR-L105::Alisertib
SW780::AGI-6780
SF539::Alisertib
TE-10::Afatinib
HCT-116::Doramapimod
DB::Osimertinib
OSC-19::Cediranib
A204::Sepantronium bromide
RD::XAV939
NB17::Cediranib
D-263MG::Osimertinib
OVMIU::Motesanib
TE-9::AZD7762
H4::Avagacestat
KOPN-8::Cediranib
OV-56::VX-11e
BT-549::AGI-6780
KYSE-450::MK-8776
NCI-H358::Telomerase Inhibitor IX
Detroit562::Motesanib
SW954::AZD7762
HCC1569::AZD7762
NCI-H740::Osimertinib
SJSA-1::Doramapimod
HL-60::Telomerase Inhibitor IX
HOP-92::Cediranib
no-10::BX795
VMRC-RCZ::Alisertib
RPMI-8226::Avagacestat
697::Sepantronium bromide
Caov-4::AZD7762
BICR78::Afatinib
GP5d::VX-11e
NCI-H1755::Telomerase Inhibitor IX
SW982::VX-11e
HCC1569::Foretinib
YKG-1::Telomerase Inhibitor IX
KG-1::VX-11e
LOXIMVI::Osimertinib
NCI-H322M::XAV939
TC-YIK::Osimertinib
CP50-MEL-B::Dabrafenib
G-401::AGI-6780
PANC-03-27::Osimertinib
IGR-1::Alisertib
NCI-H2030::Dabrafenib
NCI-H835::Cediranib
DU-145::Alisertib
SR::I-BRD9
LCLC-97TM1::Motesanib
CaR-1::Afatinib
JHOS-2::Sepantronium bromide
SW982::Avagacestat
HuO-3N1::I-BRD9
PF-382::Doramapimod
NCI-H2347::ZM447439
SK-N-FI::Sepantronium bromide
NCI-H2405::AGI-6780
NCI-H146::Avagacestat
HuCCT1::Osimertinib
IM-95::ZM447439
NCC021::BX795
NAMALWA::Telomerase Inhibitor IX
DJM-1::Dabrafenib
JHH-6::Doramapimod
SK-MEL-31::Avagacestat
NCI-N87::I-BRD9
CHSA0011::AZD7762
BxPC-3::XAV939
DU-4475::Doramapimod
EVSA-T::Foretinib
MRK-nu-1::Sepantronium bromide
UM-UC-3::Telomerase Inhibitor IX
JVM-3::Sepantronium bromide
SW1710::AGI-6780
SK-HEP-1::Telomerase Inhibitor IX
SCC-9::Telomerase Inhibitor IX
YT::Motesanib
HCC1419::Doramapimod
EW-1::Doramapimod
LN-405::Dabrafenib
RH-41::Cediranib
OVK-18::XAV939
TT::I-BRD9
EB2::AZD7762
KYSE-140::Afatinib
NB6::Cediranib
EFO-27::Foretinib
SW872::AGI-6780
NCI-H660::VX-11e
KP-4::AGI-6780
JHH-6::Afatinib
GR-ST::Alisertib
YAPC::VX-11e
JiyoyeP-2003::Osimertinib
MOG-G-UVW::Afatinib
FU97::ZM447439
NCI-H1092::Motesanib
IGROV-1::Avagacestat
LK-2::Cediranib
RKN::Afatinib
P32-ISH::AZD7762
NCI-H2122::Telomerase Inhibitor IX
CGTH-W-1::Cediranib
TUR::Afatinib
NB5::Motesanib
SNG-M::AZD7762
MDA-MB-231::Osimertinib
SR::Osimertinib
OCUM-1::Dabrafenib
JHH-6::Avagacestat
RERF-LC-Sq1::ZM447439
JJN-3::ZM447439
NCI-H526::XAV939
SK-GT-2::Osimertinib
NCI-H1623::Doramapimod
DU-145::Sepantronium bromide
D-392MG::Alisertib
PCI-6A::Doramapimod
P32-ISH::Foretinib
LNCaP-Clone-FGC::MK-8776
NCI-H2141::Cediranib
GRANTA-519::Alisertib
HTC-C3::Avagacestat
COLO-668::Foretinib
LAN-6::Cediranib
KE-37::Cediranib
A375::Alisertib
CAL-72::Dabrafenib
TE-8::AZD7762
L-428::I-BRD9
SUP-B8::Foretinib
LU-134-A::AZD7762
NCI-H2172::Alisertib
SIG-M5::I-BRD9
HCC1954::XAV939
Daoy::Motesanib
CW-2::Foretinib
HL-60::Avagacestat
COLO-668::Avagacestat
Mo-T::AGI-6780
A253::ZM447439
HCC1569::BX795
Detroit562::Afatinib
SK-LMS-1::VX-11e
RL95-2::ZM447439
EMC-BAC-2::Cediranib
A673::AGI-6780
BHT-101::AZD7762
GI-ME-N::Alisertib
NUGC-4::VX-11e
JEG-3::Motesanib
UACC-812::I-BRD9
NALM-6::Motesanib
H9::Motesanib
MDA-MB-453::I-BRD9
SH-4::Doramapimod
PSN1::Dabrafenib
PFSK-1::Dabrafenib
MKN45::Osimertinib
CPC-N::Foretinib
LAMA-84::AZD7762
Daoy::I-BRD9
PA-1::ZM447439
MLMA::Telomerase Inhibitor IX
HT-3::Foretinib
MIA-PaCa-2::ZM447439
BHY::Alisertib
MEL-HO::MK-8776
WIL2-NS::Sepantronium bromide
GR-ST::Motesanib
MEL-JUSO::MK-8776
EJM::AZD7762
JHOS-2::Afatinib
HOP-62::Doramapimod
NCI-H2405::Doramapimod
NCI-H596::Afatinib
NCI-H1975::Telomerase Inhibitor IX
DEL::MK-8776
NCI-H524::AGI-6780
NCI-H3122::Afatinib
SNU-C2B::Afatinib
SW837::AGI-6780
RH-1::Avagacestat
NCI-H2196::Dabrafenib
MHH-NB-11::Cediranib
NCI-H1623::Sepantronium bromide
CHSA8926::Sepantronium bromide
MDA-MB-330::Dabrafenib
NCI-H2023::Osimertinib
HSC-4::Doramapimod
NB1::Foretinib
SK-MEL-2::Doramapimod
LS-1034::Avagacestat
CAL-51::VX-11e
COR-L279::Avagacestat
HCC1806::AGI-6780
NCI-N87::ZM447439
OV-17R::Cediranib
SK-PN-DW::Afatinib
MC116::Alisertib
G-401::Cediranib
HCT-116::XAV939
RCC-AB::Motesanib
LU-135::Doramapimod
RCC-AB::AZD7762
JHOS-3::Doramapimod
VAL::Dabrafenib
CHSA0011::Doramapimod
SF126::Alisertib
TC-71::MK-8776
639-V::Dabrafenib
HO-1-N-1::Alisertib
CHL-1::Cediranib
TGBC1TKB::AZD7762
OCUB-M::Doramapimod
TOV-21G::AZD7762
KMS-12-BM::Avagacestat
KNS-81-FD::Alisertib
GAMG::Foretinib
D-263MG::XAV939
BPH-1::Doramapimod
NCI-H1836::Cediranib
BC-1::AZD7762
SW1088::I-BRD9
KP-2::Cediranib
MOLT-4::Dabrafenib
GAMG::XAV939
OSC-19::Avagacestat
HEC-1::Avagacestat
LU-134-A::BX795
BFTC-909::Dabrafenib
NCI-H2141::Telomerase Inhibitor IX
LAN-6::Osimertinib
HDLM-2::Doramapimod
NMC-G1::BX795
MDA-MB-361::Afatinib
RERF-LC-Sq1::AGI-6780
ES1::AZD7762
NAMALWA::Doramapimod
G-401::Sepantronium bromide
ST486::Telomerase Inhibitor IX
TCCSUP::Doramapimod
SCC90::Alisertib
ES7::VX-11e
SK-MEL-1::Afatinib
NCI-H841::Avagacestat
SBC-5::Cediranib
SK-OV-3::ZM447439
HCC1187::MK-8776
BL-41::XAV939
COLO-824::Telomerase Inhibitor IX
KELLY::Cediranib
CAL-54::I-BRD9
GA-10::AZD7762
MZ7-mel::AZD7762
MDA-MB-415::Osimertinib
LB2518-MEL::XAV939
KYSE-450::AGI-6780
ES8::VX-11e
LP-1::Alisertib
SK-MEL-28::I-BRD9
HCC-15::I-BRD9
ALL-PO::Alisertib
RKO::VX-11e
SKM-1::Avagacestat
KP-4::Avagacestat
EB2::Sepantronium bromide
FTC-133::Foretinib
RCC10RGB::Afatinib
KNS-42::Sepantronium bromide
IM-9::Foretinib
NCI-H1915::MK-8776
DG-75::Telomerase Inhibitor IX
KLE::Afatinib
MKN7::Telomerase Inhibitor IX
NAMALWA::Afatinib
FTC-133::Alisertib
EMC-BAC-2::VX-11e
KMS-11::Cediranib
NB1::VX-11e
KMS-12-BM::MK-8776
KNS-81-FD::Cediranib
NCI-H1650::Motesanib
TK::AZD7762
G-401::Dabrafenib
SU-DHL-4::Afatinib
JM1::BX795
NCC021::MK-8776
TOV-21G::AGI-6780
LC-1-sq::Osimertinib
HCC-366::AGI-6780
EB-3::Doramapimod
PCI-4B::Motesanib
RPMI-7951::Motesanib
KS-1::Osimertinib
HCC-366::I-BRD9
GA-10::Sepantronium bromide
SKN-3::AGI-6780
BE2-M17::Doramapimod
NCI-H1993::Doramapimod
TK::ZM447439
H9::MK-8776
JEKO-1::Dabrafenib
TE-12::AGI-6780
CAL-33::Dabrafenib
CAL-120::I-BRD9
MHH-NB-11::Osimertinib
VMRC-LCD::Dabrafenib
IHH-4::Avagacestat
KU-19-19::Foretinib
IHH-4::Alisertib
NCI-H1092::Telomerase Inhibitor IX
G-401::Osimertinib
OAW-28::Telomerase Inhibitor IX
SJRH30::Alisertib
SKG-IIIa::XAV939
D-283MED::Foretinib
EoL-1-cell::AGI-6780
SNU-398::Dabrafenib
LB771-HNC::Afatinib
HCC70::Telomerase Inhibitor IX
HT-1376::Cediranib
42-MG-BA::ZM447439
OAW-28::AZD7762
KYSE-410::Osimertinib
RCC-FG2::Dabrafenib
SK-MEL-1::I-BRD9
HCE-4::BX795
DU-4475::Cediranib
BT-20::Alisertib
SW1463::Sepantronium bromide
LB831-BLC::Dabrafenib
SU-DHL-16::Telomerase Inhibitor IX
MZ1-PC::ZM447439
NCI-H1092::Afatinib
CHP-212::MK-8776
MEL-JUSO::Sepantronium bromide
SBC-3::Avagacestat
MKN45::AGI-6780
MDA-MB-330::AGI-6780
LOU-NH91::XAV939
AU565::Telomerase Inhibitor IX
SNU-81::Doramapimod
SW962::Telomerase Inhibitor IX
EC-GI-10::Cediranib
TK10::Telomerase Inhibitor IX
NCI-H292::Foretinib
NCI-H1836::I-BRD9
BxPC-3::Telomerase Inhibitor IX
SKN::Osimertinib
EW-16::Osimertinib
D-283MED::I-BRD9
KYSE-180::Doramapimod
HAL-01::Alisertib
NCI-H441::I-BRD9
RCC-ER::Osimertinib
K5::Afatinib
NUGC-4::Osimertinib
SUP-M2::Alisertib
A4-Fuk::AGI-6780
NCI-H1975::Cediranib
huH-1::Sepantronium bromide
CP50-MEL-B::Cediranib
GI-1::Doramapimod
K2::Motesanib
RERF-LC-MS::VX-11e
GAK::Cediranib
YT::Foretinib
NCI-H841::Foretinib
PC-14::BX795
NCI-H2172::VX-11e
SCC-3::Osimertinib
NCI-H2444::Avagacestat
BL-41::Alisertib
JAR::Alisertib
L-540::Cediranib
NUGC-4::Afatinib
RPMI-6666::Afatinib
CAL-39::Afatinib
BB65-RCC::BX795
HT-115::AGI-6780
NCI-H1836::Dabrafenib
D-392MG::I-BRD9
HCC38::Afatinib
MDA-MB-468::Avagacestat
MDST8::Cediranib
Mewo::Cediranib
CCRF-CEM::Alisertib
PL-21::Alisertib
MFE-296::Osimertinib
KS-1::ZM447439
OS-RC-2::Telomerase Inhibitor IX
RS4-11::Foretinib
HA7-RCC::MK-8776
OCI-LY-19::Afatinib
SUP-M2::XAV939
NCI-H441::VX-11e
IST-SL2::BX795
NCI-H1563::ZM447439
PC-3::Motesanib
CHSA0108::BX795
DMS-79::Alisertib
HuO-3N1::Dabrafenib
NCI-H23::Doramapimod
ESO51::Sepantronium bromide
OVCAR-4::I-BRD9
TOV-21G::Osimertinib
LB2518-MEL::Osimertinib
A204::VX-11e
MKN28::ZM447439
CAL-39::Avagacestat
IM-95::I-BRD9
BICR10::XAV939
MOG-G-UVW::Alisertib
PANC-08-13::Telomerase Inhibitor IX
NCI-H209::Sepantronium bromide
NCI-H847::Afatinib
HAL-01::XAV939
ATN-1::VX-11e
OVTOKO::Avagacestat
LP-1::Telomerase Inhibitor IX
KASUMI-1::Afatinib
SK-GT-2::ZM447439
BE2-M17::Afatinib
SW780::MK-8776
SW1990::VX-11e
RCM-1::MK-8776
KARPAS-299::AZD7762
C3A::Avagacestat
IGR-37::VX-11e
NB1::Motesanib
KMRC-20::Cediranib
IGR-37::Foretinib
IPC-298::Telomerase Inhibitor IX
NCI-H1915::Osimertinib
NCC021::Sepantronium bromide
SJRH30::Foretinib
SBC-1::Osimertinib
JHOS-4::Sepantronium bromide
SW626::Osimertinib
TGBC11TKB::Foretinib
LN-405::AGI-6780
ZR-75-30::I-BRD9
OCI-AML3::Avagacestat
MOG-G-UVW::Foretinib
VMRC-LCD::Foretinib
RXF393::VX-11e
LN-405::Sepantronium bromide
MS751::Sepantronium bromide
NCI-H446::Alisertib
NCI-H2347::Sepantronium bromide
TT::Avagacestat
FADU::Afatinib
BxPC-3::Foretinib
SUP-B15::Sepantronium bromide
OVMIU::Foretinib
ROS-50::I-BRD9
PANC-04-03::Afatinib
KS-1::VX-11e
TE-4::Telomerase Inhibitor IX
OVCA420::Alisertib
HCC1937::Doramapimod
NCI-H2023::Afatinib
RMG-I::Foretinib
SW1990::I-BRD9
SNU-81::ZM447439
BT-549::MK-8776
PC-3::Foretinib
CAKI-1::Osimertinib
SW1271::I-BRD9
WM278::Sepantronium bromide
NB(TU)1-10::Foretinib
TE-1::Alisertib
Mo-T::Cediranib
SHP-77::MK-8776
COR-L23::AGI-6780
CAL-39::Alisertib
Calu-3::AZD7762
Becker::Foretinib
GRANTA-519::I-BRD9
MS-1::I-BRD9
NB1::AZD7762
SW837::Motesanib
BxPC-3::I-BRD9
TYK-nu::Foretinib
ES7::Foretinib
SW620::I-BRD9
SW1573::Afatinib
CS1::MK-8776
MOLM-13::Foretinib
EMC-BAC-1::XAV939
FLO-1::Sepantronium bromide
CAL-78::Avagacestat
ES-2::Telomerase Inhibitor IX
FADU::Alisertib
AGS::Dabrafenib
PANC-08-13::Doramapimod
KATOIII::ZM447439
LS-1034::I-BRD9
IM-95::AZD7762
SCC90::Cediranib
GCT::Sepantronium bromide
Calu-6::Alisertib
Ca9-22::Motesanib
P30-OHK::MK-8776
C-33-A::Alisertib
AN3-CA::Sepantronium bromide
HT-115::Sepantronium bromide
KY821::I-BRD9
ALL-SIL::Motesanib
CHSA8926::AGI-6780
NCI-H1581::VX-11e
NB69::Motesanib
RT-112::I-BRD9
MKN45::MK-8776
JHOS-4::Avagacestat
GRANTA-519::MK-8776
SK-ES-1::Dabrafenib
JHU-022::Foretinib
DAN-G::Telomerase Inhibitor IX
no-10::AGI-6780
JHOS-4::BX795
EW-7::Avagacestat
SW948::Sepantronium bromide
CL-11::Avagacestat
NCI-H2023::Avagacestat
BALL-1::Avagacestat
CaR-1::Telomerase Inhibitor IX
A673::Sepantronium bromide
NCI-H2135::Afatinib
ML-2::Foretinib
HDLM-2::AGI-6780
NCI-H1048::Cediranib
COR-L105::Foretinib
SK-GT-4::Sepantronium bromide
KM-H2::I-BRD9
KATOIII::Osimertinib
ME-1::Motesanib
SW156::AGI-6780
VMRC-LCD::Afatinib
NCI-H2087::Foretinib
RPMI-7951::ZM447439
SW1417::AZD7762
HCC-78::I-BRD9
Calu-6::Afatinib
KELLY::VX-11e
HuCCT1::AZD7762
NUGC-3::I-BRD9
TE-15::Alisertib
SW1573::VX-11e
NH-12::Doramapimod
EM-2::VX-11e
KYAE-1::AGI-6780
JJN-3::Avagacestat
NCI-H1781::MK-8776
G-361::Foretinib
KP-1N::XAV939
RT4::Dabrafenib
Daudi::ZM447439
YAPC::Motesanib
NCCIT::Cediranib
SHP-77::Osimertinib
SK-MEL-24::Cediranib
K2::Osimertinib
ES-2::Sepantronium bromide
BE2-M17::I-BRD9
TE-8::ZM447439
OPM-2::I-BRD9
SW13::XAV939
COLO-684::Motesanib
LB2518-MEL::Motesanib
U031::BX795
JAR::Afatinib
SW948::Foretinib
CAL-54::AGI-6780
SCC-9::AGI-6780
ALL-SIL::AZD7762
EW-22::Avagacestat
SNG-M::Cediranib
PCI-15A::I-BRD9
UACC-257::VX-11e
OV-17R::Avagacestat
BFTC-905::I-BRD9
KYSE-520::AGI-6780
NCI-H2135::Foretinib
AMO-1::VX-11e
MHH-CALL-2::Foretinib
KARPAS-299::Alisertib
A704::Doramapimod
BALL-1::MK-8776
RPMI-6666::MK-8776
RVH-421::Motesanib
MS751::Osimertinib
TC-YIK::Alisertib
RXF393::ZM447439
KMOE-2::MK-8776
SU-DHL-6::XAV939
SNU-407::Telomerase Inhibitor IX
ES6::Doramapimod
RL95-2::VX-11e
SK-PN-DW::Motesanib
PA-TU-8902::Telomerase Inhibitor IX
A498::Sepantronium bromide
MEL-JUSO::XAV939
DOHH-2::Sepantronium bromide
ES7::AZD7762
SK-LMS-1::AGI-6780
CAL-72::VX-11e
UMC-11::AGI-6780
LAN-6::MK-8776
T-T::Sepantronium bromide
ES4::Osimertinib
LC4-1::Afatinib
SNU-61::XAV939
NCI-H446::AGI-6780
BALL-1::Cediranib
D-423MG::BX795
SW872::Alisertib
LB2241-RCC::Avagacestat
ML-2::MK-8776
HCC1143::AGI-6780
NCI-H2122::Cediranib
NCI-H1651::Avagacestat
GI-1::Sepantronium bromide
SK-MEL-2::Foretinib
T98G::Foretinib
A2058::AZD7762
A388::Avagacestat
LB996-RCC::Telomerase Inhibitor IX
TE-5::Foretinib
BFTC-909::Cediranib
EFM-19::AZD7762
COLO-320-HSR::Osimertinib
PWR-1E::Telomerase Inhibitor IX
IST-SL2::Motesanib
huH-1::Telomerase Inhibitor IX
NB(TU)1-10::AZD7762
SF268::Motesanib
CP50-MEL-B::Foretinib
KNS-42::Telomerase Inhibitor IX
RCC-ER::AZD7762
no-10::Telomerase Inhibitor IX
Ca-Ski::Doramapimod
8305C::Dabrafenib
SW1417::ZM447439
LC-1-sq::MK-8776
NCI-H522::Alisertib
CAL-85-1::ZM447439
KALS-1::I-BRD9
OE19::Foretinib
SW962::MK-8776
KARPAS-1106P::MK-8776
UACC-893::AGI-6780
WM278::Alisertib
NCI-H660::Cediranib
NCI-H322M::Avagacestat
MDST8::Doramapimod
SNB75::I-BRD9
JVM-2::AZD7762
G-402::Dabrafenib
CPC-N::Sepantronium bromide
PA-TU-8902::Foretinib
BALL-1::Telomerase Inhibitor IX
Mewo::Dabrafenib
LoVo::AZD7762
NB13::Avagacestat
OVTOKO::Alisertib
KCL-22::Avagacestat
NCI-H1838::Osimertinib
RCH-ACV::Alisertib
MN-60::Motesanib
H9::Avagacestat
PA-TU-8902::Afatinib
NCI-H1793::Sepantronium bromide
WSU-DLCL2::ZM447439
JHOS-3::ZM447439
HH::VX-11e
SW948::AGI-6780
C-33-A::VX-11e
M059J::Osimertinib
CAL-12T::Sepantronium bromide
NCI-H209::ZM447439
HuCCT1::VX-11e
SW620::Foretinib
SCC-25::Avagacestat
IM-95::Doramapimod
ES6::Cediranib
C2BBe1::XAV939
MDST8::Dabrafenib
COLO-684::Sepantronium bromide
EW-11::Afatinib
NCI-H23::VX-11e
HCC38::AGI-6780
ST486::VX-11e
SBC-5::Osimertinib
LB771-HNC::Osimertinib
IST-SL2::Doramapimod
ES4::Avagacestat
NCI-H838::Alisertib
PSN1::Osimertinib
NCI-H1963::Cediranib
LS-1034::Doramapimod
LU-134-A::VX-11e
8-MG-BA::Afatinib
KINGS-1::XAV939
NCI-H929::Afatinib
SAT::Avagacestat
HH::Osimertinib
GI-ME-N::MK-8776
KALS-1::Avagacestat
GCIY::Motesanib
DOK::Afatinib
FU-OV-1::Afatinib
CFPAC-1::Telomerase Inhibitor IX
P30-OHK::Dabrafenib
KOPN-8::VX-11e
NCI-H1573::VX-11e
SBC-3::Cediranib
KGN::AZD7762
NCI-H524::I-BRD9
SUP-B15::AZD7762
NCI-H747::Dabrafenib
SK-OV-3::Avagacestat
HCC38::Alisertib
PA-1::Osimertinib
COLO-829::Afatinib
KASUMI-1::Alisertib
NCI-H2227::BX795
ME-180::Avagacestat
YAPC::Cediranib
NCI-H524::XAV939
GCIY::Cediranib
TE-5::ZM447439
NCI-H2110::Foretinib
LC4-1::I-BRD9
CAL-85-1::AZD7762
EN::AZD7762
GA-10::Avagacestat
MOLT-13::ZM447439
CAL-120::ZM447439
DSH1::I-BRD9
NCI-H358::Sepantronium bromide
NCI-H2029::Doramapimod
CFPAC-1::Doramapimod
OC-314::Doramapimod
SW962::Foretinib
NCI-H2170::AGI-6780
NCI-H1092::Doramapimod
NCI-H716::MK-8776
HC-1::Afatinib
NCI-H1944::Cediranib
MES-SA::Telomerase Inhibitor IX
SK-LU-1::Doramapimod
DB::Afatinib
TGBC1TKB::Afatinib
PA-1::Dabrafenib
P12-ICHIKAWA::Cediranib
TYK-nu::Avagacestat
CAL-27::XAV939
IPC-298::I-BRD9
P32-ISH::Telomerase Inhibitor IX
NMC-G1::ZM447439
SW1463::Telomerase Inhibitor IX
Daoy::Sepantronium bromide
BL-41::Telomerase Inhibitor IX
SBC-1::AZD7762
IM-95::XAV939
OCUB-M::AGI-6780
5637::ZM447439
A204::Cediranib
A388::VX-11e
HOP-62::Telomerase Inhibitor IX
JSC-1::Avagacestat
JURL-MK1::Foretinib
U-698-M::Doramapimod
VCaP::Osimertinib
T98G::I-BRD9
RO82-W-1::Avagacestat
451Lu::VX-11e
DU-4475::MK-8776
GP5d::AZD7762
SKM-1::BX795
DAN-G::Dabrafenib
TC-71::AGI-6780
PA-TU-8902::VX-11e
BT-474::ZM447439
COLO-800::Avagacestat
NCI-H2444::MK-8776
EM-2::Afatinib
EPLC-272H::XAV939
Mo-T::MK-8776
HO-1-u-1::Afatinib
EKVX::XAV939
VAL::VX-11e
NCI-H1651::AGI-6780
RCC-MF::XAV939
GI-ME-N::Cediranib
SN12C::Foretinib
NCI-H838::Sepantronium bromide
LS-180::ZM447439
L-540::AZD7762
ETK-1::Sepantronium bromide
RKO::Alisertib
Mo-T::Motesanib
NCI-H1975::Afatinib
SAT::Foretinib
NCI-H209::Foretinib
NCI-H1734::Cediranib
ONS-76::Dabrafenib
ZR-75-30::Doramapimod
RT4::VX-11e
U-118-MG::Cediranib
NCI-H2405::Foretinib
JSC-1::Dabrafenib
IPC-298::AGI-6780
SUP-B8::Osimertinib
KYSE-140::Foretinib
OCI-LY-19::I-BRD9
COLO-783::I-BRD9
HuO9::Telomerase Inhibitor IX
CL-11::Motesanib
A204::Telomerase Inhibitor IX
JAR::Dabrafenib
EW-1::MK-8776
COLO-668::AZD7762
HCC2157::Telomerase Inhibitor IX
RERF-GC-1B::XAV939
NB7::Dabrafenib
OCI-M1::Motesanib
MRK-nu-1::AZD7762
CAL-78::Dabrafenib
NCI-H2452::Dabrafenib
BT-20::Cediranib
COLO-792::XAV939
KURAMOCHI::Foretinib
Saos-2::Avagacestat
A4-Fuk::I-BRD9
T98G::AZD7762
AM-38::Osimertinib
ES-2::Foretinib
LoVo::MK-8776
HuCCT1::Afatinib
KYSE-70::Alisertib
EFO-21::Alisertib
IGR-37::Sepantronium bromide
HLE::XAV939
GOTO::Alisertib
KP-1N::Doramapimod
EW-7::Cediranib
NCI-H1734::Dabrafenib
LNCaP-Clone-FGC::XAV939
RVH-421::AZD7762
NB10::Doramapimod
RPMI-6666::VX-11e
PCI-6A::Osimertinib
HCC-44::XAV939
K2::Alisertib
SW626::VX-11e
RCH-ACV::VX-11e
HCC-44::Sepantronium bromide
KASUMI-1::Sepantronium bromide
HT-3::Sepantronium bromide
SF268::Doramapimod
LS-1034::ZM447439
CA46::Telomerase Inhibitor IX
DOHH-2::AGI-6780
PC-3::Dabrafenib
CAL-120::Dabrafenib
HEL::VX-11e
EoL-1-cell::Alisertib
RF-48::Avagacestat
HAL-01::Motesanib
JHH-6::Dabrafenib
NCI-H1573::Dabrafenib
T98G::MK-8776
OCI-LY-19::Telomerase Inhibitor IX
NCI-H1755::Afatinib
RC-K8::Sepantronium bromide
JM1::XAV939
YKG-1::Sepantronium bromide
RCH-ACV::Dabrafenib
MN-60::Dabrafenib
NY::Alisertib
ESS-1::Avagacestat
U031::Foretinib
G-MEL::VX-11e
EW-7::Osimertinib
ST486::Dabrafenib
SJRH30::Motesanib
SCC-9::ZM447439
HSC-2::Dabrafenib
42-MG-BA::VX-11e
SW1573::Telomerase Inhibitor IX
SNU-407::Dabrafenib
NB6::MK-8776
EFM-192A::AGI-6780
OV-90::Motesanib
CAL-51::Osimertinib
EW-18::VX-11e
LOXIMVI::I-BRD9
LOUCY::Afatinib
HARA::Cediranib
Hs-578-T::Sepantronium bromide
SK-MM-2::Avagacestat
SK-MEL-5::VX-11e
WM1552C::Cediranib
VAL::Cediranib
EoL-1-cell::MK-8776
GDM-1::Cediranib
SW684::Motesanib
EFO-27::XAV939
23132-87::Afatinib
NCI-H2085::I-BRD9
NCI-H1435::MK-8776
PANC-04-03::Avagacestat
RXF393::Afatinib
MC116::Telomerase Inhibitor IX
MV-4-11::Afatinib
BHY::Motesanib
SHP-77::I-BRD9
MIA-PaCa-2::Sepantronium bromide
NCI-H1341::Doramapimod
LU-65::Avagacestat
FLO-1::Motesanib
HDQ-P1::Dabrafenib
NCI-H2170::Afatinib
HCC1806::MK-8776
SF268::Telomerase Inhibitor IX
U-266::Alisertib
NB7::I-BRD9
SK-MEL-28::Telomerase Inhibitor IX
K2::Cediranib
JAR::Motesanib
NALM-6::I-BRD9
CAL-85-1::Dabrafenib
LU-134-A::Doramapimod
P12-ICHIKAWA::Alisertib
BPH-1::AGI-6780
KNS-81-FD::AZD7762
NCI-H1581::Afatinib
ESO51::Osimertinib
BxPC-3::VX-11e
SK-UT-1::Motesanib
MOG-G-CCM::ZM447439
A253::XAV939
EW-22::Dabrafenib
A388::Motesanib
MES-SA::I-BRD9
BPH-1::XAV939
NCI-H929::Alisertib
CAPAN-1::Osimertinib
DAN-G::Cediranib
SNU-423::MK-8776
SIMA::Cediranib
IST-MES1::Cediranib
EW-11::Cediranib
DEL::Afatinib
NCI-H727::Cediranib
NCI-H2291::Motesanib
NCI-H1781::Cediranib
NCI-H810::Osimertinib
NCI-H2228::I-BRD9
SCC-25::Osimertinib
KYSE-510::Telomerase Inhibitor IX
NCC010::MK-8776
HCC2998::AZD7762
NCI-H1993::Osimertinib
KATOIII::MK-8776
TT2609-C02::Afatinib
BALL-1::AZD7762
SF539::VX-11e
EoL-1-cell::AZD7762
LOXIMVI::MK-8776
OAW-28::VX-11e
IPC-298::BX795
LN-229::Foretinib
PC-3::AZD7762
NCI-H2405::I-BRD9
EFO-21::AZD7762
NCI-H1563::XAV939
NCI-H520::XAV939
CAL-51::Doramapimod
JHOS-2::Cediranib
TK10::MK-8776
OACM5-1::Afatinib
RERF-GC-1B::Afatinib
PL4::VX-11e
KYSE-270::I-BRD9
LK-2::Doramapimod
DK-MG::Motesanib
NKM-1::Sepantronium bromide
SW982::MK-8776
NCI-N87::Telomerase Inhibitor IX
A253::Foretinib
ES-2::Avagacestat
TE-6::MK-8776
NCI-H2342::AZD7762
KYSE-70::MK-8776
SHP-77::Foretinib
MSTO-211H::MK-8776
EFM-19::Doramapimod
OC-314::I-BRD9
SCC-4::Motesanib
P12-ICHIKAWA::Afatinib
CAL-85-1::MK-8776
SK-MM-2::Doramapimod
BV-173::MK-8776
KY821::Telomerase Inhibitor IX
LB831-BLC::AGI-6780
IGROV-1::AZD7762
MFE-280::Dabrafenib
H3255::Sepantronium bromide
OCI-AML5::XAV939
RPMI-8226::Cediranib
AMO-1::Motesanib
Raji::I-BRD9
OCI-M1::Telomerase Inhibitor IX
P31-FUJ::MK-8776
MZ2-MEL::Motesanib
ACHN::MK-8776
REH::Motesanib
COLO-829::AZD7762
LOU-NH91::Doramapimod
A204::Alisertib
IM-95::Osimertinib
Detroit562::Dabrafenib
SHP-77::VX-11e
MKN7::BX795
OVCAR-8::I-BRD9
NCI-H716::Motesanib
BHT-101::Osimertinib
MDA-MB-468::Doramapimod
JHU-022::Telomerase Inhibitor IX
769-P::VX-11e
MG-63::Avagacestat
TE-441-T::Osimertinib
M14::AZD7762
HCC-827::Dabrafenib
SK-N-SH::ZM447439
BE-13::VX-11e
LS-411N::Motesanib
KU-19-19::ZM447439
LB1047-RCC::BX795
TT::Doramapimod
SF268::Avagacestat
UM-UC-3::I-BRD9
NCI-H441::Cediranib
A4-Fuk::VX-11e
OCUB-M::Telomerase Inhibitor IX
SW620::Avagacestat
NCI-H1435::Afatinib
NCI-H292::XAV939
NCI-H596::ZM447439
HO-1-N-1::VX-11e
SW954::VX-11e
MOLT-13::I-BRD9
Hey::Cediranib
DU-4475::Sepantronium bromide
HT-1080::Avagacestat
SNU-175::I-BRD9
SW1088::Alisertib
G-401::Doramapimod
NCI-H747::XAV939
TE-9::AGI-6780
IST-MEL1::Cediranib
PF-382::Foretinib
Mo-T::Osimertinib
IA-LM::ZM447439
HT-3::VX-11e
A427::Motesanib
EW-24::Alisertib
QGP-1::MK-8776
KURAMOCHI::Avagacestat
L-1236::I-BRD9
SCC-9::Dabrafenib
MOLM-13::Avagacestat
MFE-319::I-BRD9
LU-134-A::Sepantronium bromide
SK-MES-1::AGI-6780
ES4::Motesanib
WSU-NHL::Sepantronium bromide
SIMA::Afatinib
NCI-H2066::Dabrafenib
JHH-6::VX-11e
COLO-678::I-BRD9
TGW::Avagacestat
LC-2-ad::VX-11e
CAL-62::Foretinib
OACM5-1::ZM447439
SW1573::Sepantronium bromide
AGS::Alisertib
TCCSUP::MK-8776
MOLT-13::Doramapimod
HTC-C3::MK-8776
TGW::XAV939
CAL-120::Avagacestat
NCI-H1838::Motesanib
LN-229::Afatinib
OVK-18::Avagacestat
D-263MG::Telomerase Inhibitor IX
MDA-MB-361::XAV939
COR-L32::Alisertib
SNU-387::Osimertinib
HL-60::ZM447439
MFE-280::Afatinib
EW-1::XAV939
ALL-SIL::Doramapimod
SNU-407::AZD7762
SBC-5::VX-11e
COLO-668::VX-11e
ABC-1::Dabrafenib
GI-ME-N::Foretinib
NCI-H520::Alisertib
A204::AGI-6780
Detroit562::Doramapimod
RCC-ER::Telomerase Inhibitor IX
BFTC-905::Telomerase Inhibitor IX
H3255::AGI-6780
MDA-MB-231::Telomerase Inhibitor IX
U-87-MG::VX-11e
GI-ME-N::ZM447439
OE21::Motesanib
JVM-2::VX-11e
HCC-78::VX-11e
H-EMC-SS::Avagacestat
RCM-1::Afatinib
MFE-280::AGI-6780
RL95-2::Osimertinib
PANC-10-05::Dabrafenib
NCI-H2052::Cediranib
CAL-62::Telomerase Inhibitor IX
OVISE::I-BRD9
IST-MES1::Avagacestat
NCI-H2052::Osimertinib
MZ2-MEL::Avagacestat
GB-1::MK-8776
PC-3::XAV939
NCI-H520::AGI-6780
LK-2::MK-8776
RERF-LC-MS::I-BRD9
G-MEL::BX795
ESO26::ZM447439
HCC1954::Dabrafenib
YAPC::Avagacestat
NCI-H1703::Motesanib
MFE-280::Doramapimod
CHP-212::XAV939
KARPAS-422::Alisertib
CAL-62::I-BRD9
MHH-NB-11::Sepantronium bromide
TE-8::Osimertinib
EW-16::Motesanib
NCI-H1436::Sepantronium bromide
RCC10RGB::Telomerase Inhibitor IX
JHH-4::Afatinib
NMC-G1::Osimertinib
KARPAS-1106P::Afatinib
ES1::I-BRD9
NCI-H1781::Telomerase Inhibitor IX
CAS-1::AGI-6780
T47D::Afatinib
OV-7::Doramapimod
HCC38::Motesanib
MDA-MB-330::Sepantronium bromide
U-2-OS::MK-8776
NCI-H650::I-BRD9
CAL-148::Dabrafenib
KNS-81-FD::Sepantronium bromide
NCI-N87::XAV939
NU-DUL-1::Osimertinib
NCI-H596::Osimertinib
MFE-319::ZM447439
A549::Avagacestat
SNU-423::Avagacestat
WSU-DLCL2::Cediranib
NCI-H720::AZD7762
DOK::VX-11e
GP5d::ZM447439
BL-41::Avagacestat
CCRF-CEM::AZD7762
EW-7::Sepantronium bromide
SW1783::Telomerase Inhibitor IX
RKN::Avagacestat
MDA-MB-436::Sepantronium bromide
GP5d::Doramapimod
NCI-H2009::Sepantronium bromide
NCI-H3122::Dabrafenib
KP-4::Cediranib
SK-MM-2::Dabrafenib
HT-1197::VX-11e
RF-48::Doramapimod
P31-FUJ::Avagacestat
RCC-JW::I-BRD9
HDQ-P1::Foretinib
LXF-289::AGI-6780
NCI-H838::Avagacestat
KINGS-1::Motesanib
D-247MG::Afatinib
U031::AGI-6780
A388::I-BRD9
ESO51::Cediranib
HCT-15::Telomerase Inhibitor IX
KP-2::ZM447439
EFO-21::AGI-6780
EW-22::Motesanib
HCC1395::Sepantronium bromide
LN-229::Alisertib
H-EMC-SS::Foretinib
RS4-11::XAV939
no-11::I-BRD9
HLE::Motesanib
NCI-H1869::XAV939
KP-3::AZD7762
LP-1::Sepantronium bromide
Ca9-22::Cediranib
SW48::ZM447439
A375::Cediranib
OS-RC-2::VX-11e
H-EMC-SS::Osimertinib
HDQ-P1::Avagacestat
HCC2998::AGI-6780
U-2-OS::AZD7762
KINGS-1::Doramapimod
KYSE-140::Dabrafenib
NCI-H2196::Avagacestat
Becker::XAV939
MFE-280::MK-8776
KARPAS-620::I-BRD9
JHH-7::Alisertib
SW620::Doramapimod
NCI-H596::Doramapimod
OCUM-1::Foretinib
EW-1::Foretinib
SU8686::Doramapimod
NCI-H1105::Alisertib
COLO-320-HSR::Alisertib
KG-1::Avagacestat
EB2::XAV939
EW-3::Alisertib
DU-145::Telomerase Inhibitor IX
UACC-62::Cediranib
Ramos-2G6-4C10::Cediranib
HCC1187::Telomerase Inhibitor IX
IA-LM::Motesanib
RT-112::Dabrafenib
SW872::Foretinib
42-MG-BA::Alisertib
OC-314::Dabrafenib
HT-1080::Cediranib
SJRH30::AZD7762
DG-75::Dabrafenib
EW-13::Doramapimod
ONS-76::Sepantronium bromide
DMS-273::Telomerase Inhibitor IX
IGR-37::Afatinib
NCI-H1666::Sepantronium bromide
NCI-H596::Cediranib
NCI-H1299::XAV939
HMV-II::Telomerase Inhibitor IX
SBC-3::ZM447439
SK-MEL-30::Telomerase Inhibitor IX
CaR-1::Motesanib
H-EMC-SS::Dabrafenib
NCI-H146::Afatinib
M059J::ZM447439
KYSE-150::VX-11e
RT-112::MK-8776
KM-H2::Alisertib
RPMI-8226::Foretinib
HCC2157::Sepantronium bromide
KP-3::Afatinib
SCC-25::Alisertib
NCI-H2196::Afatinib
COLO-824::Dabrafenib
MRK-nu-1::Osimertinib
HH::Doramapimod
OE33::Telomerase Inhibitor IX
MDST8::AZD7762
NUGC-4::Motesanib
NUGC-3::Osimertinib
Mewo::VX-11e
MN-60::Sepantronium bromide
KALS-1::XAV939
SNU-283::Doramapimod
SISO::Osimertinib
SK-OV-3::AGI-6780
EFO-27::Sepantronium bromide
BV-173::Telomerase Inhibitor IX
TCCSUP::Sepantronium bromide
NCI-H441::AGI-6780
JHOS-4::Motesanib
SNU-175::AZD7762
NB(TU)1-10::Cediranib
HC-1::Alisertib
SU-DHL-16::VX-11e
KS-1::MK-8776
OVISE::Avagacestat
D-263MG::Avagacestat
D-542MG::Foretinib
OSC-20::XAV939
CHP-134::XAV939
LB771-HNC::Alisertib
LN-18::AZD7762
COLO-829::Motesanib
NCI-H2085::Afatinib
L-363::Afatinib
EBC-1::Telomerase Inhibitor IX
ATN-1::Doramapimod
KYSE-270::Afatinib
LU-165::XAV939
PFSK-1::Foretinib
NCI-H1975::Osimertinib
SW156::Doramapimod
JHH-1::Afatinib
RCC-JW::Cediranib
NCI-H1993::Dabrafenib
DMS-53::Cediranib
KP-N-YN::AZD7762
SU-DHL-8::Alisertib
RCH-ACV::Motesanib
TK::XAV939
NCI-H209::Osimertinib
JHU-022::Cediranib
Becker::I-BRD9
SBC-5::AZD7762
STS-0421::BX795
NCI-H1048::Doramapimod
NCI-H3122::VX-11e
KMRC-20::XAV939
JM1::Sepantronium bromide
SK-MEL-24::Motesanib
HCE-4::Alisertib
LU-99A::Doramapimod
FTC-133::Osimertinib
KP-1N::Alisertib
NCI-H1975::Foretinib
NCI-H660::Dabrafenib
EW-18::Osimertinib
HLE::Cediranib
L-428::AZD7762
SK-MEL-31::I-BRD9
LOUCY::Cediranib
PF-382::Dabrafenib
WM1552C::Doramapimod
NCI-H720::Avagacestat
OE19::Avagacestat
SKN-3::XAV939
KLE::XAV939
NCI-H660::Foretinib
DoTc2-4510::ZM447439
NCI-H2030::XAV939
VMRC-LCD::Doramapimod
PEO1::MK-8776
NB12::Telomerase Inhibitor IX
SNU-283::MK-8776
Mo-T::Dabrafenib
BICR31::AGI-6780
MM1S::VX-11e
JHU-011::Cediranib
KARPAS-422::Dabrafenib
EW-16::XAV939
NCI-H747::Afatinib
Calu-6::Avagacestat
BE-13::Doramapimod
VMRC-RCZ::Sepantronium bromide
KYSE-270::ZM447439
LB373-MEL-D::BX795
BFTC-905::MK-8776
NCI-H1876::MK-8776
JEKO-1::I-BRD9
LB2518-MEL::Avagacestat
EW-13::Cediranib
HCC70::Afatinib
NCI-H2029::Sepantronium bromide
NCI-H1435::AZD7762
J82::Alisertib
JHH-6::I-BRD9
KARPAS-1106P::AGI-6780
NCI-H1693::MK-8776
CCK-81::I-BRD9
CAL-54::VX-11e
KNS-62::Osimertinib
NUGC-3::Afatinib
KU-19-19::XAV939
SUP-HD1::Osimertinib
A388::Doramapimod
ES7::ZM447439
QIMR-WIL::ZM447439
OV-56::Dabrafenib
A388::Telomerase Inhibitor IX
Farage::Doramapimod
NCI-N87::Cediranib
KMS-12-BM::Afatinib
HuP-T4::I-BRD9
K5::Sepantronium bromide
HCC1599::Afatinib
COLO-205::Telomerase Inhibitor IX
MKN45::Foretinib
PEO1::Foretinib
LU-65::Foretinib
EM-2::XAV939
MES-SA::AZD7762
NCI-H747::Sepantronium bromide
CCRF-CEM::Afatinib
OVTOKO::Dabrafenib
Calu-3::Avagacestat
VMRC-RCZ::MK-8776
MHH-NB-11::Telomerase Inhibitor IX
ES4::I-BRD9
MHH-PREB-1::AGI-6780
A549::ZM447439
OACM5-1::Osimertinib
SK-MEL-30::Sepantronium bromide
A375::VX-11e
BHY::XAV939
ALL-SIL::Afatinib
NCI-H1650::Afatinib
RCC-ER::ZM447439
HCC70::Dabrafenib
FU-OV-1::I-BRD9
HuP-T3::Doramapimod
MONO-MAC-6::VX-11e
HCT-15::AZD7762
OVISE::Alisertib
A498::Doramapimod
RT4::Alisertib
DU-145::Dabrafenib
D-566MG::Cediranib
AsPC-1::Cediranib
SK-LMS-1::Foretinib
RCM-1::Avagacestat
EoL-1-cell::Motesanib
LXF-289::I-BRD9
NCI-H1792::AZD7762
IHH-4::Cediranib
BPH-1::Afatinib
SNU-175::Cediranib
OVMIU::Sepantronium bromide
MOLM-13::AGI-6780
HCC1599::AZD7762
EFM-192A::Sepantronium bromide
KATOIII::AGI-6780
AsPC-1::AGI-6780
SUP-B8::Alisertib
HCC2157::AZD7762
8-MG-BA::MK-8776
SK-MEL-3::Cediranib
KYSE-70::Telomerase Inhibitor IX
Hs-445::AGI-6780
HARA::AGI-6780
ESO51::MK-8776
EW-12::Doramapimod
KMS-11::XAV939
HPAC::Osimertinib
BICR78::Doramapimod
OVCA420::I-BRD9
NCI-H1651::XAV939
SW948::Telomerase Inhibitor IX
MM1S::I-BRD9
UACC-257::AZD7762
ACHN::Foretinib
BICR78::Telomerase Inhibitor IX
UWB1.289::Dabrafenib
NCI-H929::Doramapimod
DU-4475::XAV939
SW1271::MK-8776
SW1417::Telomerase Inhibitor IX
SN12C::Dabrafenib
SIG-M5::Dabrafenib
MES-SA::Cediranib
A2058::ZM447439
SW1710::ZM447439
WM-115::Motesanib
T47D::Avagacestat
COLO-678::MK-8776
KP-4::Sepantronium bromide
KYSE-220::VX-11e
SW1116::AGI-6780
TE-5::MK-8776
COLO-680N::Avagacestat
SNU-C5::AZD7762
OCI-AML2::Osimertinib
HCC1428::Sepantronium bromide
RCC-ER::VX-11e
8305C::Osimertinib
HCC1187::ZM447439
MFE-319::Alisertib
NCI-H2066::Telomerase Inhibitor IX
SK-MEL-5::MK-8776
COR-L32::Avagacestat
ETK-1::Telomerase Inhibitor IX
SK-N-DZ::Doramapimod
NCI-H2110::BX795
IGR-1::MK-8776
NCI-H64::VX-11e
C3A::I-BRD9
NCI-H196::AGI-6780
BICR31::Dabrafenib
IPC-298::Afatinib
NCI-H1563::MK-8776
ESS-1::VX-11e
LS-411N::Sepantronium bromide
CPC-N::AGI-6780
NCI-H250::Dabrafenib
WSU-NHL::Telomerase Inhibitor IX
NCI-H835::Telomerase Inhibitor IX
DMS-273::AGI-6780
MOLT-4::XAV939
NCI-H2444::Motesanib
OVK-18::I-BRD9
LC-2-ad::Telomerase Inhibitor IX
RCM-1::ZM447439
CAL-62::Dabrafenib
23132-87::Motesanib
NCI-H841::Alisertib
P31-FUJ::Afatinib
LN-18::Doramapimod
NCI-H28::Dabrafenib
DMS-53::XAV939
LB1047-RCC::Dabrafenib
RCC-JW::XAV939
U-698-M::VX-11e
CGTH-W-1::MK-8776
TE-5::AZD7762
HTC-C3::Foretinib
RPMI-7951::VX-11e
CHP-126::Foretinib
HPAC::Telomerase Inhibitor IX
A101D::Telomerase Inhibitor IX
OCUB-M::I-BRD9
SUIT-2::ZM447439
MONO-MAC-6::Motesanib
JHH-6::AZD7762
SW1990::Cediranib
OACp4C::Dabrafenib
DSH1::Motesanib
UACC-62::XAV939
A431::AZD7762
DND-41::Cediranib
MOG-G-CCM::VX-11e
T84::Motesanib
AN3-CA::Telomerase Inhibitor IX
SISO::Alisertib
SAT::VX-11e
SW872::MK-8776
NCI-H1436::Motesanib
ECC10::Alisertib
FADU::Foretinib
MN-60::Foretinib
COR-L88::VX-11e
OCUM-1::Telomerase Inhibitor IX
COLO-783::VX-11e
HOP-62::MK-8776
EW-12::MK-8776
AMO-1::Avagacestat
LN-18::Alisertib
RCC-AB::Cediranib
JHH-1::MK-8776
SNG-M::Osimertinib
no-10::Dabrafenib
BICR22::ZM447439
SK-CO-1::Afatinib
JHU-011::Sepantronium bromide
BV-173::AZD7762
SW626::Dabrafenib
SK-MEL-31::MK-8776
D-566MG::XAV939
DSH1::Telomerase Inhibitor IX
KGN::I-BRD9
DND-41::Alisertib
OSC-20::ZM447439
NCI-H1155::VX-11e
MONO-MAC-6::Alisertib
HCC1428::AZD7762
A3-KAW::Sepantronium bromide
KM12::MK-8776
CCRF-CEM::Motesanib
SCC-25::Doramapimod
NCI-H1694::Alisertib
SKM-1::ZM447439
CAL-29::AGI-6780
BL-41::AZD7762
HT55::Sepantronium bromide
COR-L279::Alisertib
EN::Afatinib
LB996-RCC::I-BRD9
EB2::Motesanib
OVCAR-4::Foretinib
HCT-15::Sepantronium bromide
LAN-6::Doramapimod
A427::Telomerase Inhibitor IX
VAL::MK-8776
SW1573::XAV939
RD::Cediranib
RF-48::Afatinib
NCI-H2347::AZD7762
KP-N-YN::Afatinib
SK-MEL-24::Doramapimod
NCI-H748::Alisertib
SK-MEL-1::Dabrafenib
RO82-W-1::Motesanib
OCI-AML2::Foretinib
OE33::MK-8776
KNS-62::Afatinib
D-423MG::Osimertinib
647-V::Alisertib
MOG-G-UVW::Dabrafenib
EFO-27::Doramapimod
SW13::Afatinib
EB-3::Sepantronium bromide
AM-38::Doramapimod
PANC-02-03::MK-8776
HOS::Alisertib
HCC2218::I-BRD9
NY::AZD7762
SNU-C2B::Cediranib
SU-DHL-4::Doramapimod
NCI-H1755::Foretinib
MOG-G-CCM::Doramapimod
LXF-289::Motesanib
RL::Afatinib
CFPAC-1::AGI-6780
LK-2::VX-11e
SK-MES-1::MK-8776
DSH1::Osimertinib
IGR-37::AGI-6780
SCC-9::Doramapimod
OS-RC-2::Motesanib
A4-Fuk::XAV939
KARPAS-231::Doramapimod
KYSE-50::Foretinib
CAS-1::Afatinib
NCI-H2228::Avagacestat
D-423MG::AZD7762
MZ1-PC::XAV939
KYSE-510::Afatinib
MOLT-4::AZD7762
NCI-H2009::AZD7762
NAMALWA::MK-8776
HARA::ZM447439
LOXIMVI::Alisertib
SISO::MK-8776
L-363::Dabrafenib
ML-2::Alisertib
RC-K8::VX-11e
JM1::Osimertinib
MEL-HO::Avagacestat
LU-139::Foretinib
SKG-IIIa::Afatinib
NCI-H1568::MK-8776
EN::Osimertinib
SCC-15::VX-11e
JHOS-4::ZM447439
NCI-H1838::Telomerase Inhibitor IX
TOV-112D::Osimertinib
D-336MG::Alisertib
COR-L23::ZM447439
SU-DHL-1::Dabrafenib
KU812::Doramapimod
UACC-257::Telomerase Inhibitor IX
KYSE-150::I-BRD9
EMC-BAC-2::AGI-6780
BE2-M17::Alisertib
huH-1::ZM447439
GI-1::AZD7762
YH-13::MK-8776
T47D::I-BRD9
LCLC-103H::AZD7762
ETK-1::Afatinib
HSC-39::Osimertinib
NEC8::Telomerase Inhibitor IX
JIMT-1::Dabrafenib
OVKATE::Afatinib
NCI-H747::AZD7762
Mo-T::VX-11e
CGTH-W-1::Avagacestat
PANC-08-13::Motesanib
EW-16::Foretinib
MM1S::Cediranib
GRANTA-519::Foretinib
EW-18::Alisertib
ECC10::MK-8776
BC-1::Doramapimod
AGS::ZM447439
JHU-029::Osimertinib
UACC-893::Foretinib
SW684::AZD7762
NB(TU)1-10::Osimertinib
SF539::Doramapimod
NCI-H510A::XAV939
HMV-II::MK-8776
KYSE-70::Doramapimod
639-V::ZM447439
BB65-RCC::I-BRD9
8-MG-BA::AZD7762
TE-11::Motesanib
NCI-H1869::Dabrafenib
CS1::Alisertib
LC-2-ad::Sepantronium bromide
COR-L32::ZM447439
SCC90::Osimertinib
HTC-C3::ZM447439
WSU-DLCL2::VX-11e
ESO51::Avagacestat
NCI-H1944::Avagacestat
HT-1197::I-BRD9
TGBC1TKB::Cediranib
JHOS-3::VX-11e
HLE::VX-11e
COR-L88::Afatinib
NCI-H810::AZD7762
BT-20::Dabrafenib
SH-4::I-BRD9
NCI-H647::Afatinib
GA-10::Osimertinib
NCI-H1836::MK-8776
KYSE-510::BX795
SU8686::Cediranib
HOP-62::Osimertinib
OVMIU::XAV939
EBC-1::AGI-6780
KYSE-180::Telomerase Inhibitor IX
HEC-1::MK-8776
TE-12::XAV939
KNS-81-FD::VX-11e
NB7::Foretinib
NCI-H28::Cediranib
CAL-33::I-BRD9
DSH1::ZM447439
MDA-MB-231::AGI-6780
A2058::AGI-6780
RL::I-BRD9
647-V::Osimertinib
U-118-MG::Sepantronium bromide
NCI-H1770::Osimertinib
SIMA::ZM447439
MFE-296::MK-8776
HDLM-2::Alisertib
NCI-H810::Dabrafenib
SW1573::Osimertinib
SK-N-AS::Dabrafenib
OCI-LY-19::Cediranib
KP-2::XAV939
TE-4::ZM447439
RCC-AB::Avagacestat
OCUB-M::Dabrafenib
JHH-2::Avagacestat
IPC-298::Foretinib
SW756::VX-11e
NCI-H1623::Foretinib
IGR-1::AZD7762
BICR10::MK-8776
DMS-114::Sepantronium bromide
HMV-II::Avagacestat
DMS-79::ZM447439
CAL-72::Alisertib
LC-1-sq::Sepantronium bromide
ChaGo-K-1::VX-11e
NCI-H250::Osimertinib
BEN::Dabrafenib
HT-29::BX795
451Lu::Doramapimod
no-10::I-BRD9
KNS-42::VX-11e
Hs-445::Dabrafenib
NUGC-3::AGI-6780
ROS-50::Foretinib
MOLP-8::Cediranib
M14::XAV939
JEG-3::Osimertinib
NMC-G1::Telomerase Inhibitor IX
IST-MES1::MK-8776
TT2609-C02::Cediranib
A2780::Afatinib
HT-29::Afatinib
PANC-03-27::Avagacestat
KP-3::I-BRD9
SN12C::Afatinib
5637::Dabrafenib
NB14::AZD7762
SK-MEL-3::Doramapimod
MS751::Foretinib
SW156::ZM447439
HuP-T4::Doramapimod
HA7-RCC::Avagacestat
CPC-N::Osimertinib
NCI-H929::Dabrafenib
NCI-H1836::AGI-6780
NCI-H28::XAV939
CP50-MEL-B::BX795
KY821::Motesanib
PCI-30::ZM447439
BL-41::ZM447439
BPH-1::Avagacestat
HOP-92::Osimertinib
UACC-257::Cediranib
NCI-H510A::Afatinib
NCI-H209::Dabrafenib
CAPAN-1::MK-8776
ES7::Telomerase Inhibitor IX
SU-DHL-5::Afatinib
SNG-M::Doramapimod
ESO26::AZD7762
HCC-78::AZD7762
P32-ISH::MK-8776
KON::Doramapimod
NOMO-1::AZD7762
L-540::Alisertib
IHH-4::Motesanib
LU-65::Alisertib
KP-N-YN::Foretinib
HSC-3::MK-8776
KNS-62::Foretinib
GR-ST::Osimertinib
CHSA8926::Avagacestat
Ca-Ski::Sepantronium bromide
RMG-I::ZM447439
HAL-01::ZM447439
WM793B::Telomerase Inhibitor IX
BL-41::I-BRD9
TE-5::AGI-6780
MHH-CALL-4::Doramapimod
769-P::AZD7762
SW626::I-BRD9
LoVo::AGI-6780
STS-0421::Afatinib
ChaGo-K-1::Motesanib
VAL::ZM447439
KYSE-220::Sepantronium bromide
NCI-H727::Foretinib
HO-1-u-1::AZD7762
no-10::Doramapimod
DMS-79::Cediranib
KURAMOCHI::Doramapimod
SUP-M2::VX-11e
SNU-387::Foretinib
HOP-62::Avagacestat
HCC1428::XAV939
A3-KAW::VX-11e
EW-11::ZM447439
MKN28::AGI-6780
PA-TU-8988T::Alisertib
NB(TU)1-10::AGI-6780
JiyoyeP-2003::Afatinib
MHH-CALL-2::Doramapimod
TE-12::Osimertinib
L-1236::Dabrafenib
GR-ST::Cediranib
NCI-H2228::ZM447439
NCI-H1781::Afatinib
HTC-C3::XAV939
LCLC-103H::Telomerase Inhibitor IX
NCI-H2228::VX-11e
A2780::MK-8776
CTV-1::ZM447439
KLE::Alisertib
ESO51::Afatinib
HARA::MK-8776
OVTOKO::Sepantronium bromide
CL-11::Cediranib
LXF-289::VX-11e
Caov-4::Dabrafenib
IGR-37::ZM447439
JURL-MK1::VX-11e
COR-L279::Doramapimod
JiyoyeP-2003::AGI-6780
OPM-2::Afatinib
NAMALWA::Sepantronium bromide
TE-9::Dabrafenib
TK10::Alisertib
JSC-1::AGI-6780
NCI-H3122::MK-8776
MEG-01::Telomerase Inhibitor IX
U031::VX-11e
UWB1.289::Alisertib
GI-ME-N::AGI-6780
AMO-1::ZM447439
HSC-39::Sepantronium bromide
MDA-MB-468::MK-8776
KLE::Avagacestat
CaR-1::Doramapimod
NB6::Osimertinib
NCI-H250::AZD7762
HT-29::Osimertinib
Farage::AGI-6780
KYSE-520::Motesanib
HT55::Motesanib
FTC-133::I-BRD9
SKM-1::XAV939
D-502MG::Dabrafenib
CFPAC-1::AZD7762
L-428::Cediranib
SK-MEL-3::Foretinib
COLO-680N::Dabrafenib
EFO-27::ZM447439
MRK-nu-1::I-BRD9
TOV-112D::Telomerase Inhibitor IX
NCI-H1770::MK-8776
BC-1::Sepantronium bromide
LB647-SCLC::Doramapimod
KYSE-50::Dabrafenib
NCI-H1876::Alisertib
JHU-022::Osimertinib
NCI-H838::I-BRD9
SU-DHL-5::I-BRD9
HCC2157::AGI-6780
CRO-AP2::AGI-6780
NH-12::Telomerase Inhibitor IX
GR-ST::Sepantronium bromide
CAL-148::Afatinib
NCI-H2087::Avagacestat
COLO-800::Foretinib
TE-1::AZD7762
ONS-76::MK-8776
L-540::Afatinib
RVH-421::Afatinib
8505C::AZD7762
DK-MG::XAV939
UACC-257::Sepantronium bromide
MEL-JUSO::Motesanib
NCI-H2170::Dabrafenib
AMO-1::Dabrafenib
Hs-445::Avagacestat
KMRC-1::MK-8776
KYSE-450::XAV939
IGROV-1::ZM447439
CP66-MEL::Telomerase Inhibitor IX
NCI-H716::Avagacestat
SNU-283::VX-11e
PA-TU-8902::XAV939
ROS-50::BX795
SU-DHL-4::Foretinib
AN3-CA::Motesanib
MEL-HO::AZD7762
RCH-ACV::ZM447439
MOLM-16::I-BRD9
D-283MED::Osimertinib
QGP-1::Motesanib
TK::Doramapimod
SNU-387::Sepantronium bromide
JHOS-2::ZM447439
TE-11::Osimertinib
GRANTA-519::XAV939
NB5::Osimertinib
A2780::Motesanib
SW872::XAV939
NCI-H64::Dabrafenib
YAPC::Alisertib
EW-22::I-BRD9
SKN-3::Motesanib
JEKO-1::Telomerase Inhibitor IX
NCI-H28::Afatinib
SNB75::AZD7762
UM-UC-3::Afatinib
KARPAS-299::AGI-6780
SR::Doramapimod
PL-21::Foretinib
VA-ES-BJ::Avagacestat
NB(TU)1-10::Afatinib
EW-7::Afatinib
SNB75::ZM447439
no-11::ZM447439
A431::Telomerase Inhibitor IX
SNB75::MK-8776
NB13::XAV939
OV-7::MK-8776
LB996-RCC::Doramapimod
SBC-5::Afatinib
MS-1::Motesanib
OC-314::Alisertib
SUP-T1::Dabrafenib
VCaP::AZD7762
MOLT-16::XAV939
EB2::MK-8776
SK-N-AS::Telomerase Inhibitor IX
PCI-6A::AGI-6780
no-11::Telomerase Inhibitor IX
KON::ZM447439
SU-DHL-6::Dabrafenib
MKN45::Alisertib
NEC8::Cediranib
PSN1::Cediranib
ES8::XAV939
KMS-12-BM::VX-11e
U251::Motesanib
DAN-G::Avagacestat
RH-1::Dabrafenib
SU8686::AZD7762
SNU-81::Motesanib
SNU-C2B::ZM447439
PC-3::Telomerase Inhibitor IX
SU-DHL-5::AZD7762
TCCSUP::Cediranib
BFTC-909::AGI-6780
HCC1395::Alisertib
SK-N-FI::Alisertib
NCI-H524::Alisertib
TE-4::Cediranib
Raji::VX-11e
A101D::Afatinib
IM-9::MK-8776
HEC-1::Afatinib
LOU-NH91::AGI-6780
BHT-101::Afatinib
DMS-79::Doramapimod
HT55::Doramapimod
OPM-2::Cediranib
UACC-893::Osimertinib
BC-1::VX-11e
HCC1954::Afatinib
NCI-H82::Avagacestat
GAMG::Afatinib
NCI-H82::Foretinib
DOK::Motesanib
JHH-7::AZD7762
HPAF-II::Alisertib
ATN-1::Dabrafenib
KYSE-150::Motesanib
NCI-H647::XAV939
Detroit562::Avagacestat
SK-OV-3::VX-11e
GOTO::XAV939
SKN-3::AZD7762
EB-3::AZD7762
NCI-H929::Foretinib
LAMA-84::I-BRD9
ChaGo-K-1::XAV939
DOV13::I-BRD9
NCI-H1693::Doramapimod
HO-1-N-1::Osimertinib
NCI-H345::Cediranib
OV-17R::Afatinib
ESS-1::Afatinib
NCI-H1581::AGI-6780
SF539::Osimertinib
GOTO::Osimertinib
QGP-1::Osimertinib
NCI-H650::VX-11e
SUP-T1::Avagacestat
KMRC-1::Motesanib
COR-L32::Cediranib
GA-10::Alisertib
EW-3::Foretinib
D-566MG::AZD7762
OVCAR-5::ZM447439
SW872::Dabrafenib
HGC-27::XAV939
LNZTA3WT4::ZM447439
HuO9::Osimertinib
K5::Alisertib
D-263MG::Afatinib
HCC1187::I-BRD9
SCC-9::Osimertinib
JEG-3::MK-8776
SK-CO-1::Telomerase Inhibitor IX
TGBC11TKB::Motesanib
HSC-39::Avagacestat
SUP-M2::Sepantronium bromide
DG-75::Motesanib
NCI-H661::I-BRD9
OVCAR-5::I-BRD9
PC-14::Alisertib
TE-9::XAV939
IPC-298::VX-11e
MFE-280::I-BRD9
HSC-4::XAV939
ECC12::Motesanib
T98G::XAV939
CRO-AP2::Dabrafenib
OV-7::I-BRD9
YH-13::Alisertib
SK-MEL-24::Alisertib
IPC-298::Avagacestat
C32::ZM447439
COLO-800::BX795
SNU-81::Telomerase Inhibitor IX
OVCAR-4::AZD7762
MKN1::Dabrafenib
OCUB-M::AZD7762
OVKATE::Alisertib
RCC-JW::Motesanib
U-2-OS::AGI-6780
BT-549::XAV939
SK-MEL-31::BX795
NCI-H1563::Dabrafenib
NCI-H1563::Foretinib
JHU-029::Alisertib
NCI-H1836::Telomerase Inhibitor IX
GCT::Dabrafenib
EPLC-272H::Cediranib
HuO-3N1::AZD7762
TE-9::Afatinib
YKG-1::Alisertib
NOS-1::Alisertib
DOK::Cediranib
SNU-283::Alisertib
HCT-116::Telomerase Inhibitor IX
NU-DUL-1::Telomerase Inhibitor IX
JHH-1::Cediranib
SU8686::Avagacestat
QIMR-WIL::Avagacestat
COR-L32::XAV939
ECC12::Avagacestat
NCI-N87::AZD7762
A427::Osimertinib
JHH-4::XAV939
UMC-11::Sepantronium bromide
SLVL::Foretinib
EFM-192A::MK-8776
ES-2::Doramapimod
SU8686::Dabrafenib
A101D::I-BRD9
SK-N-DZ::Foretinib
MFE-296::Cediranib
KMS-11::BX795
ES4::Telomerase Inhibitor IX
SW1116::Doramapimod
MOLM-16::Foretinib
TE-10::Dabrafenib
639-V::Telomerase Inhibitor IX
BT-549::Motesanib
ME-1::MK-8776
BL-41::Cediranib
NCI-H2087::ZM447439
KATOIII::Motesanib
BB30-HNC::VX-11e
RT4::Foretinib
MCF7::Cediranib
NCI-H2347::VX-11e
JIMT-1::XAV939
HSC-3::Afatinib
NB5::I-BRD9
HOP-92::Sepantronium bromide
G-401::Foretinib
SU-DHL-6::Alisertib
BE-13::Foretinib
SW13::Sepantronium bromide
HCC2998::VX-11e
GRANTA-519::Afatinib
NCI-H322M::Osimertinib
OCI-LY7::Telomerase Inhibitor IX
NCI-H226::Sepantronium bromide
TT::Cediranib
COR-L321::AZD7762
MCF7::Alisertib
BT-20::I-BRD9
LCLC-97TM1::Doramapimod
HCC1569::Alisertib
VA-ES-BJ::Osimertinib
JEG-3::VX-11e
SW837::ZM447439
huH-1::Foretinib
LU-139::VX-11e
HCC1599::Alisertib
IGROV-1::VX-11e
CHSA8926::VX-11e
ES8::Motesanib
HPAC::Alisertib
JIMT-1::Afatinib
DOHH-2::ZM447439
NCI-H358::Cediranib
RERF-GC-1B::Avagacestat
AU565::Osimertinib
SCC-4::Avagacestat
SUP-B8::AZD7762
RCC-FG2::BX795
EPLC-272H::I-BRD9
TYK-nu::Cediranib
WSU-DLCL2::Sepantronium bromide
MEG-01::ZM447439
QGP-1::Doramapimod
NCI-H1355::Avagacestat
NCI-H345::BX795
KARPAS-1106P::Alisertib
CAPAN-1::AZD7762
CS1::Motesanib
BEN::Osimertinib
KNS-42::Avagacestat
JSC-1::Afatinib
K-562::Afatinib
EW-22::Sepantronium bromide
NCI-H1092::AZD7762
Jurkat::Osimertinib
OS-RC-2::Foretinib
HCC70::Alisertib
MDA-MB-415::I-BRD9
ML-1::BX795
GP5d::AGI-6780
LB996-RCC::Sepantronium bromide
KMRC-1::Avagacestat
K2::Sepantronium bromide
HSC-2::AZD7762
NB14::Doramapimod
EW-1::Cediranib
SF539::AGI-6780
RXF393::Telomerase Inhibitor IX
DMS-79::Dabrafenib
NB12::AZD7762
AsPC-1::XAV939
OVCAR-5::Telomerase Inhibitor IX
NCCIT::Motesanib
BB30-HNC::Cediranib
LXF-289::Sepantronium bromide
LXF-289::Afatinib
OE33::Avagacestat
EPLC-272H::Afatinib
NUGC-4::XAV939
NCI-H1734::AZD7762
HO-1-N-1::Motesanib
GI-ME-N::Telomerase Inhibitor IX
HCC2218::Sepantronium bromide
CAPAN-1::Sepantronium bromide
MZ2-MEL::MK-8776
JURL-MK1::Doramapimod
TK10::AZD7762
LB647-SCLC::AZD7762
NCI-H2052::MK-8776
NCI-H520::Sepantronium bromide
KYAE-1::AZD7762
TT2609-C02::Motesanib
PL-21::Cediranib
SCC90::Avagacestat
CHL-1::Sepantronium bromide
Ca9-22::XAV939
SW1463::Osimertinib
A253::AZD7762
ESO51::ZM447439
EFO-21::Osimertinib
SW1463::ZM447439
NY::I-BRD9
HARA::Alisertib
C-33-A::AZD7762
SW948::Dabrafenib
TE-6::Sepantronium bromide
NCI-H2444::Osimertinib
JIMT-1::ZM447439
MC116::Osimertinib
HCC2157::Afatinib
T-T::Osimertinib
SIG-M5::Afatinib
SNU-C1::Doramapimod
FLO-1::Doramapimod
RCH-ACV::XAV939
SK-N-SH::Osimertinib
DBTRG-05MG::VX-11e
NCI-H2135::BX795
HT-1376::Dabrafenib
SF539::Telomerase Inhibitor IX
ECC12::Alisertib
NCI-H841::Motesanib
KP-2::Afatinib
KON::AGI-6780
NB10::Motesanib
PANC-04-03::AZD7762
U-2-OS::Dabrafenib
RPMI-7951::Doramapimod
TE-4::Alisertib
AMO-1::AGI-6780
NCI-H69::Afatinib
EW-24::Cediranib
CAL-29::Cediranib
LCLC-103H::Motesanib
JIMT-1::Doramapimod
ES7::Motesanib
ABC-1::AGI-6780
NCI-H196::Telomerase Inhibitor IX
CAMA-1::Osimertinib
MFM-223::MK-8776
JHU-029::Doramapimod
MZ7-mel::Afatinib
MEG-01::AGI-6780
CW-2::Osimertinib
MHH-CALL-4::AGI-6780
ES5::Afatinib
KASUMI-1::VX-11e
CP50-MEL-B::VX-11e
NCI-H520::ZM447439
HTC-C3::AGI-6780
JHH-2::XAV939
NCI-H1436::AZD7762
COLO-829::Avagacestat
MOG-G-CCM::Osimertinib
SNU-C1::Telomerase Inhibitor IX
SW962::AZD7762
AGS::Foretinib
EW-11::XAV939
TE-8::Cediranib
K5::Foretinib
T98G::AGI-6780
SNU-407::Alisertib
ESO51::Foretinib
HuH-7::Foretinib
EB-3::Avagacestat
SF268::AZD7762
NCI-H28::Foretinib
HOP-62::Dabrafenib
MOLT-13::AZD7762
K5::Cediranib
MHH-CALL-4::VX-11e
TOV-21G::Doramapimod
CAL-29::Sepantronium bromide
MOLT-4::Cediranib
PANC-04-03::Telomerase Inhibitor IX
CCRF-CEM::Sepantronium bromide
HCC1428::I-BRD9
Hs-578-T::AGI-6780
MC116::AGI-6780
CHP-212::Motesanib
MFH-ino::Cediranib
HCC-78::Motesanib
KM12::Alisertib
DMS-79::AGI-6780
NCI-H841::Osimertinib
KYSE-50::VX-11e
CAL-85-1::Osimertinib
NCI-H727::Sepantronium bromide
NCI-H1792::Dabrafenib
BE-13::AGI-6780
MDA-MB-415::VX-11e
CAL-54::Cediranib
P30-OHK::Doramapimod
CESS::Avagacestat
L-1236::Motesanib
EFO-27::Avagacestat
SKG-IIIa::Foretinib
LB831-BLC::MK-8776
COR-L311::Telomerase Inhibitor IX
GRANTA-519::Doramapimod
ML-1::VX-11e
NCI-H740::Dabrafenib
SNU-407::XAV939
NCI-H211::Doramapimod
KARPAS-45::Afatinib
NCI-N87::VX-11e
PANC-10-05::XAV939
SK-CO-1::Foretinib
SK-MEL-30::VX-11e
NKM-1::Cediranib
YH-13::VX-11e
H4::Osimertinib
SF126::Osimertinib
A4-Fuk::Motesanib
D-283MED::Dabrafenib
WSU-NHL::Avagacestat
PL4::Cediranib
OVCAR-3::Foretinib
OCI-AML3::Doramapimod
SH-4::Telomerase Inhibitor IX
MDA-MB-468::Telomerase Inhibitor IX
LU-99A::Foretinib
COR-L303::Telomerase Inhibitor IX
QIMR-WIL::Telomerase Inhibitor IX
CAL-39::Osimertinib
SAT::AZD7762
TGW::Foretinib
KELLY::Avagacestat
PANC-02-03::Alisertib
ROS-50::Dabrafenib
EFO-27::AGI-6780
ES1::Motesanib
RCC-JF::Motesanib
MLMA::Osimertinib
RCC-JW::Alisertib
MDA-MB-453::AZD7762
HOP-62::Foretinib
EFM-19::I-BRD9
DBTRG-05MG::I-BRD9
EMC-BAC-2::Telomerase Inhibitor IX
DMS-79::Avagacestat
NMC-G1::XAV939
CAL-120::Osimertinib
GCIY::I-BRD9
ALL-PO::Sepantronium bromide
NCI-H64::Afatinib
LAMA-84::Sepantronium bromide
MS-1::AGI-6780
RC-K8::AZD7762
OV-7::Motesanib
MOG-G-UVW::MK-8776
SW837::Osimertinib
TE-1::MK-8776
HCC1395::VX-11e
BE2-M17::Telomerase Inhibitor IX
NCI-H2023::AGI-6780
CAL-54::XAV939
TYK-nu::I-BRD9
EM-2::Foretinib
SW1463::AGI-6780
HCC1937::Afatinib
KINGS-1::Avagacestat
DMS-114::Cediranib
OCUB-M::Alisertib
HCC1500::Telomerase Inhibitor IX
NCI-H2029::Avagacestat
SU-DHL-10::MK-8776
TE-6::Alisertib
OCI-M1::ZM447439
P32-ISH::AGI-6780
RPMI-7951::Telomerase Inhibitor IX
SKM-1::Foretinib
SUP-M2::Dabrafenib
LS-180::Doramapimod
MDA-MB-157::AGI-6780
COLO-684::Dabrafenib
H3255::MK-8776
KARPAS-1106P::AZD7762
KYAE-1::Avagacestat
UACC-893::Sepantronium bromide
HPAC::Doramapimod
SLVL::VX-11e
NCI-H740::Avagacestat
ROS-50::XAV939
SUP-HD1::Alisertib
COLO-829::Doramapimod
HGC-27::Motesanib
NCI-H2110::AGI-6780
GI-1::XAV939
RCC-JF::BX795
LCLC-97TM1::MK-8776
COLO-678::VX-11e
NCI-H520::Osimertinib
SK-MEL-2::AZD7762
L-363::Motesanib
RMG-I::Motesanib
SNU-387::MK-8776
RCC-ER::I-BRD9
STS-0421::Cediranib
MOLP-8::Dabrafenib
DMS-53::Motesanib
ME-180::VX-11e
NCI-H2029::BX795
ML-1::XAV939
SJRH30::Telomerase Inhibitor IX
DJM-1::Foretinib
CS1::Cediranib
HCC-827::I-BRD9
SU-DHL-8::Dabrafenib
OCI-M1::Alisertib
HT-3::Telomerase Inhibitor IX
EFM-19::VX-11e
NCI-H2347::Motesanib
CTV-1::Osimertinib
ESO51::AZD7762
HCC1395::Dabrafenib
COLO-800::Sepantronium bromide
HGC-27::Osimertinib
HDLM-2::Avagacestat
42-MG-BA::Telomerase Inhibitor IX
A375::Afatinib
COLO-824::Motesanib
SCC-3::AZD7762
SNU-61::Osimertinib
HCC1569::XAV939
NB17::Osimertinib
BL-41::Motesanib
LOXIMVI::AGI-6780
SK-N-AS::Alisertib
NCI-H209::Alisertib
G-MEL::ZM447439
HCC1143::Afatinib
MSTO-211H::AGI-6780
EB2::I-BRD9
NCI-H650::XAV939
NCI-H322M::Afatinib
MDA-MB-157::Cediranib
HAL-01::Foretinib
NOMO-1::AGI-6780
LU-135::VX-11e
WM35::Telomerase Inhibitor IX
PANC-02-03::Dabrafenib
Detroit562::VX-11e
BEN::AGI-6780
CS1::AGI-6780
OE21::AGI-6780
SCC-3::XAV939
RCC10RGB::Foretinib
SIMA::AZD7762
ES7::Doramapimod
RCM-1::Telomerase Inhibitor IX
COR-L105::AGI-6780
SCC-9::Sepantronium bromide
COLO-680N::Telomerase Inhibitor IX
D-336MG::Dabrafenib
MC116::Motesanib
HOS::Avagacestat
KYSE-220::AZD7762
BE-13::MK-8776
HEC-1::Telomerase Inhibitor IX
NCI-H1781::AZD7762
BV-173::Avagacestat
SK-MEL-28::Afatinib
JVM-3::Osimertinib
NU-DUL-1::Alisertib
DBTRG-05MG::Motesanib
CESS::Foretinib
DSH1::Alisertib
SK-ES-1::AGI-6780
IM-95::Sepantronium bromide
A375::ZM447439
BT-20::Telomerase Inhibitor IX
CADO-ES1::Sepantronium bromide
MDA-MB-436::Doramapimod
KMOE-2::Telomerase Inhibitor IX
HT-1197::Doramapimod
TE-11::Avagacestat
EPLC-272H::Doramapimod
NCI-H1792::Osimertinib
SUP-B15::Afatinib
KCL-22::Motesanib
TOV-112D::Foretinib
TUR::ZM447439
COR-L311::Osimertinib
HCC-44::Dabrafenib
YH-13::Motesanib
SK-N-FI::AZD7762
LB2518-MEL::Doramapimod
LB647-SCLC::I-BRD9
BE2-M17::AZD7762
PL-21::Motesanib
P30-OHK::Cediranib
M14::VX-11e
CAL-62::Motesanib
NCI-H1963::AZD7762
EKVX::Telomerase Inhibitor IX
MHH-CALL-2::Dabrafenib
NCI-H524::Telomerase Inhibitor IX
SK-MEL-24::Afatinib
KARPAS-422::AGI-6780
YT::Doramapimod
CTB-1::Telomerase Inhibitor IX
NCI-H1092::AGI-6780
GP5d::Foretinib
HOP-62::VX-11e
U-87-MG::Dabrafenib
KMOE-2::XAV939
MOLP-8::Foretinib
SW954::Osimertinib
NOMO-1::Afatinib
HTC-C3::Afatinib
NCI-H661::AGI-6780
SW684::Cediranib
RKN::Telomerase Inhibitor IX
EBC-1::Avagacestat
EW-1::AGI-6780
NCI-H2066::Doramapimod
CAL-39::Telomerase Inhibitor IX
HCC2998::XAV939
HCC-366::Telomerase Inhibitor IX
OE19::Motesanib
OVISE::ZM447439
HOP-62::Motesanib
T-T::Afatinib
NCI-H1341::I-BRD9
A2058::Avagacestat
639-V::Osimertinib
CHSA0011::Avagacestat
MZ7-mel::Osimertinib
NCI-H716::VX-11e
GAK::Motesanib
KELLY::XAV939
ME-180::Osimertinib
H9::AGI-6780
BPH-1::AZD7762
SK-N-FI::Cediranib
L-1236::Avagacestat
CESS::AZD7762
KYSE-220::Alisertib
NCI-H1836::XAV939
SK-MEL-3::AZD7762
COLO-680N::AGI-6780
647-V::VX-11e
SW620::Dabrafenib
RCH-ACV::Doramapimod
NCI-H2023::Telomerase Inhibitor IX
U-87-MG::Telomerase Inhibitor IX
KARPAS-45::AGI-6780
K-562::Dabrafenib
NCI-H2227::Doramapimod
NCI-H1693::AZD7762
8305C::ZM447439
MCF7::MK-8776
MDA-MB-415::Motesanib
NB17::Telomerase Inhibitor IX
SK-MM-2::Alisertib
KYSE-50::Cediranib
KE-37::Avagacestat
KARPAS-299::Motesanib
NCI-H1105::Motesanib
GDM-1::I-BRD9
huH-1::I-BRD9
NCI-H292::Afatinib
SK-N-AS::AGI-6780
C3A::Alisertib
HT-29::Alisertib
HCC1954::Cediranib
HPAC::VX-11e
NCI-H1568::Motesanib
WM1552C::Alisertib
SR::Avagacestat
SW13::Osimertinib
T47D::Doramapimod
MES-SA::XAV939
A704::Telomerase Inhibitor IX
SNU-423::Osimertinib
KARPAS-299::Doramapimod
C32::Afatinib
PANC-02-03::Foretinib
OE21::Osimertinib
D-283MED::Telomerase Inhibitor IX
COR-L303::I-BRD9
MCF7::Doramapimod
NCI-H2087::I-BRD9
KP-1N::MK-8776
SISO::Sepantronium bromide
NCC021::Motesanib
DOV13::ZM447439
BALL-1::VX-11e
LCLC-103H::Avagacestat
EPLC-272H::AGI-6780
NCI-H2347::Cediranib
RVH-421::XAV939
CCK-81::AGI-6780
MC116::Doramapimod
SUIT-2::Telomerase Inhibitor IX
MOLT-4::AGI-6780
OVMIU::VX-11e
SCC-15::AZD7762
AsPC-1::Dabrafenib
CML-T1::ZM447439
OC-314::MK-8776
SNU-387::Cediranib
NALM-6::Sepantronium bromide
CCRF-CEM::Foretinib
G-402::I-BRD9
LU-134-A::Afatinib
A704::AGI-6780
AMO-1::Sepantronium bromide
KOSC-2::XAV939
NCI-H835::Osimertinib
NCI-H838::Dabrafenib
A3-KAW::Telomerase Inhibitor IX
TC-YIK::Foretinib
KON::I-BRD9
NMC-G1::Afatinib
CaR-1::ZM447439
ME-1::Dabrafenib
NCI-H1975::Doramapimod
YH-13::AGI-6780
JAR::BX795
Raji::Motesanib
TGW::VX-11e
C-4-I::MK-8776
A172::Cediranib
HPAF-II::Dabrafenib
GI-1::Cediranib
CRO-AP2::I-BRD9
CAL-51::AGI-6780
SW1783::VX-11e
U-87-MG::XAV939
EC-GI-10::I-BRD9
ASH-3::Foretinib
DBTRG-05MG::AZD7762
JHH-2::I-BRD9
MFE-319::Osimertinib
JHU-029::VX-11e
Hs-445::Alisertib
DOK::Foretinib
RL95-2::Alisertib
NCI-H1299::MK-8776
HT-115::Doramapimod
BPH-1::Alisertib
NB6::Doramapimod
CCK-81::Afatinib
HCC2157::Cediranib
Ramos-2G6-4C10::AZD7762
SK-GT-2::AZD7762
TC-YIK::AZD7762
MFE-319::Doramapimod
LU-134-A::Telomerase Inhibitor IX
HCC2218::Motesanib
SK-PN-DW::VX-11e
A375::Doramapimod
NUGC-4::Alisertib
MRK-nu-1::AGI-6780
HGC-27::AGI-6780
OE21::Avagacestat
BHY::MK-8776
OCI-AML5::Alisertib
huH-1::Cediranib
OE21::ZM447439
HuP-T4::Afatinib
NCI-H2110::Alisertib
OACM5-1::Motesanib
42-MG-BA::Motesanib
RH-41::VX-11e
HO-1-N-1::MK-8776
ONS-76::Alisertib
MHH-PREB-1::AZD7762
HDLM-2::Dabrafenib
RPMI-8226::AGI-6780
H9::Sepantronium bromide
KYSE-520::XAV939
NCI-H1792::Motesanib
C3A::AZD7762
QIMR-WIL::Cediranib
NB12::Foretinib
OCI-AML2::AZD7762
DU-145::Motesanib
SW948::I-BRD9
DSH1::VX-11e
NCI-H1048::ZM447439
JHU-011::BX795
BB49-HNC::Telomerase Inhibitor IX
DU-4475::ZM447439
MS-1::Doramapimod
NUGC-3::XAV939
TE-11::AGI-6780
HEL::ZM447439
HARA::AZD7762
HT55::Foretinib
BL-41::VX-11e
NCI-H1963::XAV939
JiyoyeP-2003::ZM447439
BHT-101::Doramapimod
TGBC11TKB::Sepantronium bromide
Ca9-22::Alisertib
HT-1080::Sepantronium bromide
NCI-H2444::AGI-6780
IM-95::MK-8776
M14::Afatinib
D-566MG::Foretinib
KURAMOCHI::XAV939
NCI-H1436::Foretinib
G-361::Dabrafenib
OV-90::Dabrafenib
SNU-449::ZM447439
JHOS-3::Motesanib
U-2-OS::Telomerase Inhibitor IX
T47D::Foretinib
PL-21::Afatinib
IST-MES1::ZM447439
NCI-H1648::Foretinib
LK-2::AZD7762
OVCAR-3::Cediranib
D-392MG::Osimertinib
NCI-H196::VX-11e
NCC010::Afatinib
SU-DHL-16::BX795
GCT::Foretinib
KOPN-8::Foretinib
H9::I-BRD9
L-363::Avagacestat
A427::BX795
EW-13::Afatinib
EKVX::Avagacestat
YKG-1::BX795
PANC-10-05::AZD7762
CHP-134::Alisertib
EW-16::Cediranib
HCC1599::Sepantronium bromide
A3-KAW::Cediranib
KMOE-2::AGI-6780
WM278::AGI-6780
SIG-M5::Osimertinib
8505C::MK-8776
OACM5-1::Telomerase Inhibitor IX
NKM-1::Osimertinib
HT-144::MK-8776
NCI-H2196::Doramapimod
SK-MEL-28::VX-11e
WM278::Osimertinib
EoL-1-cell::Afatinib
NUGC-4::I-BRD9
T47D::XAV939
GRANTA-519::VX-11e
SK-LU-1::Dabrafenib
HCC1143::Sepantronium bromide
Daudi::Foretinib
SW1710::Avagacestat
NCI-H2135::XAV939
WM-115::AGI-6780
A2780::VX-11e
SKG-IIIa::Alisertib
WM793B::Motesanib
VA-ES-BJ::Cediranib
ME-180::I-BRD9
OCI-AML5::VX-11e
HCC70::XAV939
GR-ST::AGI-6780
NCI-H1876::Avagacestat
SCC-3::I-BRD9
SCC-4::Dabrafenib
CS1::AZD7762
NCI-H2405::Alisertib
C32::Osimertinib
HSC-39::MK-8776
CHL-1::Avagacestat
BB30-HNC::Avagacestat
PCI-30::Motesanib
BT-20::XAV939
RERF-GC-1B::Motesanib
ARH-77::Foretinib
Daoy::Cediranib
RERF-LC-MS::Cediranib
HCC1806::Foretinib
PL4::MK-8776
KOPN-8::AGI-6780
PANC-03-27::Telomerase Inhibitor IX
NEC8::XAV939
NALM-6::Cediranib
MFM-223::Afatinib
JHOS-3::Sepantronium bromide
Calu-6::AZD7762
NCI-H647::MK-8776
KYSE-70::AGI-6780
ES6::MK-8776
HMV-II::Alisertib
SU-DHL-1::AGI-6780
SW872::Motesanib
NALM-6::VX-11e
SNB75::Sepantronium bromide
CHSA0011::Sepantronium bromide
UWB1.289::Telomerase Inhibitor IX
SK-MEL-5::XAV939
RERF-LC-Sq1::I-BRD9
RERF-LC-Sq1::Afatinib
8-MG-BA::Telomerase Inhibitor IX
ChaGo-K-1::Doramapimod
ST486::AGI-6780
NCI-H524::AZD7762
SK-MEL-2::Afatinib
EW-24::AZD7762
CaR-1::AGI-6780
L-363::I-BRD9
MKN7::MK-8776
SU-DHL-6::ZM447439
MDA-MB-361::Doramapimod
IST-SL2::Foretinib
NCI-H3122::Telomerase Inhibitor IX
NB7::Doramapimod
MDA-MB-453::Osimertinib
HPAF-II::Foretinib
NB6::I-BRD9
ESS-1::MK-8776
NMC-G1::I-BRD9
PA-TU-8902::Dabrafenib
RERF-LC-Sq1::Alisertib
RCC-AB::ZM447439
LOXIMVI::Motesanib
NCI-H1793::VX-11e
8-MG-BA::Foretinib
ONS-76::Osimertinib
NCI-H1734::Sepantronium bromide
BICR10::I-BRD9
ESO26::Alisertib
KYSE-70::XAV939
SW1710::Alisertib
MFH-ino::VX-11e
EMC-BAC-2::XAV939
NCI-H2030::ZM447439
NB12::Alisertib
NB5::Doramapimod
MOLT-4::Motesanib
A101D::Avagacestat
CAL-78::Sepantronium bromide
RH-41::ZM447439
NCI-H196::Cediranib
VCaP::Alisertib
CS1::Osimertinib
L-540::Dabrafenib
OVCAR-8::XAV939
NU-DUL-1::Sepantronium bromide
RPMI-8402::AZD7762
SW948::Cediranib
J82::Dabrafenib
D-247MG::BX795
SK-N-SH::Foretinib
NCI-H2066::AZD7762
647-V::Afatinib
LAMA-84::ZM447439
IST-SL1::Telomerase Inhibitor IX
OE19::Alisertib
NCI-H2172::BX795
NCI-H1435::Alisertib
SU-DHL-8::AGI-6780
RCM-1::Foretinib
HOS::AZD7762
LU-135::Afatinib
TE-10::Doramapimod
SW1783::Dabrafenib
ATN-1::AZD7762
D-502MG::Avagacestat
CCK-81::Doramapimod
NCI-H1573::Afatinib
DG-75::XAV939
BICR78::AGI-6780
C3A::XAV939
RO82-W-1::Alisertib
EBC-1::VX-11e
MOLT-13::AGI-6780
SU-DHL-6::VX-11e
NCI-H2172::Cediranib
SHP-77::Telomerase Inhibitor IX
OV-17R::Motesanib
ECC10::Afatinib
CHP-126::I-BRD9
CAL-39::Foretinib
NY::Afatinib
NCI-H720::MK-8776
RS4-11::Sepantronium bromide
C-4-I::Avagacestat
NCI-H345::ZM447439
HCC1187::Foretinib
NCI-H23::ZM447439
BHY::Afatinib
SK-MEL-28::Dabrafenib
SW982::Telomerase Inhibitor IX
KY821::VX-11e
TGBC24TKB::Motesanib
LB2241-RCC::Alisertib
H9::ZM447439
8505C::Foretinib
SIMA::VX-11e
YKG-1::Avagacestat
ES4::ZM447439
A101D::Motesanib
GAMG::I-BRD9
H4::Telomerase Inhibitor IX
ChaGo-K-1::Foretinib
SNU-C1::Motesanib
LS-180::Foretinib
OS-RC-2::Alisertib
K5::AZD7762
KG-1::MK-8776
TCCSUP::Foretinib
P31-FUJ::I-BRD9
NCI-H2009::Avagacestat
CCK-81::ZM447439
CAKI-1::BX795
RO82-W-1::Doramapimod
SW780::XAV939
PWR-1E::MK-8776
KMRC-1::Doramapimod
HCT-15::Cediranib
Daudi::VX-11e
LC4-1::Foretinib
U-2-OS::Doramapimod
KELLY::MK-8776
Calu-6::XAV939
RCC-ER::Cediranib
QIMR-WIL::BX795
NAMALWA::I-BRD9
SK-LU-1::Sepantronium bromide
PF-382::AGI-6780
HT-3::Avagacestat
SW756::I-BRD9
U251::I-BRD9
QIMR-WIL::Motesanib
NB7::Afatinib
KY821::XAV939
COR-L32::Afatinib
SW837::Afatinib
SF268::Foretinib
CAL-12T::Doramapimod
PCI-30::Sepantronium bromide
HT-3::Afatinib
IMR-5::Foretinib
KMOE-2::Doramapimod
NCI-H1048::AGI-6780
Jurkat::Foretinib
LU-65::Osimertinib
DOHH-2::XAV939
NCI-H835::Motesanib
KARPAS-620::Sepantronium bromide
IGR-37::Avagacestat
42-MG-BA::Avagacestat
RERF-LC-KJ::AGI-6780
SLVL::ZM447439
SU-DHL-4::Telomerase Inhibitor IX
BT-483::VX-11e
SUP-M2::Avagacestat
RPMI-8402::Afatinib
HGC-27::Doramapimod
JHU-011::Avagacestat
SW1271::Motesanib
HCC2218::MK-8776
JHU-022::XAV939
VCaP::Foretinib
MOLP-8::AGI-6780
NCI-H2228::Foretinib
HTC-C3::Telomerase Inhibitor IX
CAL-120::Alisertib
SK-MEL-24::XAV939
JHU-029::BX795
BFTC-905::AGI-6780
Hey::MK-8776
ROS-50::Telomerase Inhibitor IX
TUR::Telomerase Inhibitor IX
SCC-3::Sepantronium bromide
KE-37::Doramapimod
SW1710::Foretinib
OV-56::ZM447439
IST-MEL1::AZD7762
BE2-M17::Avagacestat
HOS::MK-8776
RC-K8::Foretinib
KELLY::Motesanib
MIA-PaCa-2::Alisertib
C-33-A::Telomerase Inhibitor IX
Farage::Cediranib
EKVX::Alisertib
NCI-H1915::Cediranib
OVISE::Afatinib
NCI-H1915::Dabrafenib
D-566MG::BX795
NCI-H1876::Afatinib
EPLC-272H::Motesanib
LU-135::Motesanib
UWB1.289::I-BRD9
Ca-Ski::AZD7762
MFH-ino::MK-8776
OV-7::ZM447439
HT-144::Osimertinib
KYSE-220::I-BRD9
WM-115::I-BRD9
SNU-175::MK-8776
EFM-192A::I-BRD9
JEG-3::AGI-6780
D-502MG::Telomerase Inhibitor IX
HCC2998::Sepantronium bromide
CFPAC-1::MK-8776
CADO-ES1::AGI-6780
QGP-1::Avagacestat
T98G::Dabrafenib
CHSA0108::Afatinib
TYK-nu::AZD7762
no-11::Alisertib
647-V::Dabrafenib
NCI-H1568::Foretinib
KINGS-1::Telomerase Inhibitor IX
VA-ES-BJ::ZM447439
CCRF-CEM::AGI-6780
NCI-H835::AZD7762
MV-4-11::Cediranib
NB5::VX-11e
EW-13::XAV939
U-2-OS::Alisertib
PA-TU-8902::Motesanib
HOP-62::XAV939
KYSE-70::AZD7762
MES-SA::ZM447439
ESS-1::Osimertinib
COLO-800::Motesanib
NU-DUL-1::AGI-6780
LS-513::AZD7762
Ca9-22::Afatinib
NCI-H1993::XAV939
KATOIII::Avagacestat
ETK-1::I-BRD9
MZ1-PC::AZD7762
VA-ES-BJ::AGI-6780
SK-N-AS::Cediranib
LOUCY::I-BRD9
NCI-H1793::Telomerase Inhibitor IX
EMC-BAC-1::Telomerase Inhibitor IX
SW620::Telomerase Inhibitor IX
COLO-205::Cediranib
HuO-3N1::VX-11e
SKM-1::AGI-6780
LOUCY::VX-11e
CTB-1::MK-8776
TE-441-T::Doramapimod
NCI-H720::Motesanib
TE-11::Foretinib
NCI-H1770::I-BRD9
LC-2-ad::Avagacestat
D-502MG::Osimertinib
EM-2::MK-8776
A704::ZM447439
D-263MG::Sepantronium bromide
CL-11::ZM447439
NCI-H522::Doramapimod
U031::I-BRD9
NCI-H1703::Sepantronium bromide
KARPAS-299::Avagacestat
BC-1::XAV939
CAL-39::I-BRD9
NCI-H522::Telomerase Inhibitor IX
RPMI-8226::Motesanib
NCI-H69::Dabrafenib
CGTH-W-1::Dabrafenib
ETK-1::Alisertib
PCI-4B::Foretinib
IGROV-1::Doramapimod
KINGS-1::Alisertib
CAL-85-1::Alisertib
AsPC-1::Osimertinib
HCC1569::Osimertinib
BALL-1::XAV939
RH-1::VX-11e
NCI-H1944::MK-8776
COLO-205::Motesanib
NCI-H841::AGI-6780
LB771-HNC::Sepantronium bromide
COLO-829::Alisertib
NCI-H716::Foretinib
SCC-25::I-BRD9
Jurkat::Telomerase Inhibitor IX
CL-11::Afatinib
SW1573::I-BRD9
MHH-NB-11::Doramapimod
SK-MEL-2::I-BRD9
KM12::VX-11e
HDLM-2::Cediranib
SK-MES-1::Alisertib
NCI-H748::BX795
TGBC11TKB::XAV939
NCI-H596::Dabrafenib
BHT-101::Alisertib
BONNA-12::Alisertib
RCC-FG2::Sepantronium bromide
MPP-89::Motesanib
NCI-H835::Afatinib
ALL-SIL::AGI-6780
JHU-011::Foretinib
SNU-387::Afatinib
PA-1::Telomerase Inhibitor IX
NALM-6::Alisertib
PANC-10-05::Motesanib
SF295::Cediranib
MZ1-PC::AGI-6780
UMC-11::Foretinib
RPMI-7951::Afatinib
RKO::Cediranib
RPMI-7951::Osimertinib
OSC-20::AZD7762
LB2518-MEL::ZM447439
IST-MEL1::Foretinib
TT2609-C02::Doramapimod
CCK-81::Telomerase Inhibitor IX
BEN::AZD7762
D-502MG::Alisertib
A673::Motesanib
EN::Dabrafenib
RL95-2::I-BRD9
HT-29::I-BRD9
RCM-1::AZD7762
EVSA-T::Telomerase Inhibitor IX
RT4::MK-8776
CAL-78::Doramapimod
HuCCT1::Foretinib
LU-134-A::ZM447439
H3255::Avagacestat
U-266::AGI-6780
8-MG-BA::Motesanib
HOS::VX-11e
OVCAR-5::MK-8776
NCI-H660::MK-8776
MHH-CALL-4::Alisertib
JEKO-1::Sepantronium bromide
TE-5::Motesanib
SK-MEL-28::AGI-6780
COLO-679::VX-11e
NCI-H28::MK-8776
HL-60::AGI-6780
U251::XAV939
IHH-4::Sepantronium bromide
U-87-MG::I-BRD9
TE-5::I-BRD9
EBC-1::Cediranib
NCI-H727::MK-8776
HDQ-P1::Alisertib
T84::I-BRD9
IST-SL2::Dabrafenib
MKN1::XAV939
YKG-1::MK-8776
MOLM-16::MK-8776
EC-GI-10::Telomerase Inhibitor IX
NCI-H1105::XAV939
DMS-114::ZM447439
MKN45::VX-11e
OVCAR-4::Cediranib
GAK::AZD7762
KP-3::VX-11e
LU-165::AGI-6780
A375::XAV939
CHP-134::MK-8776
MDA-MB-436::VX-11e
EW-3::VX-11e
NCI-H1092::Sepantronium bromide
NCI-H446::Avagacestat
SW13::AZD7762
Detroit562::Osimertinib
KS-1::Motesanib
AU565::AZD7762
BICR31::BX795
NCI-H2405::Osimertinib
HCE-4::Cediranib
IHH-4::Osimertinib
SW837::Avagacestat
OVCAR-4::MK-8776
MFE-319::Motesanib
CADO-ES1::MK-8776
SCC-25::Dabrafenib
NUGC-4::Foretinib
AGS::Telomerase Inhibitor IX
CAL-12T::Alisertib
DOHH-2::Osimertinib
DBTRG-05MG::ZM447439
COLO-668::Dabrafenib
TUR::AZD7762
Raji::Doramapimod
LC-2-ad::Motesanib
LXF-289::AZD7762
NCI-H1876::Dabrafenib
EN::Avagacestat
HT-3::Cediranib
UM-UC-3::Avagacestat
MS-1::Afatinib
MES-SA::Osimertinib
NCI-H2085::MK-8776
OCI-AML3::AGI-6780
BONNA-12::XAV939
JM1::Foretinib
MOG-G-CCM::MK-8776
U-87-MG::Sepantronium bromide
COR-L23::MK-8776
NKM-1::Dabrafenib
MFE-296::XAV939
HCE-4::Osimertinib
LAN-6::Foretinib
CHP-134::Dabrafenib
ROS-50::AZD7762
BICR22::Sepantronium bromide
SF268::ZM447439
NOS-1::AZD7762
WM278::Doramapimod
SNU-C5::Afatinib
NCI-H1666::Dabrafenib
OE21::Alisertib
OVCAR-5::AZD7762
NCI-H660::AZD7762
SCH::Foretinib
LN-18::XAV939
Becker::Cediranib
TE-441-T::I-BRD9
MZ2-MEL::VX-11e
CAMA-1::Dabrafenib
NCI-H1436::Dabrafenib
NCI-H740::Alisertib
PFSK-1::XAV939
CAL-33::Doramapimod
NCI-H250::Doramapimod
OCI-AML2::I-BRD9
YH-13::ZM447439
WM278::Foretinib
GB-1::ZM447439
L-1236::AZD7762
OVCAR-5::Osimertinib
CAL-85-1::Afatinib
MFH-ino::Foretinib
LU-65::Afatinib
LB1047-RCC::Osimertinib
P31-FUJ::Foretinib
ChaGo-K-1::AGI-6780
786-0::XAV939
SKG-IIIa::I-BRD9
MONO-MAC-6::Dabrafenib
BT-483::Afatinib
DEL::Telomerase Inhibitor IX
SCC-3::MK-8776
ES4::XAV939
NCI-H1563::Sepantronium bromide
A101D::Dabrafenib
LN-405::I-BRD9
DG-75::Doramapimod
JIMT-1::MK-8776
Ramos-2G6-4C10::ZM447439
NCI-H1915::Doramapimod
HDLM-2::VX-11e
NCI-H740::BX795
OCI-AML5::ZM447439
COR-L321::AGI-6780
OAW-28::Motesanib
OCUB-M::Sepantronium bromide
K-562::Doramapimod
KELLY::Foretinib
SCH::BX795
SW1463::VX-11e
JHU-022::Alisertib
UMC-11::Telomerase Inhibitor IX
ESS-1::ZM447439
WM35::Foretinib
PEO1::Sepantronium bromide
C2BBe1::Afatinib
SW756::AZD7762
HCC1599::I-BRD9
NCI-H647::Doramapimod
Farage::AZD7762
SW156::Dabrafenib
MOLM-16::Alisertib
SNU-407::Afatinib
WSU-DLCL2::Alisertib
JHOS-2::AZD7762
LS-180::I-BRD9
HT-144::I-BRD9
JHH-4::AZD7762
KYSE-510::AGI-6780
MLMA::VX-11e
DoTc2-4510::Cediranib
COLO-320-HSR::XAV939
PC-14::Foretinib
LU-99A::Osimertinib
HCC2157::Foretinib
A427::Doramapimod
A204::Motesanib
A204::ZM447439
NCI-H1299::Alisertib
SW982::XAV939
697::Afatinib
KARPAS-299::Sepantronium bromide
SHP-77::Afatinib
MOG-G-UVW::VX-11e
NCI-H1693::XAV939
MHH-CALL-2::XAV939
D-392MG::Avagacestat
ML-1::Motesanib
SK-CO-1::Avagacestat
OCI-AML3::Sepantronium bromide
YH-13::Osimertinib
KARPAS-422::Cediranib
SK-MM-2::Afatinib
DU-145::Osimertinib
G-MEL::Cediranib
BICR31::Afatinib
A4-Fuk::AZD7762
RCC10RGB::Dabrafenib
OCI-LY-19::VX-11e
LNCaP-Clone-FGC::Telomerase Inhibitor IX
Hs-578-T::Telomerase Inhibitor IX
SR::Alisertib
TE-8::Sepantronium bromide
ESO26::Doramapimod
KYSE-70::Cediranib
P30-OHK::Motesanib
ES8::ZM447439
PCI-6A::Dabrafenib
SK-MES-1::XAV939
GI-ME-N::VX-11e
AN3-CA::Afatinib
CHSA0108::AZD7762
TE-15::Dabrafenib
CAL-12T::Avagacestat
ES-2::Motesanib
RERF-GC-1B::MK-8776
PCI-4B::AZD7762
NCI-H2342::Osimertinib
IST-SL2::AGI-6780
OSC-20::AGI-6780
PWR-1E::Osimertinib
8505C::Motesanib
LC4-1::Cediranib
DU-145::VX-11e
RXF393::Foretinib
LB1047-RCC::VX-11e
NCI-H2023::Dabrafenib
639-V::Doramapimod
NY::XAV939
IPC-298::Dabrafenib
OVK-18::ZM447439
EW-18::AZD7762
HCC-827::Avagacestat
SK-ES-1::AZD7762
NB5::ZM447439
NCCIT::AZD7762
PEO1::Avagacestat
NCI-H1869::AZD7762
NCI-H1436::I-BRD9
EMC-BAC-1::MK-8776
8505C::Telomerase Inhibitor IX
OCI-M1::I-BRD9
ASH-3::Sepantronium bromide
COLO-680N::Motesanib
SK-UT-1::ZM447439
KE-37::VX-11e
HT-29::Foretinib
JSC-1::Foretinib
NMC-G1::AZD7762
KP-1N::Afatinib
KARPAS-422::Motesanib
Detroit562::Sepantronium bromide
GDM-1::Motesanib
MOG-G-UVW::Cediranib
SW1088::Dabrafenib
LC4-1::Telomerase Inhibitor IX
SU-DHL-16::Alisertib
KG-1::AZD7762
NCI-H526::AZD7762
HEL::Motesanib
KURAMOCHI::AZD7762
SiHa::MK-8776
CAKI-1::Telomerase Inhibitor IX
MEL-JUSO::Dabrafenib
FLO-1::Foretinib
DoTc2-4510::XAV939
NCI-H1436::Doramapimod
HT-29::AZD7762
KARPAS-231::Sepantronium bromide
P12-ICHIKAWA::XAV939
LB996-RCC::XAV939
HSC-3::Doramapimod
NCI-H1688::Doramapimod
SU-DHL-8::Telomerase Inhibitor IX
L-428::Alisertib
LB2518-MEL::Telomerase Inhibitor IX
NCI-H1975::MK-8776
SW780::Foretinib
KP-1N::Sepantronium bromide
KM-H2::Doramapimod
TGBC24TKB::Sepantronium bromide
SBC-3::XAV939
CAL-39::XAV939
HTC-C3::VX-11e
HuO9::ZM447439
SK-N-FI::VX-11e
SU-DHL-5::AGI-6780
SW13::Telomerase Inhibitor IX
BFTC-909::Doramapimod
PANC-04-03::Cediranib
KYM-1::VX-11e
NCI-H1155::Osimertinib
HCC2218::XAV939
CCRF-CEM::Avagacestat
SAT::Afatinib
RPMI-7951::Dabrafenib
MDA-MB-436::Cediranib
SW1573::Avagacestat
OVK-18::Telomerase Inhibitor IX
MKN28::Avagacestat
PCI-30::Cediranib
KARPAS-422::VX-11e
KE-37::Alisertib
COLO-679::Alisertib
KU812::AZD7762
RD::AGI-6780
NCI-H322M::AZD7762
IA-LM::Avagacestat
CAL-12T::Foretinib
SF295::Avagacestat
MRK-nu-1::Afatinib
HEL::Avagacestat
WIL2-NS::MK-8776
HCE-4::Foretinib
CAPAN-1::ZM447439
KMS-11::Motesanib
ES4::Cediranib
RPMI-8866::ZM447439
MDA-MB-453::Afatinib
BHT-101::Avagacestat
FTC-133::Avagacestat
OVISE::Telomerase Inhibitor IX
MKN7::Dabrafenib
NOMO-1::Telomerase Inhibitor IX
HeLa::VX-11e
BPH-1::Cediranib
SK-N-AS::Avagacestat
A427::Sepantronium bromide
LAMA-84::Telomerase Inhibitor IX
KYSE-520::Dabrafenib
BB65-RCC::ZM447439
CHSA8926::ZM447439
NCI-H1781::AGI-6780
NCI-H2110::VX-11e
Daudi::Avagacestat
SiHa::Cediranib
NCI-H1568::Avagacestat
NCI-H1651::I-BRD9
RH-41::Sepantronium bromide
HCC1428::Foretinib
HC-1::Osimertinib
TYK-nu::Telomerase Inhibitor IX
LB771-HNC::Cediranib
HuO-3N1::Telomerase Inhibitor IX
TC-YIK::I-BRD9
JHH-2::AGI-6780
SF126::Motesanib
DU-4475::Afatinib
NCI-H1792::Afatinib
NCI-H1355::Doramapimod
JHU-029::Cediranib
KE-37::Afatinib
OAW-42::Telomerase Inhibitor IX
SW1783::Sepantronium bromide
OACp4C::Motesanib
NU-DUL-1::Motesanib
HuH-7::Dabrafenib
SCC90::Afatinib
RL95-2::MK-8776
WM1552C::MK-8776
CS1::Afatinib
GP5d::Cediranib
OCI-LY7::Avagacestat
LC-2-ad::ZM447439
LU-99A::VX-11e
KGN::Osimertinib
LS-180::Osimertinib
Ramos-2G6-4C10::Osimertinib
PA-1::AZD7762
BL-41::Osimertinib
SiHa::Telomerase Inhibitor IX
NCI-H1993::Afatinib
JJN-3::I-BRD9
NEC8::MK-8776
SF295::AZD7762
DND-41::ZM447439
COLO-783::Telomerase Inhibitor IX
NCI-H1155::MK-8776
COLO-668::Osimertinib
ME-1::Cediranib
DOV13::Avagacestat
WIL2-NS::XAV939
NCI-H2110::Telomerase Inhibitor IX
HL-60::Motesanib
NU-DUL-1::BX795
SK-MG-1::I-BRD9
HCC-366::AZD7762
A498::ZM447439
JiyoyeP-2003::Motesanib
KNS-62::Cediranib
EKVX::Dabrafenib
SNU-398::Afatinib
GDM-1::XAV939
HCC-78::Afatinib
MG-63::XAV939
NCI-H2172::AGI-6780
769-P::AGI-6780
MM1S::Alisertib
PANC-10-05::Alisertib
UACC-893::BX795
U-2-OS::XAV939
CHL-1::Foretinib
A549::I-BRD9
LB831-BLC::ZM447439
NY::Foretinib
AN3-CA::MK-8776
A673::MK-8776
NCI-H1836::Afatinib
SK-N-AS::AZD7762
NCI-H2135::MK-8776
SW1710::Dabrafenib
SBC-1::VX-11e
K-562::Foretinib
KYSE-510::Avagacestat
PCI-30::Telomerase Inhibitor IX
MZ2-MEL::Foretinib
D-283MED::XAV939
HARA::XAV939
LB2518-MEL::BX795
KON::Cediranib
OAW-42::Sepantronium bromide
NCI-H2196::ZM447439
ES5::Dabrafenib
NH-12::AGI-6780
U031::Dabrafenib
SCC90::VX-11e
NCI-H2110::Cediranib
HL-60::Cediranib
G-361::Osimertinib
OSC-20::I-BRD9
SIG-M5::VX-11e
MONO-MAC-6::Osimertinib
VCaP::Telomerase Inhibitor IX
DB::Avagacestat
PWR-1E::Sepantronium bromide
RMG-I::Osimertinib
PF-382::AZD7762
MDST8::Motesanib
RCC-JW::Doramapimod
CHP-212::Doramapimod
ME-180::Sepantronium bromide
KP-4::AZD7762
H-EMC-SS::XAV939
PCI-15A::AZD7762
KYSE-510::ZM447439
OCI-AML3::MK-8776
CAS-1::I-BRD9
DK-MG::Foretinib
SNU-61::ZM447439
RL::Dabrafenib
LS-180::Afatinib
JHOS-4::Osimertinib
CW-2::Motesanib
EW-12::Foretinib
NCI-H747::Alisertib
A172::Doramapimod
no-11::Cediranib
MES-SA::AGI-6780
P12-ICHIKAWA::MK-8776
NCI-H1435::Foretinib
RPMI-6666::AZD7762
COR-L303::BX795
SW1463::Cediranib
EBC-1::AZD7762
SBC-1::Cediranib
U251::Foretinib
NCI-H1869::Osimertinib
Hs-578-T::Avagacestat
TE-5::Doramapimod
NCI-H660::Sepantronium bromide
NCI-H2066::I-BRD9
NCI-H1092::VX-11e
A2780::Alisertib
NB13::Afatinib
NMC-G1::Sepantronium bromide
SCC90::MK-8776
SNU-C5::Motesanib
HuH-7::Cediranib
CAKI-1::XAV939
NCI-H1648::Alisertib
NOMO-1::Osimertinib
MN-60::VX-11e
CW-2::I-BRD9
TE-6::Motesanib
RH-41::Telomerase Inhibitor IX
BEN::VX-11e
WSU-DLCL2::Foretinib
KARPAS-422::Afatinib
MDA-MB-330::I-BRD9
KU812::I-BRD9
U-2-OS::Avagacestat
MSTO-211H::Dabrafenib
RMG-I::Afatinib
ST486::ZM447439
SJRH30::Osimertinib
RCC-FG2::VX-11e
BEN::Foretinib
WM793B::MK-8776
RH-1::AZD7762
KARPAS-620::ZM447439
MDA-MB-415::Sepantronium bromide
SUP-M2::Doramapimod
KMRC-20::Motesanib
KELLY::I-BRD9
CAL-29::XAV939
HCC1806::XAV939
LB2518-MEL::AZD7762
KYSE-70::Sepantronium bromide
HH::MK-8776
SBC-1::Doramapimod
OS-RC-2::Doramapimod
DOHH-2::Avagacestat
DU-4475::AZD7762
UACC-893::Doramapimod
SW954::ZM447439
SKN::Foretinib
BFTC-909::AZD7762
OVMIU::MK-8776
EVSA-T::MK-8776
DOK::XAV939
LS-1034::AGI-6780
MG-63::Foretinib
SCC90::XAV939
CCK-81::Cediranib
JHU-022::ZM447439
NUGC-3::Avagacestat
GDM-1::Osimertinib
A375::Osimertinib
WSU-DLCL2::Dabrafenib
Ca-Ski::MK-8776
MDA-MB-415::MK-8776
QIMR-WIL::XAV939
LOUCY::Dabrafenib
AMO-1::Cediranib
HOP-62::Afatinib
BC-1::Afatinib
GOTO::MK-8776
EVSA-T::Alisertib
EW-3::XAV939
NCI-H1836::BX795
COLO-800::Afatinib
NCI-H211::VX-11e
AM-38::MK-8776
LC-2-ad::AZD7762
LCLC-97TM1::Osimertinib
TE-5::VX-11e
SJSA-1::Foretinib
LCLC-97TM1::ZM447439
NCI-H1703::I-BRD9
HSC-39::Telomerase Inhibitor IX
ES5::ZM447439
RF-48::Motesanib
OSC-20::Motesanib
NCI-H1876::Cediranib
VCaP::XAV939
NB10::XAV939
NCI-H1563::Doramapimod
U-2-OS::Motesanib
HCC2998::Foretinib
HT-29::Dabrafenib
SK-MEL-5::Telomerase Inhibitor IX
COLO-684::Telomerase Inhibitor IX
L-540::VX-11e
NCI-H226::VX-11e
SNU-1040::Alisertib
HT-144::Cediranib
NCI-H2052::AGI-6780
NUGC-3::Cediranib
NCI-H748::Foretinib
IM-95::Avagacestat
NOS-1::AGI-6780
NCI-H1568::AGI-6780
ARH-77::I-BRD9
KS-1::XAV939
SU-DHL-8::VX-11e
HCC1187::Avagacestat
EN::MK-8776
SNU-81::Dabrafenib
23132-87::Alisertib
NCI-H747::Telomerase Inhibitor IX
KMS-12-BM::AZD7762
MES-SA::MK-8776
MONO-MAC-6::Doramapimod
PA-1::AGI-6780
NCI-H1341::Alisertib
KP-N-YN::Dabrafenib
SLVL::Dabrafenib
WM-115::Alisertib
NCI-H1581::Motesanib
EC-GI-10::Sepantronium bromide
KP-N-YN::Sepantronium bromide
HT-1080::AZD7762
JHH-4::Osimertinib
OCI-AML3::Telomerase Inhibitor IX
COLO-679::Foretinib
HCC-15::Foretinib
MDA-MB-415::Alisertib
OVCAR-5::Foretinib
NCI-H2452::MK-8776
EKVX::I-BRD9
AGS::Avagacestat
NEC8::Foretinib
NB69::VX-11e
HeLa::Motesanib
HCC1954::MK-8776
PCI-6A::Afatinib
AMO-1::Osimertinib
HCT-15::ZM447439
HOP-92::XAV939
KY821::Avagacestat
Calu-6::I-BRD9
RT4::Sepantronium bromide
NCI-H596::Alisertib
TE-441-T::VX-11e
PFSK-1::MK-8776
NUGC-3::ZM447439
SBC-3::I-BRD9
NCI-H740::ZM447439
NCI-N87::Doramapimod
EM-2::Avagacestat
OAW-28::Sepantronium bromide
NCI-H1435::I-BRD9
JHH-1::Doramapimod
CGTH-W-1::Motesanib
G-401::I-BRD9
RO82-W-1::Telomerase Inhibitor IX
PWR-1E::Dabrafenib
TC-YIK::Telomerase Inhibitor IX
IM-95::VX-11e
P32-ISH::Alisertib
SU-DHL-1::BX795
JURL-MK1::XAV939
BB49-HNC::XAV939
SW13::Motesanib
BT-549::Cediranib
NB17::Dabrafenib
NCI-H1666::Foretinib
PA-1::Afatinib
UM-UC-3::MK-8776
HuP-T4::Osimertinib
D-423MG::I-BRD9
SW684::Avagacestat
8305C::Alisertib
KYAE-1::Doramapimod
HO-1-N-1::AGI-6780
U-266::VX-11e
NCI-H522::Afatinib
786-0::Dabrafenib
SW1463::Foretinib
Detroit562::AGI-6780
REH::ZM447439
K5::Dabrafenib
EFM-19::Telomerase Inhibitor IX
HCC-827::AZD7762
A549::Telomerase Inhibitor IX
OS-RC-2::ZM447439
T-T::Dabrafenib
RH-1::Motesanib
LN-229::Telomerase Inhibitor IX
KLE::VX-11e
WM35::MK-8776
RKO::Doramapimod
JSC-1::MK-8776
JAR::Telomerase Inhibitor IX
EW-7::MK-8776
BICR78::Motesanib
OVISE::Osimertinib
OCI-AML5::Doramapimod
NCI-H526::ZM447439
ZR-75-30::Alisertib
SW1417::Motesanib
MFE-296::ZM447439
HCC1428::MK-8776
MZ2-MEL::Alisertib
DMS-53::Afatinib
JHU-011::Dabrafenib
MG-63::AGI-6780
KP-3::Alisertib
Ca-Ski::ZM447439
HCC1143::Telomerase Inhibitor IX
OACM5-1::AGI-6780
SUP-T1::AGI-6780
HuP-T3::VX-11e
Ca-Ski::Foretinib
TC-YIK::Sepantronium bromide
IST-MEL1::I-BRD9
SW626::Motesanib
SNU-C1::Alisertib
SNU-81::Avagacestat
QIMR-WIL::VX-11e
PA-TU-8988T::Foretinib
KARPAS-1106P::Osimertinib
COLO-680N::Sepantronium bromide
Daudi::AGI-6780
HCC1187::Motesanib
PSN1::VX-11e
HLE::ZM447439
H3255::Foretinib
TE-441-T::AZD7762
COLO-800::Telomerase Inhibitor IX
HCC70::Avagacestat
NCI-H810::Motesanib
H-EMC-SS::Alisertib
HCC-827::Osimertinib
HT55::AGI-6780
HA7-RCC::Foretinib
Mo-T::Doramapimod
NKM-1::Doramapimod
HT-29::Motesanib
KP-3::Avagacestat
SKM-1::Telomerase Inhibitor IX
OCI-M1::XAV939
JM1::MK-8776
HCE-4::Avagacestat
JEKO-1::ZM447439
SK-MEL-5::Foretinib
NCI-H1993::Alisertib
CESS::Doramapimod
JHH-1::Motesanib
CCRF-CEM::MK-8776
CHSA8926::I-BRD9
MOLT-4::I-BRD9
LP-1::BX795
FADU::Telomerase Inhibitor IX
HSC-39::ZM447439
DK-MG::AZD7762
SH-4::XAV939
EVSA-T::VX-11e
HCC1500::Avagacestat
CHSA0011::AGI-6780
LK-2::XAV939
NCI-H1623::Alisertib
EJM::MK-8776
DMS-79::MK-8776
RF-48::AGI-6780
SK-MES-1::I-BRD9
Hey::ZM447439
NB69::ZM447439
CADO-ES1::Afatinib
SNU-407::AGI-6780
SU-DHL-6::AZD7762
LN-18::ZM447439
JURL-MK1::Afatinib
SUP-HD1::ZM447439
CHSA0011::Foretinib
MHH-NB-11::I-BRD9
OV-7::AGI-6780
VMRC-LCD::Motesanib
SF126::BX795
SIG-M5::XAV939
DJM-1::AGI-6780
NCI-H2030::Avagacestat
MDA-MB-330::VX-11e
SK-GT-2::XAV939
YT::Afatinib
OVCA420::Avagacestat
MHH-CALL-2::AZD7762
CAL-12T::AGI-6780
NCI-H660::ZM447439
HT-1376::I-BRD9
RXF393::BX795
HH::XAV939
NCI-H2052::Avagacestat
BB49-HNC::MK-8776
CTB-1::Afatinib
IMR-5::AZD7762
IHH-4::Afatinib
RS4-11::VX-11e
SU-DHL-1::VX-11e
KINGS-1::Dabrafenib
BICR10::Alisertib
MOLM-16::Afatinib
SW1783::Doramapimod
WIL2-NS::I-BRD9
TT::Dabrafenib
RT-112::Cediranib
EFM-19::Motesanib
SK-MEL-3::AGI-6780
EW-7::Foretinib
Hs-578-T::Doramapimod
TE-5::Afatinib
LAMA-84::Osimertinib
WM793B::VX-11e
HEL::Telomerase Inhibitor IX
RL::XAV939
KYAE-1::XAV939
IST-SL1::I-BRD9
IGROV-1::Foretinib
SNU-81::AZD7762
SAS::Foretinib
KMOE-2::Alisertib
OV-90::Telomerase Inhibitor IX
RS4-11::Avagacestat
NB14::Osimertinib
PWR-1E::ZM447439
DAN-G::Sepantronium bromide
SF295::Alisertib
SW1783::Afatinib
NCI-H250::MK-8776
PANC-02-03::XAV939
HeLa::Osimertinib
SNU-C2B::AZD7762
QGP-1::XAV939
KYSE-410::VX-11e
NB5::Cediranib
A172::Afatinib
RERF-LC-KJ::Cediranib
Saos-2::Alisertib
CAL-62::AGI-6780
8305C::Cediranib
CP66-MEL::Doramapimod
KARPAS-45::Telomerase Inhibitor IX
LOU-NH91::Foretinib
MFH-ino::ZM447439
KLE::Sepantronium bromide
D-336MG::Cediranib
NCI-H650::Sepantronium bromide
SNU-C5::XAV939
U-87-MG::AGI-6780
SW756::AGI-6780
NCI-H1299::Motesanib
KMRC-1::VX-11e
KATOIII::Sepantronium bromide
NCI-H2172::Motesanib
HA7-RCC::I-BRD9
OCI-LY7::Foretinib
UACC-257::Afatinib
NCI-H2452::Doramapimod
CAMA-1::Sepantronium bromide
NCI-H748::AGI-6780
CRO-AP2::MK-8776
SK-PN-DW::Dabrafenib
GR-ST::XAV939
ARH-77::Alisertib
Raji::Telomerase Inhibitor IX
SW872::Afatinib
OC-314::AZD7762
EM-2::ZM447439
CCK-81::VX-11e
EW-18::Cediranib
T98G::Telomerase Inhibitor IX
COLO-678::Cediranib
PA-TU-8988T::XAV939
NCI-H211::I-BRD9
KGN::Motesanib
SKN::AZD7762
KP-4::Doramapimod
SW780::ZM447439
AsPC-1::Sepantronium bromide
NCI-H661::MK-8776
NCI-H146::Osimertinib
HCC-827::Telomerase Inhibitor IX
SW684::Osimertinib
MHH-NB-11::XAV939
SK-MEL-28::AZD7762
GAK::ZM447439
GCIY::MK-8776
KMS-12-BM::Foretinib
C-33-A::MK-8776
NCI-H2009::ZM447439
CAS-1::Avagacestat
BE-13::XAV939
WM35::AZD7762
Hs-445::AZD7762
RT4::ZM447439
C2BBe1::I-BRD9
CAL-148::Sepantronium bromide
HCC1937::Sepantronium bromide
SW837::Cediranib
MHH-CALL-2::Alisertib
A498::MK-8776
G-361::VX-11e
SW948::Alisertib
MPP-89::Osimertinib
RO82-W-1::Foretinib
Jurkat::Cediranib
CAL-148::ZM447439
HCC1419::XAV939
ABC-1::Foretinib
TCCSUP::Telomerase Inhibitor IX
UWB1.289::ZM447439
NCC010::Avagacestat
CS1::Foretinib
SW1573::MK-8776
JJN-3::Dabrafenib
KNS-42::AZD7762
ETK-1::Avagacestat
HT-29::ZM447439
RF-48::AZD7762
SISO::I-BRD9
NCI-H1993::ZM447439
JHH-7::AGI-6780
NCI-H1341::Sepantronium bromide
U-118-MG::AZD7762
BB30-HNC::Telomerase Inhibitor IX
SF126::Dabrafenib
D-423MG::Afatinib
LOXIMVI::AZD7762
KURAMOCHI::I-BRD9
Mewo::I-BRD9
HEC-1::XAV939
HT-1197::Osimertinib
ES-2::Osimertinib
RL95-2::Afatinib
TE-9::Doramapimod
EJM::Motesanib
NCI-H1693::Motesanib
NCI-H2196::BX795
RL::Cediranib
KYSE-70::Foretinib
SR::VX-11e
CHL-1::Doramapimod
TYK-nu::Afatinib
LK-2::Motesanib
KP-N-YN::Osimertinib
SK-ES-1::Afatinib
NCI-H1781::VX-11e
HSC-3::I-BRD9
SNU-175::Osimertinib
HO-1-N-1::Sepantronium bromide
VA-ES-BJ::AZD7762
CTV-1::Foretinib
NCI-H3122::ZM447439
Mewo::Telomerase Inhibitor IX
COLO-684::Doramapimod
HSC-3::Sepantronium bromide
SNU-61::Motesanib
RCC-JW::Dabrafenib
UACC-62::Afatinib
KARPAS-45::Foretinib
OAW-28::Doramapimod
CAL-148::Avagacestat
NCI-H716::AGI-6780
YH-13::Dabrafenib
NCCIT::Telomerase Inhibitor IX
ACHN::XAV939
JIMT-1::Sepantronium bromide
OPM-2::MK-8776
SK-N-AS::VX-11e
SW1417::Dabrafenib
TCCSUP::ZM447439
HAL-01::AZD7762
PCI-15A::Afatinib
TT::Foretinib
RPMI-7951::Cediranib
CCRF-CEM::XAV939
KALS-1::Motesanib
TK10::Afatinib
RMG-I::Alisertib
TOV-112D::Avagacestat
451Lu::AGI-6780
JVM-2::Cediranib
COLO-205::Avagacestat
SK-GT-4::AGI-6780
JHOS-4::Dabrafenib
NCI-H2087::Doramapimod
SU8686::Osimertinib
NCI-H1581::Sepantronium bromide
MZ7-mel::BX795
NAMALWA::Osimertinib
HEC-1::AGI-6780
SW1463::Doramapimod
ASH-3::Doramapimod
LU-99A::Dabrafenib
SU-DHL-1::Afatinib
EW-13::Alisertib
KS-1::I-BRD9
SW1088::AGI-6780
CHP-134::AGI-6780
NCI-H2291::Sepantronium bromide
CESS::Alisertib
BB49-HNC::Foretinib
HCC1187::Dabrafenib
MIA-PaCa-2::AZD7762
639-V::XAV939
MHH-CALL-4::Avagacestat
COLO-679::AZD7762
IST-SL2::Alisertib
KE-37::XAV939
NCC021::AGI-6780
KYSE-180::Afatinib
SW1710::I-BRD9
HO-1-N-1::AZD7762
NEC8::Afatinib
SCC-15::AGI-6780
EW-11::I-BRD9
OCUM-1::Osimertinib
KARPAS-422::Osimertinib
KCL-22::Afatinib
KINGS-1::AZD7762
PSN1::AGI-6780
MDA-MB-468::ZM447439
HCC-15::MK-8776
HCC1143::MK-8776
TOV-21G::VX-11e
Calu-6::Sepantronium bromide
RD::ZM447439
GB-1::Foretinib
LOUCY::Motesanib
SCC-25::Telomerase Inhibitor IX
OVCAR-8::Dabrafenib
VMRC-LCD::AGI-6780
RC-K8::XAV939
SIG-M5::AZD7762
GA-10::Cediranib
SBC-3::Afatinib
OAW-42::Foretinib
ROS-50::Sepantronium bromide
TE-12::Cediranib
A204::Doramapimod
EW-16::VX-11e
SK-LMS-1::Dabrafenib
WM-115::Doramapimod
JSC-1::Motesanib
K-562::I-BRD9
TE-4::Dabrafenib
TOV-112D::Afatinib
COLO-680N::XAV939
NCI-H250::ZM447439
DU-145::ZM447439
Ca9-22::Dabrafenib
KP-2::Telomerase Inhibitor IX
SK-MEL-30::Osimertinib
SN12C::VX-11e
A431::BX795
ALL-PO::AZD7762
NCI-H1755::Cediranib
OAW-42::Dabrafenib
JHU-022::AGI-6780
UACC-812::Osimertinib
DJM-1::XAV939
NCCIT::Afatinib
D-502MG::ZM447439
EVSA-T::AGI-6780
LS-411N::ZM447439
PANC-08-13::MK-8776
SW1088::AZD7762
SW948::XAV939
WM793B::Doramapimod
NB69::AGI-6780
ChaGo-K-1::Osimertinib
Caov-4::Cediranib
CHSA0011::Dabrafenib
OSC-19::ZM447439
BV-173::Dabrafenib
CAL-62::AZD7762
MFE-319::Foretinib
TE-6::Doramapimod
HSC-3::VX-11e
SK-GT-4::Foretinib
SNU-449::Afatinib
D-542MG::AZD7762
NCI-H1770::VX-11e
SK-OV-3::Alisertib
UMC-11::AZD7762
NCI-H841::I-BRD9
DMS-114::MK-8776
TUR::Alisertib
YT::Cediranib
KP-4::Telomerase Inhibitor IX
ES8::Foretinib
ME-180::Doramapimod
HCC-366::Sepantronium bromide
OCI-AML5::Dabrafenib
SK-MEL-3::BX795
HCC38::Doramapimod
FLO-1::VX-11e
MS751::Afatinib
KYSE-270::Sepantronium bromide
SCH::Doramapimod
SUP-T1::Doramapimod
GAK::Dabrafenib
SK-UT-1::Sepantronium bromide
NCI-H1963::Sepantronium bromide
KARPAS-422::Sepantronium bromide
HeLa::Foretinib
LC-2-ad::Dabrafenib
IST-MEL1::Osimertinib
NCI-H810::Cediranib
LS-123::AGI-6780
HCC-44::MK-8776
NCI-H1781::Avagacestat
Hs-445::Sepantronium bromide
SW684::ZM447439
EKVX::Afatinib
SW948::Osimertinib
OSC-20::Afatinib
A172::Dabrafenib
TE-15::VX-11e
NCI-H2227::I-BRD9
NCI-H2052::I-BRD9
OE33::AZD7762
LB831-BLC::Doramapimod
DG-75::Cediranib
CGTH-W-1::Osimertinib
JVM-3::Telomerase Inhibitor IX
ECC12::Doramapimod
LS-1034::Telomerase Inhibitor IX
GRANTA-519::Dabrafenib
WSU-NHL::Dabrafenib
SW962::Cediranib
SW1088::Sepantronium bromide
Jurkat::ZM447439
HDLM-2::I-BRD9
RMG-I::VX-11e
GP5d::XAV939
EoL-1-cell::I-BRD9
BB49-HNC::AGI-6780
LN-405::MK-8776
KARPAS-1106P::XAV939
SK-UT-1::Telomerase Inhibitor IX
LB373-MEL-D::Avagacestat
HCC-15::Telomerase Inhibitor IX
NH-12::Alisertib
SK-MEL-28::Avagacestat
TOV-112D::Doramapimod
NCI-H292::Dabrafenib
CAL-27::Telomerase Inhibitor IX
SAT::XAV939
MONO-MAC-6::Cediranib
NCI-H446::I-BRD9
NCI-H196::Osimertinib
MV-4-11::Dabrafenib
MDA-MB-436::Foretinib
CPC-N::AZD7762
OCI-AML5::AGI-6780
COLO-783::Osimertinib
COR-L88::Osimertinib
SK-HEP-1::Cediranib
SUP-HD1::Cediranib
SK-CO-1::Osimertinib
HOP-92::Doramapimod
OS-RC-2::Sepantronium bromide
MIA-PaCa-2::Motesanib
MZ7-mel::Telomerase Inhibitor IX
KYSE-50::Afatinib
COLO-679::Telomerase Inhibitor IX
NCC010::Dabrafenib
NCI-H510A::ZM447439
SW1463::XAV939
U251::Dabrafenib
ES4::Foretinib
NCI-H2030::Foretinib
MHH-NB-11::Motesanib
8-MG-BA::VX-11e
DEL::AZD7762
DMS-114::VX-11e
SJRH30::VX-11e
OSC-19::Sepantronium bromide
SU-DHL-10::Telomerase Inhibitor IX
NCI-H1688::AZD7762
MSTO-211H::Cediranib
NALM-6::MK-8776
NCI-H1650::VX-11e
LAMA-84::Afatinib
LU-99A::AZD7762
JAR::Foretinib
RD::Foretinib
OVISE::Foretinib
LB2518-MEL::VX-11e
SCC-3::Dabrafenib
LB647-SCLC::MK-8776
YAPC::I-BRD9
BB30-HNC::AGI-6780
TE-6::ZM447439
KP-4::MK-8776
FTC-133::Sepantronium bromide
EMC-BAC-2::Alisertib
MDA-MB-468::Sepantronium bromide
EB2::Cediranib
NCI-H1651::AZD7762
JIMT-1::VX-11e
EM-2::AZD7762
PA-TU-8902::Doramapimod
D-566MG::Avagacestat
NCI-H727::AGI-6780
ABC-1::Avagacestat
SNU-C1::Sepantronium bromide
SUIT-2::Dabrafenib
OVMIU::AZD7762
CAL-85-1::Telomerase Inhibitor IX
HOS::Dabrafenib
COR-L311::AGI-6780
SCC-4::Afatinib
JHU-011::Afatinib
NCI-H2291::I-BRD9
SNU-423::Alisertib
MDA-MB-231::MK-8776
NCI-H1155::ZM447439
D-247MG::Doramapimod
CADO-ES1::VX-11e
KCL-22::Cediranib
H-EMC-SS::VX-11e
COLO-320-HSR::MK-8776
SK-LU-1::Osimertinib
OCI-LY7::Osimertinib
DEL::AGI-6780
YH-13::XAV939
L-428::ZM447439
OV-56::Sepantronium bromide
EW-3::Dabrafenib
WM278::Dabrafenib
SW1271::Telomerase Inhibitor IX
RS4-11::Alisertib
GDM-1::Afatinib
SNU-423::ZM447439
KNS-81-FD::Osimertinib
KS-1::Alisertib
ABC-1::Doramapimod
NCI-H835::Foretinib
GDM-1::Dabrafenib
NCI-H446::Sepantronium bromide
THP-1::Cediranib
CHSA0011::ZM447439
SK-OV-3::Motesanib
JHH-4::ZM447439
TGBC1TKB::Alisertib
CPC-N::VX-11e
OV-7::VX-11e
JAR::Osimertinib
NAMALWA::Foretinib
NCI-N87::Osimertinib
NCI-H2291::VX-11e
EN::Sepantronium bromide
ATN-1::Motesanib
RL95-2::Motesanib
FU97::MK-8776
TT::Afatinib
HCC1428::Dabrafenib
Hs-578-T::MK-8776
NCI-H1563::Osimertinib
PL4::Telomerase Inhibitor IX
CHP-212::AGI-6780
TGBC24TKB::AZD7762
KARPAS-231::ZM447439
BHT-101::Cediranib
AN3-CA::Doramapimod
A2780::Doramapimod
RMG-I::Cediranib
ESS-1::Doramapimod
H3255::I-BRD9
CAS-1::AZD7762
NCC021::Dabrafenib
OSC-20::Sepantronium bromide
PA-1::Motesanib
JEG-3::AZD7762
MOLP-8::Doramapimod
NCI-H1299::Cediranib
H9::Cediranib
HT-115::Avagacestat
NCI-H1155::Motesanib
PANC-10-05::Sepantronium bromide
BEN::Avagacestat
RXF393::AZD7762
EFO-21::XAV939
PANC-03-27::Doramapimod
D-542MG::Telomerase Inhibitor IX
ESO51::I-BRD9
TT::Telomerase Inhibitor IX
MHH-NB-11::AGI-6780
MOLT-13::Motesanib
DSH1::Doramapimod
KY821::Doramapimod
KARPAS-620::Osimertinib
SNU-398::MK-8776
LS-123::MK-8776
COR-L279::ZM447439
HCC1395::MK-8776
RCC-ER::Dabrafenib
COR-L303::Foretinib
OAW-28::AGI-6780
WM793B::Afatinib
HCC2218::Foretinib
UWB1.289::VX-11e
JEKO-1::Afatinib
NUGC-4::Avagacestat
CAL-62::Doramapimod
OVISE::AGI-6780
ES6::Afatinib
NCI-H1048::VX-11e
HT-1080::Telomerase Inhibitor IX
KURAMOCHI::Osimertinib
NCI-H2196::Alisertib
D-263MG::Doramapimod
SKN-3::VX-11e
A704::Sepantronium bromide
COLO-680N::VX-11e
NB17::XAV939
OSC-20::MK-8776
CHP-126::AZD7762
SK-MEL-30::MK-8776
Daoy::AGI-6780
OVKATE::Sepantronium bromide
HC-1::AGI-6780
DOV13::Osimertinib
NCI-H226::AZD7762
FU97::Afatinib
YH-13::Telomerase Inhibitor IX
QIMR-WIL::Sepantronium bromide
ESO26::AGI-6780
KARPAS-1106P::VX-11e
KMRC-20::Foretinib
Mo-T::AZD7762
HuP-T3::Cediranib
OVCAR-4::Afatinib
HT-115::ZM447439
CAL-39::Sepantronium bromide
NCI-H2227::AGI-6780
RS4-11::MK-8776
KYSE-270::Telomerase Inhibitor IX
TCCSUP::Motesanib
CHSA0108::Alisertib
D-392MG::Motesanib
SW982::AGI-6780
OVKATE::Osimertinib
SIMA::Sepantronium bromide
KYSE-520::Cediranib
EM-2::Telomerase Inhibitor IX
D-502MG::VX-11e
SBC-5::Dabrafenib
PFSK-1::Sepantronium bromide
SK-MEL-31::Doramapimod
RH-1::MK-8776
DMS-273::MK-8776
HC-1::Doramapimod
SKN::Afatinib
CaR-1::Osimertinib
HuCCT1::Alisertib
MPP-89::Foretinib
BT-474::Cediranib
EW-16::Dabrafenib
NCI-H345::XAV939
Daudi::AZD7762
IMR-5::Sepantronium bromide
U-266::Osimertinib
CESS::I-BRD9
NCI-H322M::I-BRD9
HEC-1::ZM447439
RPMI-6666::I-BRD9
MZ7-mel::ZM447439
HO-1-N-1::Cediranib
SW626::Sepantronium bromide
NCI-H647::Sepantronium bromide
REH::Osimertinib
HCC70::Motesanib
MDA-MB-231::Avagacestat
SIG-M5::Doramapimod
SKM-1::Motesanib
TK::Alisertib
HT-1197::ZM447439
NCI-H3122::AZD7762
LC-2-ad::Osimertinib
HDQ-P1::Osimertinib
DK-MG::Doramapimod
RCC-AB::MK-8776
EJM::Osimertinib
CAMA-1::VX-11e
HCC1569::AGI-6780
MDA-MB-415::AGI-6780
HMV-II::Afatinib
COR-L88::Dabrafenib
NCI-H660::I-BRD9
NCI-H2029::Alisertib
NCI-H1568::Alisertib
MSTO-211H::Avagacestat
JHH-6::XAV939
KY821::ZM447439
BICR22::Osimertinib
COLO-792::I-BRD9
RPMI-8866::Dabrafenib
P30-OHK::Osimertinib
SNU-C1::AGI-6780
FLO-1::Afatinib
LCLC-97TM1::XAV939
NCI-H1355::Telomerase Inhibitor IX
no-11::Doramapimod
BE2-M17::Cediranib
C-33-A::ZM447439
GB-1::Telomerase Inhibitor IX
NU-DUL-1::MK-8776
KMOE-2::Dabrafenib
KYSE-410::Doramapimod
COLO-668::ZM447439
LU-65::Doramapimod
HT-1197::AGI-6780
NH-12::VX-11e
MDA-MB-231::Motesanib
SF539::Dabrafenib
KYSE-220::XAV939
ARH-77::Avagacestat
EW-24::I-BRD9
LU-165::I-BRD9
DMS-79::BX795
MFE-296::AZD7762
A3-KAW::Avagacestat
AM-38::Avagacestat
HEL::I-BRD9
EW-12::VX-11e
NCI-H747::VX-11e
TE-441-T::BX795
COLO-800::Alisertib
MCF7::I-BRD9
RKO::Foretinib
NCI-H446::Afatinib
SNU-175::Foretinib
EW-11::Dabrafenib
VA-ES-BJ::VX-11e
NCI-H82::XAV939
RCC-ER::XAV939
ARH-77::Cediranib
NCI-H716::Afatinib
OACp4C::Osimertinib
COLO-792::AGI-6780
CML-T1::Avagacestat
PA-TU-8902::Sepantronium bromide
HuH-7::Telomerase Inhibitor IX
G-MEL::Dabrafenib
MLMA::Cediranib
NCI-H1048::AZD7762
MC116::I-BRD9
GAK::VX-11e
NCI-H1105::AGI-6780
HH::Alisertib
A375::Foretinib
TE-1::Afatinib
OVCAR-4::XAV939
LS-513::VX-11e
SCC-15::Dabrafenib
M059J::MK-8776
KOPN-8::Sepantronium bromide
OV-90::Afatinib
MOLM-13::Doramapimod
SNU-C5::I-BRD9
SBC-1::XAV939
EW-3::Avagacestat
NCI-H716::Doramapimod
U-266::MK-8776
8-MG-BA::Cediranib
HT-29::Sepantronium bromide
HEL::Alisertib
WM793B::ZM447439
OVCAR-3::Motesanib
HT-29::Cediranib
NCI-H1666::Avagacestat
A388::XAV939
T-T::Motesanib
CAL-148::Foretinib
NCI-H841::Dabrafenib
MEL-HO::I-BRD9
ESS-1::AGI-6780
SK-CO-1::Cediranib
HSC-4::AZD7762
SNU-407::Sepantronium bromide
EW-3::Sepantronium bromide
5637::Doramapimod
OACM5-1::Alisertib
ALL-SIL::Osimertinib
HCC1500::AZD7762
BL-41::Afatinib
NCI-H1876::Foretinib
HCT-116::VX-11e
NB10::AGI-6780
LS-123::AZD7762
KARPAS-1106P::I-BRD9
PANC-08-13::VX-11e
NCI-H1299::Osimertinib
CP66-MEL::Afatinib
C2BBe1::Cediranib
BV-173::Motesanib
JHH-6::Cediranib
NCC010::Doramapimod
HCC70::AZD7762
KMS-12-BM::Motesanib
UM-UC-3::AZD7762
COLO-320-HSR::Avagacestat
BE2-M17::VX-11e
NCI-H1341::Foretinib
ES6::Dabrafenib
NCI-H1993::Sepantronium bromide
MEG-01::VX-11e
SK-LMS-1::ZM447439
K5::AGI-6780
NCI-H748::Afatinib
OE33::Foretinib
NB13::I-BRD9
SW1088::Cediranib
CAKI-1::Alisertib
CHL-1::MK-8776
LS-411N::Doramapimod
HO-1-u-1::Doramapimod
NCI-H3122::Doramapimod
BV-173::XAV939
JAR::ZM447439
JM1::ZM447439
RPMI-6666::Cediranib
C2BBe1::AZD7762
ES1::Osimertinib
NCI-H1944::I-BRD9
NCI-H1838::I-BRD9
A375::Avagacestat
ALL-SIL::Foretinib
NCI-H2170::Foretinib
U251::Alisertib
U251::Afatinib
VAL::Alisertib
COR-L311::Motesanib
HCC1937::AGI-6780
SKM-1::Osimertinib
NCI-H69::ZM447439
NCI-H2227::Osimertinib
A3-KAW::MK-8776
TK10::XAV939
HuH-7::ZM447439
SIG-M5::ZM447439
OVCAR-4::Doramapimod
SNB75::Telomerase Inhibitor IX
A4-Fuk::Afatinib
HCC1187::Afatinib
COR-L105::MK-8776
L-1236::Afatinib
HO-1-u-1::Motesanib
EMC-BAC-1::Doramapimod
HT-1376::XAV939
REH::Telomerase Inhibitor IX
KYSE-270::Dabrafenib
TE-441-T::Afatinib
TE-12::Avagacestat
P30-OHK::Telomerase Inhibitor IX
FU-OV-1::Alisertib
NCI-H1781::Alisertib
ECC12::Foretinib
OE21::Afatinib
LN-229::XAV939
CAL-51::Foretinib
VAL::XAV939
T-T::MK-8776
HCC1187::VX-11e
RXF393::Avagacestat
SW626::Telomerase Inhibitor IX
TE-4::XAV939
CHP-212::Afatinib
LNCaP-Clone-FGC::Avagacestat
KP-3::MK-8776
IHH-4::AGI-6780
ABC-1::VX-11e
LS-123::XAV939
T-T::Avagacestat
NCI-H2052::Telomerase Inhibitor IX
PC-14::ZM447439
EJM::AGI-6780
P31-FUJ::Motesanib
SW954::BX795
HCC-15::VX-11e
COLO-205::I-BRD9
SF295::Afatinib
DMS-273::ZM447439
BB49-HNC::Alisertib
A427::Dabrafenib
HOS::Afatinib
NCI-H2170::Alisertib
HGC-27::Telomerase Inhibitor IX
EW-3::Cediranib
NCI-H1650::ZM447439
Ca-Ski::Alisertib
NCI-H1876::Doramapimod
NCI-H847::MK-8776
NCI-H1838::Cediranib
no-11::VX-11e
ACHN::Motesanib
SLVL::Telomerase Inhibitor IX
SW620::XAV939
TC-YIK::Cediranib
NCI-H2342::I-BRD9
JAR::I-BRD9
HCC1569::Cediranib
DU-4475::Motesanib
HPAF-II::I-BRD9
OE19::XAV939
NCI-H1563::Afatinib
CAL-12T::Motesanib
KM-H2::ZM447439
ES1::Alisertib
SF539::MK-8776
MG-63::Osimertinib
EW-12::BX795
LS-180::Sepantronium bromide
L-1236::AGI-6780
L-428::Dabrafenib
BE-13::ZM447439
TCCSUP::Afatinib
SNU-423::AZD7762
MEG-01::Foretinib
NB10::Cediranib
MCF7::Afatinib
HCT-15::Motesanib
PF-382::Telomerase Inhibitor IX
NCI-N87::Afatinib
COR-L311::Avagacestat
HCC1806::Afatinib
SNU-398::Osimertinib
NCI-H2009::Dabrafenib
RERF-LC-KJ::Sepantronium bromide
NCI-H211::XAV939
NCI-H835::Sepantronium bromide
SUP-B8::Motesanib
COR-L105::Dabrafenib
FU97::Foretinib
OE33::Motesanib
LS-180::Alisertib
SK-N-FI::Afatinib
JHU-011::Osimertinib
CHP-212::Avagacestat
GOTO::AGI-6780
MRK-nu-1::Dabrafenib
TC-YIK::Dabrafenib
NCI-H650::MK-8776
TE-12::ZM447439
MKN28::Osimertinib
MCF7::Dabrafenib
EN::Doramapimod
DOK::MK-8776
BB30-HNC::Foretinib
GI-1::Telomerase Inhibitor IX
NCI-H2085::AZD7762
KP-N-YN::Avagacestat
Becker::Alisertib
LN-18::Afatinib
TGBC1TKB::Telomerase Inhibitor IX
A204::Afatinib
MONO-MAC-6::Sepantronium bromide
U-87-MG::Doramapimod
YAPC::MK-8776
D-566MG::ZM447439
697::I-BRD9
KINGS-1::I-BRD9
CHSA0108::Osimertinib
TGBC11TKB::I-BRD9
NH-12::AZD7762
NCI-H1048::I-BRD9
H3255::XAV939
LB831-BLC::I-BRD9
NCI-H720::ZM447439
NCI-H1581::Cediranib
HCC1419::Osimertinib
OVMIU::ZM447439
A253::Doramapimod
K2::AZD7762
HuP-T4::Cediranib
CAL-51::ZM447439
LP-1::I-BRD9
NCI-H2170::Cediranib
HGC-27::Sepantronium bromide
HTC-C3::Doramapimod
SK-LU-1::Afatinib
OACp4C::Afatinib
GR-ST::Foretinib
OE19::ZM447439
NCI-H64::Motesanib
BALL-1::Doramapimod
EB-3::MK-8776
GI-ME-N::Dabrafenib
KALS-1::Cediranib
OV-56::Avagacestat
HT-1080::ZM447439
SW954::Doramapimod
SKN-3::MK-8776
BEN::MK-8776
TGBC1TKB::Dabrafenib
MCF7::ZM447439
SW1990::Sepantronium bromide
RPMI-8866::VX-11e
NCI-H1793::Alisertib
T47D::Alisertib
CGTH-W-1::VX-11e
HPAC::MK-8776
NCI-H1581::I-BRD9
NCI-H2085::Osimertinib
SUP-T1::Afatinib
NCI-H1341::Avagacestat
NCI-H1755::Sepantronium bromide
BICR10::Afatinib
CW-2::Alisertib
SBC-3::AZD7762
HT-1376::Doramapimod
HGC-27::VX-11e
IST-SL1::BX795
D-423MG::ZM447439
EW-18::Dabrafenib
KARPAS-620::Doramapimod
KU-19-19::I-BRD9
RL95-2::Doramapimod
SK-N-DZ::Afatinib
HCC1500::Alisertib
LB2518-MEL::Cediranib
MIA-PaCa-2::MK-8776
SK-N-AS::I-BRD9
OCUM-1::Alisertib
PEO1::Telomerase Inhibitor IX
MLMA::Dabrafenib
RT-112::AGI-6780
EJM::Alisertib
SK-MEL-30::Cediranib
MDA-MB-330::Motesanib
KARPAS-231::Dabrafenib
BONNA-12::Telomerase Inhibitor IX
ME-1::AGI-6780
JVM-2::Dabrafenib
NCI-H2347::MK-8776
IGROV-1::XAV939
COR-L23::Telomerase Inhibitor IX
451Lu::I-BRD9
YAPC::AGI-6780
JEG-3::Sepantronium bromide
TCCSUP::Dabrafenib
DU-145::MK-8776
LS-411N::Avagacestat
MEG-01::I-BRD9
NCC010::Cediranib
TUR::I-BRD9
HGC-27::Alisertib
Hey::Foretinib
WM1552C::Avagacestat
NCI-H2291::Dabrafenib
Daudi::Osimertinib
SK-GT-4::ZM447439
JM1::Telomerase Inhibitor IX
A673::Afatinib
HCT-15::AGI-6780
LOXIMVI::Foretinib
SW756::Afatinib
SW1573::AZD7762
PL-21::XAV939
BC-1::Dabrafenib
G-361::Cediranib
SK-GT-2::Alisertib
no-11::Osimertinib
MCF7::XAV939
HT-144::Avagacestat
NCI-H748::Sepantronium bromide
SNU-407::Cediranib
SU-DHL-6::Sepantronium bromide
KARPAS-231::XAV939
H9::Dabrafenib
COLO-829::I-BRD9
KYSE-510::AZD7762
CAL-29::Alisertib
BV-173::Cediranib
SK-LMS-1::Cediranib
SK-N-SH::Alisertib
OACp4C::Foretinib
NCI-H2085::VX-11e
DU-145::Cediranib
YT::Osimertinib
PANC-02-03::AZD7762
JHH-2::Afatinib
NCI-H1355::MK-8776
GOTO::Sepantronium bromide
CaR-1::VX-11e
NCI-H1355::AZD7762
769-P::XAV939
GCT::Alisertib
NCI-H650::Avagacestat
HO-1-u-1::Osimertinib
MFH-ino::Sepantronium bromide
CW-2::Dabrafenib
HSC-4::Afatinib
NCI-H1734::Afatinib
SK-MM-2::AZD7762
CAMA-1::Doramapimod
HCC1419::Telomerase Inhibitor IX
NCI-H2029::AGI-6780
IGROV-1::MK-8776
BE2-M17::Motesanib
DOHH-2::Afatinib
NB13::Telomerase Inhibitor IX
HCC70::VX-11e
C32::Sepantronium bromide
MEL-HO::Telomerase Inhibitor IX
NCI-H250::Cediranib
OCUM-1::AGI-6780
A2058::Cediranib
EFM-192A::VX-11e
OAW-42::AZD7762
Farage::Afatinib
ESO51::Motesanib
TT2609-C02::AGI-6780
IPC-298::Doramapimod
WSU-DLCL2::Doramapimod
NCI-H1694::Sepantronium bromide
DJM-1::Doramapimod
NB6::BX795
SW1271::Alisertib
EVSA-T::Cediranib
SK-MES-1::ZM447439
NAMALWA::VX-11e
NCI-H810::Doramapimod
RERF-LC-KJ::Doramapimod
Farage::I-BRD9
COR-L105::Sepantronium bromide
KG-1::Foretinib
SW756::Osimertinib
KARPAS-299::Osimertinib
NB13::Osimertinib
JHU-029::MK-8776
OCI-AML2::Dabrafenib
NCI-H1694::AZD7762
ALL-SIL::Alisertib
A253::Sepantronium bromide
HCC1187::AGI-6780
SW837::Sepantronium bromide
A427::I-BRD9
SW756::Alisertib
LB2241-RCC::XAV939
DB::AZD7762
SU-DHL-10::Motesanib
SCC-3::Avagacestat
LXF-289::Alisertib
KE-37::AZD7762
TE-5::Dabrafenib
KYSE-520::Sepantronium bromide
MDA-MB-468::AZD7762
SW1417::VX-11e
CaR-1::Dabrafenib
AsPC-1::Doramapimod
NCI-H2023::MK-8776
LU-165::Alisertib
IMR-5::AGI-6780
DG-75::Foretinib
MKN1::VX-11e
A673::Foretinib
KARPAS-422::AZD7762
HCC38::Osimertinib
IPC-298::Osimertinib
HCC1143::Doramapimod
DU-145::I-BRD9
T47D::Cediranib
PA-TU-8988T::Telomerase Inhibitor IX
WM1552C::Osimertinib
EKVX::Osimertinib
JHH-4::AGI-6780
NOS-1::Foretinib
WM-115::Afatinib
NCI-H1703::MK-8776
KARPAS-422::MK-8776
SK-MEL-5::Osimertinib
NCI-H1666::Alisertib
K2::Foretinib
NCI-H2444::AZD7762
SNU-C2B::Motesanib
23132-87::Osimertinib
COLO-679::ZM447439
no-11::AZD7762
GP5d::I-BRD9
KARPAS-620::MK-8776
SK-MEL-28::Cediranib
NCI-H2029::Dabrafenib
22RV1::XAV939
G-361::AGI-6780
JHOS-3::MK-8776
NCI-H727::I-BRD9
TK10::Sepantronium bromide
HCC2157::Doramapimod
SW1710::XAV939
HPAC::I-BRD9
EVSA-T::Sepantronium bromide
J82::ZM447439
BT-20::Doramapimod
LU-139::Doramapimod
LS-180::AGI-6780
RERF-LC-MS::Motesanib
G-MEL::I-BRD9
KYSE-150::Dabrafenib
JHH-6::Sepantronium bromide
NCI-H929::Motesanib
LB996-RCC::Cediranib
SW954::Cediranib
OV-17R::I-BRD9
BT-474::Foretinib
NCI-H1092::MK-8776
EFM-192A::Doramapimod
MFE-319::Cediranib
TE-441-T::Avagacestat
OCI-LY-19::Osimertinib
RS4-11::Motesanib
DBTRG-05MG::MK-8776
BICR31::Cediranib
NCI-H2135::Alisertib
639-V::Cediranib
CAKI-1::Foretinib
LNCaP-Clone-FGC::VX-11e
RERF-LC-MS::AGI-6780
H-EMC-SS::Cediranib
OSC-19::Osimertinib
SK-MEL-28::Motesanib
42-MG-BA::AZD7762
LAN-6::Afatinib
CAL-78::Foretinib
MS-1::Telomerase Inhibitor IX
OE21::Dabrafenib
STS-0421::Osimertinib
TGW::Cediranib
HT-1376::Avagacestat
NCI-H2291::Doramapimod
WM278::XAV939
T84::Afatinib
IA-LM::I-BRD9
MDA-MB-157::Foretinib
NCI-H720::Sepantronium bromide
KYSE-180::Sepantronium bromide
UM-UC-3::Doramapimod
MV-4-11::Osimertinib
COLO-680N::I-BRD9
MDST8::AGI-6780
RCM-1::I-BRD9
SNU-283::Foretinib
D-392MG::Sepantronium bromide
CAKI-1::ZM447439
LB1047-RCC::Doramapimod
NCI-H720::AGI-6780
PL-21::I-BRD9
IPC-298::Sepantronium bromide
SK-UT-1::AZD7762
CL-11::AZD7762
BT-483::Alisertib
C-4-I::Foretinib
KYSE-520::Doramapimod
HCC1428::VX-11e
MLMA::ZM447439
Calu-6::MK-8776
KGN::Avagacestat
SW626::AZD7762
CAL-33::Afatinib
NCI-H2009::Afatinib
NCI-H28::AGI-6780
MDA-MB-231::Alisertib
NCI-H1436::Alisertib
SLVL::Alisertib
CCK-81::Dabrafenib
NCI-H1581::MK-8776
SKN::Cediranib
KALS-1::Dabrafenib
Hey::Alisertib
HC-1::Sepantronium bromide
SW780::Doramapimod
SR::XAV939
CHP-134::Sepantronium bromide
NCI-H2444::Sepantronium bromide
NCI-H716::AZD7762
DAN-G::VX-11e
RPMI-8402::I-BRD9
ML-1::MK-8776
ST486::XAV939
EBC-1::Osimertinib
ES5::Avagacestat
RH-1::XAV939
OVMIU::Alisertib
NCI-H226::Alisertib
JVM-2::Osimertinib
MC116::Dabrafenib
JHH-2::AZD7762
D-283MED::ZM447439
NAMALWA::Alisertib
RPMI-6666::Dabrafenib
PA-1::MK-8776
MFM-223::Foretinib
Caov-4::Afatinib
KYSE-270::Alisertib
CAL-33::Alisertib
WM35::Sepantronium bromide
EM-2::Osimertinib
IGR-37::Telomerase Inhibitor IX
C32::MK-8776
KATOIII::Cediranib
NCI-H720::Alisertib
UACC-257::MK-8776
RERF-LC-Sq1::Foretinib
BxPC-3::ZM447439
HCE-4::Sepantronium bromide
BICR22::AZD7762
ES1::Sepantronium bromide
HCC1937::Osimertinib
BFTC-909::Motesanib
COLO-792::Avagacestat
SLVL::Avagacestat
BT-483::I-BRD9
CaR-1::Avagacestat
KYSE-510::Cediranib
IGR-1::AGI-6780
NCI-H2227::VX-11e
OVCA420::Foretinib
LB831-BLC::Avagacestat
SJSA-1::AZD7762
MOLT-16::Dabrafenib
KM12::I-BRD9
U-87-MG::Afatinib
CP50-MEL-B::Telomerase Inhibitor IX
CAS-1::Telomerase Inhibitor IX
DOV13::Foretinib
KARPAS-231::Telomerase Inhibitor IX
RPMI-8402::Motesanib
NUGC-3::AZD7762
A253::Cediranib
CHSA0108::Sepantronium bromide
COLO-783::AGI-6780
NCI-H446::Dabrafenib
22RV1::Telomerase Inhibitor IX
COLO-320-HSR::ZM447439
TT::MK-8776
CHSA0011::Alisertib
Raji::MK-8776
Ramos-2G6-4C10::Foretinib
VCaP::Cediranib
KP-3::Foretinib
CAL-51::Avagacestat
GI-ME-N::AZD7762
SNU-398::Foretinib
CaR-1::I-BRD9
DB::Motesanib
NCI-H1869::AGI-6780
KYSE-50::ZM447439
no-10::Afatinib
CTV-1::Avagacestat
NCI-H747::Cediranib
SKM-1::Dabrafenib
LB2241-RCC::Sepantronium bromide
L-428::Osimertinib
ME-180::XAV939
HO-1-u-1::ZM447439
KARPAS-45::Cediranib
KP-3::Sepantronium bromide
CP66-MEL::BX795
OCI-AML3::I-BRD9
NCI-H1755::MK-8776
LN-229::I-BRD9
NCI-H1734::AGI-6780
SU-DHL-4::AZD7762
LB647-SCLC::Cediranib
SW48::Dabrafenib
OVKATE::VX-11e
HEL::XAV939
CAL-54::ZM447439
CP50-MEL-B::Alisertib
Hs-445::Doramapimod
PANC-08-13::Alisertib
RH-1::Cediranib
Hey::AZD7762
KYSE-410::AZD7762
LCLC-97TM1::I-BRD9
MHH-PREB-1::Telomerase Inhibitor IX
SU-DHL-16::Sepantronium bromide
ABC-1::BX795
U-118-MG::MK-8776
OE19::Afatinib
DK-MG::Telomerase Inhibitor IX
G-MEL::Doramapimod
NCI-H2141::VX-11e
D-502MG::AGI-6780
SCC-25::AGI-6780
A431::Doramapimod
SiHa::Foretinib
KARPAS-1106P::ZM447439
HT-29::Doramapimod
NB6::Avagacestat
K-562::AZD7762
L-1236::Osimertinib
NCI-H2172::Afatinib
COR-L105::Telomerase Inhibitor IX
NCI-H2023::Foretinib
RCH-ACV::Avagacestat
JEKO-1::Cediranib
HCC-78::Sepantronium bromide
KE-37::ZM447439
COLO-783::Foretinib
KM-H2::Sepantronium bromide
RT-112::Doramapimod
Raji::ZM447439
KP-3::Dabrafenib
OS-RC-2::AGI-6780
COLO-824::ZM447439
MPP-89::Telomerase Inhibitor IX
ES4::VX-11e
NCI-H596::Avagacestat
DAN-G::Foretinib
HARA::Sepantronium bromide
SW756::Avagacestat
AM-38::Cediranib
G-402::Avagacestat
CML-T1::Motesanib
KARPAS-1106P::Telomerase Inhibitor IX
U251::ZM447439
SF539::Afatinib
JAR::Sepantronium bromide
ASH-3::Telomerase Inhibitor IX
U-698-M::Dabrafenib
NCI-H660::AGI-6780
LP-1::AZD7762
SK-MEL-2::MK-8776
GCIY::Osimertinib
Mo-T::Afatinib
U-266::Afatinib
SK-GT-2::Cediranib
HOP-92::AZD7762
RERF-LC-Sq1::Motesanib
CAL-78::ZM447439
CAL-33::MK-8776
KMRC-1::I-BRD9
CP66-MEL::I-BRD9
DMS-53::I-BRD9
JIMT-1::Foretinib
EW-11::Avagacestat
AM-38::Telomerase Inhibitor IX
PANC-04-03::Sepantronium bromide
COLO-829::AGI-6780
EW-16::AZD7762
697::Doramapimod
MKN45::I-BRD9
LNCaP-Clone-FGC::Motesanib
NCI-H1876::ZM447439
EW-22::Doramapimod
NCI-H1734::Motesanib
PA-1::XAV939
SK-MEL-30::Afatinib
MDA-MB-231::ZM447439
KYAE-1::Motesanib
HA7-RCC::AGI-6780
ACHN::I-BRD9
A3-KAW::Afatinib
BPH-1::ZM447439
PANC-04-03::I-BRD9
IST-MES1::Alisertib
A4-Fuk::ZM447439
A498::Osimertinib
8305C::Avagacestat
SUP-B15::Avagacestat
EW-11::Motesanib
D-247MG::Foretinib
HOP-92::ZM447439
JHH-2::Osimertinib
KYSE-510::Foretinib
GI-1::AGI-6780
NCI-H28::Motesanib
KP-2::Doramapimod
KU-19-19::Telomerase Inhibitor IX
PSN1::I-BRD9
JHH-1::Dabrafenib
ECC10::Motesanib
COLO-205::Foretinib
MKN7::Osimertinib
SNU-C1::VX-11e
KYSE-450::Telomerase Inhibitor IX
ASH-3::I-BRD9
HO-1-N-1::Afatinib
SHP-77::Alisertib
HLE::Foretinib
A2058::Foretinib
SK-OV-3::Afatinib
BE2-M17::AGI-6780
ESS-1::Cediranib
U-698-M::AZD7762
NCI-H2196::Motesanib
SW756::Motesanib
MPP-89::Afatinib
42-MG-BA::Dabrafenib
OVMIU::Osimertinib
NCI-H1770::Dabrafenib
OV-7::Osimertinib
JHH-7::Dabrafenib
SNU-283::Sepantronium bromide
PCI-15A::Alisertib
ALL-PO::ZM447439
NB10::I-BRD9
BT-483::Motesanib
COR-L279::Osimertinib
MN-60::MK-8776
KOPN-8::Afatinib
SK-MEL-28::XAV939
H-EMC-SS::Doramapimod
VMRC-RCZ::AZD7762
HGC-27::ZM447439
NCI-H1648::ZM447439
HCC-44::AGI-6780
KP-4::Dabrafenib
SCC90::Sepantronium bromide
COLO-800::XAV939
MHH-NB-11::MK-8776
PCI-4B::Avagacestat
IA-LM::Osimertinib
LU-165::Telomerase Inhibitor IX
SU-DHL-10::AZD7762
KNS-81-FD::ZM447439
SW1417::Afatinib
YT::ZM447439
MFE-280::Motesanib
SKN::Sepantronium bromide
SUP-B15::Dabrafenib
RH-1::Osimertinib
BxPC-3::Sepantronium bromide
HCT-116::Motesanib
SN12C::AGI-6780
NCI-H2009::Cediranib
NB69::MK-8776
COR-L303::MK-8776
NB17::I-BRD9
BT-549::ZM447439
SNU-407::VX-11e
OVMIU::Doramapimod
EW-22::Alisertib
Mo-T::I-BRD9
P12-ICHIKAWA::Osimertinib
NB7::Alisertib
RO82-W-1::Sepantronium bromide
NCI-H661::Osimertinib
SW982::Foretinib
SUP-B15::Alisertib
BB49-HNC::VX-11e
GAK::MK-8776
BT-474::AGI-6780
LS-180::Motesanib
OCI-LY7::I-BRD9
Caov-4::Telomerase Inhibitor IX
BFTC-905::Dabrafenib
U-118-MG::XAV939
IGROV-1::I-BRD9
ESO26::Telomerase Inhibitor IX
SCC-15::Foretinib
MKN1::I-BRD9
SU-DHL-4::VX-11e
LAN-6::ZM447439
PWR-1E::XAV939
TYK-nu::Doramapimod
T98G::Cediranib
SUP-B8::Telomerase Inhibitor IX
OSC-19::AZD7762
697::Foretinib
CAL-120::Doramapimod
D-566MG::Telomerase Inhibitor IX
SW48::Osimertinib
HCC1569::VX-11e
MDA-MB-468::Osimertinib
NB5::Afatinib
Saos-2::I-BRD9
NY::Doramapimod
PL4::Dabrafenib
MOLT-4::MK-8776
HCT-15::Osimertinib
8-MG-BA::Avagacestat
JHH-2::Foretinib
TK10::Doramapimod
GCIY::Afatinib
U-118-MG::Dabrafenib
BC-1::Avagacestat
BICR10::AZD7762
TE-10::Osimertinib
SW756::Dabrafenib
SW982::Alisertib
NCI-H1563::AZD7762
MOLM-16::AGI-6780
EW-1::ZM447439
HCC70::Cediranib
NCI-H510A::Osimertinib
SUP-B15::Telomerase Inhibitor IX
SK-MG-1::Alisertib
KU-19-19::AZD7762
DSH1::Cediranib
FADU::XAV939
NCI-H1355::Osimertinib
CAL-72::Avagacestat
HMV-II::ZM447439
NCI-H1993::Avagacestat
HC-1::AZD7762
CRO-AP2::Sepantronium bromide
LB2241-RCC::I-BRD9
RPMI-6666::AGI-6780
SAS::MK-8776
EBC-1::ZM447439
MES-SA::VX-11e
RKN::AGI-6780
A172::ZM447439
OVCAR-8::Cediranib
KARPAS-1106P::Motesanib
U-118-MG::Avagacestat
SNU-81::Sepantronium bromide
D-283MED::Sepantronium bromide
CAS-1::VX-11e
IST-MES1::AGI-6780
OCI-AML3::Osimertinib
EJM::Doramapimod
HSC-3::Telomerase Inhibitor IX
ES4::MK-8776
TE-6::Telomerase Inhibitor IX
NCI-H196::Dabrafenib
NCI-H929::AZD7762
H4::ZM447439
MFH-ino::Motesanib
ECC12::Dabrafenib
KMS-11::Dabrafenib
RT4::Cediranib
YKG-1::Motesanib
BFTC-909::Sepantronium bromide
769-P::Avagacestat
NCI-H1876::AGI-6780
BT-483::Cediranib
JEKO-1::Doramapimod
RKN::VX-11e
DoTc2-4510::VX-11e
CADO-ES1::Doramapimod
SK-UT-1::Foretinib
KM12::AGI-6780
KMOE-2::Motesanib
NCI-H2066::Alisertib
HCC1395::AZD7762
GR-ST::VX-11e
SJSA-1::Motesanib
AMO-1::Alisertib
HSC-3::Dabrafenib
SW1116::Osimertinib
CA46::I-BRD9
SNU-449::MK-8776
RF-48::Telomerase Inhibitor IX
LNCaP-Clone-FGC::Dabrafenib
ME-1::XAV939
HT-29::MK-8776
KYSE-150::Cediranib
JHU-029::Foretinib
CTV-1::VX-11e
HCC38::I-BRD9
CAL-148::I-BRD9
EW-18::AGI-6780
CADO-ES1::Motesanib
LC-1-sq::Avagacestat
FU-OV-1::MK-8776
JHH-4::Cediranib
SW156::AZD7762
GB-1::Afatinib
SK-LMS-1::Afatinib
COLO-783::AZD7762
8305C::Motesanib
SU-DHL-8::Foretinib
BONNA-12::Motesanib
JVM-3::ZM447439
JHU-029::Motesanib
LB373-MEL-D::Alisertib
NCI-H358::I-BRD9
CADO-ES1::Osimertinib
HuP-T3::Alisertib
HT-1376::MK-8776
FADU::Sepantronium bromide
NCI-H1155::Sepantronium bromide
LNCaP-Clone-FGC::ZM447439
Caov-4::MK-8776
TCCSUP::I-BRD9
EoL-1-cell::Doramapimod
T-T::I-BRD9
KYSE-180::Foretinib
RT-112::Alisertib
NCI-H740::Foretinib
HO-1-N-1::Telomerase Inhibitor IX
SW48::I-BRD9
NH-12::Foretinib
U-266::Dabrafenib
NCI-H1838::Dabrafenib
Becker::AGI-6780
SU-DHL-6::MK-8776
KYSE-150::Doramapimod
SK-ES-1::Alisertib
DB::MK-8776
SNU-398::Doramapimod
YH-13::Sepantronium bromide
Mewo::Foretinib
Hs-578-T::ZM447439
NCC010::Foretinib
LS-180::Dabrafenib
OVK-18::MK-8776
AN3-CA::XAV939
ML-1::Alisertib
JVM-2::Alisertib
ST486::I-BRD9
SK-MEL-30::AGI-6780
L-540::Doramapimod
VA-ES-BJ::Sepantronium bromide
KARPAS-422::ZM447439
NCI-H2228::Afatinib
KOSC-2::Motesanib
JSC-1::VX-11e
RL95-2::Sepantronium bromide
UWB1.289::Osimertinib
BFTC-909::Foretinib
COLO-679::Doramapimod
LB996-RCC::Foretinib
IST-SL1::Osimertinib
ES5::Telomerase Inhibitor IX
LK-2::ZM447439
MHH-PREB-1::Foretinib
IST-SL2::AZD7762
LN-405::Doramapimod
EMC-BAC-1::VX-11e
NCI-H526::Doramapimod
SUP-T1::ZM447439
CP50-MEL-B::Doramapimod
YAPC::Dabrafenib
NCI-H2196::Foretinib
RCH-ACV::AGI-6780
NCI-H446::Osimertinib
LoVo::Avagacestat
LB373-MEL-D::AGI-6780
HA7-RCC::Sepantronium bromide
KP-2::Foretinib
ATN-1::Telomerase Inhibitor IX
VMRC-LCD::VX-11e
KARPAS-45::MK-8776
EB-3::AGI-6780
SH-4::MK-8776
TUR::Sepantronium bromide
SUP-HD1::AZD7762
KELLY::AZD7762
OV-7::Foretinib
SW1463::I-BRD9
SCH::XAV939
SK-N-SH::Afatinib
Ca-Ski::Cediranib
A2780::Telomerase Inhibitor IX
RH-1::Alisertib
KM12::Foretinib
G-361::Telomerase Inhibitor IX
KYAE-1::Afatinib
SKG-IIIa::AGI-6780
SAT::Dabrafenib
KON::BX795
TT::Motesanib
TE-441-T::AGI-6780
REH::Doramapimod
NCI-H2122::I-BRD9
KP-1N::Motesanib
PANC-08-13::Dabrafenib
CFPAC-1::Avagacestat
REH::Dabrafenib
MDA-MB-157::I-BRD9
NCI-H196::ZM447439
A498::Alisertib
SNU-C5::Dabrafenib
H3255::BX795
OVKATE::Foretinib
ABC-1::XAV939
HCC-827::Cediranib
SNU-175::Afatinib
PSN1::MK-8776
NUGC-4::AZD7762
PEO1::Afatinib
NCI-H2087::VX-11e
IMR-5::Telomerase Inhibitor IX
MOLT-13::Cediranib
Raji::Cediranib
PL4::XAV939
Hs-445::XAV939
COR-L23::Cediranib
JHU-029::AZD7762
OE19::Dabrafenib
TOV-21G::Afatinib
SCC-4::VX-11e
ES6::Sepantronium bromide
CAL-148::Telomerase Inhibitor IX
NCI-H838::Osimertinib
SK-UT-1::Cediranib
SCC-15::Cediranib
Calu-3::Sepantronium bromide
KU-19-19::Doramapimod
A2780::AZD7762
MLMA::Alisertib
HCC38::Foretinib
CML-T1::I-BRD9
ML-1::Telomerase Inhibitor IX
NCI-H526::Motesanib
KMRC-20::VX-11e
OE19::Sepantronium bromide
HCC1954::Motesanib
HPAC::Avagacestat
SAS::Afatinib
SCC-3::Afatinib
RO82-W-1::MK-8776
SK-UT-1::Osimertinib
BV-173::Osimertinib
NCI-H358::Motesanib
EW-22::Cediranib
OE19::Telomerase Inhibitor IX
HCC1569::ZM447439
PCI-6A::I-BRD9
NCI-H847::ZM447439
ES8::Telomerase Inhibitor IX
SU-DHL-5::Sepantronium bromide
SCC-15::MK-8776
IGR-1::Doramapimod
MM1S::Dabrafenib
LB647-SCLC::XAV939
LU-99A::Motesanib
LU-139::Alisertib
MEL-HO::BX795
ML-1::AGI-6780
CAL-78::Alisertib
KOSC-2::I-BRD9
NCI-H647::Telomerase Inhibitor IX
MKN1::Doramapimod
Daoy::MK-8776
RF-48::Alisertib
TE-12::Doramapimod
ME-1::Alisertib
ECC12::VX-11e
SiHa::ZM447439
LB647-SCLC::AGI-6780
TE-10::XAV939
BEN::Sepantronium bromide
HOS::Telomerase Inhibitor IX
SR::AZD7762
NCI-H250::Alisertib
KINGS-1::ZM447439
OAW-42::AGI-6780
NCI-H1770::AZD7762
GRANTA-519::ZM447439
NCI-H2110::AZD7762
LB1047-RCC::Motesanib
YT::Telomerase Inhibitor IX
PA-TU-8902::I-BRD9
SNU-423::Motesanib
Calu-6::Cediranib
RKN::Motesanib
L-363::Sepantronium bromide
WM-115::MK-8776
TE-11::Sepantronium bromide
KP-2::Alisertib
WM793B::Osimertinib
HuO-3N1::Doramapimod
NCI-H196::Afatinib
TE-15::MK-8776
BB65-RCC::Cediranib
769-P::Motesanib
CaR-1::Foretinib
EW-16::Telomerase Inhibitor IX
KNS-62::Avagacestat
PCI-15A::Dabrafenib
SK-MM-2::Foretinib
NCI-H524::Doramapimod
ES6::Alisertib
ES7::I-BRD9
NCI-H1623::I-BRD9
SNG-M::I-BRD9
A427::AZD7762
H9::Osimertinib
HGC-27::I-BRD9
PC-14::Motesanib
NCI-H2030::AZD7762
LS-123::Alisertib
COLO-824::Alisertib
HuO9::Alisertib
SK-MEL-24::Telomerase Inhibitor IX
769-P::MK-8776
NCI-H345::I-BRD9
Calu-3::MK-8776
COR-L303::Osimertinib
NCI-H441::Afatinib
HO-1-u-1::VX-11e
EW-16::Doramapimod
ES5::Sepantronium bromide
MZ7-mel::Alisertib
MS751::Doramapimod
NCI-H1793::Avagacestat
CAL-120::Foretinib
HCC-78::Cediranib
U-698-M::Avagacestat
HT-1376::ZM447439
HT-3::Alisertib
SNB75::BX795
ASH-3::ZM447439
MDA-MB-157::AZD7762
NCI-H1770::Telomerase Inhibitor IX
MV-4-11::ZM447439
SAS::VX-11e
A253::Avagacestat
CAS-1::Motesanib
CAL-72::Telomerase Inhibitor IX
LS-513::Dabrafenib
BPH-1::Dabrafenib
QGP-1::Dabrafenib
OSC-20::Foretinib
NCI-H522::Osimertinib
PANC-03-27::Afatinib
OV-7::Afatinib
HH::Foretinib
TE-8::AGI-6780
OCI-AML2::Afatinib
OC-314::Sepantronium bromide
PANC-04-03::Motesanib
NCI-H510A::VX-11e
D-336MG::ZM447439
UACC-257::XAV939
A673::AZD7762
KMRC-1::Alisertib
WM-115::Foretinib
MDA-MB-157::ZM447439
JM1::I-BRD9
SNU-407::ZM447439
MDST8::VX-11e
Daudi::Cediranib
SW1783::ZM447439
EBC-1::Sepantronium bromide
BxPC-3::AGI-6780
SU-DHL-5::Alisertib
NCI-H196::Foretinib
RMG-I::Doramapimod
A431::Afatinib
NCI-H2066::Sepantronium bromide
Calu-3::I-BRD9
ES4::Alisertib
SKM-1::Cediranib
NCI-H1299::Telomerase Inhibitor IX
SNU-398::Avagacestat
RCH-ACV::MK-8776
IA-LM::VX-11e
Ca9-22::Avagacestat
HPAF-II::Telomerase Inhibitor IX
NCI-H1623::Telomerase Inhibitor IX
UACC-893::Telomerase Inhibitor IX
HOP-92::I-BRD9
OCI-M1::AZD7762
MOLT-4::Telomerase Inhibitor IX
HL-60::VX-11e
CAL-33::Osimertinib
22RV1::Foretinib
NCI-H1651::Sepantronium bromide
HCC1395::I-BRD9
OVTOKO::Cediranib
BB49-HNC::Dabrafenib
HARA::Avagacestat
SW13::Alisertib
NCI-H2110::Osimertinib
BHY::Telomerase Inhibitor IX
NB10::Telomerase Inhibitor IX
GA-10::Afatinib
SAT::ZM447439
EoL-1-cell::Sepantronium bromide
D-502MG::BX795
NCI-H740::Sepantronium bromide
LOUCY::Foretinib
Becker::Dabrafenib
HT-1080::XAV939
MRK-nu-1::Foretinib
CPC-N::ZM447439
PANC-02-03::ZM447439
KOPN-8::Osimertinib
MEG-01::AZD7762
BT-483::AZD7762
LK-2::I-BRD9
OVCA420::AGI-6780
IST-SL1::Alisertib
REH::AZD7762
RMG-I::Sepantronium bromide
PCI-6A::MK-8776
BB49-HNC::Osimertinib
BFTC-909::I-BRD9
MONO-MAC-6::ZM447439
OCI-AML3::Cediranib
NEC8::AZD7762
MS-1::Cediranib
SN12C::Avagacestat
SW626::ZM447439
K5::ZM447439
H9::Telomerase Inhibitor IX
SW1417::AGI-6780
EM-2::Alisertib
FADU::VX-11e
IM-9::AGI-6780
8505C::Avagacestat
MHH-CALL-4::Cediranib
MFE-319::Dabrafenib
WIL2-NS::AGI-6780
HCC1937::Foretinib
T84::Sepantronium bromide
TGBC24TKB::Avagacestat
DoTc2-4510::Sepantronium bromide
KNS-62::I-BRD9
ES1::ZM447439
MDA-MB-157::Avagacestat
VMRC-LCD::ZM447439
SK-ES-1::Cediranib
NMC-G1::Avagacestat
5637::Cediranib
KY821::Alisertib
UM-UC-3::ZM447439
SAS::Avagacestat
RXF393::Dabrafenib
RPMI-8226::Dabrafenib
DEL::Cediranib
NCI-H1563::Telomerase Inhibitor IX
KP-2::AGI-6780
NCI-H1341::Dabrafenib
NB13::AZD7762
HSC-2::Alisertib
UACC-893::MK-8776
ABC-1::Motesanib
NCI-H2110::Sepantronium bromide
T98G::ZM447439
COLO-783::Doramapimod
NCI-H1666::AZD7762
SK-MEL-24::Avagacestat
TGBC24TKB::XAV939
KMOE-2::VX-11e
HCC1599::MK-8776
JVM-3::Dabrafenib
NCI-H322M::VX-11e
WIL2-NS::Cediranib
RPMI-6666::Avagacestat
5637::VX-11e
ChaGo-K-1::Telomerase Inhibitor IX
SW156::Motesanib
NB69::Foretinib
KE-37::Osimertinib
OVKATE::Dabrafenib
LS-1034::Dabrafenib
SK-N-SH::Doramapimod
FLO-1::Cediranib
GP5d::MK-8776
OVCA420::Dabrafenib
T84::Dabrafenib
HCT-116::Afatinib
NCI-H82::Cediranib
HCC-827::Motesanib
SK-UT-1::Doramapimod
ETK-1::ZM447439
NCI-H322M::AGI-6780
H9::Afatinib
Farage::VX-11e
FTC-133::Cediranib
PCI-15A::ZM447439
DOV13::Afatinib
SJRH30::Sepantronium bromide
CGTH-W-1::Foretinib
MFE-319::VX-11e
SK-GT-4::Dabrafenib
TGBC24TKB::VX-11e
HCC1937::VX-11e
A673::VX-11e
RCC-ER::Foretinib
MOLM-16::Telomerase Inhibitor IX
M14::Telomerase Inhibitor IX
C2BBe1::MK-8776
HPAF-II::Cediranib
ABC-1::Cediranib
SNU-398::ZM447439
EFO-27::Osimertinib
DoTc2-4510::Afatinib
U-2-OS::I-BRD9
A3-KAW::Doramapimod
MHH-CALL-2::I-BRD9
LB2241-RCC::BX795
A2058::Alisertib
WM-115::VX-11e
DOK::AZD7762
MKN28::Afatinib
SCC90::Telomerase Inhibitor IX
OCUB-M::Osimertinib
SK-LU-1::Foretinib
HCC1395::ZM447439
KMRC-20::Doramapimod
LN-229::ZM447439
NCI-H64::MK-8776
TGBC11TKB::Alisertib
SW1710::Motesanib
RCM-1::VX-11e
RERF-LC-MS::Dabrafenib
SU-DHL-10::Avagacestat
PCI-4B::Doramapimod
HSC-4::VX-11e
PANC-03-27::Motesanib
A4-Fuk::Telomerase Inhibitor IX
SW1990::Motesanib
SNU-283::AGI-6780
HuCCT1::I-BRD9
SW626::Afatinib
SNU-61::Cediranib
GAMG::Osimertinib
STS-0421::Dabrafenib
JVM-3::XAV939
KASUMI-1::Doramapimod
SK-MG-1::MK-8776
ES7::Cediranib
PCI-4B::Telomerase Inhibitor IX
L-540::Motesanib
OCI-LY7::Sepantronium bromide
RPMI-8226::I-BRD9
HT-1080::VX-11e
MDA-MB-436::Osimertinib
NCI-H209::AGI-6780
LU-134-A::Cediranib
SUIT-2::Osimertinib
GI-ME-N::Afatinib
LU-99A::Alisertib
DK-MG::Afatinib
RCC10RGB::MK-8776
HGC-27::AZD7762
RS4-11::AZD7762
PANC-08-13::ZM447439
8305C::Doramapimod
HCC-366::XAV939
AU565::VX-11e
NCI-H1755::Alisertib
HDQ-P1::Sepantronium bromide
COR-L88::Telomerase Inhibitor IX
LoVo::XAV939
GAK::Alisertib
NCI-H64::Telomerase Inhibitor IX
COR-L279::Sepantronium bromide
MFE-280::Osimertinib
HT-29::Telomerase Inhibitor IX
NCI-H1623::XAV939
23132-87::Doramapimod
SNU-175::Alisertib
LB1047-RCC::Alisertib
LU-165::Avagacestat
A427::Afatinib
DND-41::I-BRD9
NCI-H929::I-BRD9
NCI-H1703::Telomerase Inhibitor IX
G-MEL::Osimertinib
NCI-H747::ZM447439
SK-MEL-30::Foretinib
BC-1::Osimertinib
GOTO::Foretinib
AU565::Alisertib
42-MG-BA::Afatinib
MDA-MB-468::Motesanib
EW-22::XAV939
JM1::Dabrafenib
NCI-H1355::Afatinib
786-0::AGI-6780
GB-1::Osimertinib
CAL-12T::Dabrafenib
RPMI-8226::Osimertinib
U-118-MG::Alisertib
KNS-81-FD::Telomerase Inhibitor IX
SUP-HD1::XAV939
OVK-18::AGI-6780
MKN45::Telomerase Inhibitor IX
DMS-273::AZD7762
NCI-H1688::I-BRD9
OSC-19::Dabrafenib
HA7-RCC::Afatinib
LB996-RCC::AZD7762
ARH-77::AZD7762
K-562::Telomerase Inhibitor IX
EW-12::I-BRD9
VCaP::MK-8776
NCI-H1703::ZM447439
NB7::Telomerase Inhibitor IX
TGBC11TKB::Telomerase Inhibitor IX
769-P::Alisertib
HCC-15::ZM447439
CAL-51::Cediranib
TGW::Osimertinib
RPMI-8226::XAV939
NB17::Foretinib
Ramos-2G6-4C10::I-BRD9
SU-DHL-5::Foretinib
U251::MK-8776
KMRC-20::I-BRD9
COLO-684::Osimertinib
MIA-PaCa-2::Foretinib
JHU-011::ZM447439
TGBC24TKB::Osimertinib
KNS-62::XAV939
SU-DHL-10::XAV939
H9::Doramapimod
SNB75::Afatinib
NCI-H1838::Afatinib
SCC90::Dabrafenib
LN-18::VX-11e
CaR-1::MK-8776
HEC-1::Sepantronium bromide
SUP-B15::ZM447439
NCI-H1915::Avagacestat
CCRF-CEM::I-BRD9
697::Dabrafenib
CaR-1::AZD7762
NCI-H211::Motesanib
HT-144::Afatinib
PCI-4B::Osimertinib
GR-ST::AZD7762
NCI-H847::AZD7762
LS-411N::Cediranib
KON::Alisertib
SU-DHL-6::AGI-6780
SW1783::Alisertib
ES5::Cediranib
MS751::VX-11e
CAL-85-1::Doramapimod
BICR78::Osimertinib
NCI-H661::Alisertib
IHH-4::Foretinib
KGN::Telomerase Inhibitor IX
OVCAR-3::Osimertinib
LXF-289::Avagacestat
BICR10::Telomerase Inhibitor IX
Mo-T::ZM447439
CAL-51::Telomerase Inhibitor IX
D-542MG::Avagacestat
OS-RC-2::MK-8776
KYSE-140::MK-8776
NCI-H2227::Afatinib
KMS-11::Avagacestat
PA-TU-8902::AZD7762
SK-HEP-1::XAV939
RH-41::Afatinib
23132-87::Sepantronium bromide
A204::Foretinib
LS-123::Doramapimod
NCI-H650::Afatinib
SNU-283::BX795
SUIT-2::VX-11e
SF268::Sepantronium bromide
HuCCT1::Dabrafenib
DK-MG::Avagacestat
NCI-H211::AGI-6780
KMS-11::Osimertinib
NB14::Sepantronium bromide
SBC-3::Sepantronium bromide
SUP-M2::AGI-6780
NCI-H441::Avagacestat
HCC1806::Telomerase Inhibitor IX
GI-1::I-BRD9
NY::AGI-6780
JHOS-4::XAV939
SNU-398::XAV939
MKN45::Sepantronium bromide
EMC-BAC-1::Cediranib
FU97::Avagacestat
LC4-1::Sepantronium bromide
KP-3::Cediranib
SNU-175::VX-11e
RCC-FG2::MK-8776
TE-15::XAV939
SW780::Alisertib
PL-21::Dabrafenib
SNU-C1::ZM447439
WM35::Afatinib
OV-17R::Sepantronium bromide
BPH-1::Osimertinib
CAL-39::Doramapimod
OV-56::Afatinib
JHH-7::Cediranib
IM-9::ZM447439
TE-6::Dabrafenib
A4-Fuk::Avagacestat
MV-4-11::Sepantronium bromide
NCI-H660::Doramapimod
G-MEL::Telomerase Inhibitor IX
Hs-578-T::AZD7762
OPM-2::Telomerase Inhibitor IX
SCC-15::ZM447439
8505C::Osimertinib
MHH-PREB-1::Alisertib
JHH-4::Sepantronium bromide
RL95-2::AZD7762
HCC1395::Telomerase Inhibitor IX
HuO-3N1::Cediranib
PL-21::MK-8776
PANC-10-05::Afatinib
HO-1-u-1::MK-8776
MN-60::Cediranib
SBC-3::Dabrafenib
NCI-H28::AZD7762
647-V::XAV939
HCC1599::AGI-6780
U-2-OS::ZM447439
NCI-H1703::Afatinib
Mewo::Afatinib
SW1783::Foretinib
RT-112::AZD7762
BV-173::VX-11e
PL-21::Osimertinib
M14::MK-8776
MS751::XAV939
SCC-9::I-BRD9
EW-24::Doramapimod
HuP-T4::VX-11e
KYSE-520::I-BRD9
HCC1806::Doramapimod
NCI-H1836::Motesanib
Farage::MK-8776
MHH-CALL-2::Osimertinib
KMS-12-BM::Sepantronium bromide
TE-6::Osimertinib
K5::Motesanib
LS-180::Avagacestat
A549::Doramapimod
OVCAR-5::Dabrafenib
NY::ZM447439
HCC-78::Avagacestat
HCC1500::AGI-6780
MOLT-16::Avagacestat
LOU-NH91::Motesanib
SK-PN-DW::Foretinib
SF295::ZM447439
OV-17R::Telomerase Inhibitor IX
GR-ST::Avagacestat
SCC-25::VX-11e
SCC-15::Afatinib
TK::Cediranib
SU-DHL-16::Afatinib
CAL-33::ZM447439
WM-115::Osimertinib
DAN-G::XAV939
NB12::Doramapimod
HMV-II::Cediranib
NCI-H446::MK-8776
NB1::Afatinib
NCI-H1581::AZD7762
RKN::Cediranib
ABC-1::I-BRD9
NCI-H1944::Telomerase Inhibitor IX
A3-KAW::I-BRD9
NCI-H292::Avagacestat
KNS-62::MK-8776
SK-OV-3::MK-8776
COR-L32::Dabrafenib
SW1271::Doramapimod
LU-134-A::Osimertinib
COLO-668::XAV939
C3A::VX-11e
HT-144::Dabrafenib
HCC-15::Afatinib
KOSC-2::Doramapimod
NCI-H2110::Dabrafenib
JHOS-2::Alisertib
ACHN::Avagacestat
HO-1-u-1::Telomerase Inhibitor IX
NCI-H1650::AGI-6780
MOLT-4::Sepantronium bromide
SLVL::Afatinib
Jurkat::Alisertib
MS-1::Foretinib
SCH::Sepantronium bromide
A673::ZM447439
NCI-H2444::I-BRD9
KURAMOCHI::Alisertib
JEG-3::Telomerase Inhibitor IX
KYSE-180::I-BRD9
OACp4C::AGI-6780
NCI-H2085::Alisertib
PF-382::Osimertinib
SK-N-AS::Sepantronium bromide
MDA-MB-468::I-BRD9
EW-1::Avagacestat
NUGC-3::Telomerase Inhibitor IX
RPMI-6666::Osimertinib
EPLC-272H::Avagacestat
LoVo::Telomerase Inhibitor IX
DOK::I-BRD9
Calu-6::Osimertinib
Caov-4::Foretinib
HMV-II::AZD7762
NCI-H358::Avagacestat
G-MEL::AZD7762
BHT-101::Motesanib
8305C::Foretinib
EFM-19::AGI-6780
HSC-2::Afatinib
SKN::Telomerase Inhibitor IX
COR-L23::Foretinib
SR::AGI-6780
SCH::Alisertib
HMV-II::Foretinib
KYM-1::Sepantronium bromide
RCM-1::Dabrafenib
BT-474::AZD7762
NCI-H1781::Sepantronium bromide
BE2-M17::MK-8776
HCC1419::I-BRD9
RCC-MF::Alisertib
SKN-3::Alisertib
UM-UC-3::Dabrafenib
SW1463::Afatinib
LNZTA3WT4::Doramapimod
OSC-19::Afatinib
SBC-5::Sepantronium bromide
SBC-5::Foretinib
NB14::Telomerase Inhibitor IX
Calu-6::VX-11e
TE-441-T::Cediranib
JiyoyeP-2003::Cediranib
LB647-SCLC::ZM447439
SF126::Avagacestat
DB::Foretinib
MFM-223::Doramapimod
huH-1::Motesanib
NCI-H720::Osimertinib
KS-1::Doramapimod
NCI-H661::Afatinib
HCC38::Avagacestat
SK-ES-1::VX-11e
MZ2-MEL::Sepantronium bromide
MG-63::Telomerase Inhibitor IX
SCC-9::Cediranib
MEG-01::Dabrafenib
GCT::Doramapimod
COR-L95::ZM447439
TE-11::BX795
KALS-1::Doramapimod
DND-41::Motesanib
SK-MEL-30::XAV939
NCI-H1155::Telomerase Inhibitor IX
SW948::ZM447439
SK-MEL-1::VX-11e
NCI-H524::Cediranib
KYSE-70::I-BRD9
NCI-H64::Alisertib
PSN1::Avagacestat
BHY::BX795
OCI-M1::Doramapimod
KP-1N::I-BRD9
HCC2218::Telomerase Inhibitor IX
LU-99A::Telomerase Inhibitor IX
HA7-RCC::Doramapimod
22RV1::AZD7762
NCI-H2009::MK-8776
HSC-39::VX-11e
OVTOKO::Doramapimod
HCC-44::Avagacestat
SK-MEL-31::Afatinib
RERF-LC-MS::BX795
NCI-H345::MK-8776
K2::Doramapimod
HuP-T4::AZD7762
EC-GI-10::Foretinib
SU-DHL-6::Cediranib
ME-180::Alisertib
NOMO-1::Foretinib
SW1463::AZD7762
SIG-M5::Motesanib
BICR31::Alisertib
RL95-2::XAV939
A3-KAW::Osimertinib
CW-2::AZD7762
SW780::Telomerase Inhibitor IX
SK-MEL-5::AZD7762
NCI-H2135::I-BRD9
RCM-1::Osimertinib
WSU-DLCL2::Afatinib
KMRC-20::Avagacestat
D-392MG::AZD7762
KLE::AGI-6780
LB647-SCLC::Afatinib
TE-5::Sepantronium bromide
OVCAR-4::Osimertinib
KYM-1::Telomerase Inhibitor IX
RERF-LC-KJ::XAV939
PANC-02-03::Afatinib
KNS-62::Sepantronium bromide
SW962::XAV939
UACC-257::ZM447439
A4-Fuk::Sepantronium bromide
RERF-LC-MS::MK-8776
RVH-421::Doramapimod
786-0::Alisertib
JVM-2::Foretinib
JJN-3::AZD7762
AsPC-1::MK-8776
HuO9::Doramapimod
NCI-H748::AZD7762
RC-K8::I-BRD9
BT-483::Doramapimod
LOUCY::AGI-6780
NCI-H441::Sepantronium bromide
HCT-15::Alisertib
Mo-T::Avagacestat
MDST8::XAV939
OCI-AML3::AZD7762
TE-1::Avagacestat
BB30-HNC::MK-8776
UACC-893::Cediranib
NB1::I-BRD9
KS-1::Dabrafenib
MDA-MB-415::Doramapimod
MDA-MB-157::XAV939
KATOIII::Doramapimod
SK-LMS-1::Sepantronium bromide
NCI-H345::Avagacestat
KLE::Doramapimod
CRO-AP2::Foretinib
LNCaP-Clone-FGC::I-BRD9
KG-1::Osimertinib
IA-LM::AZD7762
A431::AGI-6780
A3-KAW::AZD7762
no-11::Motesanib
KGN::Doramapimod
MS751::Alisertib
ZR-75-30::XAV939
HPAF-II::VX-11e
TE-1::Sepantronium bromide
JIMT-1::Motesanib
JHU-011::Telomerase Inhibitor IX
HCC1569::MK-8776
PFSK-1::Osimertinib
NB12::I-BRD9
CAL-62::MK-8776
EKVX::Sepantronium bromide
EN::Motesanib
DSH1::Dabrafenib
OCI-LY7::XAV939
DOHH-2::Alisertib
C-4-I::ZM447439
KALS-1::Alisertib
MHH-CALL-4::BX795
SNU-407::Osimertinib
SUP-B8::Dabrafenib
AMO-1::XAV939
NCC010::AZD7762
HMV-II::Sepantronium bromide
SW1783::Avagacestat
MDA-MB-468::Alisertib
J82::MK-8776
MDA-MB-453::Sepantronium bromide
TE-1::Foretinib
Daoy::Osimertinib
SW1417::Avagacestat
SUP-T1::Osimertinib
D-502MG::Foretinib
TOV-112D::MK-8776
OVCAR-5::Cediranib
OCI-LY7::BX795
DAN-G::AZD7762
COLO-680N::MK-8776
IGR-37::XAV939
JIMT-1::Telomerase Inhibitor IX
NCC021::Osimertinib
CAL-33::Motesanib
KG-1::I-BRD9
MKN1::Avagacestat
SK-MES-1::Sepantronium bromide
KNS-42::ZM447439
UACC-893::Avagacestat
HCC1954::AZD7762
MV-4-11::AZD7762
CAL-85-1::I-BRD9
LC4-1::Dabrafenib
VMRC-LCD::MK-8776
NEC8::ZM447439
D-263MG::Foretinib
TE-1::ZM447439
J82::VX-11e
AsPC-1::VX-11e
MIA-PaCa-2::Doramapimod
SUIT-2::Foretinib
NAMALWA::AGI-6780
SK-N-SH::Sepantronium bromide
D-392MG::VX-11e
HEL::MK-8776
MHH-NB-11::Avagacestat
5637::Telomerase Inhibitor IX
H3255::VX-11e
DB::XAV939
SK-OV-3::Foretinib
LOXIMVI::Telomerase Inhibitor IX
DOHH-2::I-BRD9
NCI-H23::Avagacestat
RCC-AB::XAV939
SCC-3::Cediranib
H-EMC-SS::AGI-6780
SW156::Alisertib
RCC-JF::ZM447439
KM12::Cediranib
SW1088::VX-11e
SW962::ZM447439
AsPC-1::Telomerase Inhibitor IX
CHL-1::Afatinib
OVMIU::AGI-6780
SUP-B8::XAV939
SU8686::Afatinib
GB-1::VX-11e
PANC-02-03::Sepantronium bromide
SH-4::VX-11e
LAMA-84::Foretinib
SBC-3::Foretinib
DMS-114::Telomerase Inhibitor IX
SU-DHL-4::Avagacestat
PL4::Sepantronium bromide
C3A::Motesanib
NCI-H661::Cediranib
5637::XAV939
KMS-11::Alisertib
22RV1::MK-8776
LB373-MEL-D::I-BRD9
CCK-81::Foretinib
KMS-12-BM::ZM447439
CPC-N::I-BRD9
FLO-1::AGI-6780
VAL::Avagacestat
SF126::VX-11e
ES-2::Alisertib
EW-11::AGI-6780
IPC-298::Alisertib
DK-MG::Cediranib
CESS::Cediranib
EM-2::Dabrafenib
OACp4C::MK-8776
BEN::ZM447439
TE-11::ZM447439
Caov-4::Motesanib
DEL::Dabrafenib
SNU-283::I-BRD9
DMS-79::XAV939
P32-ISH::Dabrafenib
NCI-H1869::Sepantronium bromide
EW-13::Telomerase Inhibitor IX
EKVX::VX-11e
SK-MEL-30::AZD7762
Ca9-22::Foretinib
OCI-LY7::Dabrafenib
COR-L303::Alisertib
JM1::VX-11e
CTB-1::AZD7762
MHH-NB-11::ZM447439
ONS-76::AGI-6780
NCI-H1915::AGI-6780
BONNA-12::Sepantronium bromide
COLO-320-HSR::Dabrafenib
FU-OV-1::Doramapimod
HA7-RCC::Telomerase Inhibitor IX
OACM5-1::I-BRD9
CGTH-W-1::Telomerase Inhibitor IX
JSC-1::AZD7762
BL-41::Foretinib
SW1990::Dabrafenib
DMS-53::Dabrafenib
EFO-21::Foretinib
IST-SL2::XAV939
KMRC-1::Foretinib
MFM-223::AZD7762
HT55::AZD7762
JHH-7::MK-8776
HT-1080::Doramapimod
D-566MG::Alisertib
NCI-H647::I-BRD9
ChaGo-K-1::Avagacestat
NCI-H1563::AGI-6780
SK-GT-4::XAV939
HuO9::Cediranib
RCC-AB::Doramapimod
NCI-H1792::VX-11e
NCI-H1155::I-BRD9
NB10::ZM447439
MFE-296::VX-11e
RKO::I-BRD9
HLE::MK-8776
HT-3::ZM447439
HCC2218::BX795
NCI-H2452::Foretinib
LS-180::Cediranib
KYSE-140::Sepantronium bromide
IHH-4::XAV939
HLE::Afatinib
NCI-H1573::Telomerase Inhibitor IX
SBC-5::XAV939
PWR-1E::Afatinib
NCI-H1688::Afatinib
CAL-148::AZD7762
OVCAR-5::Sepantronium bromide
OE33::AGI-6780
LK-2::Avagacestat
NCI-H292::AZD7762
NCI-H1623::AGI-6780
HCC1500::Osimertinib
PFSK-1::AZD7762
MM1S::Doramapimod
Hs-445::Telomerase Inhibitor IX
GP5d::Osimertinib
NCI-H1568::VX-11e
SK-GT-2::AGI-6780
HTC-C3::Cediranib
DEL::Doramapimod
MDA-MB-157::Afatinib
SCC-4::I-BRD9
NCI-H1048::MK-8776
OV-7::XAV939
HPAC::AZD7762
SW48::Avagacestat
CADO-ES1::Telomerase Inhibitor IX
GCIY::Sepantronium bromide
NCI-H69::Sepantronium bromide
NCI-H716::Dabrafenib
8505C::AGI-6780
MS751::Cediranib
TE-5::Cediranib
LAN-6::AGI-6780
CHSA0108::ZM447439
COLO-824::VX-11e
KMRC-1::Sepantronium bromide
OE19::I-BRD9
NCI-H526::MK-8776
SBC-5::Alisertib
KCL-22::Foretinib
MOG-G-CCM::Dabrafenib
DBTRG-05MG::XAV939
NCI-H1734::I-BRD9
NCI-H2029::Motesanib
NCC010::BX795
NCI-H650::AZD7762
MDA-MB-157::Telomerase Inhibitor IX
HT-1197::XAV939
TOV-21G::XAV939
LN-229::Avagacestat
PSN1::AZD7762
IMR-5::I-BRD9
DJM-1::Motesanib
HEL::Foretinib
PFSK-1::Alisertib
CAMA-1::Telomerase Inhibitor IX
LN-405::Afatinib
GCT::Telomerase Inhibitor IX
ESO51::Telomerase Inhibitor IX
WM793B::AZD7762
JHOS-3::Dabrafenib
MFM-223::Dabrafenib
RF-48::Sepantronium bromide
TE-9::VX-11e
H-EMC-SS::Afatinib
FADU::Cediranib
KYSE-270::Avagacestat
K2::I-BRD9
NCI-N87::Alisertib
SW156::Foretinib
RERF-LC-Sq1::Sepantronium bromide
CRO-AP2::ZM447439
RCC-FG2::AGI-6780
WIL2-NS::Avagacestat
RERF-GC-1B::Dabrafenib
EFO-27::Motesanib
MLMA::Motesanib
NKM-1::Afatinib
NCI-H1869::MK-8776
SCC-4::MK-8776
SW948::AZD7762
SU-DHL-6::I-BRD9
CP66-MEL::Osimertinib
NCI-H720::Afatinib
NKM-1::Motesanib
NCI-H2122::VX-11e
JHU-022::AZD7762
SNU-283::Cediranib
NCI-H1355::Foretinib
WM793B::Cediranib
NCI-H1105::Afatinib
OVCAR-4::VX-11e
HPAF-II::AGI-6780
LS-411N::Alisertib
JAR::MK-8776
CA46::Motesanib
MOLP-8::Alisertib
ES1::Cediranib
CTV-1::Telomerase Inhibitor IX
G-361::Afatinib
D-566MG::Motesanib
HCC1954::AGI-6780
DG-75::I-BRD9
PCI-30::Dabrafenib
EC-GI-10::Osimertinib
MZ1-PC::Avagacestat
RCC-MF::Cediranib
CRO-AP2::Motesanib
KNS-81-FD::Doramapimod
KGN::Dabrafenib
Farage::Dabrafenib
SUP-B8::Sepantronium bromide
TT2609-C02::Telomerase Inhibitor IX
451Lu::ZM447439
KU-19-19::Alisertib
Saos-2::XAV939
CHSA8926::Foretinib
D-502MG::AZD7762
LU-139::Motesanib
Ca-Ski::VX-11e
NB10::MK-8776
FU97::Osimertinib
RERF-LC-Sq1::Cediranib
DU-4475::VX-11e
MM1S::Telomerase Inhibitor IX
MZ7-mel::AGI-6780
KYSE-180::Osimertinib
KNS-42::Dabrafenib
DMS-273::Doramapimod
LU-134-A::Alisertib
HCC1428::AGI-6780
SNU-398::Alisertib
SW1990::AZD7762
NCI-H146::AZD7762
CHSA0108::Avagacestat
TK::Motesanib
786-0::VX-11e
SW954::Dabrafenib
MHH-PREB-1::Osimertinib
RVH-421::Avagacestat
A549::Alisertib
SKM-1::MK-8776
EW-11::Doramapimod
U-266::AZD7762
NCI-H524::Dabrafenib
OVK-18::VX-11e
UACC-812::Sepantronium bromide
SK-CO-1::I-BRD9
DoTc2-4510::Doramapimod
IM-9::Afatinib
NUGC-3::VX-11e
JEG-3::Foretinib
A3-KAW::ZM447439
WM1552C::XAV939
RCC-JW::MK-8776
23132-87::XAV939
OE33::Doramapimod
SK-MEL-3::ZM447439
HSC-4::Osimertinib
NCI-H841::Afatinib
FU-OV-1::Cediranib
COR-L303::XAV939
NCC021::VX-11e
NCI-H345::Motesanib
SAS::Alisertib
NMC-G1::AGI-6780
JHOS-2::Osimertinib
VA-ES-BJ::Alisertib
GRANTA-519::Avagacestat
NCI-H292::Telomerase Inhibitor IX
LU-65::AGI-6780
WM-115::ZM447439
GAK::Osimertinib
KP-1N::Foretinib
PCI-30::MK-8776
NCI-H510A::Doramapimod
SNU-C2B::Alisertib
LS-1034::Osimertinib
SK-N-SH::VX-11e
EJM::Afatinib
NCI-H358::AGI-6780
A431::MK-8776
PCI-15A::Motesanib
THP-1::Dabrafenib
NB12::VX-11e
NCI-H2052::XAV939
Farage::Telomerase Inhibitor IX
COR-L303::Afatinib
MC116::AZD7762
P31-FUJ::AZD7762
786-0::Telomerase Inhibitor IX
A673::XAV939
TGBC11TKB::ZM447439
RPMI-8866::AGI-6780
EW-24::MK-8776
NB69::Telomerase Inhibitor IX
U-698-M::I-BRD9
JEKO-1::XAV939
NCI-H835::MK-8776
RERF-LC-Sq1::MK-8776
SK-MEL-28::Sepantronium bromide
SK-N-DZ::Telomerase Inhibitor IX
JVM-2::Avagacestat
KYSE-180::Avagacestat
JHU-011::MK-8776
CTB-1::BX795
NCI-H322M::Telomerase Inhibitor IX
TE-8::I-BRD9
KARPAS-1106P::Foretinib
WM-115::Sepantronium bromide
D-423MG::VX-11e
PC-3::I-BRD9
ABC-1::MK-8776
COR-L23::Dabrafenib
KU812::Cediranib
SU-DHL-8::Cediranib
CAL-85-1::VX-11e
TGBC1TKB::Sepantronium bromide
P30-OHK::Avagacestat
CHP-212::Telomerase Inhibitor IX
ABC-1::Alisertib
SAT::AGI-6780
BICR22::Afatinib
KYAE-1::I-BRD9
RPMI-8866::Alisertib
KYSE-140::Alisertib
ATN-1::AGI-6780
OE21::Telomerase Inhibitor IX
RCH-ACV::Telomerase Inhibitor IX
HEL::Doramapimod
NCI-H3122::I-BRD9
PANC-10-05::Telomerase Inhibitor IX
SK-MES-1::AZD7762
COLO-800::VX-11e
TOV-112D::Dabrafenib
FTC-133::Telomerase Inhibitor IX
A4-Fuk::Cediranib
G-401::MK-8776
RT4::XAV939
HT-1080::Dabrafenib
TOV-21G::I-BRD9
RH-41::Motesanib
HDQ-P1::AZD7762
BC-1::MK-8776
NCI-H1650::XAV939
NCI-H1436::Afatinib
D-392MG::Cediranib
TE-6::Afatinib
SU-DHL-8::Doramapimod
PWR-1E::AZD7762
BHT-101::ZM447439
PC-14::Cediranib
PFSK-1::Telomerase Inhibitor IX
BALL-1::Afatinib
HCC2218::ZM447439
UM-UC-3::Sepantronium bromide
HCC38::XAV939
EMC-BAC-2::MK-8776
NCI-H226::ZM447439
UACC-62::Sepantronium bromide
SNB75::XAV939
KURAMOCHI::Cediranib
CHSA0108::Cediranib
SF126::Sepantronium bromide
IST-MES1::XAV939
NCI-H1651::Motesanib
NCI-H1436::VX-11e
NCI-H196::Alisertib
NCI-H2452::Telomerase Inhibitor IX
OCUB-M::Avagacestat
SAT::Alisertib
SKN-3::I-BRD9
JHH-1::AGI-6780
TE-10::Motesanib
DMS-79::AZD7762
BT-483::ZM447439
NCI-H1092::Alisertib
SN12C::Sepantronium bromide
KYSE-220::Dabrafenib
TT2609-C02::Osimertinib
LU-99A::Avagacestat
NCI-H2085::XAV939
SNU-423::VX-11e
COR-L23::Sepantronium bromide
EM-2::Doramapimod
CADO-ES1::Avagacestat
BB30-HNC::Sepantronium bromide
HSC-39::Afatinib
JJN-3::Osimertinib
BFTC-905::Sepantronium bromide
NCI-H720::Telomerase Inhibitor IX
MDA-MB-330::XAV939
PCI-4B::Sepantronium bromide
CAL-27::Foretinib
EW-3::Afatinib
COLO-680N::AZD7762
NB17::Sepantronium bromide
U-698-M::Sepantronium bromide
EM-2::I-BRD9
SW1271::Dabrafenib
MKN1::MK-8776
SCC-9::Afatinib
A498::Avagacestat
UACC-812::VX-11e
MOLM-13::Motesanib
FU97::VX-11e
KMRC-20::Dabrafenib
TGBC11TKB::VX-11e
NCI-H1581::Alisertib
LXF-289::Osimertinib
SNU-C1::Osimertinib
RL::Sepantronium bromide
LOUCY::AZD7762
WSU-NHL::ZM447439
OSC-20::Osimertinib
CaR-1::Alisertib
MRK-nu-1::Cediranib
SIG-M5::BX795
8305C::VX-11e
PA-TU-8988T::Osimertinib
SCC-9::Avagacestat
BB30-HNC::Afatinib
RCC-JW::Foretinib
AGS::Osimertinib
SK-LMS-1::Doramapimod
KYSE-140::Motesanib
C-33-A::AGI-6780
HCT-116::Alisertib
SK-UT-1::AGI-6780
DK-MG::AGI-6780
COLO-678::XAV939
LAN-6::I-BRD9
Saos-2::AZD7762
EN::Cediranib
LCLC-97TM1::VX-11e
NCI-H929::Osimertinib
OCI-M1::Avagacestat
DK-MG::Osimertinib
RO82-W-1::AZD7762
KYSE-180::VX-11e
RL::Telomerase Inhibitor IX
NCI-H720::XAV939
RO82-W-1::Cediranib
EMC-BAC-1::Afatinib
SiHa::Motesanib
NCI-H322M::Alisertib
Hs-445::ZM447439
AGS::Cediranib
BB30-HNC::ZM447439
OCI-AML2::Motesanib
H4::Foretinib
NCI-H1435::Cediranib
MN-60::Afatinib
NOS-1::Sepantronium bromide
SISO::Avagacestat
NCI-H2122::MK-8776
C3A::Osimertinib
ML-2::I-BRD9
SW1088::Afatinib
LB647-SCLC::Alisertib
NCI-H146::Motesanib
KP-1N::VX-11e
RMG-I::Avagacestat
ST486::Doramapimod
NB69::Dabrafenib
Ramos-2G6-4C10::Avagacestat
NCI-H526::Telomerase Inhibitor IX
SW982::Doramapimod
WM793B::XAV939
SF295::Motesanib
NCI-H2347::Osimertinib
ML-1::Sepantronium bromide
AGS::MK-8776
KU812::Dabrafenib
DoTc2-4510::Telomerase Inhibitor IX
KP-3::Doramapimod
RD::Doramapimod
ES6::ZM447439
MFH-ino::Doramapimod
BT-483::Telomerase Inhibitor IX
CHP-134::VX-11e
CHSA0108::VX-11e
KALS-1::Sepantronium bromide
JEKO-1::Foretinib
SW1417::I-BRD9
PC-14::VX-11e
DOK::Dabrafenib
K2::Avagacestat
JEG-3::Cediranib
BxPC-3::Doramapimod
HPAC::Sepantronium bromide
NCCIT::VX-11e
SK-CO-1::VX-11e
OSC-19::BX795
BC-1::Cediranib
TT2609-C02::AZD7762
NCI-H3122::AGI-6780
TE-9::Sepantronium bromide
U-87-MG::Cediranib
DJM-1::Osimertinib
SK-HEP-1::Foretinib
NCI-H1299::VX-11e
NCI-H2227::Motesanib
MOLT-16::Afatinib
DND-41::Foretinib
OAW-28::Osimertinib
SNU-61::I-BRD9
KCL-22::Alisertib
DU-4475::Dabrafenib
KYM-1::Dabrafenib
COLO-684::Foretinib
ONS-76::AZD7762
SW13::ZM447439
OCUM-1::Motesanib
COLO-320-HSR::Sepantronium bromide
SBC-3::Telomerase Inhibitor IX
NCI-H1876::Osimertinib
SW872::Osimertinib
SF295::MK-8776
NCI-H740::Doramapimod
KALS-1::ZM447439
KM-H2::Avagacestat
NCI-H446::Telomerase Inhibitor IX
GCIY::ZM447439
NCI-H211::Cediranib
BE2-M17::Osimertinib
MM1S::Avagacestat
LC-2-ad::Cediranib
HPAF-II::Afatinib
LU-99A::ZM447439
DU-145::AGI-6780
L-1236::Sepantronium bromide
CCRF-CEM::Telomerase Inhibitor IX
P12-ICHIKAWA::Doramapimod
TE-5::XAV939
DMS-273::Cediranib
NUGC-4::Dabrafenib
HuO9::Foretinib
OSC-19::Telomerase Inhibitor IX
EMC-BAC-2::Afatinib
LNCaP-Clone-FGC::AZD7762
IST-MES1::Dabrafenib
NCI-H292::ZM447439
HSC-3::Osimertinib
NCI-H1963::Afatinib
KOSC-2::AZD7762
HCC1419::VX-11e
SK-MEL-30::Motesanib
NKM-1::I-BRD9
NB10::Foretinib
8-MG-BA::Alisertib
LU-65::ZM447439
KP-1N::AZD7762
HCC1143::I-BRD9
C2BBe1::VX-11e
PANC-03-27::Foretinib
Hs-578-T::Alisertib
NCI-H520::Afatinib
ONS-76::XAV939
NCI-H2291::Telomerase Inhibitor IX
C-4-I::VX-11e
NCI-H524::Avagacestat
KYSE-510::Alisertib
A431::Sepantronium bromide
CAS-1::Dabrafenib
COLO-680N::Doramapimod
PF-382::I-BRD9
D-263MG::Cediranib
COR-L311::I-BRD9
SK-N-DZ::AZD7762
IST-SL2::Afatinib
MPP-89::Doramapimod
LB647-SCLC::Sepantronium bromide
SJSA-1::ZM447439
NCI-H841::VX-11e
NCI-H1838::Foretinib
U031::MK-8776
ES5::Doramapimod
NCI-H838::Afatinib
NCI-H838::ZM447439
NB5::AZD7762
RPMI-8402::Foretinib
D-502MG::Sepantronium bromide
PANC-04-03::Foretinib
COLO-829::ZM447439
TE-10::Cediranib
JHU-029::Dabrafenib
DU-145::Avagacestat
KP-4::Afatinib
SHP-77::Cediranib
HuO-3N1::Avagacestat
PANC-10-05::ZM447439
NCI-H720::VX-11e
ESS-1::I-BRD9
NCCIT::ZM447439
CA46::Alisertib
OVMIU::Telomerase Inhibitor IX
SF295::AGI-6780
SHP-77::AZD7762
SW962::Sepantronium bromide
ESO51::Doramapimod
RS4-11::Afatinib
JHOS-3::Afatinib
LS-123::Cediranib
CADO-ES1::XAV939
NCI-H2444::ZM447439
KMS-12-BM::Alisertib
LAN-6::Motesanib
OE33::I-BRD9
NCI-H1155::Afatinib
Jurkat::Sepantronium bromide
RS4-11::Cediranib
CW-2::XAV939
NCI-H2452::I-BRD9
HLE::Dabrafenib
SCC-9::AZD7762
NB5::AGI-6780
ES8::Osimertinib
LU-135::Sepantronium bromide
HCE-4::Motesanib
PA-1::Foretinib
TGW::Sepantronium bromide
HuP-T4::Avagacestat
NCI-H1666::Doramapimod
MKN1::Alisertib
MKN45::ZM447439
TE-441-T::Motesanib
CTB-1::Sepantronium bromide
TE-10::Avagacestat
LU-165::MK-8776
TE-11::AZD7762
COLO-800::Dabrafenib
UACC-893::Dabrafenib
MLMA::AZD7762
NCI-H2196::Osimertinib
SU-DHL-1::Avagacestat
NCI-H1048::Foretinib
ROS-50::Alisertib
LB1047-RCC::AZD7762
LCLC-103H::MK-8776
ZR-75-30::AGI-6780
8505C::ZM447439
NCI-H647::Foretinib
KATOIII::Foretinib
HCC2998::Cediranib
SK-N-DZ::AGI-6780
MEG-01::MK-8776
RT4::Afatinib
EMC-BAC-1::Dabrafenib
ML-1::AZD7762
PSN1::Sepantronium bromide
CHP-126::AGI-6780
NCI-H2052::AZD7762
G-402::MK-8776
JHH-7::ZM447439
D-247MG::Sepantronium bromide
D-423MG::AGI-6780
RCC10RGB::I-BRD9
COLO-824::AGI-6780
OVCAR-8::Avagacestat
NCI-H146::Sepantronium bromide
KM-H2::Dabrafenib
NKM-1::MK-8776
647-V::Doramapimod
J82::AZD7762
DSH1::Sepantronium bromide
MV-4-11::XAV939
SCC-4::Alisertib
ME-1::I-BRD9
KCL-22::I-BRD9
NCI-H211::AZD7762
SW1417::Foretinib
SW837::VX-11e
MIA-PaCa-2::XAV939
NCI-H1915::Sepantronium bromide
NCI-H1648::AZD7762
SW48::XAV939
SW626::Alisertib
L-428::Avagacestat
NCI-H748::Cediranib
LU-165::ZM447439
CA46::Avagacestat
MOLM-13::Afatinib
ES8::Avagacestat
SNU-387::Doramapimod
SK-UT-1::XAV939
MS751::Motesanib
Daoy::Doramapimod
TE-8::Motesanib
TK10::VX-11e
DMS-114::Foretinib
OV-90::Doramapimod
KARPAS-231::AGI-6780
Raji::AZD7762
C32::BX795
IGROV-1::Motesanib
CP66-MEL::Sepantronium bromide
CAPAN-1::Telomerase Inhibitor IX
BT-549::Avagacestat
GR-ST::Telomerase Inhibitor IX
D-566MG::AGI-6780
MEL-HO::ZM447439
ACHN::Alisertib
NCI-H1703::Alisertib
KOSC-2::VX-11e
HL-60::Osimertinib
NCI-N87::Sepantronium bromide
NCI-H1650::Telomerase Inhibitor IX
KYSE-140::VX-11e
42-MG-BA::XAV939
D-392MG::Doramapimod
CAL-33::VX-11e
MOLP-8::Motesanib
DG-75::MK-8776
SK-HEP-1::Doramapimod
KATOIII::Alisertib
KARPAS-45::AZD7762
SW620::Afatinib
SNG-M::VX-11e
DEL::Avagacestat
MHH-PREB-1::I-BRD9
KYSE-520::Osimertinib
NB17::Doramapimod
MDA-MB-330::Afatinib
OSC-20::Cediranib
T47D::Osimertinib
SK-N-FI::Dabrafenib
RPMI-8402::Avagacestat
NCI-H1105::AZD7762
NOS-1::Osimertinib
NB13::ZM447439
NB1::ZM447439
ML-2::Motesanib
HSC-2::I-BRD9
KURAMOCHI::AGI-6780
HuH-7::XAV939
451Lu::Foretinib
HCC1187::Doramapimod
JiyoyeP-2003::AZD7762
COR-L311::Dabrafenib
TGW::AGI-6780
SCC-15::Motesanib
KINGS-1::AGI-6780
HCC1937::Avagacestat
SNU-1040::AGI-6780
TE-441-T::MK-8776
NCI-H1666::VX-11e
COR-L321::Sepantronium bromide
NCI-H810::Foretinib
HT55::Telomerase Inhibitor IX
MKN28::Motesanib
SUP-B15::MK-8776
MOLM-13::AZD7762
JHU-011::Motesanib
SISO::XAV939
SCC-15::Avagacestat
RH-1::Afatinib
TE-11::Cediranib
LS-513::Alisertib
NMC-G1::Dabrafenib
HH::Dabrafenib
TOV-21G::MK-8776
Ramos-2G6-4C10::Motesanib
LS-411N::Dabrafenib
DOK::Telomerase Inhibitor IX
NCI-H1623::MK-8776
NCC010::Alisertib
NCI-H196::I-BRD9
PCI-4B::I-BRD9
COR-L311::XAV939
COR-L32::Motesanib
ETK-1::AZD7762
EB2::Osimertinib
PC-14::AGI-6780
OVCAR-3::ZM447439
IHH-4::Telomerase Inhibitor IX
PA-TU-8902::AGI-6780
STS-0421::Alisertib
LU-139::AGI-6780
KYSE-520::MK-8776
A498::AZD7762
TE-6::Avagacestat
NB6::Motesanib
BALL-1::ZM447439
RKN::Dabrafenib
KARPAS-422::Avagacestat
NCI-H28::Avagacestat
VAL::Telomerase Inhibitor IX
MFE-296::Sepantronium bromide
PANC-08-13::Avagacestat
MKN7::AGI-6780
ME-180::Telomerase Inhibitor IX
TOV-112D::ZM447439
NCI-H2085::Motesanib
PSN1::Foretinib
SAS::Doramapimod
HCC2998::Doramapimod
LB373-MEL-D::Cediranib
WM35::Motesanib
NCI-H226::Osimertinib
OS-RC-2::Dabrafenib
JHH-1::Telomerase Inhibitor IX
NCI-H64::ZM447439
PANC-08-13::Sepantronium bromide
HT-115::Foretinib
D-542MG::Motesanib
TYK-nu::MK-8776
HOP-92::Afatinib
RCC-AB::Telomerase Inhibitor IX
SW48::AZD7762
HT-144::VX-11e
JEG-3::Alisertib
TGW::Telomerase Inhibitor IX
NB6::Afatinib
NCI-H23::Dabrafenib
KINGS-1::Osimertinib
RXF393::Sepantronium bromide
NCI-H1048::Dabrafenib
SK-CO-1::Motesanib
NCI-H358::Foretinib
OPM-2::Avagacestat
Detroit562::MK-8776
SK-MEL-2::Dabrafenib
NOMO-1::VX-11e
JEG-3::BX795
BFTC-909::Osimertinib
SK-GT-4::Cediranib
OV-56::Foretinib
RCH-ACV::Osimertinib
NCI-H2141::MK-8776
DU-145::XAV939
GCT::AGI-6780
NCI-H1648::Sepantronium bromide
SW620::BX795
EB2::AGI-6780
GI-ME-N::Doramapimod
A101D::Doramapimod
NB12::Cediranib
CAL-72::Sepantronium bromide
EW-16::I-BRD9
PCI-4B::BX795
HeLa::Dabrafenib
HuCCT1::Telomerase Inhibitor IX
HCC1806::Sepantronium bromide
IST-MEL1::ZM447439
KYSE-410::ZM447439
HCC2157::Avagacestat
NCI-H209::Motesanib
SNU-C2B::Doramapimod
NB6::Telomerase Inhibitor IX
AsPC-1::Alisertib
JVM-2::Afatinib
MDA-MB-231::I-BRD9
HeLa::MK-8776
GDM-1::Telomerase Inhibitor IX
GI-1::Motesanib
D-392MG::XAV939
KYSE-410::Afatinib
GDM-1::Foretinib
JHU-022::Avagacestat
Mewo::Avagacestat
LC-1-sq::Alisertib
COLO-824::I-BRD9
RH-41::XAV939
KATOIII::I-BRD9
C32::XAV939
NCI-H1436::XAV939
H3255::Telomerase Inhibitor IX
CAKI-1::Doramapimod
NCI-H1650::Alisertib
NCI-H1563::Alisertib
MZ1-PC::Afatinib
CHP-134::Cediranib
LC-2-ad::I-BRD9
KON::Telomerase Inhibitor IX
COR-L88::I-BRD9
SK-ES-1::Sepantronium bromide
MZ7-mel::I-BRD9
IST-SL1::Afatinib
HPAC::AGI-6780
OVK-18::Doramapimod
NCI-H1876::Motesanib
OV-56::Motesanib
M059J::Motesanib
NCI-H82::AZD7762
D-392MG::Foretinib
SNU-175::Dabrafenib
SISO::Afatinib
UACC-62::Telomerase Inhibitor IX
K-562::Sepantronium bromide
RD::I-BRD9
RF-48::I-BRD9
NOS-1::Telomerase Inhibitor IX
D-283MED::Afatinib
EFO-21::I-BRD9
NCI-H1792::Cediranib
RCC-ER::Doramapimod
NCI-H2141::Dabrafenib
DK-MG::Dabrafenib
U-118-MG::I-BRD9
KNS-42::I-BRD9
697::VX-11e
COLO-679::MK-8776
MES-SA::Dabrafenib
HuH-7::AZD7762
OV-90::Alisertib
A673::Cediranib
MOLP-8::Afatinib
CAS-1::Osimertinib
SK-MM-2::I-BRD9
SW1116::I-BRD9
RH-1::Doramapimod
BHY::Dabrafenib
ES-2::AGI-6780
HCC1954::I-BRD9
PWR-1E::Motesanib
MOLT-16::Foretinib
OPM-2::XAV939
L-428::XAV939
HT-1376::Foretinib
NCI-H2030::Sepantronium bromide
SU-DHL-5::Motesanib
NCI-H2227::AZD7762
NCI-H2452::Osimertinib
BT-483::Foretinib
NU-DUL-1::XAV939
KOSC-2::Avagacestat
BT-474::Doramapimod
MHH-NB-11::BX795
ES8::Cediranib
SK-MEL-31::ZM447439
LoVo::Sepantronium bromide
SU-DHL-16::ZM447439
HOP-62::Alisertib
LU-135::Foretinib
MHH-CALL-4::Telomerase Inhibitor IX
DMS-273::Afatinib
CAKI-1::Afatinib
HuO9::Afatinib
DOHH-2::Foretinib
MEL-JUSO::Alisertib
NMC-G1::VX-11e
EW-11::Alisertib
ABC-1::Telomerase Inhibitor IX
SKN-3::Dabrafenib
NCI-H1341::VX-11e
EMC-BAC-1::I-BRD9
NCI-H810::XAV939
NCI-H1876::AZD7762
ES6::Telomerase Inhibitor IX
LCLC-97TM1::Cediranib
SCC-25::MK-8776
OC-314::VX-11e
EVSA-T::Osimertinib
KYM-1::Motesanib
LK-2::Osimertinib
DOV13::Telomerase Inhibitor IX
D-542MG::I-BRD9
ESS-1::Telomerase Inhibitor IX
HCC1937::Telomerase Inhibitor IX
VA-ES-BJ::MK-8776
KARPAS-620::Dabrafenib
G-401::AZD7762
huH-1::Osimertinib
BEN::BX795
NCI-H3122::Cediranib
HuP-T3::Foretinib
EJM::Cediranib
HCC1954::Telomerase Inhibitor IX
PCI-30::VX-11e
SK-CO-1::Doramapimod
JEKO-1::BX795
NCI-H2172::XAV939
JM1::Motesanib
ChaGo-K-1::ZM447439
RPMI-8866::Afatinib
NCI-H2227::Dabrafenib
MIA-PaCa-2::Afatinib
OCI-AML2::Sepantronium bromide
OVK-18::Afatinib
GAK::Telomerase Inhibitor IX
ESO51::VX-11e
HMV-II::Osimertinib
OCI-AML5::Motesanib
RKO::Dabrafenib
LB2518-MEL::Foretinib
EPLC-272H::Osimertinib
OCI-LY-19::AZD7762
LS-411N::XAV939
A2058::Osimertinib
HCC2157::Dabrafenib
JAR::AGI-6780
JAR::AZD7762
NCI-H69::AZD7762
CAL-39::AGI-6780
BV-173::ZM447439
EW-22::AGI-6780
TC-YIK::AGI-6780
NCI-H1693::Sepantronium bromide
CAL-120::VX-11e
CML-T1::Telomerase Inhibitor IX
IST-SL2::Sepantronium bromide
MFE-280::Foretinib
RCC-MF::AZD7762
LB831-BLC::XAV939
SNU-C2B::Sepantronium bromide
NEC8::Osimertinib
IM-9::Dabrafenib
SF539::Avagacestat
NCI-H1299::Avagacestat
MZ7-mel::Foretinib
NCI-H1781::ZM447439
RT-112::XAV939
RCC-ER::Afatinib
TC-71::Doramapimod
KM-H2::Foretinib
HuO-3N1::ZM447439
OC-314::Avagacestat
DJM-1::Avagacestat
HARA::Dabrafenib
NCI-H2135::Telomerase Inhibitor IX
DOK::Osimertinib
MOLT-16::Cediranib
OCI-AML2::ZM447439
UMC-11::Dabrafenib
OVCAR-5::Afatinib
JHU-011::VX-11e
MOLT-13::Sepantronium bromide
NCI-H64::Avagacestat
PC-3::Afatinib
LS-513::ZM447439
451Lu::MK-8776
SCC90::Motesanib
D-336MG::MK-8776
CHP-212::Foretinib
EN::I-BRD9
KCL-22::AGI-6780
647-V::I-BRD9
SNU-449::VX-11e
LN-18::Avagacestat
769-P::Dabrafenib
EN::Telomerase Inhibitor IX
QIMR-WIL::Doramapimod
SK-N-DZ::ZM447439
RCC-ER::Sepantronium bromide
CW-2::Afatinib
SIMA::I-BRD9
TE-1::VX-11e
A101D::VX-11e
SCC-4::Sepantronium bromide
MV-4-11::I-BRD9
WM278::AZD7762
CCRF-CEM::Cediranib
NCI-H810::AGI-6780
DSH1::Afatinib
NU-DUL-1::Cediranib
NCI-H358::Dabrafenib
BICR78::ZM447439
EW-1::Osimertinib
JHU-029::Telomerase Inhibitor IX
MDA-MB-415::AZD7762
C-33-A::Sepantronium bromide
A549::Cediranib
HCC-44::Afatinib
GAMG::AZD7762
KARPAS-299::I-BRD9
NKM-1::Foretinib
NB(TU)1-10::Avagacestat
769-P::Afatinib
NCI-H2029::Cediranib
PF-382::Afatinib
SK-MEL-30::BX795
MDA-MB-330::Doramapimod
BC-1::Alisertib
TOV-112D::XAV939
LCLC-103H::VX-11e
COLO-205::VX-11e
J82::Motesanib
SK-LU-1::I-BRD9
TT2609-C02::Sepantronium bromide
NCI-H740::I-BRD9
FU97::Sepantronium bromide
Farage::Sepantronium bromide
NCI-H292::Doramapimod
PCI-6A::Motesanib
KMS-12-BM::Doramapimod
KOPN-8::AZD7762
COLO-678::Afatinib
JJN-3::Doramapimod
RPMI-8226::MK-8776
HuP-T3::Telomerase Inhibitor IX
LCLC-103H::I-BRD9
ME-180::AZD7762
ECC12::Cediranib
EMC-BAC-1::Sepantronium bromide
NCI-H82::Doramapimod
RCC-ER::Alisertib
MDA-MB-361::I-BRD9
LB771-HNC::Foretinib
DSH1::Avagacestat
MFE-280::Cediranib
LB1047-RCC::Avagacestat
SK-HEP-1::Dabrafenib
P30-OHK::XAV939
DB::VX-11e
OVKATE::Cediranib
NCI-H748::Telomerase Inhibitor IX
NCI-H226::Doramapimod
JHOS-4::I-BRD9
COLO-783::Sepantronium bromide
SU-DHL-16::I-BRD9
NCI-H596::AZD7762
SK-MEL-24::AZD7762
A3-KAW::Motesanib
NCI-H345::VX-11e
SK-GT-2::MK-8776
IA-LM::Cediranib
KYSE-450::I-BRD9
PSN1::Doramapimod
U031::Cediranib
NCI-H1693::VX-11e
KARPAS-231::Osimertinib
AM-38::VX-11e
KYSE-410::Telomerase Inhibitor IX
ZR-75-30::Dabrafenib
HCC-78::Telomerase Inhibitor IX
PCI-4B::Alisertib
T84::AGI-6780
KLE::Foretinib
A388::Dabrafenib
KM-H2::Telomerase Inhibitor IX
QIMR-WIL::AGI-6780
RCC-FG2::Osimertinib
U-2-OS::Sepantronium bromide
COLO-320-HSR::Telomerase Inhibitor IX
NB(TU)1-10::Telomerase Inhibitor IX
SK-GT-2::I-BRD9
ARH-77::Afatinib
BE-13::Osimertinib
HeLa::Cediranib
A4-Fuk::Foretinib
SJSA-1::Avagacestat
THP-1::MK-8776
BHY::Cediranib
COLO-680N::Alisertib
NCI-H647::Osimertinib
23132-87::Dabrafenib
AM-38::I-BRD9
SBC-5::MK-8776
MKN28::Foretinib
H4::Doramapimod
PANC-10-05::I-BRD9
OACp4C::Avagacestat
BHT-101::MK-8776
CP50-MEL-B::Afatinib
NCI-H2122::Afatinib
ASH-3::VX-11e
DK-MG::I-BRD9
JURL-MK1::MK-8776
FTC-133::XAV939
NU-DUL-1::Dabrafenib
NCI-H2009::Osimertinib
A431::Osimertinib
786-0::Foretinib
ACHN::AGI-6780
MZ7-mel::Avagacestat
HGC-27::Dabrafenib
P32-ISH::Doramapimod
JSC-1::I-BRD9
KYSE-270::Doramapimod
IGR-1::Motesanib
HuCCT1::Sepantronium bromide
UACC-62::Foretinib
NCC010::XAV939
NCI-H2122::Doramapimod
A204::I-BRD9
D-392MG::MK-8776
NCI-H2023::Cediranib
CAL-51::XAV939
HDLM-2::Motesanib
MKN7::Foretinib
SUP-HD1::MK-8776
NCI-H1781::Foretinib
NCI-H28::ZM447439
LS-123::VX-11e
KYSE-410::MK-8776
HuO9::MK-8776
MRK-nu-1::Alisertib
CAS-1::ZM447439
MFE-280::VX-11e
G-401::Motesanib
EW-1::VX-11e
H-EMC-SS::AZD7762
MPP-89::AZD7762
BICR31::Avagacestat
SK-MEL-30::Doramapimod
AGS::I-BRD9
CML-T1::Sepantronium bromide
TC-71::Dabrafenib
HCC1500::ZM447439
NCI-H510A::AZD7762
NCI-H446::Motesanib
JHH-4::Doramapimod
TK10::Motesanib
CAL-27::Alisertib
EFM-19::Avagacestat
NB13::AGI-6780
WM278::Motesanib
KYSE-70::Avagacestat
YAPC::Doramapimod
SJRH30::Afatinib
NCI-H2342::Dabrafenib
KM12::Afatinib
VMRC-RCZ::XAV939
VA-ES-BJ::I-BRD9
OCUM-1::MK-8776
NCI-H28::Doramapimod
KARPAS-45::Alisertib
EW-11::AZD7762
SK-MEL-24::Osimertinib
SW962::I-BRD9
KINGS-1::Sepantronium bromide
VMRC-RCZ::Dabrafenib
TGBC1TKB::VX-11e
SK-MM-2::Telomerase Inhibitor IX
COR-L303::Motesanib
MFH-ino::Alisertib
NCI-H2291::Osimertinib
VMRC-LCD::Avagacestat
A498::I-BRD9
SCH::AZD7762
DAN-G::Afatinib
639-V::Avagacestat
LS-513::Avagacestat
CW-2::AGI-6780
EW-18::MK-8776
NCI-H522::AZD7762
HCC1500::Cediranib
TK::VX-11e
OV-90::Osimertinib
KYSE-70::Dabrafenib
CPC-N::Afatinib
GP5d::Avagacestat
AU565::Afatinib
OSC-19::VX-11e
BFTC-909::ZM447439
FTC-133::ZM447439
8-MG-BA::Doramapimod
647-V::Telomerase Inhibitor IX
BICR78::Foretinib
CFPAC-1::Alisertib
RCC-JW::ZM447439
CAMA-1::Afatinib
EoL-1-cell::VX-11e
NB17::Afatinib
Calu-3::Foretinib
786-0::Afatinib
ALL-PO::XAV939
LN-18::AGI-6780
MPP-89::ZM447439
SU-DHL-4::Motesanib
CP50-MEL-B::Sepantronium bromide
CGTH-W-1::Afatinib
TC-YIK::Avagacestat
CML-T1::XAV939
KU812::Avagacestat
RT-112::VX-11e
CHSA8926::Motesanib
LB771-HNC::VX-11e
NCI-H1693::AGI-6780
RCC-FG2::Cediranib
CAL-27::ZM447439
CAL-72::Motesanib
NEC8::Dabrafenib
U-2-OS::Cediranib
QGP-1::VX-11e
MDA-MB-453::Doramapimod
PEO1::Osimertinib
OCI-AML2::XAV939
YKG-1::XAV939
CRO-AP2::Alisertib
NCI-H2085::Doramapimod
P32-ISH::ZM447439
MOG-G-CCM::Cediranib
CAL-51::AZD7762
ZR-75-30::ZM447439
KARPAS-422::Doramapimod
SW684::Alisertib
NCI-H358::MK-8776
EMC-BAC-1::Foretinib
SK-N-AS::Doramapimod
GI-1::Alisertib
BHY::VX-11e
HEL::BX795
HCC38::AZD7762
CAL-72::I-BRD9
5637::AGI-6780
JJN-3::XAV939
NCI-H2342::Alisertib
Calu-6::Motesanib
LXF-289::XAV939
SAS::AGI-6780
JHU-029::Sepantronium bromide
IGR-1::Dabrafenib
MSTO-211H::Motesanib
IST-SL1::Motesanib
8-MG-BA::XAV939
MC116::Avagacestat
CL-11::Foretinib
COLO-829::Telomerase Inhibitor IX
MDA-MB-231::XAV939
MOLT-13::MK-8776
BB30-HNC::Dabrafenib
769-P::Telomerase Inhibitor IX
RH-41::AGI-6780
MC116::XAV939
ALL-PO::Dabrafenib
SK-MEL-1::Alisertib
RERF-LC-Sq1::Doramapimod
HCC-366::Alisertib
COLO-320-HSR::VX-11e
SUP-HD1::I-BRD9
TGW::I-BRD9
CS1::VX-11e
MDA-MB-468::XAV939
EB-3::ZM447439
HCC-827::Doramapimod
TC-71::Afatinib
AM-38::Sepantronium bromide
NCI-H526::Sepantronium bromide
EW-24::AGI-6780
KYSE-510::Motesanib
PF-382::Motesanib
COLO-792::Dabrafenib
JiyoyeP-2003::Avagacestat
HeLa::ZM447439
TC-YIK::Motesanib
KG-1::Motesanib
KP-1N::AGI-6780
ATN-1::Alisertib
SK-MEL-5::Motesanib
MKN28::VX-11e
HCC-15::XAV939
KP-3::Motesanib
HuO-3N1::Motesanib
HLE::Telomerase Inhibitor IX
DJM-1::MK-8776
Jurkat::AZD7762
SJRH30::ZM447439
NCI-H1355::Motesanib
LB1047-RCC::I-BRD9
NCI-H647::ZM447439
MN-60::AGI-6780
UACC-893::ZM447439
SK-MEL-28::Osimertinib
BE-13::Cediranib
SU-DHL-8::MK-8776
AU565::Foretinib
NCI-H2066::MK-8776
SNU-81::AGI-6780
HuP-T4::Foretinib
ML-1::Afatinib
BT-474::Motesanib
NCI-H2135::Doramapimod
BFTC-909::MK-8776
BC-1::Motesanib
WSU-NHL::XAV939
LOUCY::Doramapimod
TC-71::Avagacestat
A431::ZM447439
LP-1::AGI-6780
MN-60::XAV939
RCC-MF::Dabrafenib
NCI-H1666::Osimertinib
BICR78::XAV939
Ca9-22::Telomerase Inhibitor IX
SK-MEL-24::Dabrafenib
NCI-H1770::Cediranib
OPM-2::Alisertib
A2780::I-BRD9
PA-TU-8988T::VX-11e
TT2609-C02::XAV939
SK-N-DZ::Osimertinib
TE-9::Foretinib
NCI-H1792::Doramapimod
KARPAS-231::Cediranib
GAK::I-BRD9
EW-12::AGI-6780
NB1::Osimertinib
COLO-792::ZM447439
BB65-RCC::Foretinib
TCCSUP::Avagacestat
KLE::ZM447439
LB771-HNC::Doramapimod
KNS-42::XAV939
huH-1::Doramapimod
SK-MEL-31::Motesanib
COLO-792::Telomerase Inhibitor IX
NCI-H1435::Motesanib
COLO-680N::Osimertinib
DMS-114::AGI-6780
MZ7-mel::VX-11e
JHH-1::Alisertib
NCI-H1963::I-BRD9
NCI-H1436::Cediranib
ML-2::Sepantronium bromide
SK-MM-2::Sepantronium bromide
MKN28::Telomerase Inhibitor IX
DU-4475::AGI-6780
LC4-1::AZD7762
CAS-1::MK-8776
HSC-2::VX-11e
EW-12::Alisertib
NCI-H23::I-BRD9
IM-9::Telomerase Inhibitor IX
TOV-112D::AZD7762
IST-MES1::Foretinib
LC-1-sq::Motesanib
NCI-H2228::Cediranib
HCC1395::Motesanib
MPP-89::AGI-6780
SW948::VX-11e
CTV-1::Alisertib
EBC-1::MK-8776
OV-90::Avagacestat
NCI-H1299::AGI-6780
NCI-H1651::Doramapimod
42-MG-BA::AGI-6780
K5::Avagacestat
OE33::Alisertib
MDA-MB-436::MK-8776
SU-DHL-10::VX-11e
MN-60::Avagacestat
D-392MG::Afatinib
NCCIT::Dabrafenib
KON::MK-8776
SCC-15::I-BRD9
IST-SL1::Doramapimod
CAL-78::Afatinib
RCC-JW::Avagacestat
KYSE-50::Sepantronium bromide
DoTc2-4510::I-BRD9
A498::Cediranib
NCI-H1155::Foretinib
J82::Telomerase Inhibitor IX
NCI-H82::MK-8776
SK-HEP-1::ZM447439
NCI-H441::Dabrafenib
NCI-H1105::Osimertinib
MONO-MAC-6::Afatinib
SK-ES-1::Doramapimod
HuCCT1::MK-8776
EKVX::Motesanib
MKN45::Afatinib
SKM-1::Afatinib
U-698-M::Cediranib
HT-1197::Dabrafenib
EFM-19::Sepantronium bromide
SU-DHL-16::Cediranib
MDA-MB-453::AGI-6780
G-361::I-BRD9
ECC12::I-BRD9
MDA-MB-415::Afatinib
U251::Doramapimod
KARPAS-231::VX-11e
TC-71::Alisertib
MCF7::AGI-6780
KCL-22::ZM447439
NCI-H522::Avagacestat
no-10::Motesanib
OE21::Doramapimod
IMR-5::Motesanib
CAKI-1::Motesanib
U-266::Telomerase Inhibitor IX
LOUCY::ZM447439
NCI-H841::AZD7762
LU-135::MK-8776
REH::MK-8776
DG-75::Sepantronium bromide
SCC90::Foretinib
VCaP::Avagacestat
SW962::Doramapimod
HDLM-2::Telomerase Inhibitor IX
LCLC-97TM1::AGI-6780
ST486::Alisertib
SK-MEL-30::ZM447439
NCI-H2087::AGI-6780
NCI-H929::Avagacestat
EFO-21::MK-8776
LB2241-RCC::Dabrafenib
SW982::Osimertinib
Raji::Avagacestat
NCI-H2141::I-BRD9
RCC-FG2::Foretinib
LB373-MEL-D::MK-8776
HuO9::Avagacestat
NUGC-4::AGI-6780
IM-9::Cediranib
KP-2::MK-8776
D-392MG::Telomerase Inhibitor IX
D-336MG::Osimertinib
OAW-28::MK-8776
OAW-28::Afatinib
L-1236::Telomerase Inhibitor IX
SK-MG-1::AZD7762
RCC-FG2::Alisertib
SNU-C2B::XAV939
GR-ST::I-BRD9
DMS-273::Osimertinib
Jurkat::XAV939
T47D::Motesanib
CHP-212::I-BRD9
MS751::I-BRD9
EW-3::AGI-6780
GA-10::Foretinib
KYSE-70::ZM447439
BT-20::Avagacestat
BT-20::Sepantronium bromide
SH-4::AZD7762
COLO-668::MK-8776
IST-MEL1::MK-8776
HuO-3N1::Alisertib
NCI-H647::Avagacestat
SISO::Doramapimod
CAS-1::Alisertib
SNU-175::XAV939
OE19::Osimertinib
NCI-H838::AGI-6780
COR-L105::XAV939
NCI-H1963::Doramapimod
A253::Dabrafenib
SK-N-DZ::Alisertib
CAL-54::MK-8776
U-698-M::Telomerase Inhibitor IX
SNU-398::VX-11e
Daoy::Afatinib
SW948::Avagacestat
CHP-126::Alisertib
EKVX::MK-8776
LAMA-84::MK-8776
C-4-I::Afatinib
MOLM-16::Motesanib
CFPAC-1::Afatinib
LB373-MEL-D::Foretinib
KARPAS-1106P::Doramapimod
MOLM-16::VX-11e
SJSA-1::Dabrafenib
LU-65::VX-11e
NCI-H211::Afatinib
LB373-MEL-D::Telomerase Inhibitor IX
SK-MEL-31::Sepantronium bromide
EMC-BAC-2::Avagacestat
IGR-1::VX-11e
HT-144::Foretinib
SBC-5::AGI-6780
HA7-RCC::Dabrafenib
NB69::Osimertinib
HT55::VX-11e
NCI-H2291::XAV939
D-566MG::Dabrafenib
H4::Dabrafenib
KASUMI-1::Motesanib
U-118-MG::VX-11e
VMRC-RCZ::VX-11e
OCI-AML2::Avagacestat
BPH-1::Telomerase Inhibitor IX
Calu-6::ZM447439
KS-1::AZD7762
DMS-79::Sepantronium bromide
H-EMC-SS::I-BRD9
NCI-H716::I-BRD9
SBC-5::Doramapimod
EFM-192A::Osimertinib
NCI-H2122::Osimertinib
MDA-MB-468::Afatinib
BFTC-905::Doramapimod
NCI-H1563::Motesanib
HEL::Osimertinib
PCI-15A::MK-8776
CHSA0011::Osimertinib
HeLa::Doramapimod
SKN::Dabrafenib
SUP-B8::Cediranib
OPM-2::Dabrafenib
SNU-175::Telomerase Inhibitor IX
BICR22::Avagacestat
MONO-MAC-6::Telomerase Inhibitor IX
CAL-54::Telomerase Inhibitor IX
HL-60::Alisertib
NOMO-1::Cediranib
MOLT-16::Sepantronium bromide
SK-MES-1::Avagacestat
LAN-6::AZD7762
PANC-04-03::MK-8776
EFO-27::I-BRD9
YKG-1::I-BRD9
MOG-G-UVW::ZM447439
SF539::XAV939
SNU-423::I-BRD9
IM-9::Osimertinib
BT-20::Foretinib
IA-LM::Afatinib
BxPC-3::Avagacestat
C2BBe1::Motesanib
HCC1937::Motesanib
MEG-01::Doramapimod
H9::XAV939
PC-14::AZD7762
FLO-1::I-BRD9
KMS-12-BM::Cediranib
QIMR-WIL::Afatinib
RCC-JF::Afatinib
U-698-M::ZM447439
STS-0421::Sepantronium bromide
OACM5-1::Foretinib
RCC10RGB::Cediranib
SF539::Cediranib
MPP-89::MK-8776
NCI-H2291::Afatinib
NCI-H250::Motesanib
SW13::Foretinib
SK-HEP-1::Osimertinib
OV-7::BX795
VAL::Osimertinib
U251::AGI-6780
OCI-AML3::XAV939
LK-2::Afatinib
JHOS-3::BX795
MES-SA::Motesanib
NCI-H1648::Telomerase Inhibitor IX
KYSE-50::Telomerase Inhibitor IX
NCI-H250::Avagacestat
KU812::AGI-6780
DMS-53::AZD7762
SW780::Motesanib
ME-180::Dabrafenib
CTV-1::Sepantronium bromide
RPMI-8402::VX-11e
NCI-H727::AZD7762
COLO-678::Motesanib
BFTC-909::VX-11e
HDQ-P1::Doramapimod
SW684::MK-8776
NCI-H209::AZD7762
SNU-1040::Dabrafenib
HuCCT1::Motesanib
D-247MG::AZD7762
AU565::Cediranib
ROS-50::Cediranib
OE33::Afatinib
CAL-27::Osimertinib
TE-4::Doramapimod
AMO-1::Telomerase Inhibitor IX
TC-71::Telomerase Inhibitor IX
DMS-273::Alisertib
IM-9::Avagacestat
SU8686::Alisertib
OV-56::Alisertib
NB10::AZD7762
NCI-H2405::XAV939
Hs-445::VX-11e
RERF-LC-MS::Doramapimod
HCC38::Telomerase Inhibitor IX
SJSA-1::Sepantronium bromide
SW1271::Cediranib
CTB-1::XAV939
Raji::Afatinib
NCI-H1944::Sepantronium bromide
RPMI-8402::Cediranib
CAMA-1::Cediranib
HDLM-2::Foretinib
647-V::Foretinib
HC-1::Foretinib
GDM-1::AGI-6780
SW13::I-BRD9
OCI-LY7::AGI-6780
JURL-MK1::AGI-6780
L-428::Sepantronium bromide
KOSC-2::Afatinib
NCI-H1299::Afatinib
NCI-H1341::Telomerase Inhibitor IX
LB831-BLC::Foretinib
ChaGo-K-1::BX795
NCI-H2052::Alisertib
RCM-1::Motesanib
TYK-nu::XAV939
SNU-387::I-BRD9
NCI-H441::Alisertib
SW837::MK-8776
NCI-H358::Osimertinib
OAW-42::Cediranib
NOMO-1::Doramapimod
JVM-3::Afatinib
CAL-148::Cediranib
KYSE-410::I-BRD9
KYSE-150::Osimertinib
KM12::Motesanib
OVCAR-3::Sepantronium bromide
COLO-320-HSR::AGI-6780
UACC-257::Doramapimod
JHU-029::Afatinib
NCI-H226::Avagacestat
DMS-53::Avagacestat
SNU-61::Doramapimod
NCI-H1876::Sepantronium bromide
NCI-H1650::I-BRD9
OCI-M1::Dabrafenib
OVTOKO::Foretinib
T98G::Alisertib
RKN::XAV939
ROS-50::Osimertinib
OVCAR-3::VX-11e
J82::Doramapimod
BT-549::Sepantronium bromide
DBTRG-05MG::Sepantronium bromide
NB12::Motesanib
HAL-01::Doramapimod
SNU-C1::AZD7762
HCC1187::XAV939
JHOS-2::I-BRD9
LB373-MEL-D::Osimertinib
MDA-MB-361::Foretinib
CS1::Avagacestat
JHOS-3::Cediranib
KMS-11::VX-11e
SK-PN-DW::Alisertib
SU8686::MK-8776
OE33::VX-11e
NB6::Dabrafenib
SW156::MK-8776
NCI-H226::XAV939
HCC1395::Osimertinib
no-10::Foretinib
KLE::AZD7762
SNB75::Motesanib
LN-18::I-BRD9
PEO1::ZM447439
KYM-1::Avagacestat
MONO-MAC-6::I-BRD9
HCC1419::Dabrafenib
A704::Alisertib
SK-PN-DW::XAV939
NCI-H1648::Motesanib
Daudi::Sepantronium bromide
OV-17R::Foretinib
451Lu::Cediranib
STS-0421::Doramapimod
KP-N-YN::XAV939
NCI-H2405::AZD7762
CRO-AP2::AZD7762
TT::Osimertinib
MHH-CALL-2::AGI-6780
NCI-H1703::Foretinib
ZR-75-30::Telomerase Inhibitor IX
PEO1::Dabrafenib
COR-L88::MK-8776
LB2518-MEL::Dabrafenib
GP5d::Sepantronium bromide
OCI-M1::Afatinib
NCI-H2135::Motesanib
FTC-133::Motesanib
KCL-22::MK-8776
LB2241-RCC::Foretinib
TE-6::XAV939
GR-ST::Doramapimod
JHH-7::Telomerase Inhibitor IX
THP-1::XAV939
K2::ZM447439
SF268::VX-11e
MDA-MB-436::AZD7762
UM-UC-3::Cediranib
GAMG::Telomerase Inhibitor IX
CHSA0108::Doramapimod
DEL::XAV939
DJM-1::Cediranib
HT-1197::MK-8776
CTV-1::Motesanib
KYAE-1::Cediranib
HCC-44::Alisertib
EJM::Telomerase Inhibitor IX
A253::AGI-6780
RKN::Foretinib
OV-90::AGI-6780
HuH-7::Doramapimod
NCI-H727::VX-11e
SK-MEL-31::XAV939
NU-DUL-1::Afatinib
ARH-77::Osimertinib
LCLC-103H::Dabrafenib
OV-7::Alisertib
ALL-PO::Doramapimod
DoTc2-4510::AGI-6780
EFO-21::Telomerase Inhibitor IX
NCI-H2347::Alisertib
BT-20::Osimertinib
MKN45::Motesanib
CHSA0108::AGI-6780
D-247MG::Telomerase Inhibitor IX
BICR10::Osimertinib
C-4-I::AZD7762
MFH-ino::Osimertinib
SK-MEL-30::I-BRD9
SCH::I-BRD9
NCI-H1355::XAV939
EW-12::Motesanib
CP66-MEL::Cediranib
A172::Sepantronium bromide
COLO-320-HSR::AZD7762
JHOS-4::Doramapimod
LU-135::XAV939
SU-DHL-1::Telomerase Inhibitor IX
MM1S::XAV939
SNU-81::XAV939
G-361::AZD7762
MRK-nu-1::XAV939
NCI-H1355::VX-11e
NCI-H1694::Doramapimod
ETK-1::Dabrafenib
VMRC-LCD::Alisertib
ACHN::VX-11e
PL4::Afatinib
NCI-H727::Osimertinib
EFO-21::Motesanib
ML-1::Cediranib
PL4::Osimertinib
TGBC24TKB::I-BRD9
MS-1::AZD7762
NCI-H1688::Foretinib
PCI-15A::Osimertinib
MDA-MB-468::VX-11e
JAR::VX-11e
EoL-1-cell::Cediranib
TGBC24TKB::AGI-6780
LB996-RCC::MK-8776
COLO-668::Sepantronium bromide
A101D::MK-8776
SW756::MK-8776
LP-1::Cediranib
BB65-RCC::Alisertib
P31-FUJ::Dabrafenib
NCI-H2227::Alisertib
GCIY::Telomerase Inhibitor IX
A2780::Avagacestat
JEG-3::Dabrafenib
FU97::I-BRD9
NCI-H1436::Osimertinib
WM-115::Dabrafenib
SR::ZM447439
ALL-PO::MK-8776
OVCAR-5::AGI-6780
COLO-800::Doramapimod
EoL-1-cell::Foretinib
HCC1500::Dabrafenib
WSU-NHL::AZD7762
NCI-H1435::AGI-6780
COLO-824::Doramapimod
SW626::Avagacestat
NCI-H740::XAV939
A2780::Dabrafenib
SK-CO-1::ZM447439
JURL-MK1::Dabrafenib
SK-MEL-3::XAV939
OCI-LY7::Motesanib
M059J::Cediranib
ACHN::Dabrafenib
8305C::AGI-6780
NALM-6::AGI-6780
NCI-H28::Telomerase Inhibitor IX
GAK::Foretinib
CAPAN-1::AGI-6780
SK-CO-1::AGI-6780
LC4-1::AGI-6780
NCI-H1694::Motesanib
ME-1::Avagacestat
OS-RC-2::I-BRD9
SW837::Dabrafenib
PEO1::Doramapimod
UMC-11::Alisertib
IHH-4::Doramapimod
IGR-1::Sepantronium bromide
CML-T1::AZD7762
MSTO-211H::Osimertinib
CHP-134::AZD7762
NCI-H69::Avagacestat
Mo-T::Foretinib
CHL-1::Osimertinib
LP-1::VX-11e
BFTC-905::Afatinib
MN-60::Doramapimod
NB6::AGI-6780
D-542MG::Sepantronium bromide
EW-13::ZM447439
EMC-BAC-1::ZM447439
PCI-6A::Foretinib
OE33::Osimertinib
NCI-H2342::MK-8776
SW1088::Motesanib
YKG-1::AGI-6780
STS-0421::AGI-6780
ME-180::Cediranib
NCI-H226::I-BRD9
A431::Avagacestat
UMC-11::Afatinib
SW872::Cediranib
ML-1::I-BRD9
CW-2::ZM447439
SW620::Cediranib
OSC-20::Telomerase Inhibitor IX
GAK::Avagacestat
JHH-2::ZM447439
CAL-27::Avagacestat
LCLC-97TM1::Sepantronium bromide
CHSA0011::Motesanib
DMS-114::I-BRD9
ESO26::Cediranib
NCI-H2122::Dabrafenib
TC-71::Motesanib
SNU-449::Dabrafenib
SCC-15::Osimertinib
LB1047-RCC::Afatinib
DG-75::VX-11e
NCI-H1648::Cediranib
MEL-JUSO::AZD7762
NCI-H28::VX-11e
UACC-257::Dabrafenib
JEG-3::ZM447439
SW780::Afatinib
JEKO-1::MK-8776
NCI-H1573::Sepantronium bromide
HO-1-N-1::XAV939
CHSA0011::Afatinib
SF126::Foretinib
KNS-62::ZM447439
ARH-77::MK-8776
HCE-4::AZD7762
VA-ES-BJ::Foretinib
NCC021::ZM447439
LC4-1::ZM447439
K2::Telomerase Inhibitor IX
CML-T1::Cediranib
HCE-4::Doramapimod
42-MG-BA::Foretinib
DOV13::MK-8776
T84::Telomerase Inhibitor IX
RS4-11::Dabrafenib
OCI-M1::MK-8776
QGP-1::I-BRD9
A375::Dabrafenib
K2::Afatinib
KP-4::ZM447439
JHOS-2::VX-11e
GOTO::Afatinib
COR-L32::I-BRD9
OPM-2::Sepantronium bromide
KON::Foretinib
HSC-2::AGI-6780
GA-10::Doramapimod
HOS::I-BRD9
L-428::Foretinib
KNS-42::AGI-6780
T84::Cediranib
BL-41::Sepantronium bromide
KMS-11::ZM447439
CAL-85-1::Motesanib
HCC38::ZM447439
SK-OV-3::AZD7762
TGBC11TKB::Doramapimod
MEG-01::XAV939
CL-11::Osimertinib
KNS-62::Doramapimod
KU812::VX-11e
TYK-nu::Dabrafenib
OCUB-M::Motesanib
MES-SA::Avagacestat
H4::Afatinib
ES-2::ZM447439
NCI-H510A::MK-8776
TC-71::Sepantronium bromide
CESS::ZM447439
C-4-I::Dabrafenib
no-10::VX-11e
NCI-H2066::Afatinib
CFPAC-1::Foretinib
BICR31::Osimertinib
UACC-62::Dabrafenib
SNU-283::ZM447439
SH-4::ZM447439
RPMI-7951::Sepantronium bromide
NCI-H1693::Dabrafenib
MDST8::Sepantronium bromide
AsPC-1::Motesanib
JHU-029::AGI-6780
KYSE-50::Alisertib
CA46::Cediranib
NCI-H1793::Osimertinib
COR-L23::Doramapimod
ES1::Doramapimod
NCI-H1694::Osimertinib
G-402::Doramapimod
U031::AZD7762
BICR22::AGI-6780
EMC-BAC-2::Doramapimod
JHU-022::MK-8776
PANC-10-05::Cediranib
NCI-H2291::ZM447439
EW-7::ZM447439
CAL-72::AZD7762
GRANTA-519::Motesanib
RC-K8::Telomerase Inhibitor IX
HO-1-N-1::ZM447439
NCI-H1341::Cediranib
Jurkat::AGI-6780
SNU-387::XAV939
KYSE-520::Telomerase Inhibitor IX
Ramos-2G6-4C10::Doramapimod
SW156::Cediranib
GA-10::AGI-6780
DMS-79::Motesanib
LS-123::ZM447439
CAL-33::Telomerase Inhibitor IX
PC-3::ZM447439
EW-18::Afatinib
RCC-FG2::AZD7762
ARH-77::Doramapimod
NCI-H2122::AGI-6780
HEL::Sepantronium bromide
JHH-2::Sepantronium bromide
KYSE-150::Telomerase Inhibitor IX
SUP-T1::Motesanib
JHH-7::Avagacestat
NCI-H2405::Dabrafenib
HeLa::XAV939
NOS-1::Dabrafenib
PA-TU-8988T::MK-8776
VCaP::Afatinib
KGN::Sepantronium bromide
D-263MG::Motesanib
CESS::AGI-6780
MOLM-16::AZD7762
KASUMI-1::Cediranib
HCC1599::Avagacestat
TE-15::Foretinib
EM-2::Motesanib
CAL-54::Doramapimod
SU-DHL-4::Osimertinib
NCI-H748::ZM447439
IM-9::Sepantronium bromide
NCI-H2087::AZD7762
HCC1599::BX795
NAMALWA::Cediranib
MFM-223::Cediranib
NCI-H2052::Afatinib
OVMIU::Avagacestat
SW626::Cediranib
OCI-LY-19::Motesanib
LB647-SCLC::Foretinib
MZ2-MEL::Cediranib
OC-314::Telomerase Inhibitor IX
NCI-H292::Alisertib
HO-1-u-1::Alisertib
OVCA420::Motesanib
MDA-MB-330::ZM447439
SK-HEP-1::Afatinib
RKO::ZM447439
JHH-2::Alisertib
RERF-LC-MS::Foretinib
NCI-H441::Foretinib
SCH::Telomerase Inhibitor IX
JEKO-1::AGI-6780
ECC10::Foretinib
KYSE-50::AZD7762
NB14::VX-11e
EVSA-T::Motesanib
NCI-H2085::Avagacestat
SK-PN-DW::Osimertinib
BB30-HNC::I-BRD9
NCI-H2052::VX-11e
DK-MG::MK-8776
OAW-28::I-BRD9
RKN::Doramapimod
ONS-76::Telomerase Inhibitor IX
ESS-1::Alisertib
A2058::XAV939
KYSE-410::Motesanib
SU-DHL-8::XAV939
SK-MEL-3::MK-8776
NCI-H847::Foretinib
NCI-H1568::Dabrafenib
NCI-H1963::Alisertib
SNB75::Dabrafenib
CW-2::MK-8776
G-401::Alisertib
EW-22::MK-8776
SBC-1::Dabrafenib
NCI-H2405::VX-11e
NCI-H747::Avagacestat
HT55::Avagacestat
NB(TU)1-10::Motesanib
HARA::VX-11e
42-MG-BA::Doramapimod
RKO::Afatinib
NCI-H23::AZD7762
RERF-LC-KJ::Motesanib
no-10::MK-8776
HCC-366::Avagacestat
MOLM-13::Cediranib
SISO::Dabrafenib
UMC-11::Doramapimod
GR-ST::MK-8776
OVISE::Doramapimod
SCH::Motesanib
A427::Avagacestat
COR-L279::I-BRD9
JHU-011::Alisertib
HCC1599::Telomerase Inhibitor IX
JHU-022::I-BRD9
SU-DHL-4::MK-8776
CPC-N::Doramapimod
A673::Avagacestat
COR-L311::Doramapimod
Calu-3::Alisertib
GI-ME-N::Osimertinib
G-MEL::Alisertib
SUP-HD1::VX-11e
SNG-M::MK-8776
WM278::I-BRD9
NCI-H2170::Telomerase Inhibitor IX
NCI-H1435::Telomerase Inhibitor IX
MDA-MB-361::Motesanib
SW954::Afatinib
COLO-679::Cediranib
SK-MES-1::Doramapimod
JJN-3::Foretinib
HCC1806::AZD7762
CCK-81::Sepantronium bromide
HT-115::Osimertinib
MKN28::AZD7762
MOLM-13::VX-11e
SU-DHL-16::AZD7762
TCCSUP::Alisertib
KARPAS-620::Cediranib
LOXIMVI::VX-11e
451Lu::XAV939
HO-1-u-1::Sepantronium bromide
KELLY::AGI-6780
C-33-A::Avagacestat
NCI-H3122::Sepantronium bromide
HCC1937::AZD7762
CHP-126::MK-8776
KYM-1::Afatinib
AMO-1::MK-8776
SW954::XAV939
KS-1::Sepantronium bromide
IMR-5::ZM447439
SUP-B8::Afatinib
LAMA-84::XAV939
HL-60::Afatinib
PANC-10-05::Doramapimod
LAMA-84::Dabrafenib
UACC-257::AGI-6780
NCI-H522::Cediranib
SIG-M5::Alisertib
COR-L32::MK-8776
NCI-H2172::Sepantronium bromide
LN-405::Telomerase Inhibitor IX
TE-8::Doramapimod
MFM-223::Osimertinib
L-1236::XAV939
SN12C::I-BRD9
SW48::Cediranib
SF126::Doramapimod
MOG-G-CCM::Foretinib
SW962::Dabrafenib
GRANTA-519::Cediranib
OVMIU::I-BRD9
MOLM-16::Osimertinib
KYSE-270::AGI-6780
SAS::XAV939
NCI-H748::Osimertinib
NCI-H2122::AZD7762
LU-134-A::XAV939
639-V::I-BRD9
TYK-nu::Osimertinib
BONNA-12::ZM447439
RT4::AZD7762
DOHH-2::VX-11e
KCL-22::Osimertinib
D-566MG::I-BRD9
U251::Telomerase Inhibitor IX
FTC-133::AGI-6780
HSC-4::ZM447439
MKN1::Cediranib
NCI-H209::Telomerase Inhibitor IX
KYSE-450::Osimertinib
NCI-H748::Dabrafenib
Hey::Doramapimod
RCC10RGB::Osimertinib
SKG-IIIa::Osimertinib
PWR-1E::Doramapimod
LOXIMVI::ZM447439
PCI-4B::MK-8776
MFE-296::Motesanib
JHU-022::Sepantronium bromide
ST486::Osimertinib
HH::Avagacestat
NCI-H2347::Dabrafenib
KYSE-410::Cediranib
BICR78::I-BRD9
HuP-T4::MK-8776
L-363::Foretinib
CFPAC-1::Motesanib
CAL-120::Cediranib
SAT::MK-8776
no-11::Avagacestat
DOK::Sepantronium bromide
HCC1143::Foretinib
SW982::Dabrafenib
D-247MG::Alisertib
SKG-IIIa::Motesanib
HDLM-2::XAV939
CESS::Motesanib
HCT-116::AGI-6780
NCI-H1105::Telomerase Inhibitor IX
MKN7::Doramapimod
MOLT-4::Doramapimod
LNCaP-Clone-FGC::AGI-6780
ARH-77::Dabrafenib
BB30-HNC::BX795
BFTC-909::Avagacestat
NCI-H3122::Motesanib
SW837::Foretinib
KP-N-YN::ZM447439
MKN7::Afatinib
786-0::Osimertinib
SK-PN-DW::AZD7762
MFE-296::Avagacestat
NCI-H1836::Osimertinib
GDM-1::AZD7762
COLO-679::I-BRD9
RCC-JW::AZD7762
J82::Sepantronium bromide
MOLM-16::ZM447439
GAK::Doramapimod
PA-TU-8902::Cediranib
TOV-21G::Telomerase Inhibitor IX
OV-17R::VX-11e
NCI-H1975::AZD7762
HC-1::I-BRD9
PF-382::MK-8776
CHP-126::VX-11e
BT-483::Avagacestat
RS4-11::Telomerase Inhibitor IX
NB14::MK-8776
EB-3::Alisertib
HAL-01::MK-8776
RERF-LC-MS::XAV939
HCC1143::VX-11e
NCI-H209::I-BRD9
TC-YIK::Afatinib
JiyoyeP-2003::XAV939
KGN::Foretinib
COLO-829::Foretinib
SNU-C2B::I-BRD9
SUP-B8::Avagacestat
JHU-022::VX-11e
ALL-PO::Avagacestat
KG-1::ZM447439
T84::Alisertib
Detroit562::I-BRD9
SiHa::Alisertib
BT-474::VX-11e
LB771-HNC::Avagacestat
UACC-257::I-BRD9
Saos-2::Afatinib
P31-FUJ::Cediranib
JHU-011::AGI-6780
NCI-H524::MK-8776
SU-DHL-6::Motesanib
MDA-MB-468::AGI-6780
SK-CO-1::Dabrafenib
OVCAR-5::VX-11e
LB831-BLC::Osimertinib
SW1116::ZM447439
LB2241-RCC::AGI-6780
LN-405::Cediranib
NALM-6::Dabrafenib
OCI-LY-19::Sepantronium bromide
SUP-B8::I-BRD9
IM-95::Cediranib
HCT-15::Avagacestat
HO-1-u-1::I-BRD9
TE-10::VX-11e
RT-112::Sepantronium bromide
FADU::I-BRD9
THP-1::Telomerase Inhibitor IX
U-118-MG::Foretinib
Detroit562::Foretinib
NCI-H510A::Sepantronium bromide
KYSE-270::XAV939
MOLP-8::Telomerase Inhibitor IX
MV-4-11::Telomerase Inhibitor IX
BHY::AZD7762
HuP-T4::ZM447439
Daudi::Motesanib
PANC-03-27::I-BRD9
RPMI-7951::AZD7762
C2BBe1::Avagacestat
SW684::XAV939
NCI-H510A::Cediranib
CRO-AP2::Cediranib
OACp4C::Sepantronium bromide
M14::Cediranib
NCI-H446::VX-11e
EW-24::Motesanib
NCI-H1693::ZM447439
MEG-01::Avagacestat
MFM-223::XAV939
Jurkat::Motesanib
BHY::ZM447439
HCC-366::Motesanib
IM-95::AGI-6780
UMC-11::MK-8776
SW982::Cediranib
DMS-114::Avagacestat
LS-180::AZD7762
SU-DHL-8::Motesanib
RERF-LC-KJ::Avagacestat
SK-MEL-31::Alisertib
LU-165::Cediranib
NCI-H1694::Afatinib
TE-15::Avagacestat
KYM-1::AGI-6780
TE-1::Doramapimod
KMRC-1::Telomerase Inhibitor IX
CHL-1::VX-11e
C2BBe1::Foretinib
NCI-H847::Avagacestat
MS751::Telomerase Inhibitor IX
KYSE-520::AZD7762
NCI-H1623::Osimertinib
DOV13::Sepantronium bromide
NCI-H810::Telomerase Inhibitor IX
NB13::Doramapimod
OAW-42::I-BRD9
NB14::I-BRD9
U-266::Avagacestat
VMRC-RCZ::Osimertinib
T84::Doramapimod
NCI-H1436::Telomerase Inhibitor IX
NOS-1::Afatinib
DMS-273::Motesanib
COLO-680N::Afatinib
EFO-21::Sepantronium bromide
MHH-PREB-1::Doramapimod
AM-38::Afatinib
A204::Avagacestat
HeLa::AGI-6780
HuP-T3::I-BRD9
SW1417::XAV939
OSC-20::Doramapimod
LU-165::AZD7762
GI-1::Osimertinib
639-V::Foretinib
G-361::Doramapimod
GAK::XAV939
COR-L23::AZD7762
MOLT-4::ZM447439
MDST8::Afatinib
697::ZM447439
A549::AZD7762
NUGC-4::Doramapimod
LC4-1::Doramapimod
Becker::Osimertinib
Mo-T::Telomerase Inhibitor IX
NCI-H1105::Foretinib
SW1990::Alisertib
ME-180::Foretinib
ABC-1::Sepantronium bromide
EFO-27::VX-11e
SW620::Osimertinib
D-542MG::Cediranib
PA-TU-8988T::Avagacestat
KOPN-8::Avagacestat
COR-L303::AZD7762
EBC-1::I-BRD9
NCI-H1792::Avagacestat
EN::VX-11e
KU812::ZM447439
JSC-1::Cediranib
NKM-1::VX-11e
NCI-H2030::Osimertinib
HAL-01::Sepantronium bromide
PA-TU-8988T::Sepantronium bromide
PSN1::Afatinib
UACC-893::XAV939
CCK-81::XAV939
NCI-H1876::Telomerase Inhibitor IX
IA-LM::Dabrafenib
Calu-3::Afatinib
SW756::Sepantronium bromide
TE-9::Avagacestat
NCI-H82::Alisertib
SNU-423::Doramapimod
AsPC-1::Foretinib
ES1::Foretinib
PC-14::Dabrafenib
HCC2218::Cediranib
NCI-H596::Sepantronium bromide
EJM::VX-11e
SF268::Cediranib
A498::AGI-6780
SW13::Dabrafenib
A101D::Alisertib
MHH-CALL-4::ZM447439
HCT-15::Foretinib
PANC-03-27::Dabrafenib
REH::Avagacestat
HGC-27::Foretinib
Hey::VX-11e
COR-L105::Osimertinib
Calu-3::Telomerase Inhibitor IX
OCI-AML3::Afatinib
HCC1419::AZD7762
SK-PN-DW::Cediranib
NCI-H2172::MK-8776
LU-99A::MK-8776
KARPAS-45::I-BRD9
Hs-445::MK-8776
WIL2-NS::ZM447439
LS-123::Foretinib
KM-H2::Afatinib
ALL-PO::Foretinib
SK-N-DZ::Sepantronium bromide
COR-L23::I-BRD9
NCI-H526::Foretinib
SNU-C5::VX-11e
ME-1::Sepantronium bromide
COLO-205::Doramapimod
HTC-C3::Dabrafenib
NCI-H1092::XAV939
SiHa::XAV939
LS-180::XAV939
OSC-20::Alisertib
NCI-H524::Motesanib
NCI-H1876::VX-11e
UWB1.289::AGI-6780
TE-8::Telomerase Inhibitor IX
SU-DHL-8::Afatinib
L-363::XAV939
NCI-H1105::I-BRD9
PANC-04-03::ZM447439
KINGS-1::Cediranib
LU-139::Afatinib
EW-12::Cediranib
NCI-H1975::ZM447439
COLO-680N::Cediranib
MOLT-13::Afatinib
AsPC-1::Afatinib
TE-11::Dabrafenib
GDM-1::Doramapimod
HCC-78::AGI-6780
BICR31::ZM447439
OCI-LY7::VX-11e
LB647-SCLC::Osimertinib
BV-173::I-BRD9
NCI-H929::Sepantronium bromide
CP66-MEL::AGI-6780
CL-11::VX-11e
RVH-421::Telomerase Inhibitor IX
KP-1N::ZM447439
SNU-C1::MK-8776
SU-DHL-8::ZM447439
RCC-JF::I-BRD9
JHH-2::Telomerase Inhibitor IX
PA-TU-8988T::ZM447439
KNS-62::Dabrafenib
23132-87::VX-11e
JJN-3::MK-8776
SW1783::Osimertinib
GR-ST::Dabrafenib
TUR::VX-11e
LS-180::VX-11e
HPAC::Cediranib
PCI-4B::AGI-6780
D-542MG::Doramapimod
8-MG-BA::ZM447439
HDQ-P1::VX-11e
EVSA-T::AZD7762
L-363::AGI-6780
JHH-1::ZM447439
COR-L88::Doramapimod
MDA-MB-361::Dabrafenib
OV-7::Sepantronium bromide
SNU-398::Telomerase Inhibitor IX
SW954::MK-8776
SNB75::Osimertinib
TCCSUP::AZD7762
NCI-H1703::Osimertinib
VCaP::ZM447439
VCaP::AGI-6780
YKG-1::AZD7762
BICR10::Sepantronium bromide
NB5::Telomerase Inhibitor IX
SNU-449::Osimertinib
RD::Telomerase Inhibitor IX
EVSA-T::Doramapimod
SNU-61::Afatinib
RC-K8::Dabrafenib
KP-2::VX-11e
IM-95::Foretinib
NCI-H322M::Motesanib
IA-LM::Alisertib
H9::AZD7762
FLO-1::Avagacestat
MES-SA::Doramapimod
FU-OV-1::Avagacestat
YAPC::Sepantronium bromide
SNG-M::Motesanib
CHSA0011::XAV939
RVH-421::BX795
COR-L321::Afatinib
ROS-50::ZM447439
PL-21::BX795
RKO::Osimertinib
HCC1599::XAV939
LXF-289::Cediranib
KY821::AGI-6780
SIMA::MK-8776
LoVo::Cediranib
PA-TU-8902::ZM447439
NCI-H292::Motesanib
RCC-MF::MK-8776
SU-DHL-5::Avagacestat
RCC-JF::VX-11e
NCI-H2023::XAV939
CAL-39::Cediranib
HL-60::Sepantronium bromide
NCI-H345::Osimertinib
IGR-1::Telomerase Inhibitor IX
LB2518-MEL::Sepantronium bromide
VCaP::Doramapimod
T98G::Motesanib
SUP-T1::Alisertib
NCI-H1838::Sepantronium bromide
A673::Dabrafenib
SNU-283::AZD7762
SK-LMS-1::Motesanib
NCI-H740::MK-8776
Raji::XAV939
CP66-MEL::MK-8776
LU-135::Osimertinib
MFM-223::Telomerase Inhibitor IX
DB::AGI-6780
SUP-HD1::Sepantronium bromide
NCI-H661::Sepantronium bromide
NCI-H847::Telomerase Inhibitor IX
KMRC-20::Alisertib
G-401::Avagacestat
ES5::MK-8776
RPMI-8866::Motesanib
BICR78::MK-8776
RMG-I::Dabrafenib
KYSE-220::Afatinib
G-361::XAV939
PANC-02-03::AGI-6780
SW872::ZM447439
ES6::VX-11e
PL4::I-BRD9
SK-MG-1::Avagacestat
MSTO-211H::Telomerase Inhibitor IX
SBC-1::Sepantronium bromide
RPMI-6666::ZM447439
H3255::Dabrafenib
CL-11::AGI-6780
8505C::Alisertib
TK10::AGI-6780
CAL-12T::I-BRD9
SK-N-DZ::Cediranib
NCI-H522::I-BRD9
AU565::Doramapimod
M059J::Dabrafenib
CAL-12T::VX-11e
NCI-H441::Osimertinib
OACp4C::ZM447439
SW626::Doramapimod
WM793B::Avagacestat
SBC-3::Motesanib
MS751::AZD7762
G-402::Afatinib
HCC2157::Motesanib
KOSC-2::BX795
SNU-C5::AGI-6780
SBC-1::Motesanib
NCI-H1155::Alisertib
NCI-H292::I-BRD9
SIG-M5::Telomerase Inhibitor IX
JHH-6::Telomerase Inhibitor IX
MHH-PREB-1::ZM447439
COLO-800::Osimertinib
IST-MES1::Motesanib
NCI-H1651::Foretinib
COR-L311::AZD7762
MOLT-16::Telomerase Inhibitor IX
SCC-3::Foretinib
SCC-25::AZD7762
LOU-NH91::Alisertib
LB996-RCC::Osimertinib
MEG-01::Sepantronium bromide
HOP-62::ZM447439
RCC-MF::Osimertinib
IGR-1::I-BRD9
NCI-H441::Telomerase Inhibitor IX
SW1417::Sepantronium bromide
EW-3::Motesanib
PCI-15A::Cediranib
KMRC-1::Afatinib
CAPAN-1::I-BRD9
Hs-578-T::Cediranib
HuP-T4::XAV939
SW620::AGI-6780
ES7::XAV939
Becker::Afatinib
NCI-H1568::I-BRD9
DMS-273::I-BRD9
SK-MEL-3::Telomerase Inhibitor IX
WIL2-NS::Doramapimod
NB17::MK-8776
HCC2218::VX-11e
VA-ES-BJ::Telomerase Inhibitor IX
UMC-11::XAV939
NCI-H2135::AZD7762
NCI-H1155::Avagacestat
SU8686::Foretinib
D-283MED::AGI-6780
KOSC-2::Sepantronium bromide
CAPAN-1::XAV939
BC-1::Foretinib
SUP-T1::Telomerase Inhibitor IX
CPC-N::Cediranib
8505C::Afatinib
SKM-1::AZD7762
SU8686::I-BRD9
SK-MEL-1::Doramapimod
OCI-AML5::Afatinib
REH::I-BRD9
TE-11::MK-8776
JHH-2::MK-8776
OCI-LY-19::Foretinib
MOLT-4::Afatinib
CAL-72::XAV939
EW-12::Telomerase Inhibitor IX
SUIT-2::XAV939
YKG-1::Foretinib
MHH-PREB-1::VX-11e
ESS-1::Sepantronium bromide
8305C::MK-8776
HCC1395::Afatinib
G-402::Telomerase Inhibitor IX
PCI-6A::ZM447439
SK-MM-2::MK-8776
BONNA-12::Afatinib
NCI-H146::Telomerase Inhibitor IX
HC-1::ZM447439
NCI-H2030::AGI-6780
SNU-C1::Foretinib
PA-1::Doramapimod
AN3-CA::Avagacestat
IST-SL2::I-BRD9
PANC-03-27::VX-11e
D-566MG::VX-11e
A172::AGI-6780
HCC1569::I-BRD9
ML-2::AGI-6780
OVISE::MK-8776
NCI-H1838::MK-8776
CA46::Dabrafenib
LS-411N::Telomerase Inhibitor IX
TE-11::XAV939
HDQ-P1::XAV939
AMO-1::Foretinib
CAL-29::Avagacestat
HT55::Afatinib
COLO-679::Dabrafenib
SH-4::Cediranib
PC-14::XAV939
SK-ES-1::Foretinib
NCI-H2141::Sepantronium bromide
FTC-133::Doramapimod
SU-DHL-4::I-BRD9
Ca9-22::ZM447439
G-402::AGI-6780
SLVL::Motesanib
D-247MG::Avagacestat
MCF7::Sepantronium bromide
FADU::AZD7762
MZ1-PC::Alisertib
CTB-1::AGI-6780
NEC8::AGI-6780
BFTC-905::XAV939
JURL-MK1::Motesanib
SBC-3::VX-11e
SUP-HD1::Motesanib
DND-41::AGI-6780
MG-63::Sepantronium bromide
SK-GT-2::Foretinib
HCC-15::Cediranib
GI-1::VX-11e
RCC-MF::I-BRD9
EW-13::Avagacestat
NU-DUL-1::AZD7762
CAL-72::AGI-6780
LU-135::I-BRD9
MFE-296::Foretinib
FU97::Dabrafenib
RERF-LC-KJ::ZM447439
KYSE-140::ZM447439
NCI-H1793::Doramapimod
NCI-H2170::Osimertinib
MM1S::Afatinib
LU-134-A::MK-8776
TE-15::Doramapimod
SK-MG-1::Doramapimod
HCC1500::I-BRD9
COLO-783::Afatinib
VAL::Doramapimod
23132-87::AGI-6780
CTB-1::I-BRD9
HSC-4::AGI-6780
LS-513::Doramapimod
LB647-SCLC::BX795
LB831-BLC::Cediranib
EN::Alisertib
NCI-H661::Doramapimod
GCIY::Doramapimod
BE-13::Afatinib
NCI-H2085::AGI-6780
NCI-H650::Motesanib
LNZTA3WT4::Alisertib
UACC-257::Alisertib
NCI-H2110::Doramapimod
SNU-C2B::Foretinib
NB10::Avagacestat
WM35::I-BRD9
SNU-1040::AZD7762
GCIY::Dabrafenib
MES-SA::Foretinib
NB14::Afatinib
MS-1::MK-8776
SHP-77::Sepantronium bromide
OVCAR-8::Foretinib
CA46::AGI-6780
KMRC-20::Telomerase Inhibitor IX
DJM-1::Alisertib
NCI-H1944::Osimertinib
BONNA-12::Dabrafenib
SW872::I-BRD9
KARPAS-45::XAV939
J82::Foretinib
LCLC-103H::Osimertinib
NKM-1::Avagacestat
CP66-MEL::Alisertib
SNB75::Foretinib
LB1047-RCC::Foretinib
SK-GT-4::Afatinib
BE2-M17::Sepantronium bromide
NCI-H1581::Osimertinib
NB69::I-BRD9
NCI-H847::Dabrafenib
JIMT-1::Alisertib
LS-411N::AZD7762
SW1990::Osimertinib
KYSE-520::Foretinib
TT::Sepantronium bromide
KELLY::Osimertinib
HT-144::ZM447439
KU-19-19::VX-11e
CRO-AP2::Afatinib
NMC-G1::Cediranib
NCI-H23::AGI-6780
MFE-280::Sepantronium bromide
HT-29::AGI-6780
IPC-298::Motesanib
KP-N-YN::I-BRD9
ESO26::I-BRD9
LU-135::Cediranib
KYSE-150::MK-8776
NCI-H1876::XAV939
CL-11::Dabrafenib
T98G::VX-11e
QIMR-WIL::I-BRD9
ChaGo-K-1::MK-8776
ES6::XAV939
JHH-6::MK-8776
NCI-H1869::VX-11e
TCCSUP::Osimertinib
SW156::Avagacestat
NCI-H358::ZM447439
LNZTA3WT4::VX-11e
OVKATE::I-BRD9
COR-L303::Avagacestat
YKG-1::Dabrafenib
SCC-4::AGI-6780
NCI-H2342::Afatinib
CAL-12T::BX795
LoVo::Osimertinib
KNS-81-FD::Avagacestat
NCI-H69::Motesanib
K5::MK-8776
COR-L303::Dabrafenib
SNU-449::Motesanib
TGBC1TKB::I-BRD9
NCI-H1963::Telomerase Inhibitor IX
CRO-AP2::VX-11e
LN-229::VX-11e
MFE-319::MK-8776
769-P::Foretinib
SU-DHL-1::Cediranib
KMS-12-BM::AGI-6780
5637::I-BRD9
MFM-223::Avagacestat
SW1417::Doramapimod
NCI-H2227::Foretinib
WSU-DLCL2::Avagacestat
NCI-H2228::AZD7762
RCC-MF::Telomerase Inhibitor IX
RCC-MF::Doramapimod
SW1417::Alisertib
NCI-H1734::Foretinib
KYAE-1::MK-8776
NCI-H650::Telomerase Inhibitor IX
KYSE-450::Motesanib
LN-405::ZM447439
H9::Foretinib
COR-L321::Dabrafenib
D-423MG::Avagacestat
Saos-2::Osimertinib
VA-ES-BJ::Dabrafenib
Ca-Ski::Osimertinib
NCI-H520::Telomerase Inhibitor IX
CFPAC-1::Dabrafenib
MOLM-13::Osimertinib
GI-ME-N::Sepantronium bromide
SK-UT-1::I-BRD9
A498::Telomerase Inhibitor IX
MLMA::XAV939
MS-1::Osimertinib
NCI-H146::BX795
IST-SL1::AZD7762
CL-11::Telomerase Inhibitor IX
CML-T1::AGI-6780
U031::XAV939
42-MG-BA::Osimertinib
SCC-9::VX-11e
BHT-101::XAV939
SCC-4::ZM447439
NCI-H1734::ZM447439
EW-18::Sepantronium bromide
IST-SL1::Sepantronium bromide
RH-1::ZM447439
OVTOKO::Afatinib
OV-90::Sepantronium bromide
RCC10RGB::Sepantronium bromide
TE-5::Avagacestat
SUIT-2::Sepantronium bromide
RPMI-8226::Telomerase Inhibitor IX
ATN-1::Avagacestat
AU565::Motesanib
UMC-11::Avagacestat
IST-SL2::Cediranib
COR-L32::Telomerase Inhibitor IX
JEG-3::I-BRD9
5637::Afatinib
GA-10::I-BRD9
JHH-2::Cediranib
639-V::AZD7762
SNU-C5::Foretinib
CAL-120::AGI-6780
MG-63::VX-11e
COLO-783::Motesanib
CAPAN-1::Motesanib
EW-3::Osimertinib
HCC1599::Dabrafenib
THP-1::Motesanib
D-263MG::Alisertib
NCI-H661::Motesanib
LB1047-RCC::Telomerase Inhibitor IX
HEC-1::Foretinib
KYM-1::XAV939
KP-2::Osimertinib
NB(TU)1-10::I-BRD9
THP-1::Alisertib
HCC1419::Sepantronium bromide
COLO-205::XAV939
THP-1::Doramapimod
MFH-ino::Avagacestat
SU-DHL-8::AZD7762
BFTC-909::Telomerase Inhibitor IX
SLVL::MK-8776
COLO-792::Cediranib
BICR78::Alisertib
SK-MEL-3::Afatinib
CAL-72::Osimertinib
HSC-3::Motesanib
LS-123::Dabrafenib
TE-8::Dabrafenib
NCI-H2347::Telomerase Inhibitor IX
EFM-19::XAV939
SK-OV-3::XAV939
IST-SL1::Dabrafenib
EFM-192A::XAV939
NCI-H661::XAV939
COLO-679::AGI-6780
NCI-H1693::I-BRD9
8-MG-BA::Dabrafenib
EW-1::Alisertib
KNS-62::AGI-6780
HH::I-BRD9
HeLa::Sepantronium bromide
NB6::Foretinib
NCI-H1688::Telomerase Inhibitor IX
SCH::Avagacestat
NOS-1::MK-8776
LC-2-ad::MK-8776
TGBC1TKB::Foretinib
A172::VX-11e
KYAE-1::Alisertib
T-T::ZM447439
NCI-H2172::ZM447439
COR-L303::ZM447439
MOG-G-UVW::Sepantronium bromide
U031::Avagacestat
KOPN-8::Dabrafenib
HOP-92::Alisertib
SNU-81::BX795
HOP-62::AZD7762
SiHa::Avagacestat
BONNA-12::Cediranib
SW1271::AGI-6780
SNU-449::Cediranib
SK-N-FI::MK-8776
EPLC-272H::Sepantronium bromide
C3A::Telomerase Inhibitor IX
IGR-1::Foretinib
MOLT-16::I-BRD9
COLO-684::I-BRD9
MEL-JUSO::Afatinib
OE21::Cediranib
5637::Osimertinib
RPMI-8226::ZM447439
A427::ZM447439
TE-4::Avagacestat
BT-20::AGI-6780
BICR22::MK-8776
EB2::Doramapimod
LNCaP-Clone-FGC::Doramapimod
HCC-44::Motesanib
NCI-H1793::XAV939
NUGC-3::Dabrafenib
NCI-H2052::ZM447439
BONNA-12::BX795
OV-7::Cediranib
TGBC1TKB::MK-8776
NCI-H1734::Doramapimod
COLO-320-HSR::Foretinib
NCI-H2122::Alisertib
Ca9-22::Sepantronium bromide
KP-2::Avagacestat
WSU-NHL::AGI-6780
NCI-H650::Foretinib
CAL-12T::Osimertinib
COR-L321::BX795
KE-37::Foretinib
KU812::MK-8776
RCC-JW::VX-11e
MOLT-13::XAV939
SW1088::Foretinib
HSC-39::AZD7762
NCI-H2023::AZD7762
NCI-H3122::XAV939
IHH-4::ZM447439
CP50-MEL-B::I-BRD9
LB771-HNC::ZM447439
GAMG::VX-11e
SNU-387::Motesanib
SK-LU-1::Telomerase Inhibitor IX
NCC010::Motesanib
RCC-AB::Alisertib
NCI-H510A::I-BRD9
SW1990::Afatinib
NB10::Afatinib
J82::Afatinib
GI-ME-N::Motesanib
HT-3::I-BRD9
KYAE-1::Foretinib
MHH-CALL-4::Motesanib
C-4-I::XAV939
G-401::ZM447439
NCI-H1781::Dabrafenib
ES4::AZD7762
MEL-HO::Foretinib
TT2609-C02::Avagacestat
RD::AZD7762
SCC-25::Afatinib
H3255::Alisertib
LAN-6::Dabrafenib
COR-L321::Alisertib
YT::Alisertib
MOLP-8::MK-8776
SJRH30::MK-8776
HT-1080::Osimertinib
EB2::Alisertib
HCC-827::Foretinib
Ca-Ski::Avagacestat
ES7::Avagacestat
CTV-1::MK-8776
TK::MK-8776
Mo-T::Alisertib
C2BBe1::AGI-6780
NCI-H2172::Dabrafenib
MHH-NB-11::Alisertib
NCI-H1975::Avagacestat
WSU-DLCL2::AZD7762
NCI-H1341::ZM447439
LN-229::Osimertinib
RD::Avagacestat
SK-GT-2::Dabrafenib
Hs-578-T::Foretinib
DB::Alisertib
DG-75::Avagacestat
SCC-9::Motesanib
ES5::AGI-6780
NCI-H1915::ZM447439
KYSE-180::MK-8776
NCI-H358::XAV939
COLO-680N::ZM447439
SW1783::AZD7762
OC-314::Motesanib
D-542MG::Alisertib
SW1116::Alisertib
OCI-LY-19::BX795
HSC-3::Avagacestat
A4-Fuk::Doramapimod
RKO::XAV939
BE-13::Alisertib
NCI-H209::XAV939
EMC-BAC-1::Avagacestat
HCC1143::Dabrafenib
NCI-H2030::I-BRD9
SKM-1::Sepantronium bromide
TGW::AZD7762
ESS-1::Dabrafenib
CAL-120::Telomerase Inhibitor IX
EFO-21::Doramapimod
H4::AZD7762
FTC-133::MK-8776
EFO-27::BX795
MZ1-PC::Foretinib
MZ2-MEL::AZD7762
NCI-H650::Dabrafenib
Calu-6::Telomerase Inhibitor IX
JHOS-2::BX795
T47D::VX-11e
NCI-H69::Osimertinib
NCI-H2135::AGI-6780
EPLC-272H::ZM447439
CP50-MEL-B::Osimertinib
RD::Alisertib
IST-MEL1::Dabrafenib
BPH-1::VX-11e
NCI-H1048::Telomerase Inhibitor IX
HDLM-2::Sepantronium bromide
A3-KAW::XAV939
HuP-T3::Avagacestat
KARPAS-422::XAV939
SK-LU-1::AZD7762
D-283MED::Doramapimod
OCI-LY7::MK-8776
TE-10::ZM447439
NCI-H1299::AZD7762
SK-MEL-1::Avagacestat
DBTRG-05MG::AGI-6780
BT-474::Afatinib
C32::AZD7762
COR-L311::Alisertib
KE-37::MK-8776
SW837::Doramapimod
SUP-M2::ZM447439
ALL-SIL::MK-8776
C2BBe1::Dabrafenib
NCI-H2452::Alisertib
SAT::Cediranib
SU-DHL-16::XAV939
NCI-H1435::Osimertinib
DBTRG-05MG::Cediranib
OVK-18::Foretinib
OCUM-1::Sepantronium bromide
SNU-387::Dabrafenib
NCI-H1651::Dabrafenib
IST-MEL1::Avagacestat
GOTO::Cediranib
DND-41::AZD7762
HLE::AGI-6780
ME-180::Afatinib
SNU-423::Afatinib
YAPC::XAV939
HCC-78::Dabrafenib
KASUMI-1::AZD7762
CTB-1::Cediranib
HCC1419::Cediranib
JHH-6::Alisertib
Calu-6::Foretinib
HARA::Motesanib
OE33::Sepantronium bromide
NCI-H211::Dabrafenib
GB-1::Motesanib
HCC1143::Alisertib
MHH-NB-11::Foretinib
KINGS-1::Foretinib
NCI-H740::AGI-6780
TE-1::I-BRD9
DU-145::Doramapimod
NCI-H1648::I-BRD9
22RV1::Avagacestat
C32::Motesanib
FLO-1::Alisertib
MDA-MB-157::Osimertinib
T-T::AZD7762
D-247MG::XAV939
HSC-2::Motesanib
CW-2::Cediranib
TE-15::Motesanib
NCI-H1836::Foretinib
EW-3::MK-8776
KARPAS-45::ZM447439
SNU-423::Dabrafenib
LU-65::XAV939
BHY::Avagacestat
MFE-319::Telomerase Inhibitor IX
HuO9::AZD7762
LC4-1::Osimertinib
NCI-H1836::AZD7762
KYSE-220::MK-8776
MRK-nu-1::Motesanib
DMS-79::Afatinib
OV-56::Osimertinib
SNU-C1::Avagacestat
HSC-3::XAV939
HO-1-N-1::Dabrafenib
SNU-81::Alisertib
ESS-1::Foretinib
SH-4::AGI-6780
CAL-78::Cediranib
HCC2157::VX-11e
FLO-1::Telomerase Inhibitor IX
HCC1143::ZM447439
SNU-423::Foretinib
T98G::Avagacestat
697::MK-8776
5637::Alisertib
MDA-MB-453::Foretinib
PF-382::ZM447439
Mewo::Sepantronium bromide
JEKO-1::Avagacestat
HCT-116::ZM447439
NCI-H209::MK-8776
SNG-M::ZM447439
no-11::Afatinib
ESO26::Sepantronium bromide
ABC-1::Afatinib
LC-2-ad::Doramapimod
SCC-3::ZM447439
OVCAR-3::Doramapimod
HT-144::Sepantronium bromide
MPP-89::Alisertib
BPH-1::Foretinib
SKM-1::I-BRD9
MDA-MB-436::I-BRD9
KNS-81-FD::Dabrafenib
SU8686::ZM447439
IST-MES1::Afatinib
EW-22::Telomerase Inhibitor IX
DoTc2-4510::Foretinib
LNCaP-Clone-FGC::Sepantronium bromide
SK-MEL-28::ZM447439
NCI-H250::Telomerase Inhibitor IX
LS-513::Motesanib
SK-OV-3::Dabrafenib
NCI-H1734::XAV939
RCC-AB::Osimertinib
CAL-27::Cediranib
DND-41::Avagacestat
MDA-MB-436::ZM447439
A431::Dabrafenib
MOG-G-CCM::Avagacestat
MFM-223::VX-11e
RH-1::I-BRD9
SK-N-DZ::Avagacestat
COR-L311::VX-11e
LB831-BLC::AZD7762
KY821::Afatinib
OVISE::Dabrafenib
TE-9::Osimertinib
NCI-H660::Motesanib
Hs-445::I-BRD9
U-698-M::XAV939
RKN::Alisertib
NCI-H209::Doramapimod
HA7-RCC::Motesanib
22RV1::AGI-6780
ESO26::Osimertinib
ECC10::VX-11e
KP-4::Foretinib
NCCIT::I-BRD9
SKN-3::ZM447439
SW1116::Avagacestat
D-542MG::Dabrafenib
JSC-1::Alisertib
SK-MEL-31::Foretinib
C2BBe1::Osimertinib
451Lu::Dabrafenib
MC116::MK-8776
MKN1::AGI-6780
HCC-44::AZD7762
A673::I-BRD9
RPMI-8402::ZM447439
MOLM-13::ZM447439
HO-1-u-1::Dabrafenib
NY::Telomerase Inhibitor IX
MHH-CALL-2::MK-8776
SAS::Sepantronium bromide
SN12C::ZM447439
TE-441-T::Dabrafenib
KARPAS-620::Motesanib
HuH-7::I-BRD9
AM-38::ZM447439
HT-1376::Motesanib
HT-1197::Sepantronium bromide
RL::Osimertinib
SW954::Motesanib
MIA-PaCa-2::Osimertinib
LS-1034::Alisertib
KYSE-510::XAV939
LN-229::AZD7762
NCI-H345::AZD7762
L-428::Telomerase Inhibitor IX
KGN::VX-11e
ECC12::XAV939
RVH-421::Osimertinib
NCI-H1568::Cediranib
HEL::Cediranib
OSC-20::Avagacestat
WSU-DLCL2::Motesanib
NCI-H720::Cediranib
NCI-H69::I-BRD9
M059J::Foretinib
SU8686::XAV939
RCC-FG2::Doramapimod
EB2::Foretinib
NCI-H1734::BX795
PANC-04-03::Osimertinib
LB2518-MEL::Afatinib
SKN::VX-11e
KE-37::I-BRD9
MZ2-MEL::BX795
EBC-1::Alisertib
NB10::Sepantronium bromide
U-118-MG::Afatinib
NCI-H2029::Osimertinib
MSTO-211H::ZM447439
TC-71::I-BRD9
MFE-319::Afatinib
NB6::Alisertib
KM12::Dabrafenib
SF295::XAV939
GDM-1::Sepantronium bromide
KYM-1::AZD7762
TE-441-T::Sepantronium bromide
NCI-H747::Doramapimod
KLE::Motesanib
C-4-I::Doramapimod
SW962::Osimertinib
huH-1::MK-8776
OCI-LY7::Afatinib
COLO-829::MK-8776
NCI-H2444::Telomerase Inhibitor IX
SF539::I-BRD9
MOG-G-UVW::Doramapimod
HCC1954::Avagacestat
NCI-H2227::Avagacestat
PC-14::MK-8776
OVK-18::Motesanib
IM-95::Alisertib
OE33::ZM447439
KALS-1::VX-11e
CAL-12T::XAV939
LS-1034::MK-8776
RERF-LC-Sq1::Dabrafenib
HCC1428::ZM447439
HSC-2::Telomerase Inhibitor IX
ESO51::XAV939
RCC-JF::Cediranib
KLE::Cediranib
EB2::VX-11e
LAN-6::Alisertib
HCE-4::ZM447439
NCI-H929::XAV939
CP66-MEL::XAV939
NCI-H1436::BX795
CTB-1::Osimertinib
A673::Osimertinib
CAL-62::VX-11e
MZ2-MEL::AGI-6780
COLO-684::Avagacestat
TE-12::I-BRD9
NOS-1::Motesanib
SK-HEP-1::AGI-6780
Hs-445::Foretinib
KYSE-70::Osimertinib
HT-144::Motesanib
SKN-3::Doramapimod
JM1::Cediranib
SK-N-SH::Telomerase Inhibitor IX
UMC-11::I-BRD9
VMRC-RCZ::Telomerase Inhibitor IX
HO-1-N-1::I-BRD9
PWR-1E::Foretinib
JHU-029::ZM447439
ZR-75-30::AZD7762
PCI-6A::Cediranib
BT-549::Doramapimod
SR::Foretinib
KYSE-410::Foretinib
NCI-H740::AZD7762
TE-12::BX795
RC-K8::Doramapimod
NCI-H1355::Cediranib
A375::AZD7762
BHT-101::Telomerase Inhibitor IX
RCC-JW::Afatinib
MCF7::Telomerase Inhibitor IX
TE-441-T::XAV939
KG-1::Cediranib
PEO1::VX-11e
HOP-92::Avagacestat
SW626::MK-8776
PC-14::I-BRD9
LAN-6::VX-11e
G-MEL::Motesanib
OCUB-M::Afatinib
HT-1080::Motesanib
WM278::MK-8776
OSC-19::MK-8776
WM278::ZM447439
Daudi::XAV939
SK-HEP-1::VX-11e
YT::MK-8776
NB13::Motesanib
KP-4::Motesanib
HT-1376::Afatinib
L-1236::Alisertib
RMG-I::MK-8776
LU-135::Avagacestat
SW1088::MK-8776
HCC1500::VX-11e
PWR-1E::Avagacestat
LB771-HNC::Telomerase Inhibitor IX
ACHN::Osimertinib
SHP-77::Doramapimod
HPAF-II::AZD7762
CHSA0108::Dabrafenib
MZ1-PC::VX-11e
NCI-H841::Cediranib
HMV-II::Dabrafenib
CaR-1::Sepantronium bromide
DOV13::AZD7762
DMS-79::Telomerase Inhibitor IX
Mewo::ZM447439
HuP-T4::Sepantronium bromide
MKN7::Avagacestat
SF126::AZD7762
L-540::ZM447439
D-247MG::AGI-6780
KG-1::Sepantronium bromide
NCI-H716::Telomerase Inhibitor IX
NB1::Telomerase Inhibitor IX
K5::VX-11e
LC4-1::VX-11e
UACC-62::AZD7762
HCC70::Sepantronium bromide
HO-1-u-1::Avagacestat
LS-411N::I-BRD9
U-266::XAV939
ECC12::Osimertinib
M059J::Telomerase Inhibitor IX
SKM-1::Alisertib
KYSE-140::Doramapimod
WM1552C::Dabrafenib
RCC-FG2::Telomerase Inhibitor IX
MDA-MB-361::MK-8776
BICR22::Motesanib
JSC-1::Telomerase Inhibitor IX
TE-12::Motesanib
U031::Doramapimod
HCC1806::Alisertib
CADO-ES1::Dabrafenib
BHY::Osimertinib
OCI-M1::VX-11e
ONS-76::VX-11e
DMS-79::I-BRD9
GP5d::Motesanib
HCC70::MK-8776
SU-DHL-5::Cediranib
A204::MK-8776
HT-115::I-BRD9
PANC-08-13::Foretinib
NALM-6::Afatinib
NCI-H2009::VX-11e
WIL2-NS::Foretinib
WM1552C::I-BRD9
LOU-NH91::VX-11e
NB6::ZM447439
NCI-H2066::ZM447439
NB1::Doramapimod
Ca-Ski::Telomerase Inhibitor IX
COR-L279::Afatinib
CRO-AP2::Doramapimod
SUIT-2::I-BRD9
NCI-H1838::Alisertib
Becker::Sepantronium bromide
42-MG-BA::Cediranib
NCI-H23::Cediranib
D-502MG::Motesanib
IST-SL1::Foretinib
A498::XAV939
NCI-H2444::Foretinib
A704::Foretinib
OV-90::XAV939
A704::MK-8776
LU-65::Sepantronium bromide
KARPAS-299::VX-11e
LN-18::Sepantronium bromide
NCI-H526::Afatinib
UWB1.289::XAV939
MS-1::Avagacestat
COLO-668::Alisertib
KU-19-19::Dabrafenib
IST-MES1::I-BRD9
BT-20::Motesanib
LB996-RCC::Alisertib
22RV1::Afatinib
RKO::AGI-6780
MDA-MB-453::VX-11e
SW1116::Cediranib
LC4-1::XAV939
NCI-H345::Telomerase Inhibitor IX
PFSK-1::Doramapimod
KNS-81-FD::Motesanib
EFO-27::Cediranib
A2058::Dabrafenib
ZR-75-30::MK-8776
NCI-H1838::VX-11e
TGBC11TKB::Osimertinib
WM35::ZM447439
RD::MK-8776
HOS::AGI-6780
NALM-6::Avagacestat
GOTO::Motesanib
C32::I-BRD9
KELLY::ZM447439
MOLT-16::ZM447439
LOU-NH91::AZD7762
KYSE-450::Avagacestat
LB2241-RCC::MK-8776
LN-229::Motesanib
ROS-50::Doramapimod
NCI-H660::Telomerase Inhibitor IX
NCI-H1341::Osimertinib
OC-314::Cediranib
DOV13::Doramapimod
BALL-1::Motesanib
ML-2::ZM447439
BHT-101::Sepantronium bromide
EW-16::AGI-6780
LC-2-ad::AGI-6780
SR::MK-8776
ES-2::AZD7762
HT-1376::Telomerase Inhibitor IX
SN12C::AZD7762
KYSE-450::Dabrafenib
NCI-H1568::ZM447439
SKG-IIIa::AZD7762
Raji::Osimertinib
NOMO-1::MK-8776
A172::Avagacestat
OVK-18::Cediranib
SK-MEL-2::Cediranib
COLO-783::Avagacestat
MDA-MB-330::BX795
PC-14::Telomerase Inhibitor IX
SAS::I-BRD9
LS-123::Motesanib
CAL-72::MK-8776
MKN1::Osimertinib
AMO-1::Doramapimod
OCUM-1::AZD7762
SKG-IIIa::Telomerase Inhibitor IX
NCI-H69::VX-11e
NCI-H1734::Avagacestat
COR-L95::Avagacestat
IGROV-1::Sepantronium bromide
RCC-JF::AZD7762
KNS-42::BX795
SW48::Doramapimod
T84::Osimertinib
MOG-G-UVW::AZD7762
RERF-LC-MS::Telomerase Inhibitor IX
DOK::ZM447439
G-402::XAV939
A549::Afatinib
A4-Fuk::Dabrafenib
C3A::ZM447439
no-11::XAV939
NCI-H1651::Osimertinib
EW-13::AGI-6780
A172::I-BRD9
LS-1034::AZD7762
CAL-12T::Telomerase Inhibitor IX
NB12::Dabrafenib
TE-11::Doramapimod
NCI-H1770::ZM447439
ARH-77::Motesanib
NCI-H1793::Afatinib
AsPC-1::ZM447439
SU-DHL-10::I-BRD9
MOLT-4::Avagacestat
SNU-C1::I-BRD9
NH-12::Cediranib
BC-1::ZM447439
CAL-29::Doramapimod
NCI-H1568::XAV939
CW-2::Avagacestat
RCC10RGB::Motesanib
DU-4475::Alisertib
UACC-893::AZD7762
RKO::Sepantronium bromide
SCC-9::Foretinib
NCI-H1648::Dabrafenib
NCI-H1793::Motesanib
VMRC-RCZ::Motesanib
ONS-76::I-BRD9
SK-LU-1::Alisertib
SW1463::Motesanib
MDST8::Alisertib
RMG-I::I-BRD9
SU-DHL-16::Dabrafenib
EFM-19::Osimertinib
CAL-78::I-BRD9
HT-115::VX-11e
NCI-H2444::Cediranib
K2::XAV939
Ca-Ski::AGI-6780
U-266::Sepantronium bromide
SH-4::Avagacestat
OACp4C::Cediranib
AN3-CA::Osimertinib
RVH-421::Cediranib
HCE-4::Telomerase Inhibitor IX
KYSE-270::Foretinib
HuH-7::Alisertib
D-336MG::Afatinib
HSC-39::Alisertib
NB5::Dabrafenib
BE-13::Telomerase Inhibitor IX
RVH-421::MK-8776
A101D::Foretinib
BV-173::Alisertib
HOP-92::VX-11e
BONNA-12::Foretinib
KYSE-520::Avagacestat
JJN-3::Telomerase Inhibitor IX
A427::Foretinib
OCI-AML5::Avagacestat
huH-1::Afatinib
NCI-H2135::Dabrafenib
HT55::XAV939
MOLM-13::Sepantronium bromide
NCI-H929::Telomerase Inhibitor IX
NH-12::Sepantronium bromide
SIG-M5::AGI-6780
OAW-28::Avagacestat
OVMIU::Cediranib
IA-LM::AGI-6780
NB69::Avagacestat
LU-65::Cediranib
NCC010::Sepantronium bromide
PANC-04-03::VX-11e
BB30-HNC::AZD7762
BFTC-905::Osimertinib
CHSA0108::Motesanib
CHP-126::Sepantronium bromide
SW684::Foretinib
KARPAS-231::Avagacestat
HCC-366::ZM447439
GRANTA-519::AGI-6780
CAL-29::AZD7762
ETK-1::Motesanib
HDQ-P1::Telomerase Inhibitor IX
NCI-H520::AZD7762
GOTO::Dabrafenib
HTC-C3::AZD7762
EFM-192A::Foretinib
NCI-H1573::AZD7762
SW48::MK-8776
SH-4::Motesanib
SW1573::Dabrafenib
COR-L279::Telomerase Inhibitor IX
A498::Motesanib
KP-N-YN::AGI-6780
NCI-H2405::Avagacestat
SR::Cediranib
A388::Alisertib
BB30-HNC::Alisertib
NCI-H1793::AZD7762
EW-7::VX-11e
UWB1.289::Afatinib
MFE-319::Sepantronium bromide
D-247MG::I-BRD9
LOUCY::Sepantronium bromide
UACC-812::Telomerase Inhibitor IX
BB30-HNC::XAV939
PCI-15A::AGI-6780
SUP-B8::MK-8776
HuP-T3::AGI-6780
BEN::I-BRD9
ML-2::Telomerase Inhibitor IX
REH::Foretinib
CHSA8926::Telomerase Inhibitor IX
EW-7::AGI-6780
OVKATE::ZM447439
NCI-H1299::ZM447439
SK-MEL-24::Foretinib
ECC10::Doramapimod
HO-1-u-1::Cediranib
SNG-M::Telomerase Inhibitor IX
SW684::I-BRD9
EW-24::Sepantronium bromide
KMRC-1::Dabrafenib
CAL-33::Foretinib
UACC-257::Osimertinib
MHH-CALL-4::Afatinib
DMS-114::AZD7762
PC-3::Sepantronium bromide
NCI-H2066::Cediranib
SUP-M2::Afatinib
DND-41::Osimertinib
LAMA-84::Avagacestat
KASUMI-1::MK-8776
COLO-668::Motesanib
C2BBe1::Alisertib
TYK-nu::VX-11e
NCI-H446::Cediranib
MDA-MB-468::Cediranib
HSC-3::AGI-6780
GCT::MK-8776
SW156::XAV939
L-428::Afatinib
LS-1034::Afatinib
NCI-H596::MK-8776
HAL-01::Afatinib
LS-123::Afatinib
EoL-1-cell::Dabrafenib
MHH-NB-11::AZD7762
UACC-62::Alisertib
HT-115::MK-8776
HT-144::Telomerase Inhibitor IX
NCI-H720::I-BRD9
LAN-6::BX795
D-336MG::AZD7762
CAPAN-1::Foretinib
HCE-4::XAV939
TT2609-C02::Dabrafenib
BEN::Cediranib
RERF-LC-MS::ZM447439
TC-71::ZM447439
SNU-423::Sepantronium bromide
SBC-3::Alisertib
639-V::Sepantronium bromide
NCI-H1435::Doramapimod
SBC-1::BX795
KARPAS-1106P::Cediranib
NB(TU)1-10::XAV939
FU-OV-1::Sepantronium bromide
RCC-JW::AGI-6780
NCI-H64::AZD7762
BT-549::Osimertinib
NCI-H847::Osimertinib
Ca-Ski::Motesanib
NCC021::Doramapimod
SHP-77::AGI-6780
TE-9::Motesanib
KU812::Motesanib
Ramos-2G6-4C10::MK-8776
SCH::Osimertinib
SIMA::Alisertib
JHH-4::MK-8776
NCI-H1092::Dabrafenib
BT-20::AZD7762
NCI-H1770::Avagacestat
KP-2::AZD7762
MDA-MB-361::Osimertinib
ASH-3::Alisertib
SUP-M2::Osimertinib
CTV-1::AGI-6780
COLO-205::Dabrafenib
DMS-114::Alisertib
H3255::Cediranib
NCI-H2141::ZM447439
NH-12::Dabrafenib
SK-OV-3::Osimertinib
ME-180::AGI-6780
FLO-1::Osimertinib
SW1990::Foretinib
PL4::Avagacestat
NCI-H1770::AGI-6780
HCC-15::Avagacestat
SW1573::Cediranib
RCC10RGB::Alisertib
KARPAS-620::Avagacestat
NCCIT::Doramapimod
MOLP-8::I-BRD9
COLO-824::Afatinib
AM-38::AGI-6780
MHH-CALL-4::AZD7762
NB10::Alisertib
ESS-1::XAV939
A253::Alisertib
NCI-H1836::Doramapimod
SK-GT-4::Avagacestat
KU812::XAV939
LB647-SCLC::Dabrafenib
Detroit562::XAV939
HuP-T3::Dabrafenib
LS-513::Afatinib
KYSE-410::AGI-6780
CW-2::Telomerase Inhibitor IX
JVM-3::AZD7762
LB373-MEL-D::ZM447439
SW962::AGI-6780
RERF-LC-MS::AZD7762
NCI-H810::VX-11e
NCI-H250::XAV939
RPMI-6666::XAV939
NMC-G1::MK-8776
TOV-21G::Cediranib
MKN28::MK-8776
IM-9::Doramapimod
NCI-H2347::I-BRD9
MPP-89::Dabrafenib
CAL-78::MK-8776
KNS-42::Cediranib
RERF-GC-1B::AGI-6780
NCC021::AZD7762
NB7::MK-8776
CRO-AP2::Osimertinib
A388::BX795
NCI-H647::Motesanib
NCI-H650::Alisertib
SK-MM-2::AGI-6780
MS751::MK-8776
NCI-H1435::Sepantronium bromide
SW1116::Sepantronium bromide
EW-18::Doramapimod
MV-4-11::Doramapimod
NCI-H1694::ZM447439
CCRF-CEM::VX-11e
NCI-H226::MK-8776
HPAC::Motesanib
A204::AZD7762
NCI-H1993::Foretinib
LB771-HNC::Dabrafenib
LK-2::Dabrafenib
SNG-M::Sepantronium bromide
Ramos-2G6-4C10::Sepantronium bromide
HCC1428::Osimertinib
MS-1::VX-11e
SK-MES-1::Cediranib
SU-DHL-10::ZM447439
PSN1::Alisertib
SCC-15::Doramapimod
NCI-H2405::Motesanib
G-MEL::Sepantronium bromide
NCI-H1048::Osimertinib
OVCA420::MK-8776
HCC-366::MK-8776
NCI-H441::Doramapimod
Hs-578-T::I-BRD9
CAL-54::Foretinib
SIG-M5::MK-8776
NCI-H1581::XAV939
D-336MG::BX795
ES8::Alisertib
AU565::MK-8776
HOP-92::MK-8776
DMS-79::Osimertinib
SK-MEL-2::Osimertinib
JHH-4::Foretinib
SIMA::Dabrafenib
H9::VX-11e
NCC021::XAV939
CAL-39::MK-8776
D-502MG::I-BRD9
CL-11::Doramapimod
NB69::XAV939
D-247MG::Motesanib
NCI-H810::MK-8776
OV-7::Avagacestat
NCI-H838::Cediranib
DEL::I-BRD9
639-V::Alisertib
HCC2998::I-BRD9
NALM-6::Osimertinib
NCI-H1755::ZM447439
BICR22::I-BRD9
LP-1::ZM447439
DMS-114::XAV939
PA-TU-8902::Avagacestat
SHP-77::Motesanib
HCC1806::Cediranib
MHH-CALL-4::XAV939
A2058::I-BRD9
MHH-PREB-1::Cediranib
CHSA8926::AZD7762
Mewo::Motesanib
NCI-H2172::I-BRD9
NCI-H1299::Doramapimod
MDA-MB-361::Sepantronium bromide
NCI-H64::Cediranib
SCH::Dabrafenib
KP-2::I-BRD9
D-423MG::XAV939
KOSC-2::Dabrafenib
PL-21::Sepantronium bromide
KOSC-2::MK-8776
OVK-18::Sepantronium bromide
EVSA-T::I-BRD9
ES-2::VX-11e
TC-71::Cediranib
HSC-4::Telomerase Inhibitor IX
GCT::ZM447439
WM278::Cediranib
GB-1::Avagacestat
ECC12::AGI-6780
KP-4::VX-11e
PCI-4B::Dabrafenib
NEC8::VX-11e
SK-N-FI::Motesanib
PANC-10-05::Avagacestat
SNU-398::Motesanib
NCI-H28::Sepantronium bromide
NCI-H835::Alisertib
A388::AGI-6780
A2780::XAV939
G-MEL::AGI-6780
NCI-H2172::Telomerase Inhibitor IX
ML-2::Doramapimod
A388::Osimertinib
CFPAC-1::Sepantronium bromide
CAL-33::AZD7762
JHOS-2::AGI-6780
KS-1::Telomerase Inhibitor IX
OAW-28::Foretinib
SK-MEL-3::Alisertib
NCI-H3122::Osimertinib
SK-N-AS::Afatinib
SK-GT-2::Telomerase Inhibitor IX
Mewo::MK-8776
EW-1::Afatinib
COLO-783::MK-8776
NCI-H2141::XAV939
SK-MM-2::VX-11e
MZ7-mel::Cediranib
RVH-421::Dabrafenib
C3A::Doramapimod
HCC1954::Sepantronium bromide
HTC-C3::Motesanib
EC-GI-10::Motesanib
NCI-H1963::Osimertinib
KATOIII::VX-11e
RC-K8::Alisertib
NCI-H661::Avagacestat
MFM-223::AGI-6780
RF-48::Cediranib
BICR31::Sepantronium bromide
A388::Sepantronium bromide
CTB-1::Doramapimod
RC-K8::MK-8776
IGR-1::Osimertinib
NCI-H1563::Cediranib
NB12::Sepantronium bromide
YAPC::Telomerase Inhibitor IX
PSN1::ZM447439
DOHH-2::Doramapimod
NCI-H526::Cediranib
NCI-H661::AZD7762
SK-UT-1::Afatinib
LOUCY::Osimertinib
JJN-3::Afatinib
NCI-H1666::XAV939
D-336MG::VX-11e
LB647-SCLC::Telomerase Inhibitor IX
SW1710::MK-8776
NCI-H1944::AZD7762
HAL-01::I-BRD9
BICR31::Foretinib
PA-TU-8988T::Doramapimod
HT-3::AGI-6780
BFTC-905::Cediranib
NCI-H2023::Doramapimod
KYSE-150::Afatinib
DMS-53::ZM447439
NB7::ZM447439
D-336MG::Avagacestat
JHU-022::Afatinib
SCC-4::Foretinib
PANC-04-03::Dabrafenib
GI-ME-N::XAV939
EW-18::XAV939
LOU-NH91::Telomerase Inhibitor IX
RVH-421::VX-11e
COLO-678::Telomerase Inhibitor IX
LXF-289::Foretinib
DJM-1::ZM447439
RCC-AB::BX795
A549::VX-11e
HOP-62::Cediranib
DMS-273::VX-11e
NCI-H2227::ZM447439
SJRH30::Dabrafenib
KYSE-70::Afatinib
NCI-H345::Sepantronium bromide
ES5::I-BRD9
HCC1419::Alisertib
TGBC1TKB::ZM447439
CAPAN-1::Alisertib
KNS-42::Foretinib
TC-71::Foretinib
LU-139::Avagacestat
LS-513::XAV939
DB::Sepantronium bromide
EMC-BAC-2::AZD7762
SK-PN-DW::Sepantronium bromide
769-P::ZM447439
LC-1-sq::Doramapimod
RPMI-7951::AGI-6780
NB69::Doramapimod
CAL-148::MK-8776
NCI-H2342::VX-11e
A4-Fuk::Osimertinib
SK-HEP-1::I-BRD9
MEL-HO::AGI-6780
HA7-RCC::XAV939
NCI-H1993::AZD7762
639-V::Afatinib
EC-GI-10::MK-8776
KYSE-270::Osimertinib
CAL-85-1::Foretinib
RERF-LC-KJ::Telomerase Inhibitor IX
SW1783::MK-8776
NCI-H292::MK-8776
TE-11::I-BRD9
HCC-44::Cediranib
JVM-2::XAV939
LB373-MEL-D::VX-11e
JHH-6::AGI-6780
MFE-319::XAV939
WM1552C::Motesanib
SK-MEL-31::VX-11e
H4::AGI-6780
UMC-11::Cediranib
NCI-H1623::Cediranib
CHSA0011::MK-8776
C-4-I::Telomerase Inhibitor IX
TE-6::Cediranib
NCI-H1793::I-BRD9
KNS-81-FD::Foretinib
CAL-29::Afatinib
SKG-IIIa::Dabrafenib
SN12C::XAV939
KINGS-1::Afatinib
KYAE-1::VX-11e
KELLY::Afatinib
NUGC-4::Cediranib
769-P::Osimertinib
NCI-H1869::I-BRD9
EPLC-272H::Alisertib
BEN::Doramapimod
647-V::AZD7762
NCI-H2030::Telomerase Inhibitor IX
SBC-5::ZM447439
JIMT-1::Osimertinib
GAMG::AGI-6780
KYSE-450::Alisertib
RT4::Motesanib
WSU-NHL::Cediranib
MONO-MAC-6::Foretinib
C3A::Dabrafenib
23132-87::AZD7762
NALM-6::Foretinib
SKG-IIIa::Sepantronium bromide
UMC-11::VX-11e
KMS-12-BM::Telomerase Inhibitor IX
SU-DHL-16::MK-8776
NCI-H740::Motesanib
MZ2-MEL::ZM447439
ETK-1::Cediranib
ECC10::Avagacestat
SNU-398::I-BRD9
EW-24::XAV939
VAL::Afatinib
Daudi::Doramapimod
OVCAR-8::Osimertinib
NCI-H929::MK-8776
451Lu::Sepantronium bromide
SLVL::XAV939
NCI-H747::Foretinib
ES8::AZD7762
HCC2998::MK-8776
KMRC-1::Osimertinib
DJM-1::I-BRD9
SAT::Telomerase Inhibitor IX
PL-21::ZM447439
JiyoyeP-2003::Sepantronium bromide
H4::Motesanib
RCC10RGB::Avagacestat
COR-L321::Motesanib
SK-MEL-28::Foretinib
Jurkat::I-BRD9
TGW::Dabrafenib
LN-18::Foretinib
G-361::MK-8776
BICR22::VX-11e
RL::ZM447439
NCI-H2087::Dabrafenib
C2BBe1::Telomerase Inhibitor IX
SW1783::Motesanib
EMC-BAC-1::Osimertinib
TT::Alisertib
NCI-H1648::MK-8776
KOPN-8::ZM447439
CHL-1::Telomerase Inhibitor IX
NCI-H2023::I-BRD9
CAL-148::Motesanib
OVISE::VX-11e
SUP-B8::BX795
MLMA::I-BRD9
huH-1::Dabrafenib
NCI-H2452::VX-11e
BB49-HNC::Sepantronium bromide
MKN45::Cediranib
NB7::Osimertinib
COLO-205::Sepantronium bromide
NCI-H510A::AGI-6780
MPP-89::I-BRD9
OV-17R::MK-8776
KG-1::Alisertib
CAL-39::ZM447439
SW626::Foretinib
NCI-H1650::Avagacestat
SUIT-2::Cediranib
LOXIMVI::Afatinib
TE-10::I-BRD9
NCI-H2122::XAV939
D-336MG::Foretinib
IM-9::XAV939
NCI-H82::VX-11e
OVCAR-3::MK-8776
THP-1::BX795
MCF7::Avagacestat
CHP-212::Dabrafenib
HAL-01::Cediranib
786-0::AZD7762
OACM5-1::Doramapimod
COR-L105::Motesanib
KINGS-1::MK-8776
KLE::MK-8776
EMC-BAC-2::Sepantronium bromide
PCI-6A::BX795
NCI-H322M::Sepantronium bromide
CP50-MEL-B::AGI-6780
SNU-398::AZD7762
JHU-029::Avagacestat
KYSE-270::Motesanib
MDA-MB-436::Motesanib
SNU-C1::XAV939
HCC2157::Alisertib
NB(TU)1-10::VX-11e
WIL2-NS::Telomerase Inhibitor IX
SNU-C1::Cediranib
NB69::AZD7762
MDA-MB-157::Dabrafenib
JHH-4::VX-11e
8505C::XAV939
CML-T1::VX-11e
SK-GT-2::Doramapimod
SKN::AGI-6780
RXF393::Motesanib
SIMA::Avagacestat
DJM-1::BX795
CADO-ES1::Cediranib
PA-1::Avagacestat
L-1236::Doramapimod
SCC-4::Telomerase Inhibitor IX
AU565::Sepantronium bromide
A375::BX795
22RV1::Sepantronium bromide
SK-MEL-5::AGI-6780
MONO-MAC-6::Avagacestat
SIMA::Motesanib
Hs-445::Cediranib
CAMA-1::Avagacestat
CW-2::Sepantronium bromide
PC-14::Doramapimod
KS-1::Avagacestat
DOK::Alisertib
SBC-3::Osimertinib
TOV-112D::Motesanib
SIMA::AGI-6780
MC116::VX-11e
JHH-7::Doramapimod
HEL::Afatinib
HTC-C3::Sepantronium bromide
ES5::Foretinib
HCC1143::AZD7762
NCI-H1105::Doramapimod
KNS-81-FD::AGI-6780
MFE-296::Alisertib
NCI-H1993::Cediranib
NCI-H847::I-BRD9
HEL::AZD7762
A549::Osimertinib
CAL-54::Afatinib
Ramos-2G6-4C10::Alisertib
KON::XAV939
GOTO::Telomerase Inhibitor IX
NCI-H1792::Alisertib
SNU-C2B::Avagacestat
MKN7::VX-11e
NCI-H292::VX-11e
CAL-72::Afatinib
NCC021::I-BRD9
HCC2218::Doramapimod
SUP-HD1::AGI-6780
786-0::Motesanib
NCC010::AGI-6780
WSU-NHL::MK-8776
KYM-1::MK-8776
COR-L88::Cediranib
NCI-H2085::ZM447439
HuP-T4::Motesanib
NCI-H1648::Avagacestat
HuO9::Dabrafenib
NB13::Foretinib
SF126::Afatinib
NCI-H838::BX795
UACC-893::Afatinib
NCI-H1092::Avagacestat
TYK-nu::AGI-6780
D-283MED::Alisertib
KP-N-YN::Cediranib
EW-24::Avagacestat
COLO-205::Alisertib
CAL-78::VX-11e
NCI-H446::AZD7762
OCUB-M::VX-11e
MHH-CALL-4::I-BRD9
D-247MG::Osimertinib
DoTc2-4510::Osimertinib
SBC-1::Afatinib
SW1116::Foretinib
LB2241-RCC::VX-11e
769-P::Doramapimod
SISO::AZD7762
NCCIT::Foretinib
SUP-B15::Osimertinib
ONS-76::Doramapimod
PC-3::AGI-6780
TE-5::Telomerase Inhibitor IX
MFE-296::AGI-6780
NU-DUL-1::I-BRD9
NCI-H358::Alisertib
OCI-LY-19::ZM447439
JHOS-4::VX-11e
Daoy::Foretinib
COR-L321::Telomerase Inhibitor IX
EW-11::Foretinib
SCC-25::Sepantronium bromide
ECC10::Cediranib
NB1::Dabrafenib
CHP-126::Afatinib
A375::Sepantronium bromide
LB996-RCC::ZM447439
RERF-GC-1B::Sepantronium bromide
T47D::ZM447439
KU812::Telomerase Inhibitor IX
D-263MG::MK-8776
MDA-MB-415::Foretinib
SW620::Sepantronium bromide
HT-1080::MK-8776
EFM-19::ZM447439
WM-115::XAV939
SK-MM-2::Cediranib
A427::Alisertib
22RV1::Motesanib
NCI-H322M::MK-8776
ROS-50::Motesanib
IA-LM::MK-8776
MIA-PaCa-2::Cediranib
HCC-366::BX795
MRK-nu-1::Telomerase Inhibitor IX
DU-145::AZD7762
CP66-MEL::Avagacestat
RCC-JF::MK-8776
K-562::ZM447439
ME-1::ZM447439
SN12C::Cediranib
NCI-H196::Sepantronium bromide
D-542MG::Afatinib
KMOE-2::I-BRD9
COR-L23::Afatinib
LK-2::Telomerase Inhibitor IX
NCI-H2170::XAV939
ME-180::MK-8776
SW1573::AGI-6780
C3A::Afatinib
RERF-GC-1B::ZM447439
NCI-H2452::Cediranib
IST-SL1::Avagacestat
TGW::Doramapimod
RPMI-7951::I-BRD9
HuH-7::VX-11e
LB771-HNC::Motesanib
LB373-MEL-D::AZD7762
SU-DHL-1::Foretinib
KOSC-2::Cediranib
OE19::AZD7762
SNU-C2B::AGI-6780
NCI-H1693::Avagacestat
GCT::Osimertinib
HCC1395::Cediranib
NMC-G1::Foretinib
NB12::Osimertinib
SK-MEL-24::MK-8776
TC-71::AZD7762
THP-1::AGI-6780
GRANTA-519::Sepantronium bromide
A253::MK-8776
GAK::Sepantronium bromide
8505C::Doramapimod
U251::Sepantronium bromide
NCI-H2196::AGI-6780
EFO-27::Alisertib
NCI-H2009::Doramapimod
IHH-4::I-BRD9
NCI-H810::Sepantronium bromide
HCC38::Cediranib
NCI-N87::MK-8776
HSC-4::MK-8776
NCI-H838::XAV939
HuO9::XAV939
PL-21::Telomerase Inhibitor IX
ML-1::Foretinib
KARPAS-45::Doramapimod
NCI-H1435::XAV939
ALL-SIL::Sepantronium bromide
Ca9-22::Osimertinib
IST-SL1::AGI-6780
DoTc2-4510::MK-8776
EFO-27::Telomerase Inhibitor IX
SW13::AGI-6780
RCM-1::XAV939
CAL-29::Foretinib
DoTc2-4510::Avagacestat
EW-12::Osimertinib
LB647-SCLC::VX-11e
SISO::AGI-6780
CGTH-W-1::I-BRD9
697::Avagacestat
DoTc2-4510::Alisertib
OVCAR-8::Afatinib
NCI-H716::Alisertib
COLO-824::Foretinib
DOK::AGI-6780
NCI-H2452::Avagacestat
ASH-3::Avagacestat
HT-1197::Cediranib
22RV1::Doramapimod
NAMALWA::XAV939
MDA-MB-157::Doramapimod
SCC-3::Alisertib
COLO-678::Foretinib
PL4::Doramapimod
VMRC-LCD::I-BRD9
NCI-H1688::Cediranib
PFSK-1::Cediranib
SF268::XAV939
CAMA-1::I-BRD9
KYSE-410::Dabrafenib
SK-MG-1::Foretinib
ASH-3::Osimertinib
SW1116::Telomerase Inhibitor IX
JVM-2::Telomerase Inhibitor IX
T84::XAV939
TE-6::AZD7762
SBC-1::Foretinib
SU-DHL-6::Osimertinib
SCH::VX-11e
NCI-H510A::Motesanib
SBC-1::I-BRD9
Jurkat::Dabrafenib
COR-L321::Osimertinib
MM1S::Motesanib
HO-1-N-1::Avagacestat
LCLC-103H::ZM447439
Becker::Doramapimod
LAN-6::Avagacestat
MZ2-MEL::Doramapimod
KYSE-150::Foretinib
MZ1-PC::Sepantronium bromide
NCI-H596::VX-11e
DAN-G::Motesanib
CAL-85-1::XAV939
U-2-OS::VX-11e
IGROV-1::Telomerase Inhibitor IX
ES6::Foretinib
NCI-H1573::Osimertinib
CAL-33::Avagacestat
KMS-11::Afatinib
TGBC11TKB::Cediranib
NCI-H23::Afatinib
SCC90::I-BRD9
BICR22::Telomerase Inhibitor IX
MC116::Sepantronium bromide
UACC-257::Motesanib
LNZTA3WT4::Motesanib
SJRH30::Avagacestat
COLO-800::MK-8776
JJN-3::VX-11e
KYSE-510::Doramapimod
NCI-H1694::Cediranib
MOG-G-UVW::Telomerase Inhibitor IX
SNU-C5::Sepantronium bromide
KNS-42::Alisertib
SW1990::ZM447439
CAMA-1::ZM447439
VAL::Sepantronium bromide
MEG-01::Afatinib
NEC8::Sepantronium bromide
DEL::Foretinib
COLO-320-HSR::Cediranib
ES7::Sepantronium bromide
NCI-H650::AGI-6780
HCC-15::Motesanib
LOU-NH91::Osimertinib
HeLa::Telomerase Inhibitor IX
SNU-407::I-BRD9
JHOS-4::Cediranib
NCI-H2141::Afatinib
OE21::Foretinib
PL-21::AZD7762
A253::I-BRD9
U-698-M::Motesanib
SU-DHL-16::Osimertinib
U-118-MG::Telomerase Inhibitor IX
OCUM-1::Afatinib
SJRH30::XAV939
RCC-ER::Avagacestat
RCC-JW::Osimertinib
SW962::Motesanib
HPAF-II::Sepantronium bromide
DMS-114::Dabrafenib
NCI-H526::VX-11e
PC-14::Avagacestat
SISO::ZM447439
TE-10::MK-8776
VAL::AGI-6780
A3-KAW::AGI-6780
NCI-H2227::Sepantronium bromide
KATOIII::AZD7762
UACC-893::Alisertib
SKG-IIIa::Doramapimod
KYM-1::Doramapimod
LB373-MEL-D::Doramapimod
NCI-H1436::MK-8776
SNU-283::Afatinib
NCI-H250::Foretinib
TE-9::ZM447439
KASUMI-1::XAV939
BALL-1::Foretinib
BB65-RCC::XAV939
huH-1::AZD7762
KNS-81-FD::XAV939
SK-ES-1::Osimertinib
SISO::VX-11e
CADO-ES1::ZM447439
KM12::Telomerase Inhibitor IX
MZ7-mel::MK-8776
Calu-3::VX-11e
DSH1::AGI-6780
C3A::Sepantronium bromide
COLO-678::Dabrafenib
SW1271::AZD7762
SF126::XAV939
MEG-01::Cediranib
BB65-RCC::Dabrafenib
CAS-1::Doramapimod
EMC-BAC-1::Motesanib
RERF-LC-MS::Sepantronium bromide
P30-OHK::Alisertib
Detroit562::Cediranib
MOLM-13::XAV939
NB14::Avagacestat
Calu-3::Osimertinib
OACM5-1::XAV939
BHT-101::Foretinib
SCC90::AGI-6780
HEC-1::I-BRD9
ASH-3::MK-8776
SF268::Dabrafenib
EFO-27::AZD7762
KARPAS-620::Telomerase Inhibitor IX
C-4-I::Sepantronium bromide
RPMI-8226::AZD7762
HuP-T3::Sepantronium bromide
MG-63::Alisertib
HuCCT1::XAV939
TE-9::MK-8776
IM-9::Motesanib
KU-19-19::Osimertinib
FADU::MK-8776
SW48::Motesanib
JiyoyeP-2003::Doramapimod
P12-ICHIKAWA::Sepantronium bromide
MFE-280::Alisertib
NCI-H2291::AGI-6780
SK-GT-4::VX-11e
JSC-1::XAV939
D-423MG::Cediranib
KYSE-270::VX-11e
HOS::Motesanib
MG-63::Cediranib
JiyoyeP-2003::Telomerase Inhibitor IX
SF295::VX-11e
MIA-PaCa-2::Telomerase Inhibitor IX
HCC-366::Foretinib
KASUMI-1::ZM447439
NCI-H1573::Alisertib
UACC-812::MK-8776
OVCAR-4::Dabrafenib
KMOE-2::ZM447439
WIL2-NS::VX-11e
COLO-783::Cediranib
RT-112::ZM447439
HT-1197::Telomerase Inhibitor IX
LAN-6::Telomerase Inhibitor IX
MOG-G-UVW::Osimertinib
KMOE-2::Sepantronium bromide
SCC-4::XAV939
MOLT-16::MK-8776
PEO1::XAV939
HT-3::XAV939
OACp4C::XAV939
NCI-H1755::VX-11e
COLO-205::AGI-6780
NCI-H660::Avagacestat
SW1710::Cediranib
NCI-H1048::Motesanib
LOU-NH91::Dabrafenib
HCT-116::Osimertinib
8505C::I-BRD9
HT-1376::Alisertib
SK-N-AS::Osimertinib
COLO-684::AZD7762
NCI-H1568::Telomerase Inhibitor IX
NCI-H1651::Alisertib
A2058::Doramapimod
RERF-LC-Sq1::AZD7762
23132-87::Avagacestat
EW-11::Sepantronium bromide
L-363::Doramapimod
P30-OHK::VX-11e
NB(TU)1-10::ZM447439
HuO-3N1::AGI-6780
NOS-1::I-BRD9
NCI-H2029::VX-11e
SNU-175::Motesanib
MOLM-16::Cediranib
PC-3::MK-8776
SW1710::Doramapimod
SBC-1::AGI-6780
SK-MEL-31::AGI-6780
D-542MG::VX-11e
OCUM-1::VX-11e
NCI-H1703::Cediranib
RCH-ACV::Sepantronium bromide
OVK-18::Dabrafenib
HT-115::Cediranib
HSC-2::XAV939
MOLM-13::Dabrafenib
SUP-B15::Cediranib
PANC-02-03::Doramapimod
JHOS-2::XAV939
KYAE-1::Osimertinib
NCI-H1666::I-BRD9
TE-4::Motesanib
SW48::Sepantronium bromide
EB-3::Cediranib
U-266::Motesanib
WM793B::Alisertib
EB-3::Motesanib
UWB1.289::Cediranib
EW-1::Dabrafenib
COR-L32::VX-11e
CESS::VX-11e
SK-MEL-5::Sepantronium bromide
OAW-42::XAV939
BB65-RCC::AGI-6780
CA46::ZM447439
MRK-nu-1::Avagacestat
KARPAS-620::Foretinib
RPMI-6666::Foretinib
NCI-H2023::ZM447439
MOLP-8::Osimertinib
EB2::ZM447439
SiHa::AZD7762
CAL-148::Alisertib
MOG-G-CCM::Sepantronium bromide
ML-2::Cediranib
DMS-79::Foretinib
G-361::Sepantronium bromide
SIMA::XAV939
OV-56::I-BRD9
NB69::Afatinib
NCI-H1436::Avagacestat
SK-N-SH::Motesanib
KM12::AZD7762
HAL-01::AGI-6780
OVCAR-4::Motesanib
JHH-7::Afatinib
SNU-449::Avagacestat
HSC-4::Motesanib
MKN45::Dabrafenib
MEL-JUSO::Osimertinib
MKN45::Avagacestat
COLO-684::ZM447439
TCCSUP::VX-11e
LB2241-RCC::Telomerase Inhibitor IX
TE-10::Foretinib
MDA-MB-157::Sepantronium bromide
NCI-H2052::Foretinib
NCI-H526::Avagacestat
NCI-H1755::Dabrafenib
PANC-03-27::ZM447439
LOU-NH91::Cediranib
SW982::I-BRD9
FU97::Doramapimod
NOMO-1::Motesanib
HARA::Osimertinib
CAL-39::Dabrafenib
RCC-ER::AGI-6780
DJM-1::AZD7762
NCI-H2087::Cediranib
TE-5::Osimertinib
SK-MEL-5::Avagacestat
NCI-H1734::Alisertib
NCI-H2110::I-BRD9
KP-4::XAV939
MC116::BX795
NCI-H64::Doramapimod
NCI-H841::Sepantronium bromide
IMR-5::MK-8776
D-423MG::Sepantronium bromide
LU-134-A::Avagacestat
EB2::Telomerase Inhibitor IX
OCI-AML3::Motesanib
MHH-PREB-1::MK-8776
NCI-H2196::Cediranib
DBTRG-05MG::Dabrafenib
NCI-H1836::Sepantronium bromide
NCI-H1581::Doramapimod
MDA-MB-231::Sepantronium bromide
KYSE-410::Sepantronium bromide
KYSE-450::Doramapimod
T84::MK-8776
COR-L105::I-BRD9
D-247MG::MK-8776
NCI-H1623::Afatinib
PC-3::Alisertib
BICR10::Cediranib
SK-MEL-2::Avagacestat
NKM-1::AZD7762
MKN28::Cediranib
IGR-37::Doramapimod
HCT-116::Sepantronium bromide
ML-1::Dabrafenib
COLO-684::XAV939
TYK-nu::ZM447439
MDST8::Telomerase Inhibitor IX
NCI-H1993::Telomerase Inhibitor IX
WM1552C::ZM447439
SK-GT-2::VX-11e
YAPC::Osimertinib
WM-115::AZD7762
BFTC-905::ZM447439
KNS-81-FD::BX795
OAW-42::MK-8776
JHOS-2::Motesanib
COR-L279::AZD7762
NCI-H740::VX-11e
RC-K8::Cediranib
SK-PN-DW::I-BRD9
NB5::BX795
LNCaP-Clone-FGC::Foretinib
RCC-FG2::Afatinib
NCI-H1355::Sepantronium bromide
BFTC-909::XAV939
KYSE-520::VX-11e
NCI-H510A::Telomerase Inhibitor IX
Mewo::Alisertib
UACC-62::I-BRD9
JHH-7::I-BRD9
NCI-H1155::Dabrafenib
SW1271::Afatinib
QGP-1::Telomerase Inhibitor IX
NCI-H1792::XAV939
JHH-7::Osimertinib
NCI-H2122::Sepantronium bromide
IHH-4::VX-11e
NCI-H2342::Avagacestat
CAL-51::Dabrafenib
MDA-MB-436::Alisertib
REH::Sepantronium bromide
CAL-51::Motesanib
KP-N-YN::Motesanib
EB-3::Foretinib
RKN::Osimertinib
SK-HEP-1::Alisertib
CAL-27::Afatinib
CP50-MEL-B::Avagacestat
LB1047-RCC::MK-8776
NCI-H661::VX-11e
EFM-192A::Motesanib
MKN28::Dabrafenib
PA-TU-8902::MK-8776
HH::Cediranib
BT-20::MK-8776
CAL-27::AGI-6780
MDA-MB-468::Dabrafenib
HT-1080::Afatinib
FU-OV-1::VX-11e
H-EMC-SS::MK-8776
RKO::MK-8776
OV-17R::AGI-6780
HCC-827::AGI-6780
YT::Avagacestat
YH-13::Cediranib
CA46::VX-11e
A704::Dabrafenib
SK-GT-4::Osimertinib
EoL-1-cell::Osimertinib
ZR-75-30::Foretinib
HCT-15::XAV939
TE-12::Sepantronium bromide
SK-LMS-1::Telomerase Inhibitor IX
BICR78::Cediranib
NCI-H1092::ZM447439
697::Motesanib
NCI-H226::Motesanib
RCC-MF::Sepantronium bromide
NCI-H2141::Avagacestat
SNG-M::Dabrafenib
KYSE-410::XAV939
MDA-MB-453::Motesanib
NB13::Sepantronium bromide
697::AZD7762
HCC-827::XAV939
KP-2::Motesanib
SF126::I-BRD9
OCI-AML5::Foretinib
IGR-37::MK-8776
LS-1034::Cediranib
DOV13::Alisertib
A3-KAW::Foretinib
VMRC-LCD::Cediranib
SNB75::VX-11e
SK-N-SH::Dabrafenib
HCC1500::Motesanib
A101D::AZD7762
LCLC-103H::Alisertib
NCI-H647::Dabrafenib
MEL-HO::Osimertinib
DMS-79::VX-11e
CS1::Doramapimod
A498::VX-11e
EW-13::Osimertinib
LOXIMVI::Cediranib
HSC-2::Osimertinib
SUIT-2::AGI-6780
A2780::Osimertinib
SNU-175::Sepantronium bromide
DOHH-2::AZD7762
P32-ISH::XAV939
IGROV-1::Osimertinib
HL-60::XAV939
UWB1.289::Sepantronium bromide
SUIT-2::Motesanib
HCT-15::MK-8776
NCI-H1944::AGI-6780
HCC2998::ZM447439
Daoy::Avagacestat
KU812::Osimertinib
D-283MED::Cediranib
NALM-6::ZM447439
SW837::Alisertib
COR-L32::Osimertinib
ATN-1::Sepantronium bromide
RPMI-8866::Foretinib
OC-314::Afatinib
KG-1::XAV939
MDST8::Avagacestat
22RV1::I-BRD9
LNCaP-Clone-FGC::Afatinib
HCC-15::Doramapimod
PA-TU-8988T::AGI-6780
KARPAS-231::Motesanib
IPC-298::XAV939
NCI-H2170::AZD7762
BT-20::VX-11e
KLE::Dabrafenib
HCC1428::Motesanib
RCC-JF::AGI-6780
CPC-N::Dabrafenib
PANC-10-05::MK-8776
NCI-H2444::VX-11e
LC-2-ad::Foretinib
NB7::AZD7762
OCI-AML3::Dabrafenib
FADU::Motesanib
CHP-212::Cediranib
MSTO-211H::XAV939
C-4-I::Osimertinib
MDA-MB-453::Telomerase Inhibitor IX
EoL-1-cell::Avagacestat
M14::Dabrafenib
CAL-54::Motesanib
IPC-298::ZM447439
MEL-HO::Dabrafenib
HDQ-P1::ZM447439
HCC38::VX-11e
SLVL::Doramapimod
VMRC-RCZ::Cediranib
TE-441-T::Foretinib
BT-474::Sepantronium bromide
MKN7::Motesanib
CAPAN-1::Avagacestat
NCI-H1688::Avagacestat
HCC2218::Alisertib
IST-MEL1::Telomerase Inhibitor IX
KATOIII::Afatinib
SW962::Afatinib
MLMA::Afatinib
HT-1197::AZD7762
OV-90::Foretinib
COLO-668::Doramapimod
NH-12::XAV939
DG-75::Alisertib
LAN-6::XAV939
NCI-H2342::Doramapimod
SU-DHL-1::Doramapimod
MDA-MB-330::AZD7762
NCI-H748::MK-8776
KNS-81-FD::I-BRD9
HuO-3N1::MK-8776
D-423MG::Foretinib
LC4-1::MK-8776
COR-L279::Motesanib
EM-2::Cediranib
T-T::VX-11e
NCI-H1915::Foretinib
P32-ISH::Afatinib
NCI-H1975::Motesanib
KGN::Alisertib
SK-N-SH::AZD7762
HOP-92::Telomerase Inhibitor IX
RD::VX-11e
JSC-1::Osimertinib
SK-PN-DW::MK-8776
CHP-126::XAV939
WSU-NHL::Osimertinib
SU-DHL-6::Telomerase Inhibitor IX
NCI-H1792::Foretinib
LS-180::MK-8776
COLO-783::XAV939
JVM-2::I-BRD9
CGTH-W-1::Alisertib
KARPAS-231::Foretinib
D-502MG::Cediranib
NCI-H510A::Avagacestat
697::Osimertinib
KOPN-8::MK-8776
MZ2-MEL::XAV939
NB14::Motesanib
OE19::AGI-6780
D-263MG::VX-11e
BV-173::Doramapimod
NCI-H69::MK-8776
8305C::Sepantronium bromide
NCI-H596::Motesanib
MM1S::MK-8776
RPMI-7951::Foretinib
A375::MK-8776
A704::Motesanib
NCI-H1092::Cediranib
Hs-578-T::Afatinib
HT-115::AZD7762
SAT::I-BRD9
SK-LMS-1::XAV939
SW837::XAV939
RPMI-7951::Alisertib
NCI-H1836::Avagacestat
HA7-RCC::Osimertinib
P30-OHK::Afatinib
SW837::Telomerase Inhibitor IX
DND-41::Telomerase Inhibitor IX
H4::Sepantronium bromide
PL4::Motesanib
KE-37::Telomerase Inhibitor IX
SU-DHL-10::Sepantronium bromide
OV-17R::XAV939
STS-0421::XAV939
MKN7::XAV939
LCLC-103H::Sepantronium bromide
SK-MEL-28::Doramapimod
SW954::AGI-6780
ROS-50::MK-8776
LB996-RCC::VX-11e
NUGC-3::Foretinib
HEC-1::Dabrafenib
COR-L88::ZM447439
MDA-MB-157::Alisertib
T47D::Telomerase Inhibitor IX
TE-4::Afatinib
SK-N-DZ::I-BRD9
L-363::Alisertib
NOMO-1::I-BRD9
MKN7::ZM447439
ONS-76::ZM447439
no-10::Alisertib
MZ7-mel::Motesanib
NCI-H650::ZM447439
DEL::Alisertib
T98G::Osimertinib
TC-YIK::MK-8776
HCC70::ZM447439
KMS-12-BM::XAV939
HuP-T3::Afatinib
PL4::Foretinib
KP-1N::Osimertinib
BPH-1::Motesanib
BEN::Motesanib
GCIY::Foretinib
MHH-CALL-4::Sepantronium bromide
DMS-273::Avagacestat
NCI-H1623::VX-11e
UWB1.289::Doramapimod
SK-N-FI::Telomerase Inhibitor IX
SUIT-2::MK-8776
RKO::Telomerase Inhibitor IX
BALL-1::I-BRD9
CA46::Osimertinib
MDST8::ZM447439
A2780::AGI-6780
EKVX::BX795
NB14::Cediranib
MDA-MB-330::Avagacestat
TK::Foretinib
HCT-116::Dabrafenib
HDQ-P1::AGI-6780
MOLM-16::Dabrafenib
NCI-H1755::I-BRD9
JVM-2::MK-8776
SCC-25::ZM447439
KE-37::AGI-6780
MONO-MAC-6::MK-8776
PA-TU-8988T::Afatinib
CHP-126::Motesanib
RD::Dabrafenib
RH-41::Alisertib
KU812::Sepantronium bromide
NCC010::Telomerase Inhibitor IX
SK-HEP-1::AZD7762
A2780::ZM447439
SH-4::Afatinib
NOS-1::VX-11e
Mewo::Osimertinib
D-336MG::Sepantronium bromide
MOLT-16::AGI-6780
HSC-3::Foretinib
JEG-3::Doramapimod
LB373-MEL-D::Motesanib
NCI-H1869::Cediranib
HDLM-2::Afatinib
RL95-2::Cediranib
HEC-1::Doramapimod
NCI-H596::I-BRD9
MS751::ZM447439
EW-1::Telomerase Inhibitor IX
G-401::Telomerase Inhibitor IX
RPMI-6666::Doramapimod
A2780::Foretinib
STS-0421::AZD7762
BxPC-3::Alisertib
CS1::I-BRD9
LB831-BLC::Telomerase Inhibitor IX
BB65-RCC::Avagacestat
SW684::Afatinib
SU-DHL-16::Motesanib
PA-TU-8988T::Motesanib
ES7::Osimertinib
K-562::MK-8776
OCI-LY-19::AGI-6780
U-2-OS::Osimertinib
SF268::Afatinib
CAL-148::VX-11e
LN-229::AGI-6780
MOLM-16::Doramapimod
A204::Dabrafenib
Hs-445::Osimertinib
SCC-3::Telomerase Inhibitor IX
ESS-1::AZD7762
MDST8::I-BRD9
RT4::I-BRD9
SUP-HD1::Afatinib
OCI-LY7::Doramapimod
NCI-H647::Cediranib
P32-ISH::Osimertinib
HCC1419::Motesanib
NB(TU)1-10::Alisertib
MZ7-mel::Dabrafenib
ETK-1::XAV939
KYSE-510::Osimertinib
NCI-H146::XAV939
HC-1::Motesanib
NCI-H2228::Doramapimod
YAPC::Afatinib
MEL-JUSO::I-BRD9
ES5::Alisertib
M059J::AGI-6780
KYSE-520::Alisertib
KM12::Sepantronium bromide
NCI-H810::Alisertib
KYSE-180::Cediranib
KM-H2::AZD7762
SK-MG-1::Motesanib
L-1236::ZM447439
JHH-7::Foretinib
SK-GT-2::Afatinib
LN-405::VX-11e
MOLP-8::VX-11e
KG-1::Dabrafenib
CAKI-1::AGI-6780
STS-0421::VX-11e
LN-405::Motesanib
D-336MG::Doramapimod
639-V::Motesanib
TE-9::I-BRD9
NALM-6::Doramapimod
KYSE-150::ZM447439
KELLY::Dabrafenib
U-2-OS::Afatinib
KELLY::Alisertib
MHH-PREB-1::Sepantronium bromide
RERF-GC-1B::Alisertib
BC-1::Telomerase Inhibitor IX
MDA-MB-330::Foretinib
MHH-CALL-4::Osimertinib
SKG-IIIa::Avagacestat
COR-L311::MK-8776
NCI-H847::Motesanib
SW156::Afatinib
WM35::Alisertib
COLO-792::Motesanib
CAL-29::I-BRD9
CHSA8926::MK-8776
SU8686::Telomerase Inhibitor IX
EMC-BAC-2::Foretinib
MZ2-MEL::Dabrafenib
HT-1197::Motesanib
D-392MG::Dabrafenib
RCC10RGB::AGI-6780
NCCIT::Avagacestat
SK-MG-1::ZM447439
AU565::XAV939
CAL-78::Telomerase Inhibitor IX
A431::Motesanib
NCI-H1963::AGI-6780
OSC-19::Foretinib
LP-1::MK-8776
NCI-H929::Cediranib
NCI-H2030::Cediranib
KYM-1::Foretinib
ESO51::Dabrafenib
NCI-H1650::Osimertinib
UACC-62::Motesanib
MDA-MB-330::Cediranib
KGN::Afatinib
IMR-5::Afatinib
647-V::MK-8776
HCC1937::Alisertib
NCI-H196::Motesanib
PANC-03-27::AZD7762
SK-MEL-31::Osimertinib
SU-DHL-5::MK-8776
PSN1::Telomerase Inhibitor IX
OCUB-M::ZM447439
G-401::VX-11e
IST-MES1::Telomerase Inhibitor IX
CCRF-CEM::Dabrafenib
HOS::Doramapimod
COLO-824::Sepantronium bromide
SK-HEP-1::Motesanib
MZ7-mel::XAV939
NCI-H747::MK-8776
EW-18::Avagacestat
NCI-H1581::Dabrafenib
COLO-668::AGI-6780
ZR-75-30::Sepantronium bromide
KMS-11::Telomerase Inhibitor IX
Saos-2::Telomerase Inhibitor IX
MDA-MB-468::Foretinib
COR-L311::Cediranib
HARA::Telomerase Inhibitor IX
SK-GT-4::Alisertib
COR-L321::XAV939
COLO-678::AGI-6780
NCI-H82::Afatinib
SK-MEL-1::Foretinib
CAL-51::Sepantronium bromide
MG-63::Afatinib
NCI-H2342::Foretinib
PEO1::AGI-6780
NCI-H2023::Motesanib
UWB1.289::BX795
RPMI-7951::Avagacestat
BT-474::XAV939
A427::MK-8776
JEKO-1::VX-11e
LoVo::Dabrafenib
HCC1428::Telomerase Inhibitor IX
COLO-829::XAV939
CAL-78::XAV939
COR-L95::Alisertib
RERF-LC-MS::Afatinib
KYSE-220::Osimertinib
NCI-H522::VX-11e
NB14::AGI-6780
MZ2-MEL::I-BRD9
MDA-MB-231::Cediranib
huH-1::XAV939
WM35::Avagacestat
NCI-H1666::Telomerase Inhibitor IX
NB7::XAV939
ONS-76::Cediranib
SW780::Avagacestat
SK-MG-1::Dabrafenib
HCC1806::Osimertinib
LP-1::Afatinib
SNU-407::Doramapimod
CAL-62::Avagacestat
NCI-H1734::VX-11e
PCI-4B::Cediranib
PSN1::Motesanib
OCUM-1::Avagacestat
OV-56::XAV939
KOPN-8::Telomerase Inhibitor IX
SW1463::Dabrafenib
ZR-75-30::Osimertinib
CAL-33::XAV939
EW-16::Alisertib
DoTc2-4510::AZD7762
DND-41::Dabrafenib
SF295::Doramapimod
MPP-89::XAV939
L-1236::Cediranib
NCI-H250::I-BRD9
RS4-11::Osimertinib
KYSE-510::MK-8776
LB771-HNC::MK-8776
HO-1-N-1::Foretinib
CAL-51::MK-8776
RERF-LC-Sq1::Avagacestat
YH-13::Afatinib
HDQ-P1::Afatinib
STS-0421::I-BRD9
KYSE-450::AZD7762
UM-UC-3::Alisertib
EW-12::ZM447439
NCI-H2291::Alisertib
5637::Sepantronium bromide
COR-L279::Foretinib
CHP-134::Osimertinib
MS-1::Alisertib
SBC-1::Telomerase Inhibitor IX
AMO-1::Afatinib
EW-12::Avagacestat
NCI-H64::Foretinib
Calu-3::Doramapimod
OCI-M1::Sepantronium bromide
BICR22::Cediranib
RVH-421::Alisertib
SH-4::Alisertib
HCC1937::ZM447439
EFM-192A::Cediranib
CML-T1::Osimertinib
PL-21::AGI-6780
L-1236::VX-11e
SW780::I-BRD9
NCI-H650::Doramapimod
RERF-GC-1B::Foretinib
HT-3::Motesanib
TE-15::Afatinib
CAL-148::Doramapimod
MN-60::Alisertib
K5::XAV939
WM1552C::AZD7762
SR::Telomerase Inhibitor IX
HCC1187::Sepantronium bromide
LU-165::Sepantronium bromide
KOSC-2::Telomerase Inhibitor IX
T98G::Afatinib
YKG-1::Doramapimod
NCI-H322M::Doramapimod
COLO-320-HSR::Doramapimod
IM-9::AZD7762
SW1271::Foretinib
EW-1::Sepantronium bromide
SISO::Telomerase Inhibitor IX
NCI-H1650::MK-8776
SNU-81::Cediranib
BFTC-905::AZD7762
Raji::Sepantronium bromide
KOPN-8::XAV939
ES4::Dabrafenib
OCUB-M::Foretinib
SF126::ZM447439
NCI-H2228::Sepantronium bromide
GRANTA-519::Osimertinib
NCI-H1568::AZD7762
CHL-1::Motesanib
NCI-H1648::Afatinib
PANC-08-13::I-BRD9
SK-MEL-31::AZD7762
VA-ES-BJ::Afatinib
J82::XAV939
COLO-783::BX795
LN-229::Dabrafenib
GRANTA-519::Telomerase Inhibitor IX
SW684::VX-11e
PCI-6A::Avagacestat
23132-87::Cediranib
SUIT-2::Alisertib
LS-411N::AGI-6780
EW-16::MK-8776
PEO1::AZD7762
P32-ISH::VX-11e
DMS-273::XAV939
OCUM-1::I-BRD9
D-566MG::Doramapimod
SF268::I-BRD9
SJRH30::I-BRD9
REH::AGI-6780
HT-29::VX-11e
MIA-PaCa-2::I-BRD9
VMRC-RCZ::Avagacestat
J82::Osimertinib
Ca9-22::I-BRD9
BICR31::I-BRD9
NCC021::Alisertib
QGP-1::BX795
U-698-M::Osimertinib
Raji::Dabrafenib
MZ7-mel::Sepantronium bromide
CHP-126::Osimertinib
647-V::Avagacestat
SW954::Avagacestat
KGN::ZM447439
Caov-4::Osimertinib
SW780::Sepantronium bromide
MKN1::Afatinib
SUP-B15::XAV939
769-P::Sepantronium bromide
HSC-2::Cediranib
ESO51::Alisertib
P12-ICHIKAWA::Telomerase Inhibitor IX
SW1710::VX-11e
NCI-H446::Foretinib
HCC2998::Telomerase Inhibitor IX
SNB75::AGI-6780
KMRC-20::Osimertinib
COR-L32::Doramapimod
OE19::VX-11e
NCI-H1993::Motesanib
SUIT-2::AZD7762
AGS::AZD7762
SW1088::Telomerase Inhibitor IX
KURAMOCHI::Dabrafenib
BL-41::MK-8776
IST-SL2::MK-8776
IPC-298::MK-8776
RH-41::Osimertinib
NCI-H1792::MK-8776
HuO9::VX-11e
PEO1::Cediranib
KMRC-20::Sepantronium bromide
RCC-JF::Alisertib
MG-63::Dabrafenib
BB65-RCC::Motesanib
DEL::Sepantronium bromide
NB5::Foretinib
SUP-T1::Foretinib
SW1116::Motesanib
SR::Afatinib
MOLM-16::Sepantronium bromide
LB1047-RCC::Cediranib
MEL-HO::Alisertib
TUR::Dabrafenib
RH-1::Foretinib
NOMO-1::Alisertib
OPM-2::AGI-6780
JURL-MK1::Alisertib
NCI-H1651::Telomerase Inhibitor IX
BT-20::ZM447439
JHH-6::Foretinib
EJM::Foretinib
HuP-T4::Dabrafenib
SK-MG-1::Afatinib
ECC12::ZM447439
RF-48::ZM447439
OCUB-M::Cediranib
GCT::AZD7762
GB-1::I-BRD9
SW1088::Avagacestat
TOV-21G::Alisertib
C32::Telomerase Inhibitor IX
NUGC-4::MK-8776
P12-ICHIKAWA::I-BRD9
SAS::Motesanib
NCI-H2444::BX795
SISO::Cediranib
NCI-H211::MK-8776
HDLM-2::AZD7762
CAL-51::Afatinib
T-T::Alisertib
JJN-3::Alisertib
D-247MG::Cediranib
EB-3::Telomerase Inhibitor IX
DAN-G::I-BRD9
ES8::MK-8776
EW-3::Doramapimod
LB2241-RCC::Afatinib
SBC-5::Telomerase Inhibitor IX
ALL-SIL::Telomerase Inhibitor IX
SH-4::Foretinib
SK-N-AS::MK-8776
NCI-H2066::Motesanib
KALS-1::Foretinib
SNU-387::VX-11e
MOLM-13::Alisertib
HT-1376::Sepantronium bromide
NCI-H2135::Osimertinib
NCI-H2228::XAV939
NEC8::Motesanib
RCC10RGB::XAV939
MEL-JUSO::VX-11e
HCC-78::XAV939
Farage::Foretinib
BEN::Afatinib
LB996-RCC::Dabrafenib
SW872::Avagacestat
EW-3::Telomerase Inhibitor IX
HuP-T3::Motesanib
SUP-B8::VX-11e
NB12::MK-8776
OCI-AML2::Cediranib
AU565::AGI-6780
NCI-H727::Motesanib
REH::XAV939
SUP-B15::Motesanib
LN-405::Foretinib
HuP-T3::XAV939
OVTOKO::AGI-6780
MV-4-11::Avagacestat
MZ1-PC::BX795
HCC2157::Osimertinib
VMRC-RCZ::I-BRD9
NCI-H28::Alisertib
KARPAS-620::Afatinib
NCI-H2066::Osimertinib
CL-11::Alisertib
TGW::MK-8776
KYM-1::Cediranib
NCI-H835::VX-11e
SK-UT-1::Avagacestat
OS-RC-2::Osimertinib
RERF-LC-KJ::Foretinib
RKO::Motesanib
ZR-75-30::Avagacestat
HuP-T3::ZM447439
SK-MES-1::Motesanib
YKG-1::ZM447439
KALS-1::MK-8776
KYSE-510::VX-11e
CPC-N::Motesanib
SCC-25::Cediranib
CADO-ES1::I-BRD9
DAN-G::ZM447439
SNU-61::Avagacestat
HCC2998::Alisertib
OPM-2::Motesanib
NCI-H2122::Foretinib
NCI-H1944::Foretinib
SW837::AZD7762
CA46::MK-8776
SNU-387::AGI-6780
BHY::AGI-6780
KYSE-180::Motesanib
ES8::Sepantronium bromide
OVCAR-8::Doramapimod
NB13::MK-8776
SUP-B8::Doramapimod
RS4-11::AGI-6780
H4::Alisertib
KMS-12-BM::Dabrafenib
SK-ES-1::Motesanib
A2058::Telomerase Inhibitor IX
RL95-2::Dabrafenib
H-EMC-SS::Motesanib
TGBC1TKB::Avagacestat
EFO-21::Afatinib
NCI-H2291::Avagacestat
NCI-H1793::ZM447439
AU565::I-BRD9
KOSC-2::Foretinib
NCI-H522::Sepantronium bromide
NCI-H2087::Alisertib
KP-4::Osimertinib
RVH-421::AGI-6780
EFM-19::MK-8776
LN-18::Motesanib
SW1417::MK-8776
MCF7::Osimertinib
OAW-42::Doramapimod
HCT-116::Avagacestat
UACC-812::AZD7762
GAMG::Cediranib
RPMI-8866::Doramapimod
ONS-76::Foretinib
D-542MG::Osimertinib
KASUMI-1::Foretinib
SNU-283::Dabrafenib
GDM-1::VX-11e
RO82-W-1::AGI-6780
D-542MG::BX795
D-247MG::ZM447439
C32::Foretinib
LC-1-sq::VX-11e
NCI-H727::Dabrafenib
KARPAS-422::Telomerase Inhibitor IX
MFE-280::Telomerase Inhibitor IX
COLO-684::MK-8776
NCI-H2030::MK-8776
BONNA-12::AGI-6780
UWB1.289::Foretinib
ES-2::Cediranib
Ca9-22::MK-8776
NCI-H2122::Avagacestat
A704::I-BRD9
SKG-IIIa::VX-11e
NCI-H1869::Alisertib
HCC2998::Avagacestat
KYSE-50::Avagacestat
NCI-H1975::XAV939
NCI-H1792::AGI-6780
NCI-H838::Telomerase Inhibitor IX
Daudi::Telomerase Inhibitor IX
HeLa::Avagacestat
PA-TU-8902::Alisertib
IGR-1::Avagacestat
BICR31::MK-8776
G-402::ZM447439
EW-1::AZD7762
THP-1::Osimertinib
KURAMOCHI::Sepantronium bromide
CHSA0108::I-BRD9
NCI-H2087::Sepantronium bromide
SK-MES-1::VX-11e
NB17::Alisertib
SU8686::VX-11e
CS1::ZM447439
GB-1::Cediranib
786-0::Avagacestat
MZ1-PC::Osimertinib
JVM-3::I-BRD9
SKG-IIIa::MK-8776
HCC1143::Osimertinib
NCI-H1650::Foretinib
RH-41::Foretinib
NCI-H441::XAV939
NCI-H1341::Afatinib
DBTRG-05MG::Doramapimod
TGBC11TKB::Dabrafenib
MC116::ZM447439
COR-L32::Foretinib
SAT::Sepantronium bromide
KS-1::Cediranib
CAL-39::Motesanib
CAL-33::Sepantronium bromide
RERF-LC-KJ::AZD7762
CAMA-1::Foretinib
SK-MEL-3::I-BRD9
KM-H2::MK-8776
A549::Motesanib
SK-PN-DW::AGI-6780
MDA-MB-453::Dabrafenib
WIL2-NS::Motesanib
ECC10::Osimertinib
UACC-812::ZM447439
RVH-421::Foretinib
NCI-H2342::ZM447439
T98G::Sepantronium bromide
NCI-H1341::MK-8776
NCI-H441::AZD7762
NCI-H82::I-BRD9
KASUMI-1::Osimertinib
HCC70::Doramapimod
SW1271::VX-11e
KYSE-150::Avagacestat
NU-DUL-1::ZM447439
RD::Afatinib
KYSE-270::MK-8776
NCI-H647::VX-11e
NCI-H748::XAV939
PC-3::Cediranib
EB2::Dabrafenib
M14::AGI-6780
NCI-H3122::Foretinib
CAL-78::Motesanib
HSC-4::Avagacestat
COLO-679::Avagacestat
MDA-MB-231::AZD7762
OV-56::MK-8776
COLO-792::Alisertib
ES6::I-BRD9
SU-DHL-4::XAV939
YKG-1::Osimertinib
NKM-1::ZM447439
M059J::Afatinib
HCC2157::I-BRD9
SCC-15::XAV939
SK-N-SH::Avagacestat
Ca-Ski::Afatinib
M059J::Avagacestat
HOP-92::Dabrafenib
NCI-H1666::Cediranib
TK::Osimertinib
OV-17R::Doramapimod
SK-ES-1::MK-8776
NCI-H727::Avagacestat
DMS-114::Doramapimod
NCI-H82::Telomerase Inhibitor IX
LXF-289::Doramapimod
VAL::AZD7762
ARH-77::XAV939
NCI-H524::VX-11e
CAL-148::Osimertinib
SIG-M5::Cediranib
TK::Sepantronium bromide
BT-474::I-BRD9
NCI-H250::AGI-6780
NCI-H146::Cediranib
RL95-2::Telomerase Inhibitor IX
SW948::Afatinib
LU-134-A::I-BRD9
NCI-H2087::MK-8776
GCT::Afatinib
L-540::Foretinib
PWR-1E::VX-11e
MZ1-PC::Motesanib
SK-MEL-2::XAV939
FADU::Dabrafenib
SW156::VX-11e
COLO-679::Osimertinib
LC-1-sq::I-BRD9
EKVX::AGI-6780
D-283MED::Motesanib
NCI-H1838::AZD7762
A2058::MK-8776
H3255::Osimertinib
COLO-678::Sepantronium bromide
NCI-N87::Avagacestat
RS4-11::Doramapimod
SNU-C2B::MK-8776
SU-DHL-6::Afatinib
TE-12::MK-8776
SNU-C5::Alisertib
CHP-134::I-BRD9
SK-LMS-1::I-BRD9
DAN-G::Alisertib
QIMR-WIL::Alisertib
LAMA-84::VX-11e
Saos-2::Motesanib
IGR-37::I-BRD9
COLO-800::AZD7762
HCT-116::Cediranib
TUR::Foretinib
ETK-1::VX-11e
FLO-1::XAV939
ASH-3::Afatinib
NCI-H1734::Osimertinib
HSC-39::Foretinib
OVCA420::Afatinib
NCI-H322M::Dabrafenib
JEKO-1::AZD7762
NEC8::Avagacestat
ACHN::Doramapimod
A4-Fuk::MK-8776
NCI-H2052::Dabrafenib
NH-12::Afatinib
C32::Cediranib
CPC-N::MK-8776
TT2609-C02::I-BRD9
ZR-75-30::Cediranib
KNS-81-FD::Afatinib
639-V::VX-11e
NCI-H1666::MK-8776
RPMI-8402::Sepantronium bromide
ZR-75-30::Motesanib
SW1710::Osimertinib
LB373-MEL-D::Afatinib
SU-DHL-10::Dabrafenib
HGC-27::Avagacestat
TE-1::AGI-6780
RCC-MF::BX795
SiHa::Sepantronium bromide
JEG-3::Afatinib
LU-99A::XAV939
RF-48::VX-11e
LP-1::XAV939
HCC-366::Cediranib
CP66-MEL::Foretinib
P30-OHK::AGI-6780
RCH-ACV::Afatinib
NCI-H345::Dabrafenib
GP5d::Telomerase Inhibitor IX
RCC-JW::Sepantronium bromide
OVKATE::MK-8776
SK-CO-1::XAV939
HCC2998::Afatinib
TC-YIK::XAV939
SK-MEL-24::AGI-6780
NCI-H1975::AGI-6780
A375::AGI-6780
CFPAC-1::I-BRD9
NCI-H1944::Afatinib
NCI-H2228::Motesanib
SNU-407::Avagacestat
NCI-H524::Osimertinib
GI-1::Avagacestat
TE-10::Alisertib
COLO-668::Afatinib
HCE-4::MK-8776
HC-1::Avagacestat
KNS-62::Telomerase Inhibitor IX
RCC-JF::XAV939
RKN::I-BRD9
A3-KAW::Alisertib
EPLC-272H::AZD7762
HCC2218::AZD7762
NCI-H146::I-BRD9
HCC1143::Cediranib
NCI-H1563::Avagacestat
TE-9::Telomerase Inhibitor IX
IHH-4::MK-8776
Caov-4::Alisertib
LS-123::Avagacestat
JIMT-1::Cediranib
CA46::AZD7762
NCI-H2452::Sepantronium bromide
CAMA-1::MK-8776
UACC-893::VX-11e
A549::XAV939
D-336MG::AGI-6780
SNG-M::XAV939
KYAE-1::Telomerase Inhibitor IX
A2058::Afatinib
SK-MEL-3::Motesanib
SNU-283::XAV939
NCI-H1688::Osimertinib
OV-56::Doramapimod
NCI-H847::Sepantronium bromide
KYSE-140::AZD7762
CAPAN-1::Doramapimod
G-361::Alisertib
LN-18::MK-8776
KARPAS-620::AZD7762
NCI-H522::AGI-6780
CHP-126::Dabrafenib
SU-DHL-10::AGI-6780
OVCAR-5::XAV939
GAMG::Sepantronium bromide
SK-MM-2::XAV939
EPLC-272H::Foretinib
ES-2::MK-8776
MOLT-16::AZD7762
EM-2::AGI-6780
SW872::Doramapimod
EW-11::Telomerase Inhibitor IX
NB7::Sepantronium bromide
KP-3::Osimertinib
EW-18::Foretinib
NCI-H1650::Dabrafenib
DOHH-2::MK-8776
ES7::Dabrafenib
SKN::I-BRD9
OVCAR-5::Doramapimod
HCC2218::Avagacestat
NCI-H292::Osimertinib
NCI-H2452::AZD7762
HT-115::Afatinib
EKVX::Cediranib
NCI-H1693::Alisertib
DB::Doramapimod
CPC-N::Alisertib
SW872::VX-11e
DMS-53::Telomerase Inhibitor IX
NAMALWA::Dabrafenib
LB771-HNC::I-BRD9
MDA-MB-436::Telomerase Inhibitor IX
CAL-62::Cediranib
EN::Foretinib
CHP-134::Telomerase Inhibitor IX
OVMIU::Dabrafenib
A549::AGI-6780
JURL-MK1::ZM447439
NCI-H1666::ZM447439
KYSE-70::Motesanib
MKN1::AZD7762
L-428::MK-8776
NCI-H2452::ZM447439
KYSE-450::Sepantronium bromide
COLO-829::Osimertinib
M14::Foretinib
GCT::Cediranib
IST-SL1::Cediranib
SCC-25::Foretinib
TE-6::VX-11e
SUP-HD1::Telomerase Inhibitor IX
KCL-22::Dabrafenib
P32-ISH::Motesanib
CAL-62::Afatinib
IGR-37::Motesanib
HCC-366::VX-11e
NCI-H1781::Osimertinib
CA46::Afatinib
NB17::Avagacestat
LB2518-MEL::AGI-6780
NCI-H720::Foretinib
ES8::Dabrafenib
K2::BX795
KON::AZD7762
NCI-H1915::Telomerase Inhibitor IX
OE19::MK-8776
MHH-PREB-1::XAV939
SW780::AZD7762
CAL-33::AGI-6780
RH-1::Telomerase Inhibitor IX
RL95-2::Foretinib
TE-8::Alisertib
NCI-H82::Dabrafenib
SK-N-DZ::XAV939
SW1990::Avagacestat
BT-549::Afatinib
BICR22::Foretinib
NB7::Motesanib
MOG-G-UVW::Avagacestat
OAW-28::ZM447439
NUGC-4::Sepantronium bromide
ESO26::Dabrafenib
OVISE::Sepantronium bromide
HT-144::AGI-6780
COR-L23::Osimertinib
HT-3::MK-8776
BE-13::Motesanib
SU-DHL-10::Cediranib
NOS-1::XAV939
KMOE-2::Osimertinib
HSC-4::Cediranib
OVCA420::Telomerase Inhibitor IX
OVCAR-4::Avagacestat
no-10::Sepantronium bromide
DoTc2-4510::Dabrafenib
HCT-15::VX-11e
Hey::I-BRD9
HuH-7::MK-8776
NCI-H716::Cediranib
FU-OV-1::Dabrafenib
CCK-81::Motesanib
RCC-AB::Afatinib
IMR-5::XAV939
NCI-H1770::Foretinib
D-542MG::XAV939
HL-60::I-BRD9
T47D::AGI-6780
JHU-011::Doramapimod
MDA-MB-361::AGI-6780
MKN28::XAV939
KMS-11::AZD7762
RCC10RGB::VX-11e
MOG-G-CCM::Motesanib
PANC-10-05::Osimertinib
NKM-1::Alisertib
L-1236::MK-8776
Becker::AZD7762
KM12::XAV939
MPP-89::Cediranib
EJM::ZM447439
HCC1954::Alisertib
U-698-M::AGI-6780
NOMO-1::Sepantronium bromide
639-V::AGI-6780
NCI-H660::Afatinib
COR-L23::VX-11e
SKN::MK-8776
SU-DHL-5::Doramapimod
MFM-223::Alisertib
CAL-29::Telomerase Inhibitor IX
KYSE-150::Sepantronium bromide
FU-OV-1::Osimertinib
PL-21::Doramapimod
SF539::Foretinib
GB-1::AGI-6780
NCI-H358::Afatinib
KNS-62::Motesanib
BB65-RCC::Sepantronium bromide
NCI-H1993::VX-11e
SW954::Foretinib
RCC-JF::Dabrafenib
MN-60::Telomerase Inhibitor IX
LOUCY::Avagacestat
HSC-39::Cediranib
PCI-15A::Doramapimod
HCC1937::I-BRD9
NCI-H2029::ZM447439
NAMALWA::Avagacestat
NCI-H2052::Motesanib
EVSA-T::Afatinib
TE-10::Telomerase Inhibitor IX
KYSE-140::Avagacestat
KP-3::XAV939
NCI-H1105::Avagacestat
TE-9::Alisertib
KOPN-8::I-BRD9
ONS-76::Afatinib
KYSE-140::I-BRD9
REH::Cediranib
IGR-1::ZM447439
HCC-78::Foretinib
LU-165::Doramapimod
NB5::MK-8776
SW13::Avagacestat
SK-N-SH::MK-8776
ST486::MK-8776
L-540::Telomerase Inhibitor IX
EB-3::I-BRD9
KYSE-70::VX-11e
ESO26::XAV939
KMS-11::Foretinib
HT-115::BX795
WM278::Afatinib
HEC-1::Osimertinib
TE-1::XAV939
SK-ES-1::Avagacestat
NCI-H1693::Afatinib
COLO-824::Cediranib
AN3-CA::VX-11e
IGR-37::AZD7762
COLO-684::Alisertib
NCI-H526::AGI-6780
LU-135::Telomerase Inhibitor IX
CAL-78::AGI-6780
NCI-H1355::Alisertib
ES1::Avagacestat
NB17::Motesanib
GA-10::XAV939
PANC-02-03::Motesanib
SNU-81::Foretinib
SK-GT-2::Sepantronium bromide
NCI-H1651::Afatinib
HT-115::Motesanib
LCLC-97TM1::Afatinib
HCC1569::Avagacestat
OAW-42::Afatinib
EC-GI-10::Afatinib
NCI-H2342::Motesanib
SNU-C5::Doramapimod
LoVo::ZM447439
JHH-7::Sepantronium bromide
LOU-NH91::Avagacestat
MEL-JUSO::Avagacestat
HT-1080::Foretinib
A2058::Motesanib
NCI-H1734::MK-8776
WM1552C::AGI-6780
RCC-AB::Dabrafenib
SK-MG-1::Sepantronium bromide
C-4-I::I-BRD9
LN-18::Cediranib
CA46::Foretinib
COLO-800::ZM447439
D-423MG::Doramapimod
DOK::Doramapimod
GOTO::VX-11e
TGBC1TKB::Motesanib
A101D::Cediranib
CAL-27::Motesanib
ESO26::Avagacestat
CESS::MK-8776
EMC-BAC-1::AZD7762
SW1573::Motesanib
NCI-H64::Osimertinib
JIMT-1::AGI-6780
Saos-2::Foretinib
Becker::MK-8776
VCaP::Sepantronium bromide
BV-173::Sepantronium bromide
MEL-JUSO::Cediranib
SCH::ZM447439
SU-DHL-1::Motesanib
ATN-1::MK-8776
SiHa::Osimertinib
KARPAS-299::Telomerase Inhibitor IX
NCI-H1838::Avagacestat
PF-382::Alisertib
no-10::Cediranib
CAL-54::Osimertinib
HT-144::Doramapimod
NCI-H2135::Avagacestat
OV-90::VX-11e
NCI-H1703::AZD7762
ES5::Osimertinib
CAL-27::I-BRD9
C32::Avagacestat
TK10::Cediranib
NCI-H1568::Osimertinib
NCI-H1436::AGI-6780
MFE-319::Avagacestat
WM793B::AGI-6780
CAL-54::Dabrafenib
HCC1419::AGI-6780
G-361::Motesanib
NCI-H520::Dabrafenib
NCI-H82::Sepantronium bromide
OE33::Cediranib
NCI-H441::ZM447439
HCC70::I-BRD9
J82::I-BRD9
KALS-1::AZD7762
MOLM-13::MK-8776
Saos-2::ZM447439
NCI-H835::I-BRD9
HCC1954::Foretinib
CAL-12T::Cediranib
MG-63::ZM447439
PCI-6A::Alisertib
OCI-AML2::MK-8776
VA-ES-BJ::XAV939
WM35::Cediranib
NCI-H1573::Doramapimod
NCI-H28::Osimertinib
SW1573::Alisertib
NCI-H727::XAV939
LC-1-sq::Telomerase Inhibitor IX
K-562::Avagacestat
SCC-4::AZD7762
HAL-01::Dabrafenib
NCI-H526::Osimertinib
DB::Telomerase Inhibitor IX
SW780::Osimertinib
A388::ZM447439
THP-1::AZD7762
KARPAS-422::Foretinib
CML-T1::Afatinib
HC-1::Dabrafenib
UACC-812::Afatinib
NCI-H1581::Telomerase Inhibitor IX
C32::VX-11e
NCI-H810::Avagacestat
MCF7::Foretinib
RCC-AB::I-BRD9
MOLM-16::Avagacestat
Ramos-2G6-4C10::AGI-6780
ML-2::Avagacestat
KALS-1::Telomerase Inhibitor IX
ARH-77::ZM447439
PCI-30::Doramapimod
RERF-LC-MS::Alisertib
LU-135::AGI-6780
VCaP::Motesanib
DoTc2-4510::Motesanib
HH::AZD7762
HT-3::AZD7762
ACHN::Afatinib
U251::Osimertinib
NCI-H1435::Dabrafenib
NAMALWA::AZD7762
U-87-MG::Alisertib
786-0::I-BRD9
OACp4C::Telomerase Inhibitor IX
NCI-H650::Cediranib
STS-0421::MK-8776
SW1088::XAV939
SK-MES-1::Dabrafenib
NCI-H1694::I-BRD9
HCC1395::Doramapimod
SNU-175::Avagacestat
NCI-H2444::Doramapimod
TE-4::AZD7762
JiyoyeP-2003::I-BRD9
NCI-H524::ZM447439
KYSE-50::Doramapimod
EJM::Sepantronium bromide
SW156::Osimertinib
FU-OV-1::Foretinib
KARPAS-299::MK-8776
ESO26::Afatinib
YAPC::Foretinib
HTC-C3::Osimertinib
JM1::Afatinib
Jurkat::Doramapimod
RD::Sepantronium bromide
NB1::Cediranib
NCI-H1651::ZM447439
SW954::Alisertib
OPM-2::VX-11e
SU-DHL-4::Sepantronium bromide
MSTO-211H::Afatinib
PEO1::I-BRD9
NB1::MK-8776
RPMI-8226::VX-11e
PANC-08-13::Osimertinib
PCI-4B::VX-11e
WSU-DLCL2::MK-8776
PF-382::VX-11e
NCI-H2172::AZD7762
CAL-27::Sepantronium bromide
OE21::MK-8776
HT-1197::Alisertib
K2::VX-11e
EN::AGI-6780
NCI-H1650::AZD7762
KASUMI-1::AGI-6780
22RV1::Cediranib
BT-549::Alisertib
CaR-1::Cediranib
MEL-JUSO::Foretinib
EW-24::ZM447439
HCC-44::VX-11e
TE-12::VX-11e
HCC1599::Motesanib
RERF-LC-Sq1::Osimertinib
HSC-2::Avagacestat
MOLT-13::Foretinib
C2BBe1::Sepantronium bromide
TOV-21G::Motesanib
KYSE-50::Osimertinib
Hs-578-T::Motesanib
BB65-RCC::MK-8776
MFE-296::Dabrafenib
QGP-1::Afatinib
Saos-2::Doramapimod
D-423MG::MK-8776
JIMT-1::Avagacestat
SK-CO-1::AZD7762
IA-LM::Foretinib
ChaGo-K-1::Alisertib
QGP-1::Alisertib
DMS-114::Osimertinib
CAL-54::AZD7762
MG-63::I-BRD9
LS-411N::MK-8776
OVCAR-5::Avagacestat
DOV13::Dabrafenib
LoVo::Foretinib
HLE::Sepantronium bromide
MHH-NB-11::Afatinib
MPP-89::Sepantronium bromide
OPM-2::Doramapimod
HuO-3N1::XAV939
TK10::ZM447439
YT::I-BRD9
EB2::Afatinib
ES5::AZD7762
NCI-H2135::ZM447439
NCI-H2141::Osimertinib
DU-4475::Foretinib
SU-DHL-5::Osimertinib
CP66-MEL::Motesanib
no-10::ZM447439
SU-DHL-1::AZD7762
NCI-H2009::Telomerase Inhibitor IX
OCI-M1::AGI-6780
NU-DUL-1::VX-11e
SK-CO-1::Alisertib
H3255::Motesanib
NCI-H1755::AZD7762
D-502MG::Afatinib
SNU-449::Doramapimod
SKN::Alisertib
HSC-39::Dabrafenib
MDA-MB-415::Telomerase Inhibitor IX
HuCCT1::Cediranib
SNB75::Alisertib
WM1552C::Telomerase Inhibitor IX
SW982::ZM447439
HT-115::XAV939
LK-2::AGI-6780
RERF-GC-1B::Cediranib
U251::Avagacestat
D-263MG::ZM447439
RT4::Telomerase Inhibitor IX
RH-1::Sepantronium bromide
UMC-11::ZM447439
FU97::Cediranib
HuP-T3::AZD7762
HH::Afatinib
HCC1500::Sepantronium bromide
NCI-H345::Alisertib
HCC1419::Avagacestat
KYAE-1::ZM447439
PF-382::Avagacestat
LOUCY::MK-8776
HEC-1::Cediranib
LN-405::Alisertib
SU-DHL-6::Foretinib
NCI-N87::Foretinib
NCI-H2110::XAV939
Daoy::Telomerase Inhibitor IX
PANC-10-05::Foretinib
OVISE::Cediranib
NCI-H23::MK-8776
SNU-423::Cediranib
SNU-398::Cediranib
D-423MG::Telomerase Inhibitor IX
HT-115::Telomerase Inhibitor IX
K-562::Motesanib
SJSA-1::Cediranib
H3255::ZM447439
AN3-CA::Dabrafenib
SNG-M::Avagacestat
LB831-BLC::Alisertib
CAL-51::I-BRD9
KNS-42::MK-8776
HuCCT1::Avagacestat
CAKI-1::AZD7762
MHH-NB-11::VX-11e
RPMI-8402::Telomerase Inhibitor IX
ECC10::Dabrafenib
SU8686::AGI-6780
NB69::Sepantronium bromide
DND-41::Doramapimod
COLO-800::Cediranib
RT4::Doramapimod
C2BBe1::ZM447439
HSC-3::ZM447439
MSTO-211H::Foretinib
SNU-449::I-BRD9
KP-2::Dabrafenib
DK-MG::VX-11e
STS-0421::Telomerase Inhibitor IX
SK-N-FI::Osimertinib
ML-1::Doramapimod
NCI-H2030::Afatinib
RCM-1::Sepantronium bromide
451Lu::Telomerase Inhibitor IX
KYSE-270::AZD7762
GI-1::Afatinib
Ramos-2G6-4C10::VX-11e
JEG-3::XAV939
NY::Avagacestat
MFM-223::Sepantronium bromide
JHH-1::AZD7762
NCI-H2110::Motesanib
Ramos-2G6-4C10::Afatinib
DMS-114::Motesanib
MZ1-PC::Dabrafenib
RCM-1::Doramapimod
HA7-RCC::Cediranib
SLVL::Cediranib
A498::Dabrafenib
CHL-1::I-BRD9
KY821::AZD7762
MS-1::Dabrafenib
CTB-1::Dabrafenib
EMC-BAC-2::Osimertinib
NCI-H2172::Foretinib
LC-1-sq::Dabrafenib
Saos-2::AGI-6780
JHOS-3::XAV939
IST-MES1::VX-11e
HOS::Cediranib
KU812::Alisertib
KYSE-140::XAV939
A431::I-BRD9
NCI-H23::Sepantronium bromide
ES4::Afatinib
SW1710::Telomerase Inhibitor IX
RCH-ACV::AZD7762
COLO-792::Osimertinib
COLO-668::Telomerase Inhibitor IX
NB7::Avagacestat
IM-95::Afatinib
KLE::Telomerase Inhibitor IX
KP-3::AGI-6780
OCI-M1::Cediranib
KALS-1::Afatinib
LU-139::MK-8776
RVH-421::ZM447439
KY821::MK-8776
OV-17R::Dabrafenib
SCC-15::Sepantronium bromide
HT55::Osimertinib
UMC-11::Motesanib
NCI-H1703::VX-11e
LCLC-103H::AGI-6780
BONNA-12::I-BRD9
Calu-6::Dabrafenib
T47D::MK-8776
KOSC-2::Osimertinib
JHOS-3::Alisertib
IMR-5::Avagacestat
CAL-72::ZM447439
KMRC-20::Afatinib
RCH-ACV::Foretinib
RCC-MF::Afatinib
M059J::VX-11e
HuO-3N1::Sepantronium bromide
SNU-449::Alisertib
C-33-A::Osimertinib
LB2518-MEL::Alisertib
SNU-449::AGI-6780
BB49-HNC::Cediranib
EW-7::XAV939
C32::AGI-6780
VAL::Motesanib
MDA-MB-330::Alisertib
SKN::XAV939
IST-SL2::VX-11e
STS-0421::Avagacestat
no-10::Avagacestat
NCI-H82::ZM447439
RH-41::Doramapimod
SKN-3::Osimertinib
NCI-H2347::Foretinib
TC-YIK::Doramapimod
SKG-IIIa::ZM447439
MZ1-PC::MK-8776
IA-LM::Sepantronium bromide
CML-T1::Foretinib
KCL-22::XAV939
FU97::Motesanib
ES-2::I-BRD9
LAMA-84::Motesanib
HCC70::AGI-6780
OAW-42::Alisertib
NCI-H23::Telomerase Inhibitor IX
OVMIU::Afatinib
NCI-H838::AZD7762
SK-GT-4::MK-8776
TOV-112D::AGI-6780
ATN-1::Cediranib
GA-10::VX-11e
DMS-273::Foretinib
SF126::Telomerase Inhibitor IX
Saos-2::MK-8776
PANC-03-27::MK-8776
QGP-1::ZM447439
NCI-H345::Afatinib
COLO-680N::Foretinib
SK-MEL-5::Afatinib
KARPAS-231::Afatinib
NCI-H2170::VX-11e
EPLC-272H::Dabrafenib
KNS-81-FD::MK-8776
NCI-H841::MK-8776
D-336MG::Motesanib
HCC2998::Motesanib
SU-DHL-16::Doramapimod
NCI-H1155::AZD7762
A375::Motesanib
NAMALWA::ZM447439
Hs-578-T::VX-11e
BT-474::Dabrafenib
TT::AZD7762
DG-75::Afatinib
SJSA-1::I-BRD9
SHP-77::Dabrafenib
A388::AZD7762
RL95-2::Avagacestat
Saos-2::Dabrafenib
NCI-H1299::Sepantronium bromide
SK-MEL-3::Osimertinib
D-566MG::Sepantronium bromide
RPMI-8866::MK-8776
LU-134-A::AGI-6780
C-4-I::Motesanib
COLO-824::Osimertinib
VCaP::VX-11e
P32-ISH::Cediranib
NCI-H441::MK-8776
COR-L321::Doramapimod
HCC1954::Doramapimod
MV-4-11::Motesanib
MHH-CALL-2::Afatinib
D-392MG::ZM447439
OACp4C::I-BRD9
LN-18::Dabrafenib
MRK-nu-1::Doramapimod
LC-1-sq::Foretinib
Caov-4::Avagacestat
LXF-289::MK-8776
SNU-61::Alisertib
COR-L311::Afatinib
Calu-3::XAV939
OVKATE::AZD7762
OACp4C::VX-11e
A704::Afatinib
UACC-812::Dabrafenib
NCI-H1915::Afatinib
RERF-GC-1B::Telomerase Inhibitor IX
huH-1::VX-11e
NH-12::Osimertinib
HSC-2::Sepantronium bromide
NCI-H211::Avagacestat
MOG-G-CCM::Alisertib
KMRC-1::ZM447439
KE-37::Dabrafenib
HCC-366::Afatinib
SKG-IIIa::Cediranib
JHOS-3::Foretinib
MEL-HO::Doramapimod
IM-9::VX-11e
A172::AZD7762
TE-441-T::Alisertib
SNU-423::XAV939
PANC-08-13::XAV939
OCI-AML2::VX-11e
SUP-B15::Foretinib
G-MEL::Avagacestat
TE-4::Osimertinib
PCI-15A::XAV939
LOUCY::XAV939
HCC1428::Doramapimod
ETK-1::AGI-6780
451Lu::Motesanib
SK-LMS-1::Osimertinib
HSC-3::Cediranib
ME-1::Afatinib
NCI-H2085::Dabrafenib
C-4-I::Cediranib
451Lu::BX795
KYSE-50::Motesanib
CAL-62::Osimertinib
NCI-H2170::Avagacestat
PF-382::XAV939
RT4::AGI-6780
SKM-1::Doramapimod
LU-135::AZD7762
D-423MG::Motesanib
OVCAR-8::MK-8776
RL::Motesanib
MOLT-16::Doramapimod
DJM-1::Sepantronium bromide
NCI-H1869::Afatinib
NB17::AGI-6780
EW-24::Foretinib
MSTO-211H::AZD7762
YAPC::ZM447439
T84::AZD7762
SW780::VX-11e
MKN1::Motesanib
VMRC-LCD::AZD7762
SNU-61::AGI-6780
OCI-LY-19::Avagacestat
Caov-4::ZM447439
RL::BX795
NCI-H2030::Alisertib
AGS::Doramapimod
JJN-3::Sepantronium bromide
ES5::BX795
RT-112::Foretinib
OV-7::Dabrafenib
NCI-H2196::AZD7762
Mewo::AZD7762
TE-11::Afatinib
SJRH30::AGI-6780
HuO-3N1::Osimertinib
WM1552C::Sepantronium bromide
IHH-4::AZD7762
GCIY::AGI-6780
SW872::AZD7762
SUP-B15::VX-11e
HSC-4::Alisertib
SU8686::Motesanib
RPMI-6666::Motesanib
HDLM-2::ZM447439
JM1::Avagacestat
NCI-H650::Osimertinib
ST486::AZD7762
A172::Osimertinib
LOU-NH91::I-BRD9
YT::AZD7762
HCC1428::Alisertib
769-P::Cediranib
AN3-CA::Foretinib
SNU-C5::Telomerase Inhibitor IX
PCI-30::Afatinib
NH-12::MK-8776
MFE-280::AZD7762
SK-MEL-5::Dabrafenib
TYK-nu::Motesanib
NB5::Avagacestat
SK-PN-DW::Doramapimod
LU-135::ZM447439
JHOS-3::Avagacestat
8505C::Cediranib
T84::ZM447439
RPMI-6666::Alisertib
A549::Dabrafenib
SCC-15::Telomerase Inhibitor IX
639-V::MK-8776
huH-1::Alisertib
NCI-H1651::Cediranib
SW684::Sepantronium bromide
ES4::Doramapimod
COR-L105::Avagacestat
SW780::Cediranib
HCC1937::MK-8776
MIA-PaCa-2::AGI-6780
KP-1N::Telomerase Inhibitor IX
ESO26::Foretinib
SW1116::VX-11e
EPLC-272H::VX-11e
NCI-H2342::Sepantronium bromide
CCRF-CEM::Doramapimod
EKVX::Doramapimod
8505C::VX-11e
HARA::Afatinib
NCI-H322M::Cediranib
KY821::Sepantronium bromide
JAR::XAV939
SUP-HD1::Avagacestat
G-402::AZD7762
NCI-H520::Motesanib
SIMA::Osimertinib
UM-UC-3::Motesanib
Becker::Telomerase Inhibitor IX
L-540::MK-8776
NCI-H1793::Dabrafenib
CTB-1::Motesanib
COR-L95::VX-11e
MS751::Dabrafenib
RS4-11::ZM447439
U031::Osimertinib
NCI-H1105::Dabrafenib
SW13::VX-11e
OAW-28::Cediranib
TGBC24TKB::ZM447439
OCI-AML3::Foretinib
PCI-6A::Sepantronium bromide
BICR78::Dabrafenib
JHH-1::Osimertinib
SW620::ZM447439
OV-90::AZD7762
RCC-FG2::Motesanib
MDA-MB-436::Afatinib
JHOS-2::Dabrafenib
AN3-CA::AZD7762
SKN-3::Avagacestat
DK-MG::ZM447439
OVKATE::Telomerase Inhibitor IX
NCC010::Osimertinib
NB1::Avagacestat
PANC-08-13::AZD7762
DB::I-BRD9
SF268::Osimertinib
HCT-116::AZD7762
SW1116::MK-8776
COR-L32::AGI-6780
TUR::MK-8776
SK-OV-3::Doramapimod
A204::XAV939
IHH-4::Dabrafenib
KE-37::Sepantronium bromide
DOV13::Motesanib
Hs-445::Afatinib
DOV13::XAV939
Calu-6::Doramapimod
JVM-3::AGI-6780
HT-115::Alisertib
THP-1::VX-11e
COR-L311::Sepantronium bromide
SW1573::Foretinib
SW620::VX-11e
SKM-1::VX-11e
NCI-H1573::Avagacestat
NCI-H740::Cediranib
DB::Dabrafenib
HCC-78::Alisertib
NCI-H1563::I-BRD9
LU-135::Dabrafenib
COLO-205::MK-8776
BxPC-3::AZD7762
IST-MEL1::Motesanib
MC116::Foretinib
HCE-4::VX-11e
KON::Dabrafenib
GAK::AGI-6780
HCT-116::Foretinib
A2058::Sepantronium bromide
NCI-H2170::MK-8776
NCI-H64::I-BRD9
UACC-812::Foretinib
RERF-LC-KJ::Alisertib
KP-N-YN::MK-8776
K-562::AGI-6780
OCUM-1::Cediranib
OCUM-1::ZM447439
CCK-81::Avagacestat
ECC10::Sepantronium bromide
HCC1599::Doramapimod
ML-2::XAV939
EFM-192A::Afatinib
HCC1143::Avagacestat
WM278::VX-11e
MLMA::Foretinib
AU565::Avagacestat
Calu-3::Motesanib
CaR-1::XAV939
NB10::Osimertinib
OE21::VX-11e
HCC38::Sepantronium bromide
DU-4475::Telomerase Inhibitor IX
NCI-H2087::XAV939
NCI-H1944::Motesanib
LoVo::I-BRD9
OV-17R::ZM447439
KP-1N::Cediranib
HOS::Sepantronium bromide
CTV-1::AZD7762
RL::Avagacestat
JVM-2::Sepantronium bromide
OACp4C::Alisertib
LK-2::Foretinib
UM-UC-3::Foretinib
NCI-H727::Telomerase Inhibitor IX
QIMR-WIL::Osimertinib
CHSA8926::Doramapimod
OVK-18::Alisertib
KASUMI-1::I-BRD9
LN-229::Sepantronium bromide
SU-DHL-5::ZM447439
JHU-022::Doramapimod
MOG-G-CCM::AZD7762
SU-DHL-4::Alisertib
HCC2157::MK-8776
HA7-RCC::AZD7762
EW-24::Telomerase Inhibitor IX
AU565::ZM447439
LB2241-RCC::Osimertinib
LXF-289::ZM447439
Calu-3::Cediranib
OV-56::AZD7762
C-33-A::Afatinib
UACC-62::Doramapimod
EVSA-T::ZM447439
KMRC-1::Cediranib
D-336MG::Telomerase Inhibitor IX
MOLT-16::Osimertinib
QIMR-WIL::Foretinib
CAL-72::Cediranib
IM-9::Alisertib
SK-MEL-28::Alisertib
5637::Foretinib
EW-24::VX-11e
SW1417::Osimertinib
Mo-T::XAV939
BV-173::Foretinib
MHH-CALL-2::Telomerase Inhibitor IX
SK-MEL-30::Avagacestat
HCC1419::Foretinib
LB996-RCC::AGI-6780
KM-H2::XAV939
SLVL::AZD7762
NCI-H23::Alisertib
NCI-H2030::BX795
MOLT-4::Osimertinib
ES6::Avagacestat
OVCAR-5::Alisertib
OV-7::AZD7762
JEG-3::Avagacestat
Farage::ZM447439
HARA::Foretinib
BONNA-12::Doramapimod
NCI-H727::ZM447439
NCI-H1792::Telomerase Inhibitor IX
LS-411N::Afatinib
EC-GI-10::Dabrafenib
HMV-II::VX-11e
BC-1::AGI-6780
NCC021::Afatinib
MN-60::Osimertinib
NCI-H748::Doramapimod
MPP-89::Avagacestat
KYSE-450::Cediranib
PL4::Alisertib
ECC12::Telomerase Inhibitor IX
COR-L105::VX-11e
Hey::Telomerase Inhibitor IX
NUGC-3::Alisertib
Farage::XAV939
LU-139::XAV939
COLO-792::Afatinib
EW-13::I-BRD9
SUP-M2::Cediranib
LU-134-A::Foretinib
OAW-42::Osimertinib
CAL-78::Osimertinib
ACHN::ZM447439
DMS-53::MK-8776
HCC-827::ZM447439
5637::Motesanib
HCC1143::XAV939
RCC-MF::VX-11e
IGR-1::XAV939
LB373-MEL-D::Sepantronium bromide
COR-L321::Cediranib
Saos-2::Sepantronium bromide
HeLa::AZD7762
KARPAS-620::XAV939
SK-N-SH::Cediranib
TUR::Osimertinib
SBC-1::ZM447439
BALL-1::AGI-6780
IST-SL1::XAV939
MDA-MB-361::Telomerase Inhibitor IX
SK-MES-1::Osimertinib
NCI-H838::Foretinib
OCI-LY-19::Dabrafenib
ES6::AZD7762
LS-1034::XAV939
Detroit562::Alisertib
L-540::I-BRD9
FLO-1::AZD7762
IST-MES1::AZD7762
WSU-DLCL2::I-BRD9
SW1116::AZD7762
KOSC-2::AGI-6780
RCC-FG2::Avagacestat
MFE-319::AGI-6780
GA-10::ZM447439
NCI-H1105::VX-11e
SW954::Sepantronium bromide
SNB75::Cediranib
HO-1-u-1::Foretinib
HCC1569::Doramapimod
KGN::MK-8776
OPM-2::ZM447439
SF126::AGI-6780
YT::Dabrafenib
HSC-39::I-BRD9
LB771-HNC::AZD7762
OACM5-1::AZD7762
MFH-ino::Dabrafenib
LN-18::Telomerase Inhibitor IX
NCI-H1092::Foretinib
NCI-H2405::ZM447439
ML-2::VX-11e
SAT::Motesanib
GDM-1::ZM447439
TE-4::VX-11e
NCI-H1651::MK-8776
SW48::Telomerase Inhibitor IX
COR-L311::ZM447439
DAN-G::AGI-6780
SU-DHL-8::Avagacestat
EJM::I-BRD9
BE-13::Sepantronium bromide
TE-12::Dabrafenib
SNU-81::Afatinib
THP-1::I-BRD9
SCC-4::Doramapimod
JIMT-1::AZD7762
NCI-H2066::Avagacestat
SKN-3::Sepantronium bromide
AsPC-1::I-BRD9
EW-24::Afatinib
CHSA8926::XAV939
NCI-H322M::Foretinib
SW48::Alisertib
NCI-H747::I-BRD9
LP-1::Doramapimod
COR-L95::Motesanib
UACC-62::MK-8776
NKM-1::Telomerase Inhibitor IX
KP-4::I-BRD9
NCI-H1688::VX-11e
DAN-G::Doramapimod
SK-GT-2::Avagacestat
COR-L32::AZD7762
TOV-112D::Sepantronium bromide
SUP-T1::AZD7762
Becker::Motesanib
CHP-126::ZM447439
LoVo::Motesanib
U-266::Cediranib
CHSA0011::Telomerase Inhibitor IX
NCI-H69::Foretinib
BxPC-3::Dabrafenib
TOV-21G::Foretinib
PANC-08-13::Afatinib
LCLC-97TM1::AZD7762
HSC-39::Motesanib
EC-GI-10::VX-11e
MIA-PaCa-2::Dabrafenib
PANC-10-05::AGI-6780
GDM-1::Avagacestat
AGS::Sepantronium bromide
SW684::Dabrafenib
SH-4::Sepantronium bromide
Saos-2::VX-11e
MLMA::MK-8776
KARPAS-620::AGI-6780
L-363::Osimertinib
C32::Doramapimod
LS-123::Telomerase Inhibitor IX
NCI-H1915::AZD7762
TGW::ZM447439
JHH-2::VX-11e
NCI-H2141::Foretinib
NCI-H2009::I-BRD9
Ca-Ski::Dabrafenib
NCI-H510A::BX795
NCI-H1975::I-BRD9
T-T::Foretinib
CAS-1::Foretinib
LU-139::Dabrafenib
HCC-78::ZM447439
NCI-H810::Afatinib
NCI-H226::AGI-6780
T-T::Cediranib
T-T::Telomerase Inhibitor IX
TE-1::Dabrafenib
L-540::Osimertinib
SBC-1::Alisertib
SKN-3::Afatinib
MN-60::ZM447439
M059J::XAV939
HL-60::Foretinib
KG-1::Afatinib
HDQ-P1::Motesanib
EW-12::AZD7762
D-566MG::MK-8776
D-283MED::Avagacestat
UACC-62::AGI-6780
KU-19-19::Avagacestat
KU-19-19::AGI-6780
NCI-H2122::Motesanib
JHH-4::Motesanib
NB14::Alisertib
SW1990::Telomerase Inhibitor IX
TGBC11TKB::Avagacestat
MDA-MB-453::Cediranib
YT::Sepantronium bromide
BxPC-3::Cediranib
NCI-H1048::Alisertib
EBC-1::Afatinib
UACC-62::ZM447439
KURAMOCHI::VX-11e
SK-N-SH::I-BRD9
CHSA8926::Alisertib
EVSA-T::Dabrafenib
UACC-812::Cediranib
G-MEL::XAV939
SK-UT-1::Alisertib
OVCA420::VX-11e
MDA-MB-330::Osimertinib
PC-3::Osimertinib
UMC-11::Osimertinib
SiHa::AGI-6780
ONS-76::Motesanib
huH-1::AGI-6780
NCI-H146::Dabrafenib
EBC-1::Doramapimod
BFTC-909::Alisertib
CP50-MEL-B::AZD7762
KS-1::AGI-6780
RPMI-8402::Doramapimod
KARPAS-299::Dabrafenib
SCH::Cediranib
NCI-H64::Sepantronium bromide
CESS::Sepantronium bromide
SNB75::Avagacestat
PA-TU-8988T::AZD7762
NCI-H2087::Osimertinib
CHSA0108::Foretinib
NB17::ZM447439
SW948::Doramapimod
OV-17R::AZD7762
CAPAN-1::Cediranib
KM12::Osimertinib
EFO-27::Dabrafenib
SUP-T1::Sepantronium bromide
TOV-112D::Alisertib
MRK-nu-1::ZM447439
TGBC24TKB::Cediranib
MOLM-16::XAV939
NCI-H1048::Avagacestat
BB49-HNC::Afatinib
OAW-28::XAV939
CHL-1::AGI-6780
LB2241-RCC::Doramapimod
COLO-678::AZD7762
RXF393::Osimertinib
COLO-684::VX-11e
697::Cediranib
BB30-HNC::Motesanib
NCI-H2347::Afatinib
SK-MES-1::Foretinib
AGS::VX-11e
WM-115::Telomerase Inhibitor IX
TE-4::Foretinib
HCC-15::Dabrafenib
KCL-22::Doramapimod
NCI-H2066::Foretinib
A704::VX-11e
ROS-50::VX-11e
TK::Afatinib
MFM-223::ZM447439
OS-RC-2::Afatinib
CAL-33::Cediranib
NCI-H211::Sepantronium bromide
TOV-112D::I-BRD9
NCI-H2291::Cediranib
OV-90::Cediranib
TE-1::Motesanib
HCC1954::ZM447439
RL::VX-11e
SW620::Motesanib
LoVo::Afatinib
EW-16::Avagacestat
TE-4::I-BRD9
8505C::Dabrafenib
NH-12::ZM447439
KGN::Cediranib
RF-48::Osimertinib
OVTOKO::AZD7762
MDA-MB-361::Alisertib
NCI-H146::Doramapimod
KM-H2::Osimertinib
RVH-421::Sepantronium bromide
SUP-M2::AZD7762
PC-3::Avagacestat
NCI-H847::Cediranib
CHL-1::ZM447439
SCC-25::BX795
NCI-H2029::I-BRD9
ES5::VX-11e
H4::MK-8776
HLE::Osimertinib
KELLY::Sepantronium bromide
KYSE-180::XAV939
SW872::Sepantronium bromide
NCI-H2009::Foretinib
TT2609-C02::MK-8776
UM-UC-3::VX-11e
SAT::Doramapimod
OV-17R::Osimertinib
K5::Osimertinib
RH-41::Dabrafenib
CTB-1::Alisertib
T84::VX-11e
SK-MEL-30::Dabrafenib
NU-DUL-1::Doramapimod
K-562::VX-11e
DND-41::XAV939
NCI-H1975::Sepantronium bromide
KOSC-2::ZM447439
SNU-61::AZD7762
SU-DHL-1::MK-8776
SU-DHL-10::Osimertinib
HT-1197::Avagacestat
NCI-H1648::Osimertinib
WM793B::Dabrafenib
HuH-7::Avagacestat
P31-FUJ::Alisertib
HCC1569::Telomerase Inhibitor IX
NCI-H716::Osimertinib
EM-2::Sepantronium bromide
Hs-578-T::Dabrafenib
NCC010::VX-11e
NCI-H1694::XAV939
COR-L88::Foretinib
NCI-H661::Telomerase Inhibitor IX
CAMA-1::Motesanib
SW780::Dabrafenib
HCC2157::XAV939
KYSE-180::Alisertib
NCI-H1755::Avagacestat
TC-YIK::VX-11e
NCI-H1915::Alisertib
AN3-CA::Alisertib
MOLM-13::I-BRD9
PANC-04-03::Doramapimod
KMS-11::Doramapimod
COLO-824::XAV939
LN-229::Doramapimod
SNU-175::Doramapimod
JHU-011::AZD7762
Daoy::Dabrafenib
NCI-H647::BX795
NCI-H748::I-BRD9
D-283MED::VX-11e
CAL-120::XAV939
RH-41::I-BRD9
MOLT-13::Avagacestat
GDM-1::MK-8776
COLO-320-HSR::I-BRD9
JHH-4::I-BRD9
PC-14::Sepantronium bromide
C-4-I::AGI-6780
TGW::Afatinib
HL-60::Dabrafenib
LOUCY::Alisertib
OACM5-1::Avagacestat
BE2-M17::Dabrafenib
PA-1::VX-11e
NCI-H1688::ZM447439
BFTC-905::Foretinib
Saos-2::Cediranib
SK-CO-1::Sepantronium bromide
NCI-H1694::Telomerase Inhibitor IX
NCI-H1781::XAV939
P32-ISH::Sepantronium bromide
Hey::Sepantronium bromide
NCI-H2029::Telomerase Inhibitor IX
SNU-398::Sepantronium bromide
HCC1187::AZD7762
A673::Telomerase Inhibitor IX
A704::Osimertinib
NCI-H345::Foretinib
KON::Avagacestat
MOLT-13::Telomerase Inhibitor IX
BICR31::VX-11e
769-P::I-BRD9
THP-1::ZM447439
MKN45::Doramapimod
EW-22::Afatinib
NCI-H835::ZM447439
ARH-77::Telomerase Inhibitor IX
TGBC1TKB::Doramapimod
A101D::XAV939
PFSK-1::AGI-6780
SIG-M5::Avagacestat
RCC-FG2::I-BRD9
WM-115::Cediranib
SF539::Sepantronium bromide
EKVX::ZM447439
CAL-29::Motesanib
SUP-T1::Cediranib
J82::AGI-6780
PCI-4B::XAV939
CP50-MEL-B::ZM447439
DMS-53::Alisertib
KON::Sepantronium bromide
COLO-824::Avagacestat
DJM-1::Telomerase Inhibitor IX
CAS-1::Sepantronium bromide
PANC-02-03::VX-11e
KYSE-450::Afatinib
MFH-ino::I-BRD9
SNU-C2B::VX-11e
Ca9-22::Doramapimod
NCI-H1869::Foretinib
SKN::ZM447439
KARPAS-231::I-BRD9
HT55::Dabrafenib
JHH-7::VX-11e
CL-11::I-BRD9
NCI-H1648::Doramapimod
BB65-RCC::VX-11e
CRO-AP2::Avagacestat
MLMA::AGI-6780
KARPAS-45::Osimertinib
WIL2-NS::Dabrafenib
M14::Sepantronium bromide
SW1271::Osimertinib
BONNA-12::Avagacestat
NCI-H1770::Sepantronium bromide
GB-1::AZD7762
KALS-1::Osimertinib
NCI-H1688::Dabrafenib
A375::I-BRD9
CCK-81::MK-8776
CESS::XAV939
TCCSUP::AGI-6780
JJN-3::AGI-6780
NCI-H2052::Sepantronium bromide
COLO-678::Alisertib
ML-2::Dabrafenib
SNU-449::Sepantronium bromide
RXF393::MK-8776
GR-ST::ZM447439
KP-N-YN::Telomerase Inhibitor IX
BALL-1::Alisertib
SUP-B15::AGI-6780
HCC-366::Doramapimod
SW626::AGI-6780
ES1::Telomerase Inhibitor IX
SW156::Telomerase Inhibitor IX
OE19::Cediranib
647-V::AGI-6780
EB2::Avagacestat
Detroit562::Telomerase Inhibitor IX
SK-N-DZ::VX-11e
NCI-H2122::ZM447439
A172::XAV939
SN12C::Telomerase Inhibitor IX
SiHa::Doramapimod
NCI-H522::ZM447439
MSTO-211H::Sepantronium bromide
SU-DHL-8::Sepantronium bromide
OVCAR-3::XAV939
NCI-H1650::Doramapimod
HCC1500::XAV939
NH-12::I-BRD9
HPAF-II::Osimertinib
HOP-62::Sepantronium bromide
SCC-9::Alisertib
BT-483::Sepantronium bromide
8305C::I-BRD9
LC-2-ad::Afatinib
KINGS-1::VX-11e
NCI-H661::ZM447439
EFM-192A::ZM447439
C-33-A::XAV939
NCI-H1623::Motesanib
NCI-H2029::XAV939
GOTO::ZM447439
JEKO-1::Osimertinib
QIMR-WIL::MK-8776
JHH-2::Dabrafenib
TOV-21G::ZM447439
BICR78::Avagacestat
GB-1::Dabrafenib
JM1::Doramapimod
NCI-H1563::VX-11e
SU-DHL-4::Dabrafenib
KU812::Afatinib
NCI-H1155::XAV939
NCI-H520::VX-11e
HCC1143::Motesanib
HCC1599::ZM447439
CP66-MEL::VX-11e
MHH-PREB-1::Afatinib
NU-DUL-1::Foretinib
KNS-42::Afatinib
KARPAS-1106P::Avagacestat
8-MG-BA::Sepantronium bromide
NCI-H2030::Doramapimod
BE-13::Avagacestat
SW620::MK-8776
M059J::Alisertib
EW-11::Osimertinib
KYSE-180::AZD7762
KMS-11::Sepantronium bromide
HuP-T4::Alisertib
MS751::AGI-6780
CP50-MEL-B::MK-8776
MDA-MB-436::AGI-6780
NB13::Alisertib
RPMI-8226::Afatinib
PWR-1E::I-BRD9
SK-MEL-5::Doramapimod
BB65-RCC::Afatinib
OPM-2::AZD7762
BL-41::Doramapimod
NCI-H1688::Alisertib
OVCAR-8::AGI-6780
KMOE-2::Avagacestat
LB373-MEL-D::Dabrafenib
D-263MG::AGI-6780
FTC-133::AZD7762
NCI-H835::Avagacestat
EW-7::I-BRD9
HT55::Cediranib
Ca-Ski::I-BRD9
